hgnc_symbol,hgnc_id,go_name,go_id,go_domain,ncon_gene,ncon_go,mean_padj,cilow_padj,ciupp_padj,mean_pval,cilow_pval,ciupp_pval,mean_sim,sem_sim
ABCB4,45,lipid homeostasis,GO:0055088,biological process,19.0,10.0,2.819e-01,1.452e-01,5.474e-01,1.140e-01,5.667e-02,2.294e-01,6.500e-01,2.530e-02
ABCB4,45,positive regulation of phospholipid transport,GO:2001140,biological process,19.0,6.0,2.819e-01,1.452e-01,5.474e-01,1.338e-01,5.032e-02,3.557e-01,6.226e-01,3.869e-02
ABCB4,45,positive regulation of phospholipid translocation,GO:0061092,biological process,19.0,6.0,2.819e-01,1.452e-01,5.474e-01,1.501e-01,5.384e-02,4.185e-01,6.031e-01,3.918e-02
ABCB4,45,positive regulation of cholesterol transport,GO:0032376,biological process,19.0,8.0,2.819e-01,1.452e-01,5.474e-01,1.756e-01,6.204e-02,4.972e-01,5.757e-01,4.237e-02
ABCB4,45,phospholipid translocation,GO:0045332,biological process,19.0,6.0,4.190e-01,1.662e-01,1.056e+00,4.063e-01,1.453e-01,1.137e+00,3.869e-01,6.193e-02
ABCB4,45,cellular response to bile acid,GO:1903413,biological process,19.0,6.0,4.293e-01,2.094e-01,8.799e-01,4.184e-01,2.128e-01,8.226e-01,3.875e-01,4.220e-02
ABCB4,45,extracellular exosome,GO:0070062,cellular component,19.0,39.0,2.819e-01,1.452e-01,5.474e-01,1.279e-01,7.127e-02,2.294e-01,6.333e-01,2.266e-02
ABCB4,45,apical plasma membrane,GO:0016324,cellular component,19.0,4.0,2.819e-01,1.452e-01,5.474e-01,1.315e-01,3.105e-02,5.567e-01,6.201e-01,5.171e-02
ABCB4,45,plasma membrane,GO:0005886,cellular component,19.0,67.0,2.819e-01,1.452e-01,5.474e-01,1.356e-01,4.946e-02,3.717e-01,6.201e-01,4.051e-02
ABCB4,45,integral component of membrane,GO:0016021,cellular component,19.0,19.0,2.819e-01,1.452e-01,5.474e-01,1.452e-01,5.095e-02,4.137e-01,6.084e-01,4.359e-02
ABCB4,45,actin cytoskeleton,GO:0015629,cellular component,19.0,6.0,2.819e-01,1.452e-01,5.474e-01,1.534e-01,9.925e-02,2.371e-01,6.042e-01,1.803e-02
ABCB4,45,focal adhesion,GO:0005925,cellular component,19.0,7.0,2.819e-01,1.452e-01,5.474e-01,1.575e-01,7.003e-02,3.541e-01,5.971e-01,3.342e-02
ABCB4,45,cytoplasm,GO:0005737,cellular component,19.0,72.0,2.942e-01,1.325e-01,6.531e-01,2.126e-01,9.959e-02,4.539e-01,5.426e-01,3.639e-02
ABCB4,45,cytosol,GO:0005829,cellular component,19.0,50.0,2.952e-01,1.316e-01,6.623e-01,2.207e-01,9.355e-02,5.209e-01,5.340e-01,4.190e-02
ABCB4,45,nucleoplasm,GO:0005654,cellular component,19.0,47.0,3.164e-01,1.632e-01,6.135e-01,2.809e-01,1.627e-01,4.847e-01,4.876e-01,2.948e-02
ABCB4,45,ATPase-coupled transmembrane transporter activity,GO:0042626,molecular function,19.0,29.0,2.819e-01,1.452e-01,5.474e-01,1.139e-01,4.075e-02,3.183e-01,6.472e-01,3.860e-02
ABCB4,45,phosphatidylcholine floppase activity,GO:0090554,molecular function,19.0,3.0,2.819e-01,1.452e-01,5.474e-01,2.028e-01,1.025e-01,4.013e-01,5.526e-01,2.991e-02
ABCB4,45,protein binding,GO:0005515,molecular function,19.0,318.0,3.044e-01,1.342e-01,6.905e-01,2.507e-01,9.948e-02,6.320e-01,5.065e-01,4.899e-02
ABLIM3,29132,,,,nan,nan,,,,,,,,
ACHE,108,cell adhesion,GO:0007155,biological process,24.0,14.0,1.036e-01,4.508e-02,2.379e-01,3.290e-02,9.963e-03,1.086e-01,8.044e-01,3.050e-02
ACHE,108,osteoblast development,GO:0002076,biological process,24.0,2.0,1.310e-01,4.475e-02,3.837e-01,6.155e-02,1.624e-02,2.332e-01,7.311e-01,3.837e-02
ACHE,108,acetylcholine catabolic process,GO:0006581,biological process,24.0,7.0,1.634e-01,1.247e-01,2.142e-01,1.059e-01,3.866e-02,2.903e-01,6.587e-01,3.493e-02
ACHE,108,extracellular region,GO:0005576,cellular component,24.0,16.0,1.531e-01,8.652e-02,2.711e-01,9.758e-02,4.144e-02,2.298e-01,6.718e-01,2.813e-02
ACHE,108,synapse,GO:0045202,cellular component,24.0,20.0,1.531e-01,8.652e-02,2.711e-01,9.791e-02,3.520e-02,2.724e-01,6.702e-01,3.327e-02
ACHE,108,extracellular space,GO:0005615,cellular component,24.0,24.0,1.576e-01,9.699e-02,2.559e-01,1.222e-01,6.223e-02,2.401e-01,6.397e-01,2.568e-02
ACHE,108,Golgi apparatus,GO:0005794,cellular component,24.0,16.0,1.576e-01,9.699e-02,2.559e-01,1.249e-01,5.932e-02,2.631e-01,6.356e-01,2.832e-02
ACHE,108,membrane,GO:0016020,cellular component,24.0,41.0,1.576e-01,9.699e-02,2.559e-01,1.250e-01,5.202e-02,3.003e-01,6.344e-01,3.262e-02
ACHE,108,perinuclear region of cytoplasm,GO:0048471,cellular component,24.0,8.0,1.657e-01,9.898e-02,2.775e-01,1.337e-01,6.453e-02,2.769e-01,6.250e-01,2.704e-02
ACHE,108,laminin binding,GO:0043236,molecular function,24.0,5.0,8.700e-02,4.733e-02,1.599e-01,9.524e-03,4.007e-03,2.264e-02,9.140e-01,1.181e-02
ACHE,108,cholinesterase activity,GO:0004104,molecular function,24.0,3.0,8.734e-02,4.703e-02,1.622e-01,9.860e-03,6.807e-03,1.428e-02,9.146e-01,5.272e-03
ACHE,108,acetylcholinesterase activity,GO:0003990,molecular function,24.0,2.0,8.799e-02,4.644e-02,1.667e-01,1.375e-02,3.891e-03,4.856e-02,8.850e-01,2.340e-02
ACHE,108,acetylcholine binding,GO:0042166,molecular function,24.0,5.0,9.904e-02,4.749e-02,2.066e-01,2.485e-02,1.164e-02,5.304e-02,8.355e-01,1.831e-02
ACHE,108,collagen binding,GO:0005518,molecular function,24.0,5.0,1.022e-01,5.449e-02,1.917e-01,3.143e-02,2.676e-02,3.691e-02,8.118e-01,4.271e-03
ACHE,108,serine hydrolase activity,GO:0017171,molecular function,24.0,3.0,1.175e-01,4.944e-02,2.792e-01,4.223e-02,1.461e-02,1.221e-01,7.774e-01,2.838e-02
ACHE,108,protein homodimerization activity,GO:0042803,molecular function,24.0,23.0,1.599e-01,1.026e-01,2.490e-01,1.194e-01,7.343e-02,1.941e-01,6.443e-01,1.850e-02
ACHE,108,hydrolase activity,GO:0016787,molecular function,24.0,25.0,1.823e-01,1.417e-01,2.344e-01,1.461e-01,9.404e-02,2.271e-01,6.124e-01,1.720e-02
ACHE,108,protein binding,GO:0005515,molecular function,24.0,318.0,1.949e-01,1.629e-01,2.332e-01,1.779e-01,1.417e-01,2.233e-01,5.792e-01,9.689e-03
ACHE,108,carboxylic ester hydrolase activity,GO:0052689,molecular function,24.0,115.0,3.077e-01,1.564e-01,6.052e-01,3.077e-01,1.564e-01,6.052e-01,4.653e-01,3.807e-02
ACOT4,19748,short-chain fatty acid metabolic process,GO:0046459,biological process,14.0,9.0,2.001e-02,1.450e-02,2.760e-02,6.437e-03,1.449e-03,2.860e-02,9.290e-01,1.760e-02
ACOT4,19748,saturated monocarboxylic acid metabolic process,GO:0032788,biological process,14.0,2.0,2.020e-02,1.418e-02,2.877e-02,7.821e-03,4.601e-03,1.329e-02,9.265e-01,5.861e-03
ACOT4,19748,unsaturated monocarboxylic acid metabolic process,GO:0032789,biological process,14.0,2.0,2.020e-02,1.418e-02,2.877e-02,8.357e-03,4.625e-03,1.510e-02,9.229e-01,6.814e-03
ACOT4,19748,dicarboxylic acid catabolic process,GO:0043649,biological process,14.0,17.0,2.020e-02,1.418e-02,2.877e-02,7.121e-03,7.732e-04,6.559e-02,9.180e-01,2.289e-02
ACOT4,19748,dicarboxylic acid metabolic process,GO:0043648,biological process,14.0,27.0,2.160e-02,1.207e-02,3.864e-02,9.396e-03,1.444e-03,6.115e-02,9.032e-01,2.956e-02
ACOT4,19748,succinyl-CoA metabolic process,GO:0006104,biological process,14.0,7.0,2.160e-02,1.207e-02,3.864e-02,1.215e-02,3.796e-03,3.886e-02,8.951e-01,2.245e-02
ACOT4,19748,very long-chain fatty acid metabolic process,GO:0000038,biological process,14.0,4.0,2.241e-02,1.574e-02,3.191e-02,1.112e-02,3.013e-03,4.106e-02,9.003e-01,1.900e-02
ACOT4,19748,long-chain fatty acid metabolic process,GO:0001676,biological process,14.0,14.0,2.252e-02,1.608e-02,3.155e-02,1.152e-02,3.361e-03,3.951e-02,8.981e-01,1.773e-02
ACOT4,19748,fatty acid metabolic process,GO:0006631,biological process,14.0,18.0,2.475e-02,2.255e-02,2.717e-02,1.952e-02,1.006e-02,3.785e-02,8.597e-01,1.484e-02
ACOT4,19748,acyl-CoA metabolic process,GO:0006637,biological process,14.0,15.0,2.730e-02,1.170e-02,6.370e-02,2.158e-02,6.012e-03,7.746e-02,8.463e-01,2.921e-02
ACOT4,19748,peroxisome,GO:0005777,cellular component,14.0,12.0,3.919e-02,1.045e-02,1.469e-01,3.706e-02,8.202e-03,1.674e-01,7.899e-01,3.872e-02
ACOT4,19748,succinyl-CoA hydrolase activity,GO:0004778,molecular function,14.0,2.0,2.262e-02,1.569e-02,3.263e-02,1.505e-02,1.282e-02,1.768e-02,8.851e-01,3.547e-03
ACOT4,19748,acyl-CoA hydrolase activity,GO:0047617,molecular function,14.0,7.0,2.262e-02,1.569e-02,3.263e-02,1.712e-02,1.343e-02,2.181e-02,8.734e-01,5.408e-03
ACR,126,,,,nan,nan,,,,,,,,
ACRBP,17195,,,,nan,nan,,,,,,,,
ADAM15,193,innate immune response,GO:0045087,biological process,18.0,24.0,3.548e-01,1.695e-01,7.426e-01,1.260e-01,2.332e-02,6.813e-01,6.208e-01,7.086e-02
ADAM15,193,negative regulation of cell-matrix adhesion,GO:0001953,biological process,18.0,6.0,3.548e-01,1.695e-01,7.426e-01,1.586e-01,4.002e-02,6.287e-01,5.881e-01,5.899e-02
ADAM15,193,integrin-mediated signaling pathway,GO:0007229,biological process,18.0,5.0,3.548e-01,1.695e-01,7.426e-01,2.137e-01,1.241e-01,3.678e-01,5.438e-01,2.587e-02
ADAM15,193,negative regulation of receptor binding,GO:1900121,biological process,18.0,10.0,3.548e-01,1.695e-01,7.426e-01,2.289e-01,8.954e-02,5.852e-01,5.253e-01,4.726e-02
ADAM15,193,immune response to tumor cell,GO:0002418,biological process,18.0,6.0,3.799e-01,1.588e-01,9.087e-01,2.846e-01,8.984e-02,9.014e-01,4.732e-01,6.576e-02
ADAM15,193,negative regulation of cell migration,GO:0030336,biological process,18.0,29.0,3.911e-01,1.409e-01,1.086e+00,3.147e-01,8.960e-02,1.105e+00,4.424e-01,8.146e-02
ADAM15,193,negative regulation of cell growth,GO:0030308,biological process,18.0,18.0,4.599e-01,3.185e-01,6.641e-01,3.753e-01,2.773e-01,5.079e-01,4.219e-01,1.859e-02
ADAM15,193,cellular response to phorbol 13-acetate 12-myristate,GO:1904628,biological process,18.0,6.0,7.398e-01,4.000e-01,1.369e+00,7.398e-01,4.000e-01,1.369e+00,1.590e-01,7.361e-02
ADAM15,193,cell surface,GO:0009986,cellular component,18.0,20.0,3.548e-01,1.695e-01,7.426e-01,1.109e-01,5.434e-02,2.262e-01,6.541e-01,2.654e-02
ADAM15,193,extracellular exosome,GO:0070062,cellular component,18.0,39.0,3.548e-01,1.695e-01,7.426e-01,1.392e-01,8.575e-02,2.260e-01,6.201e-01,1.903e-02
ADAM15,193,integrin binding,GO:0005178,molecular function,18.0,11.0,3.548e-01,1.695e-01,7.426e-01,8.953e-02,3.500e-02,2.290e-01,6.829e-01,3.231e-02
ADAM15,193,SH3 domain binding,GO:0017124,molecular function,18.0,6.0,3.548e-01,1.695e-01,7.426e-01,1.414e-01,7.188e-02,2.783e-01,6.162e-01,2.650e-02
ADAM15,193,protein binding,GO:0005515,molecular function,18.0,318.0,3.548e-01,1.695e-01,7.426e-01,2.230e-01,1.374e-01,3.620e-01,5.357e-01,2.317e-02
ADAM15,193,metallopeptidase activity,GO:0008237,molecular function,18.0,4.0,4.016e-01,2.094e-01,7.702e-01,3.435e-01,1.882e-01,6.269e-01,4.409e-01,3.344e-02
ADAMTS7,223,cellular response to tumor necrosis factor,GO:0071356,biological process,8.0,4.0,4.042e-01,2.642e-01,6.183e-01,2.468e-01,7.859e-02,7.753e-01,5.078e-01,5.384e-02
ADAMTS7,223,proteolysis involved in cellular protein catabolic process,GO:0051603,biological process,8.0,12.0,4.042e-01,2.642e-01,6.183e-01,2.751e-01,1.783e-01,4.244e-01,4.932e-01,2.272e-02
ADAMTS7,223,negative regulation of chondrocyte differentiation,GO:0032331,biological process,8.0,5.0,4.206e-01,3.116e-01,5.677e-01,2.840e-01,1.864e-01,4.328e-01,4.864e-01,2.238e-02
ADAMTS7,223,cellular response to interleukin-1,GO:0071347,biological process,8.0,4.0,4.256e-01,2.604e-01,6.955e-01,3.627e-01,1.552e-01,8.478e-01,4.228e-01,4.805e-02
ADAMTS7,223,cellular response to BMP stimulus,GO:0071773,biological process,8.0,4.0,4.428e-01,3.101e-01,6.324e-01,4.130e-01,2.762e-01,6.175e-01,3.956e-01,2.583e-02
ADAMTS7,223,metalloendopeptidase activity,GO:0004222,molecular function,8.0,4.0,4.042e-01,2.642e-01,6.183e-01,1.196e-01,5.401e-02,2.646e-01,6.421e-01,2.844e-02
ADAMTS7,223,protein binding,GO:0005515,molecular function,8.0,318.0,4.042e-01,2.642e-01,6.183e-01,1.808e-01,9.793e-02,3.338e-01,5.744e-01,2.685e-02
ADCY3,234,adenylate cyclase-activating G protein-coupled receptor signaling pathway,GO:0007189,biological process,9.0,15.0,1.423e-01,8.002e-02,2.530e-01,5.060e-02,3.362e-02,7.614e-02,7.580e-01,1.151e-02
ADCY3,234,cAMP biosynthetic process,GO:0006171,biological process,9.0,4.0,1.423e-01,8.002e-02,2.530e-01,7.065e-02,1.724e-02,2.896e-01,7.124e-01,4.229e-02
ADCY3,234,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,GO:0007193,biological process,9.0,9.0,1.641e-01,1.470e-01,1.833e-01,9.456e-02,4.853e-02,1.842e-01,6.777e-01,2.234e-02
ADCY3,234,integral component of plasma membrane,GO:0005887,cellular component,9.0,39.0,1.423e-01,8.002e-02,2.530e-01,3.732e-02,1.225e-02,1.137e-01,7.910e-01,3.036e-02
ADCY3,234,plasma membrane,GO:0005886,cellular component,9.0,67.0,1.423e-01,8.002e-02,2.530e-01,7.713e-02,3.751e-02,1.586e-01,7.052e-01,2.193e-02
ADCY3,234,cytoplasm,GO:0005737,cellular component,9.0,72.0,1.798e-01,1.537e-01,2.103e-01,1.495e-01,1.076e-01,2.075e-01,6.091e-01,1.301e-02
ADCY3,234,membrane,GO:0016020,cellular component,9.0,41.0,1.830e-01,1.672e-01,2.003e-01,1.396e-01,8.873e-02,2.196e-01,6.198e-01,1.746e-02
ADCY3,234,adenylate cyclase activity,GO:0004016,molecular function,9.0,5.0,2.822e-01,1.275e-01,6.247e-01,2.822e-01,1.275e-01,6.247e-01,4.830e-01,4.379e-02
ADCY4,235,adenylate cyclase-activating G protein-coupled receptor signaling pathway,GO:0007189,biological process,8.0,15.0,1.865e-01,1.411e-01,2.465e-01,7.108e-02,5.154e-02,9.803e-02,7.171e-01,9.981e-03
ADCY4,235,integral component of plasma membrane,GO:0005887,cellular component,8.0,39.0,1.865e-01,1.411e-01,2.465e-01,8.318e-02,4.288e-02,1.614e-01,6.955e-01,2.066e-02
ADCY4,235,cytoplasm,GO:0005737,cellular component,8.0,72.0,2.030e-01,1.319e-01,3.122e-01,1.691e-01,1.100e-01,2.601e-01,5.874e-01,1.787e-02
ADCY4,235,protein kinase C binding,GO:0005080,molecular function,8.0,3.0,1.865e-01,1.411e-01,2.465e-01,1.059e-01,7.431e-02,1.510e-01,6.629e-01,1.266e-02
ADCY4,235,protein binding,GO:0005515,molecular function,8.0,318.0,1.966e-01,1.287e-01,3.004e-01,1.347e-01,7.855e-02,2.311e-01,6.251e-01,2.127e-02
ADCY4,235,adenylate cyclase activity,GO:0004016,molecular function,8.0,5.0,4.127e-01,2.107e-01,8.084e-01,4.127e-01,2.107e-01,8.084e-01,3.915e-01,4.144e-02
ADORA2A,263,adenylate cyclase-activating G protein-coupled receptor signaling pathway,GO:0007189,biological process,15.0,15.0,3.219e-02,2.235e-02,4.636e-02,2.279e-02,9.685e-03,5.362e-02,8.438e-01,2.019e-02
ADORA2A,263,integral component of plasma membrane,GO:0005887,cellular component,15.0,39.0,3.219e-02,2.235e-02,4.636e-02,1.380e-02,7.001e-03,2.721e-02,8.900e-01,1.319e-02
ADORA2A,263,plasma membrane,GO:0005886,cellular component,15.0,67.0,3.219e-02,2.235e-02,4.636e-02,2.122e-02,1.472e-02,3.059e-02,8.528e-01,9.095e-03
ADORA2A,263,identical protein binding,GO:0042802,molecular function,15.0,24.0,3.219e-02,2.235e-02,4.636e-02,1.471e-02,1.044e-02,2.074e-02,8.866e-01,7.200e-03
ADORA2A,263,G protein-coupled adenosine receptor activity,GO:0001609,molecular function,15.0,5.0,3.219e-02,2.235e-02,4.636e-02,1.923e-02,1.358e-02,2.723e-02,8.624e-01,7.968e-03
ADORA2A,263,protein binding,GO:0005515,molecular function,15.0,318.0,3.268e-02,2.388e-02,4.473e-02,2.819e-02,2.586e-02,3.073e-02,8.234e-01,2.065e-03
ADORA2A,263,enzyme binding,GO:0019899,molecular function,15.0,35.0,6.347e-02,1.514e-02,2.661e-01,6.122e-02,1.292e-02,2.900e-01,7.302e-01,4.399e-02
ADRB3,288,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,GO:0007188,biological process,20.0,5.0,2.187e-01,1.726e-01,2.772e-01,5.105e-02,1.942e-02,1.342e-01,7.559e-01,2.668e-02
ADRB3,288,adenylate cyclase-activating adrenergic receptor signaling pathway,GO:0071880,biological process,20.0,4.0,2.187e-01,1.726e-01,2.772e-01,5.436e-02,2.028e-02,1.457e-01,7.482e-01,2.745e-02
ADRB3,288,positive regulation of MAPK cascade,GO:0043410,biological process,20.0,13.0,2.804e-01,1.879e-01,4.184e-01,1.042e-01,5.920e-02,1.834e-01,6.641e-01,2.024e-02
ADRB3,288,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,GO:0002025,biological process,20.0,3.0,5.145e-01,4.002e-01,6.615e-01,4.342e-01,2.872e-01,6.567e-01,3.815e-01,2.678e-02
ADRB3,288,cell-cell signaling,GO:0007267,biological process,20.0,35.0,5.225e-01,4.091e-01,6.672e-01,4.021e-01,1.872e-01,8.636e-01,3.968e-01,4.662e-02
ADRB3,288,activation of adenylate cyclase activity,GO:0007190,biological process,20.0,2.0,5.633e-01,5.201e-01,6.102e-01,5.069e-01,3.980e-01,6.455e-01,3.369e-01,1.919e-02
ADRB3,288,temperature homeostasis,GO:0001659,biological process,20.0,7.0,5.654e-01,5.468e-01,5.847e-01,5.384e-01,4.834e-01,5.998e-01,3.182e-01,8.926e-03
ADRB3,288,behavior,GO:0007610,biological process,20.0,28.0,6.373e-01,3.788e-01,1.072e+00,6.011e-01,3.236e-01,1.117e+00,2.602e-01,6.691e-02
ADRB3,288,integral component of plasma membrane,GO:0005887,cellular component,20.0,39.0,2.187e-01,1.726e-01,2.772e-01,5.555e-02,2.919e-02,1.057e-01,7.465e-01,1.889e-02
ADRB3,288,receptor complex,GO:0043235,cellular component,20.0,30.0,4.985e-01,4.082e-01,6.086e-01,3.235e-01,2.245e-01,4.661e-01,4.577e-01,2.056e-02
ADRB3,288,beta-adrenergic receptor activity,GO:0004939,molecular function,20.0,5.0,2.187e-01,1.726e-01,2.772e-01,4.888e-02,3.499e-02,6.829e-02,7.623e-01,9.248e-03
ADRB3,288,beta3-adrenergic receptor activity,GO:0015052,molecular function,20.0,2.0,2.194e-01,1.749e-01,2.751e-01,6.169e-02,5.300e-02,7.181e-02,7.350e-01,4.408e-03
ADRB3,288,adrenergic receptor activity,GO:0004935,molecular function,20.0,4.0,3.164e-01,2.472e-01,4.048e-01,1.238e-01,1.032e-01,1.487e-01,6.398e-01,6.965e-03
ADRB3,288,protein homodimerization activity,GO:0042803,molecular function,20.0,23.0,4.154e-01,3.533e-01,4.885e-01,2.025e-01,1.559e-01,2.629e-01,5.555e-01,1.184e-02
ADRB3,288,protein binding,GO:0005515,molecular function,20.0,318.0,4.467e-01,4.366e-01,4.571e-01,2.520e-01,2.215e-01,2.866e-01,5.132e-01,6.254e-03
ADRB3,288,norepinephrine binding,GO:0051380,molecular function,20.0,2.0,4.874e-01,3.772e-01,6.299e-01,3.429e-01,2.773e-01,4.241e-01,4.448e-01,1.246e-02
ADRB3,288,epinephrine binding,GO:0051379,molecular function,20.0,2.0,4.874e-01,3.772e-01,6.299e-01,3.515e-01,2.819e-01,4.383e-01,4.389e-01,1.314e-02
AFAP1L1,26714,cytosol,GO:0005829,cellular component,4.0,50.0,1.022e-01,5.851e-02,1.784e-01,9.516e-02,6.038e-02,1.500e-01,6.779e-01,1.498e-02
AFAP1L1,26714,SH3 domain binding,GO:0017124,molecular function,4.0,6.0,1.022e-01,5.851e-02,1.784e-01,7.345e-02,6.922e-02,7.794e-02,7.131e-01,1.821e-03
AFAP1L1,26714,protein binding,GO:0005515,molecular function,4.0,318.0,1.022e-01,5.851e-02,1.784e-01,1.022e-01,5.851e-02,1.784e-01,6.673e-01,1.867e-02
AFDN,7137,positive regulation of cell-cell adhesion mediated by cadherin,GO:2000049,biological process,28.0,3.0,1.047e-01,4.557e-02,2.404e-01,1.691e-02,1.011e-02,2.830e-02,8.741e-01,1.175e-02
AFDN,7137,positive regulation of cell-cell adhesion,GO:0022409,biological process,28.0,14.0,1.047e-01,4.557e-02,2.404e-01,1.735e-02,2.503e-03,1.202e-01,8.571e-01,3.585e-02
AFDN,7137,pore complex assembly,GO:0046931,biological process,28.0,3.0,1.047e-01,4.557e-02,2.404e-01,2.794e-02,1.019e-02,7.660e-02,8.224e-01,2.512e-02
AFDN,7137,establishment of endothelial intestinal barrier,GO:0090557,biological process,28.0,2.0,1.238e-01,6.681e-02,2.295e-01,6.079e-02,1.634e-02,2.262e-01,7.312e-01,4.129e-02
AFDN,7137,bicellular tight junction assembly,GO:0070830,biological process,28.0,3.0,1.432e-01,8.889e-02,2.307e-01,1.123e-01,5.338e-02,2.362e-01,6.520e-01,2.631e-02
AFDN,7137,positive regulation of gene expression,GO:0010628,biological process,28.0,27.0,1.433e-01,1.364e-01,1.505e-01,1.051e-01,7.414e-02,1.490e-01,6.640e-01,1.226e-02
AFDN,7137,positive regulation of GTPase activity,GO:0043547,biological process,28.0,6.0,1.451e-01,8.975e-02,2.346e-01,1.157e-01,4.946e-02,2.706e-01,6.466e-01,2.977e-02
AFDN,7137,regulation of protein localization,GO:0032880,biological process,28.0,8.0,2.350e-01,8.436e-02,6.546e-01,2.101e-01,5.925e-02,7.452e-01,5.378e-01,5.862e-02
AFDN,7137,negative regulation of cell migration,GO:0030336,biological process,28.0,29.0,2.404e-01,1.001e-01,5.772e-01,2.270e-01,9.938e-02,5.185e-01,5.288e-01,4.128e-02
AFDN,7137,tight junction,GO:0070160,cellular component,28.0,5.0,1.047e-01,4.557e-02,2.404e-01,2.542e-02,5.487e-03,1.178e-01,8.284e-01,3.551e-02
AFDN,7137,cell-cell junction,GO:0005911,cellular component,28.0,18.0,1.150e-01,6.864e-02,1.926e-01,4.444e-02,1.522e-02,1.298e-01,7.714e-01,2.923e-02
AFDN,7137,cell-cell contact zone,GO:0044291,cellular component,28.0,5.0,1.167e-01,7.312e-02,1.862e-01,5.488e-02,2.286e-02,1.318e-01,7.471e-01,2.506e-02
AFDN,7137,adherens junction,GO:0005912,cellular component,28.0,7.0,1.167e-01,7.312e-02,1.862e-01,5.995e-02,3.020e-02,1.190e-01,7.372e-01,1.956e-02
AFDN,7137,cell junction,GO:0030054,cellular component,28.0,7.0,1.259e-01,8.381e-02,1.891e-01,6.718e-02,3.715e-02,1.215e-01,7.234e-01,1.784e-02
AFDN,7137,plasma membrane,GO:0005886,cellular component,28.0,67.0,1.259e-01,1.013e-01,1.565e-01,7.513e-02,5.850e-02,9.648e-02,7.101e-01,7.852e-03
AFDN,7137,nuclear speck,GO:0016607,cellular component,28.0,7.0,1.413e-01,1.150e-01,1.737e-01,8.158e-02,3.926e-02,1.696e-01,6.973e-01,2.413e-02
AFDN,7137,cytosol,GO:0005829,cellular component,28.0,50.0,1.471e-01,1.294e-01,1.671e-01,1.087e-01,8.514e-02,1.388e-01,6.594e-01,8.800e-03
AFDN,7137,nucleoplasm,GO:0005654,cellular component,28.0,47.0,1.496e-01,1.245e-01,1.798e-01,1.129e-01,7.583e-02,1.680e-01,6.532e-01,1.440e-02
AFDN,7137,pore complex,GO:0046930,cellular component,28.0,5.0,2.486e-01,1.054e-01,5.861e-01,2.378e-01,9.145e-02,6.182e-01,5.173e-01,4.897e-02
AFDN,7137,cell adhesion molecule binding,GO:0050839,molecular function,28.0,6.0,1.047e-01,4.557e-02,2.404e-01,7.020e-03,4.444e-03,1.109e-02,9.317e-01,4.717e-03
AFDN,7137,actin filament binding,GO:0051015,molecular function,28.0,8.0,1.047e-01,4.557e-02,2.404e-01,2.048e-02,1.317e-02,3.184e-02,8.557e-01,1.036e-02
AFDN,7137,Ras GTPase binding,GO:0017016,molecular function,28.0,7.0,1.167e-01,7.312e-02,1.861e-01,5.073e-02,1.632e-02,1.576e-01,7.551e-01,3.315e-02
AFDN,7137,cadherin binding,GO:0045296,molecular function,28.0,9.0,1.259e-01,1.013e-01,1.565e-01,7.049e-02,5.626e-02,8.832e-02,7.183e-01,6.954e-03
AFDN,7137,protein binding,GO:0005515,molecular function,28.0,318.0,1.648e-01,1.287e-01,2.111e-01,1.366e-01,9.255e-02,2.015e-01,6.238e-01,1.537e-02
AGBL5,26147,mitotic spindle,GO:0072686,cellular component,10.0,3.0,1.764e-01,1.287e-01,2.418e-01,8.123e-02,6.357e-02,1.038e-01,6.998e-01,7.781e-03
AGBL5,26147,nucleus,GO:0005634,cellular component,10.0,86.0,1.764e-01,1.287e-01,2.418e-01,1.263e-01,1.130e-01,1.410e-01,6.370e-01,4.214e-03
AGBL5,26147,microtubule cytoskeleton,GO:0015630,cellular component,10.0,6.0,1.764e-01,1.287e-01,2.418e-01,1.256e-01,5.338e-02,2.956e-01,6.337e-01,3.342e-02
AGBL5,26147,cytosol,GO:0005829,cellular component,10.0,50.0,1.764e-01,1.287e-01,2.418e-01,1.309e-01,1.277e-01,1.341e-01,6.312e-01,9.725e-04
AGBL5,26147,cytoplasm,GO:0005737,cellular component,10.0,72.0,1.764e-01,1.287e-01,2.418e-01,1.338e-01,1.221e-01,1.466e-01,6.276e-01,3.622e-03
AGBL5,26147,intercellular bridge,GO:0045171,cellular component,10.0,6.0,1.764e-01,1.287e-01,2.418e-01,1.588e-01,9.833e-02,2.564e-01,5.979e-01,2.021e-02
AGBL5,26147,midbody,GO:0030496,cellular component,10.0,2.0,1.992e-01,1.687e-01,2.353e-01,1.992e-01,1.687e-01,2.353e-01,5.587e-01,7.443e-03
AGXT2,14412,"glycine biosynthetic process, by transamination of glyoxylate",GO:0019265,biological process,7.0,2.0,4.774e-02,2.443e-02,9.329e-02,7.957e-03,4.072e-03,1.555e-02,9.250e-01,8.101e-03
AGXT2,14412,"L-alanine catabolic process, by transamination",GO:0019481,biological process,7.0,2.0,1.052e-01,6.363e-02,1.740e-01,6.544e-02,3.290e-02,1.302e-01,7.261e-01,2.106e-02
AGXT2,14412,glyoxylate catabolic process,GO:0009436,biological process,7.0,4.0,1.332e-01,8.567e-02,2.071e-01,9.279e-02,2.366e-02,3.640e-01,6.748e-01,4.443e-02
AGXT2,14412,positive regulation of nitric oxide biosynthetic process,GO:0045429,biological process,7.0,6.0,1.866e-01,4.975e-02,7.002e-01,1.756e-01,3.854e-02,8.003e-01,5.682e-01,6.278e-02
AGXT2,14412,mitochondrion,GO:0005739,cellular component,7.0,12.0,1.435e-01,4.456e-02,4.621e-01,9.467e-02,1.922e-02,4.663e-01,6.679e-01,5.660e-02
AGXT2,14412,alanine-glyoxylate transaminase activity,GO:0008453,molecular function,7.0,2.0,9.803e-02,4.554e-02,2.110e-01,5.425e-02,1.059e-02,2.780e-01,7.448e-01,4.571e-02
AIF1,352,,,,nan,nan,,,,,,,,
AMDHD2,24262,,,,nan,nan,,,,,,,,
AMPH,471,synaptic vesicle endocytosis,GO:0048488,biological process,13.0,4.0,1.314e-01,6.648e-02,2.598e-01,4.423e-02,1.580e-02,1.238e-01,7.721e-01,2.767e-02
AMPH,471,plasma membrane,GO:0005886,cellular component,13.0,67.0,1.314e-01,6.648e-02,2.598e-01,4.770e-02,2.063e-02,1.103e-01,7.643e-01,2.296e-02
AMPH,471,synaptic vesicle,GO:0008021,cellular component,13.0,6.0,1.408e-01,8.288e-02,2.392e-01,1.018e-01,6.978e-02,1.486e-01,6.686e-01,1.275e-02
AMPH,471,leading edge membrane,GO:0031256,cellular component,13.0,5.0,1.773e-01,6.698e-02,4.696e-01,1.744e-01,6.241e-02,4.872e-01,5.770e-01,4.284e-02
AMPH,471,protein binding,GO:0005515,molecular function,13.0,318.0,1.408e-01,8.288e-02,2.392e-01,1.158e-01,9.422e-02,1.422e-01,6.502e-01,7.460e-03
AMPH,471,phospholipid binding,GO:0005543,molecular function,13.0,16.0,1.435e-01,7.390e-02,2.785e-01,9.548e-02,2.824e-02,3.228e-01,6.719e-01,4.105e-02
AMZ1,22231,,,,nan,nan,,,,,,,,
ANGPT1,484,positive regulation of peptidyl-tyrosine phosphorylation,GO:0050731,biological process,30.0,11.0,8.520e-02,6.543e-02,1.109e-01,5.744e-03,1.485e-03,2.222e-02,9.351e-01,1.465e-02
ANGPT1,484,positive regulation of ERK1 and ERK2 cascade,GO:0070374,biological process,30.0,7.0,8.520e-02,6.543e-02,1.109e-01,1.175e-02,9.151e-03,1.508e-02,9.043e-01,4.251e-03
ANGPT1,484,Tie signaling pathway,GO:0048014,biological process,30.0,2.0,8.520e-02,6.543e-02,1.109e-01,1.188e-02,1.028e-02,1.373e-02,9.035e-01,2.451e-03
ANGPT1,484,sprouting angiogenesis,GO:0002040,biological process,30.0,2.0,8.520e-02,6.543e-02,1.109e-01,1.630e-02,5.279e-03,5.032e-02,8.721e-01,2.140e-02
ANGPT1,484,positive regulation of blood vessel endothelial cell migration,GO:0043536,biological process,30.0,7.0,8.520e-02,6.543e-02,1.109e-01,1.877e-02,1.111e-02,3.171e-02,8.639e-01,1.239e-02
ANGPT1,484,positive regulation of protein phosphorylation,GO:0001934,biological process,30.0,16.0,8.651e-02,6.543e-02,1.144e-01,3.140e-02,1.456e-02,6.773e-02,8.109e-01,1.962e-02
ANGPT1,484,positive regulation of endothelial cell migration,GO:0010595,biological process,30.0,8.0,8.651e-02,6.543e-02,1.144e-01,3.471e-02,1.671e-02,7.212e-02,8.002e-01,1.908e-02
ANGPT1,484,protein localization to cell surface,GO:0034394,biological process,30.0,2.0,9.200e-02,8.033e-02,1.054e-01,3.167e-02,2.053e-02,4.886e-02,8.106e-01,1.117e-02
ANGPT1,484,activation of transmembrane receptor protein tyrosine kinase activity,GO:0007171,biological process,30.0,3.0,1.067e-01,7.382e-02,1.543e-01,5.062e-02,3.847e-02,6.660e-02,7.581e-01,7.713e-03
ANGPT1,484,positive regulation of receptor internalization,GO:0002092,biological process,30.0,7.0,1.204e-01,6.968e-02,2.082e-01,6.065e-02,3.028e-02,1.215e-01,7.358e-01,2.029e-02
ANGPT1,484,positive regulation of maintenance of permeability of blood-brain barrier,GO:1905605,biological process,30.0,3.0,1.240e-01,6.645e-02,2.314e-01,6.701e-02,3.133e-02,1.433e-01,7.230e-01,2.290e-02
ANGPT1,484,negative regulation of cell adhesion,GO:0007162,biological process,30.0,9.0,1.246e-01,9.006e-02,1.723e-01,7.511e-02,3.302e-02,1.708e-01,7.081e-01,2.528e-02
ANGPT1,484,regulation of skeletal muscle satellite cell proliferation,GO:0014842,biological process,30.0,5.0,1.377e-01,1.112e-01,1.706e-01,8.616e-02,6.843e-02,1.085e-01,6.921e-01,7.479e-03
ANGPT1,484,positive regulation of gene expression,GO:0010628,biological process,30.0,27.0,1.427e-01,1.037e-01,1.965e-01,9.053e-02,5.868e-02,1.397e-01,6.849e-01,1.427e-02
ANGPT1,484,positive chemotaxis,GO:0050918,biological process,30.0,12.0,1.582e-01,8.210e-02,3.047e-01,1.142e-01,5.658e-02,2.303e-01,6.499e-01,2.626e-02
ANGPT1,484,positive regulation of protein ubiquitination,GO:0031398,biological process,30.0,8.0,1.862e-01,9.196e-02,3.769e-01,1.428e-01,4.960e-02,4.111e-01,6.112e-01,3.967e-02
ANGPT1,484,positive regulation of protein kinase B signaling,GO:0051897,biological process,30.0,5.0,2.106e-01,1.592e-01,2.787e-01,1.861e-01,1.316e-01,2.632e-01,5.706e-01,1.506e-02
ANGPT1,484,negative regulation of vascular permeability,GO:0043116,biological process,30.0,3.0,2.167e-01,1.785e-01,2.629e-01,1.881e-01,1.539e-01,2.298e-01,5.692e-01,8.882e-03
ANGPT1,484,heparin biosynthetic process,GO:0030210,biological process,30.0,4.0,2.603e-01,1.399e-01,4.842e-01,2.401e-01,1.063e-01,5.423e-01,5.178e-01,3.996e-02
ANGPT1,484,negative regulation of apoptotic process,GO:0043066,biological process,30.0,25.0,2.992e-01,1.845e-01,4.850e-01,2.879e-01,1.649e-01,5.026e-01,4.821e-01,3.005e-02
ANGPT1,484,negative regulation of endothelial cell apoptotic process,GO:2000352,biological process,30.0,4.0,3.067e-01,2.662e-01,3.533e-01,2.991e-01,2.524e-01,3.544e-01,4.768e-01,8.932e-03
ANGPT1,484,membrane raft,GO:0045121,cellular component,30.0,3.0,8.614e-02,6.588e-02,1.126e-01,2.739e-02,2.001e-02,3.748e-02,8.261e-01,7.962e-03
ANGPT1,484,microvillus,GO:0005902,cellular component,30.0,5.0,8.650e-02,6.773e-02,1.105e-01,2.954e-02,1.727e-02,5.054e-02,8.181e-01,1.387e-02
ANGPT1,484,extracellular space,GO:0005615,cellular component,30.0,24.0,1.427e-01,1.037e-01,1.965e-01,9.800e-02,7.467e-02,1.286e-01,6.743e-01,9.200e-03
ANGPT1,484,plasma membrane,GO:0005886,cellular component,30.0,67.0,1.582e-01,8.210e-02,3.047e-01,1.181e-01,6.288e-02,2.219e-01,6.452e-01,2.397e-02
ANGPT1,484,extracellular exosome,GO:0070062,cellular component,30.0,39.0,1.798e-01,9.122e-02,3.545e-01,1.469e-01,6.854e-02,3.148e-01,6.092e-01,2.995e-02
ANGPT1,484,receptor tyrosine kinase binding,GO:0030971,molecular function,30.0,5.0,8.520e-02,6.543e-02,1.109e-01,1.943e-02,1.491e-02,2.531e-02,8.615e-01,5.904e-03
ANKRD6,17280,,,,nan,nan,,,,,,,,
APLNR,339,positive regulation of inhibitory G protein-coupled receptor phosphorylation,GO:1904325,biological process,12.0,3.0,3.839e-01,1.985e-01,7.423e-01,1.172e-01,3.540e-02,3.878e-01,6.407e-01,4.702e-02
APLNR,339,positive regulation of release of sequestered calcium ion into cytosol,GO:0051281,biological process,12.0,9.0,3.839e-01,1.985e-01,7.423e-01,1.612e-01,6.044e-02,4.298e-01,5.915e-01,4.016e-02
APLNR,339,G protein-coupled receptor signaling pathway,GO:0007186,biological process,12.0,48.0,3.839e-01,1.985e-01,7.423e-01,1.797e-01,3.992e-02,8.088e-01,5.648e-01,6.108e-02
APLNR,339,positive regulation of angiogenesis,GO:0045766,biological process,12.0,12.0,3.991e-01,2.346e-01,6.787e-01,2.448e-01,1.530e-01,3.915e-01,5.175e-01,2.241e-02
APLNR,339,negative regulation of cAMP-mediated signaling,GO:0043951,biological process,12.0,4.0,5.434e-01,2.945e-01,1.003e+00,4.724e-01,2.087e-01,1.069e+00,3.418e-01,6.839e-02
APLNR,339,blood vessel development,GO:0001568,biological process,12.0,8.0,5.763e-01,3.314e-01,1.002e+00,5.459e-01,2.854e-01,1.044e+00,2.999e-01,5.796e-02
APLNR,339,heart development,GO:0007507,biological process,12.0,5.0,6.191e-01,4.214e-01,9.094e-01,5.999e-01,4.544e-01,7.920e-01,2.772e-01,2.642e-02
APLNR,339,plasma membrane,GO:0005886,cellular component,12.0,67.0,3.918e-01,2.169e-01,7.078e-01,1.795e-01,1.185e-01,2.718e-01,5.768e-01,1.806e-02
APLNR,339,apelin receptor activity,GO:0060182,molecular function,12.0,2.0,3.839e-01,1.985e-01,7.423e-01,1.300e-01,4.370e-02,3.864e-01,6.259e-01,4.405e-02
APLNR,339,G protein-coupled receptor activity,GO:0004930,molecular function,12.0,47.0,3.918e-01,2.169e-01,7.078e-01,2.256e-01,1.095e-01,4.649e-01,5.317e-01,3.350e-02
APLNR,339,protein binding,GO:0005515,molecular function,12.0,318.0,4.825e-01,3.144e-01,7.405e-01,3.529e-01,2.317e-01,5.374e-01,4.362e-01,2.573e-02
APOE,613,negative regulation of neuron apoptotic process,GO:0043524,biological process,116.0,13.0,2.603e-01,1.717e-01,3.946e-01,1.904e-02,8.685e-03,4.173e-02,8.613e-01,1.731e-02
APOE,613,negative regulation of blood vessel endothelial cell migration,GO:0043537,biological process,116.0,4.0,2.603e-01,1.717e-01,3.946e-01,2.811e-02,1.321e-02,5.984e-02,8.228e-01,1.903e-02
APOE,613,chylomicron remnant clearance,GO:0034382,biological process,116.0,2.0,2.603e-01,1.717e-01,3.946e-01,3.228e-02,1.768e-02,5.896e-02,8.084e-01,1.555e-02
APOE,613,positive regulation of ERK1 and ERK2 cascade,GO:0070374,biological process,116.0,7.0,2.603e-01,1.717e-01,3.946e-01,3.363e-02,2.193e-02,5.157e-02,8.043e-01,1.145e-02
APOE,613,intermediate-density lipoprotein particle clearance,GO:0071831,biological process,116.0,2.0,2.603e-01,1.717e-01,3.946e-01,3.392e-02,2.007e-02,5.735e-02,8.030e-01,1.363e-02
APOE,613,positive regulation of cholesterol efflux,GO:0010875,biological process,116.0,3.0,2.603e-01,1.717e-01,3.946e-01,3.315e-02,7.036e-03,1.562e-01,8.017e-01,4.004e-02
APOE,613,long-term memory,GO:0007616,biological process,116.0,2.0,2.603e-01,1.717e-01,3.946e-01,3.830e-02,1.909e-02,7.686e-02,7.894e-01,1.896e-02
APOE,613,regulation of amyloid precursor protein catabolic process,GO:1902991,biological process,116.0,7.0,2.603e-01,1.717e-01,3.946e-01,4.493e-02,3.256e-02,6.200e-02,7.719e-01,8.792e-03
APOE,613,regulation of protein metabolic process,GO:0051246,biological process,116.0,22.0,2.603e-01,1.717e-01,3.946e-01,5.446e-02,2.991e-02,9.916e-02,7.490e-01,1.715e-02
APOE,613,regulation of amyloid fibril formation,GO:1905906,biological process,116.0,5.0,2.624e-01,1.778e-01,3.873e-01,5.345e-02,1.385e-02,2.062e-01,7.476e-01,3.931e-02
APOE,613,positive regulation of lipid biosynthetic process,GO:0046889,biological process,116.0,19.0,2.626e-01,1.701e-01,4.055e-01,5.129e-02,1.488e-02,1.768e-01,7.534e-01,3.607e-02
APOE,613,receptor-mediated endocytosis,GO:0006898,biological process,116.0,9.0,2.629e-01,1.700e-01,4.066e-01,7.906e-02,1.946e-02,3.212e-01,6.970e-01,4.349e-02
APOE,613,positive regulation of cholesterol esterification,GO:0010873,biological process,116.0,4.0,2.640e-01,1.689e-01,4.124e-01,7.937e-02,1.834e-02,3.436e-01,6.952e-01,4.763e-02
APOE,613,regulation of cholesterol metabolic process,GO:0090181,biological process,116.0,6.0,2.640e-01,1.689e-01,4.124e-01,8.484e-02,2.269e-02,3.172e-01,6.873e-01,4.386e-02
APOE,613,positive regulation of phospholipid efflux,GO:1902995,biological process,116.0,3.0,2.660e-01,1.672e-01,4.233e-01,8.015e-02,1.841e-02,3.489e-01,6.931e-01,4.982e-02
APOE,613,positive regulation of membrane protein ectodomain proteolysis,GO:0051044,biological process,116.0,5.0,2.696e-01,2.000e-01,3.634e-01,5.487e-02,2.366e-02,1.272e-01,7.475e-01,2.348e-02
APOE,613,negative regulation of blood coagulation,GO:0030195,biological process,116.0,12.0,2.696e-01,2.000e-01,3.634e-01,8.889e-02,4.739e-02,1.667e-01,6.863e-01,2.136e-02
APOE,613,positive regulation of lipid transport across blood-brain barrier,GO:1903002,biological process,116.0,3.0,2.718e-01,2.072e-01,3.566e-01,7.216e-02,3.130e-02,1.664e-01,7.133e-01,2.487e-02
APOE,613,positive regulation of nitric-oxide synthase activity,GO:0051000,biological process,116.0,3.0,2.719e-01,1.978e-01,3.739e-01,7.703e-02,4.248e-02,1.397e-01,7.059e-01,1.865e-02
APOE,613,negative regulation of amyloid-beta formation,GO:1902430,biological process,116.0,4.0,2.719e-01,1.978e-01,3.739e-01,9.569e-02,5.769e-02,1.587e-01,6.768e-01,1.697e-02
APOE,613,NMDA glutamate receptor clustering,GO:0097114,biological process,116.0,2.0,2.719e-01,1.978e-01,3.739e-01,1.020e-01,5.958e-02,1.747e-01,6.675e-01,1.827e-02
APOE,613,positive regulation of heparan sulfate proteoglycan binding,GO:1905860,biological process,116.0,3.0,2.734e-01,1.963e-01,3.807e-01,7.251e-02,2.092e-02,2.513e-01,7.087e-01,4.072e-02
APOE,613,negative regulation of platelet activation,GO:0010544,biological process,116.0,6.0,2.739e-01,2.131e-01,3.522e-01,1.133e-01,5.379e-02,2.388e-01,6.505e-01,2.587e-02
APOE,613,positive regulation of neuron projection development,GO:0010976,biological process,116.0,9.0,2.741e-01,1.596e-01,4.705e-01,9.395e-02,1.980e-02,4.458e-01,6.697e-01,5.433e-02
APOE,613,triglyceride-rich lipoprotein particle clearance,GO:0071830,biological process,116.0,4.0,2.742e-01,2.047e-01,3.671e-01,8.106e-02,3.440e-02,1.910e-01,6.981e-01,2.644e-02
APOE,613,AMPA glutamate receptor clustering,GO:0097113,biological process,116.0,2.0,2.742e-01,2.047e-01,3.671e-01,1.141e-01,8.320e-02,1.566e-01,6.519e-01,1.151e-02
APOE,613,cholesterol catabolic process,GO:0006707,biological process,116.0,4.0,2.764e-01,2.033e-01,3.758e-01,1.374e-01,9.373e-02,2.015e-01,6.224e-01,1.473e-02
APOE,613,very-low-density lipoprotein particle remodeling,GO:0034372,biological process,116.0,2.0,2.784e-01,1.961e-01,3.953e-01,1.194e-01,4.718e-02,3.023e-01,6.410e-01,3.366e-02
APOE,613,negative regulation of MAP kinase activity,GO:0043407,biological process,116.0,6.0,2.795e-01,1.542e-01,5.067e-01,1.058e-01,1.969e-02,5.683e-01,6.502e-01,6.227e-02
APOE,613,high-density lipoprotein particle remodeling,GO:0034375,biological process,116.0,3.0,2.796e-01,2.061e-01,3.792e-01,1.427e-01,9.266e-02,2.198e-01,6.162e-01,1.738e-02
APOE,613,cholesterol efflux,GO:0033344,biological process,116.0,2.0,2.804e-01,1.545e-01,5.087e-01,1.245e-01,2.289e-02,6.767e-01,6.251e-01,6.149e-02
APOE,613,reverse cholesterol transport,GO:0043691,biological process,116.0,2.0,2.809e-01,1.540e-01,5.125e-01,1.269e-01,2.202e-02,7.312e-01,6.210e-01,6.406e-02
APOE,613,positive regulation by host of viral process,GO:0044794,biological process,116.0,5.0,2.818e-01,2.229e-01,3.562e-01,1.534e-01,9.867e-02,2.386e-01,6.043e-01,1.758e-02
APOE,613,negative regulation of endothelial cell migration,GO:0010596,biological process,116.0,6.0,2.825e-01,2.090e-01,3.819e-01,1.582e-01,1.063e-01,2.354e-01,5.992e-01,1.616e-02
APOE,613,regulation of cellular response to very-low-density lipoprotein particle stimulus,GO:1905890,biological process,116.0,5.0,2.863e-01,2.058e-01,3.982e-01,1.116e-01,2.188e-02,5.689e-01,6.434e-01,5.669e-02
APOE,613,positive regulation of endocytosis,GO:0045807,biological process,116.0,11.0,2.870e-01,2.239e-01,3.680e-01,1.574e-01,1.079e-01,2.296e-01,6.000e-01,1.546e-02
APOE,613,high-density lipoprotein particle assembly,GO:0034380,biological process,116.0,2.0,2.881e-01,1.949e-01,4.258e-01,1.463e-01,6.877e-02,3.113e-01,6.100e-01,3.111e-02
APOE,613,negative regulation of cellular protein metabolic process,GO:0032269,biological process,116.0,9.0,2.892e-01,1.918e-01,4.362e-01,1.458e-01,5.803e-02,3.663e-01,6.090e-01,3.572e-02
APOE,613,cholesterol metabolic process,GO:0008203,biological process,116.0,7.0,2.914e-01,1.928e-01,4.406e-01,1.535e-01,6.706e-02,3.515e-01,6.014e-01,3.243e-02
APOE,613,fatty acid homeostasis,GO:0055089,biological process,116.0,4.0,2.950e-01,2.132e-01,4.082e-01,1.675e-01,7.155e-02,3.921e-01,5.861e-01,3.420e-02
APOE,613,positive regulation of dendritic spine maintenance,GO:1902952,biological process,116.0,3.0,2.985e-01,1.982e-01,4.496e-01,1.784e-01,8.729e-02,3.645e-01,5.761e-01,3.150e-02
APOE,613,negative regulation of cholesterol biosynthetic process,GO:0045541,biological process,116.0,5.0,3.027e-01,1.612e-01,5.685e-01,1.468e-01,2.945e-02,7.319e-01,5.971e-01,6.969e-02
APOE,613,regulation of proteasomal protein catabolic process,GO:0061136,biological process,116.0,8.0,3.051e-01,2.095e-01,4.442e-01,1.856e-01,8.361e-02,4.122e-01,5.682e-01,3.457e-02
APOE,613,negative regulation of endothelial cell proliferation,GO:0001937,biological process,116.0,6.0,3.060e-01,1.452e-01,6.449e-01,1.234e-01,7.087e-03,2.148e+00,6.040e-01,1.016e-01
APOE,613,cholesterol homeostasis,GO:0042632,biological process,116.0,2.0,3.073e-01,1.858e-01,5.080e-01,1.814e-01,6.042e-02,5.446e-01,5.688e-01,4.808e-02
APOE,613,positive regulation of dendritic spine development,GO:0060999,biological process,116.0,4.0,3.082e-01,1.624e-01,5.851e-01,1.408e-01,2.423e-02,8.179e-01,6.002e-01,7.815e-02
APOE,613,high-density lipoprotein particle clearance,GO:0034384,biological process,116.0,2.0,3.083e-01,1.863e-01,5.103e-01,1.997e-01,7.359e-02,5.421e-01,5.520e-01,4.570e-02
APOE,613,very-low-density lipoprotein particle clearance,GO:0034447,biological process,116.0,2.0,3.085e-01,1.884e-01,5.051e-01,2.011e-01,7.859e-02,5.145e-01,5.517e-01,4.252e-02
APOE,613,long-chain fatty acid transport,GO:0015909,biological process,116.0,6.0,3.092e-01,1.632e-01,5.857e-01,1.791e-01,4.413e-02,7.269e-01,5.652e-01,6.435e-02
APOE,613,lipoprotein catabolic process,GO:0042159,biological process,116.0,5.0,3.101e-01,1.699e-01,5.658e-01,1.889e-01,5.516e-02,6.470e-01,5.587e-01,5.676e-02
APOE,613,G protein-coupled receptor signaling pathway,GO:0007186,biological process,116.0,48.0,3.111e-01,1.819e-01,5.321e-01,2.036e-01,8.240e-02,5.031e-01,5.495e-01,4.166e-02
APOE,613,negative regulation of neuron projection development,GO:0010977,biological process,116.0,9.0,3.124e-01,2.072e-01,4.709e-01,2.212e-01,1.446e-01,3.386e-01,5.379e-01,1.964e-02
APOE,613,cGMP-mediated signaling,GO:0019934,biological process,116.0,5.0,3.124e-01,1.764e-01,5.534e-01,1.815e-01,5.832e-02,5.651e-01,5.678e-01,5.111e-02
APOE,613,positive regulation of low-density lipoprotein particle receptor catabolic process,GO:0032805,biological process,116.0,4.0,3.139e-01,1.748e-01,5.638e-01,1.741e-01,4.938e-02,6.137e-01,5.730e-01,5.812e-02
APOE,613,positive regulation of heparan sulfate binding,GO:1905855,biological process,116.0,3.0,3.149e-01,2.605e-01,3.805e-01,1.808e-01,6.794e-02,4.809e-01,5.707e-01,4.449e-02
APOE,613,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,116.0,41.0,3.216e-01,1.920e-01,5.389e-01,2.160e-01,8.361e-02,5.580e-01,5.370e-01,4.614e-02
APOE,613,protein import,GO:0017038,biological process,116.0,8.0,3.268e-01,1.786e-01,5.982e-01,2.118e-01,6.085e-02,7.372e-01,5.374e-01,5.519e-02
APOE,613,neuron projection development,GO:0031175,biological process,116.0,9.0,3.374e-01,1.575e-01,7.229e-01,2.253e-01,5.287e-02,9.603e-01,5.188e-01,7.183e-02
APOE,613,amyloid precursor protein metabolic process,GO:0042982,biological process,116.0,4.0,3.388e-01,1.777e-01,6.461e-01,2.360e-01,6.773e-02,8.226e-01,5.149e-01,5.939e-02
APOE,613,virion assembly,GO:0019068,biological process,116.0,2.0,3.699e-01,2.895e-01,4.728e-01,2.948e-01,1.915e-01,4.539e-01,4.782e-01,2.286e-02
APOE,613,negative regulation of long-term synaptic potentiation,GO:1900272,biological process,116.0,3.0,3.777e-01,2.948e-01,4.837e-01,3.108e-01,2.500e-01,3.864e-01,4.677e-01,1.206e-02
APOE,613,regulation of amyloid-beta clearance,GO:1900221,biological process,116.0,4.0,3.825e-01,1.606e-01,9.110e-01,3.021e-01,7.821e-02,1.167e+00,4.556e-01,7.330e-02
APOE,613,nitric oxide mediated signal transduction,GO:0007263,biological process,116.0,4.0,3.924e-01,2.110e-01,7.297e-01,3.576e-01,1.669e-01,7.661e-01,4.283e-01,4.278e-02
APOE,613,regulation of behavioral fear response,GO:2000822,biological process,116.0,6.0,4.013e-01,3.542e-01,4.546e-01,3.294e-01,2.071e-01,5.240e-01,4.526e-01,2.539e-02
APOE,613,negative regulation of protein secretion,GO:0050709,biological process,116.0,17.0,4.120e-01,3.261e-01,5.205e-01,3.511e-01,1.991e-01,6.190e-01,4.357e-01,3.261e-02
APOE,613,regulation of protein-containing complex assembly,GO:0043254,biological process,116.0,42.0,4.156e-01,3.676e-01,4.699e-01,3.795e-01,3.343e-01,4.308e-01,4.201e-01,7.822e-03
APOE,613,phospholipid efflux,GO:0033700,biological process,116.0,2.0,4.176e-01,1.561e-01,1.117e+00,3.693e-01,1.116e-01,1.222e+00,4.055e-01,7.646e-02
APOE,613,regulation of Cdc42 protein signal transduction,GO:0032489,biological process,116.0,2.0,4.376e-01,3.954e-01,4.844e-01,4.022e-01,3.278e-01,4.933e-01,4.047e-01,1.275e-02
APOE,613,locomotory exploration behavior,GO:0035641,biological process,116.0,3.0,4.807e-01,2.822e-01,8.187e-01,4.330e-01,2.133e-01,8.789e-01,3.754e-01,5.037e-02
APOE,613,triglyceride metabolic process,GO:0006641,biological process,116.0,6.0,4.985e-01,3.726e-01,6.671e-01,4.819e-01,3.656e-01,6.352e-01,3.525e-01,1.977e-02
APOE,613,lipoprotein biosynthetic process,GO:0042158,biological process,116.0,7.0,5.100e-01,2.330e-01,1.116e+00,4.809e-01,1.996e-01,1.158e+00,3.318e-01,7.666e-02
APOE,613,negative regulation of canonical Wnt signaling pathway,GO:0090090,biological process,116.0,13.0,5.127e-01,1.511e-01,1.740e+00,4.727e-01,1.074e-01,2.081e+00,3.171e-01,9.965e-02
APOE,613,response to caloric restriction,GO:0061771,biological process,116.0,4.0,5.700e-01,4.229e-01,7.683e-01,5.631e-01,4.293e-01,7.386e-01,3.010e-01,2.307e-02
APOE,613,synaptic cleft,GO:0043083,cellular component,116.0,2.0,2.603e-01,1.717e-01,3.946e-01,1.048e-02,4.628e-03,2.374e-02,9.086e-01,1.091e-02
APOE,613,glutamatergic synapse,GO:0098978,cellular component,116.0,3.0,2.603e-01,1.717e-01,3.946e-01,3.699e-02,7.888e-03,1.734e-01,7.897e-01,4.061e-02
APOE,613,extracellular vesicle,GO:1903561,cellular component,116.0,9.0,2.603e-01,1.717e-01,3.946e-01,4.005e-02,2.643e-02,6.068e-02,7.848e-01,1.130e-02
APOE,613,intermediate-density lipoprotein particle,GO:0034363,cellular component,116.0,2.0,2.603e-01,1.717e-01,3.946e-01,4.878e-02,1.682e-02,1.415e-01,7.606e-01,2.905e-02
APOE,613,very-low-density lipoprotein particle,GO:0034361,cellular component,116.0,2.0,2.603e-01,1.717e-01,3.946e-01,4.949e-02,1.723e-02,1.422e-01,7.590e-01,2.883e-02
APOE,613,collagen-containing extracellular matrix,GO:0062023,cellular component,116.0,20.0,2.718e-01,2.072e-01,3.566e-01,4.860e-02,1.842e-02,1.282e-01,7.612e-01,2.774e-02
APOE,613,endoplasmic reticulum,GO:0005783,cellular component,116.0,16.0,2.718e-01,2.072e-01,3.566e-01,9.581e-02,6.381e-02,1.439e-01,6.771e-01,1.336e-02
APOE,613,extracellular region,GO:0005576,cellular component,116.0,16.0,2.736e-01,2.131e-01,3.513e-01,9.247e-02,5.033e-02,1.699e-01,6.813e-01,1.977e-02
APOE,613,extracellular space,GO:0005615,cellular component,116.0,24.0,2.736e-01,2.131e-01,3.513e-01,1.014e-01,5.513e-02,1.863e-01,6.679e-01,2.122e-02
APOE,613,extracellular matrix,GO:0031012,cellular component,116.0,9.0,2.779e-01,2.280e-01,3.388e-01,1.101e-01,4.556e-02,2.659e-01,6.538e-01,3.238e-02
APOE,613,low-density lipoprotein particle,GO:0034362,cellular component,116.0,2.0,2.782e-01,2.090e-01,3.704e-01,1.486e-01,1.125e-01,1.963e-01,6.101e-01,1.114e-02
APOE,613,Golgi apparatus,GO:0005794,cellular component,116.0,16.0,2.803e-01,2.103e-01,3.736e-01,1.279e-01,6.212e-02,2.636e-01,6.320e-01,2.650e-02
APOE,613,extracellular exosome,GO:0070062,cellular component,116.0,39.0,2.855e-01,2.252e-01,3.621e-01,1.502e-01,7.827e-02,2.883e-01,6.065e-01,2.536e-02
APOE,613,membrane,GO:0016020,cellular component,116.0,41.0,2.959e-01,2.554e-01,3.429e-01,1.961e-01,1.413e-01,2.721e-01,5.612e-01,1.474e-02
APOE,613,blood microparticle,GO:0072562,cellular component,116.0,4.0,3.079e-01,2.678e-01,3.541e-01,1.689e-01,6.349e-02,4.495e-01,5.829e-01,4.360e-02
APOE,613,nucleus,GO:0005634,cellular component,116.0,86.0,3.262e-01,1.982e-01,5.368e-01,2.354e-01,1.284e-01,4.317e-01,5.239e-01,3.023e-02
APOE,613,high-density lipoprotein particle,GO:0034364,cellular component,116.0,4.0,3.263e-01,2.004e-01,5.311e-01,2.485e-01,1.557e-01,3.969e-01,5.144e-01,2.300e-02
APOE,613,chylomicron,GO:0042627,cellular component,116.0,4.0,3.301e-01,2.244e-01,4.857e-01,2.521e-01,1.823e-01,3.486e-01,5.123e-01,1.622e-02
APOE,613,lipoprotein particle,GO:1990777,cellular component,116.0,3.0,4.180e-01,3.966e-01,4.406e-01,3.699e-01,2.938e-01,4.657e-01,4.262e-01,1.365e-02
APOE,613,signaling receptor binding,GO:0005102,molecular function,116.0,63.0,2.603e-01,1.717e-01,3.946e-01,1.567e-02,1.436e-02,1.710e-02,8.816e-01,1.967e-03
APOE,613,protein dimerization activity,GO:0046983,molecular function,116.0,4.0,2.603e-01,1.717e-01,3.946e-01,3.891e-02,1.166e-02,1.298e-01,7.863e-01,3.154e-02
APOE,613,very-low-density lipoprotein particle receptor binding,GO:0070326,molecular function,116.0,2.0,2.719e-01,1.978e-01,3.739e-01,8.211e-02,4.987e-02,1.352e-01,6.978e-01,1.608e-02
APOE,613,low-density lipoprotein particle receptor binding,GO:0050750,molecular function,116.0,2.0,2.719e-01,1.978e-01,3.739e-01,8.467e-02,4.896e-02,1.464e-01,6.935e-01,1.793e-02
APOE,613,phospholipid binding,GO:0005543,molecular function,116.0,16.0,2.774e-01,2.088e-01,3.685e-01,1.330e-01,1.123e-01,1.576e-01,6.284e-01,6.688e-03
APOE,613,heparin binding,GO:0008201,molecular function,116.0,6.0,2.778e-01,2.089e-01,3.693e-01,1.394e-01,1.321e-01,1.471e-01,6.208e-01,2.068e-03
APOE,613,identical protein binding,GO:0042802,molecular function,116.0,24.0,2.934e-01,2.202e-01,3.908e-01,1.488e-01,5.908e-02,3.748e-01,6.056e-01,3.652e-02
APOE,613,heparan sulfate proteoglycan binding,GO:0043395,molecular function,116.0,4.0,2.987e-01,2.185e-01,4.082e-01,1.939e-01,1.400e-01,2.685e-01,5.634e-01,1.460e-02
APOE,613,protein homodimerization activity,GO:0042803,molecular function,116.0,23.0,2.999e-01,2.422e-01,3.713e-01,1.804e-01,8.589e-02,3.789e-01,5.740e-01,3.091e-02
APOE,613,amyloid-beta binding,GO:0001540,molecular function,116.0,2.0,3.138e-01,1.995e-01,4.935e-01,2.067e-01,1.090e-01,3.919e-01,5.494e-01,3.022e-02
APOE,613,antioxidant activity,GO:0016209,molecular function,116.0,10.0,3.194e-01,1.836e-01,5.555e-01,1.449e-01,1.572e-02,1.336e+00,5.876e-01,8.836e-02
APOE,613,metal chelating activity,GO:0046911,molecular function,116.0,2.0,3.218e-01,2.074e-01,4.994e-01,2.175e-01,1.204e-01,3.927e-01,5.401e-01,2.667e-02
APOE,613,lipid binding,GO:0008289,molecular function,116.0,14.0,3.348e-01,2.006e-01,5.589e-01,2.347e-01,1.224e-01,4.499e-01,5.247e-01,3.068e-02
APOE,613,protein binding,GO:0005515,molecular function,116.0,318.0,3.477e-01,2.222e-01,5.442e-01,2.779e-01,1.430e-01,5.400e-01,4.883e-01,3.611e-02
APOE,613,lipid transporter activity,GO:0005319,molecular function,116.0,16.0,3.528e-01,1.788e-01,6.963e-01,2.679e-01,9.176e-02,7.822e-01,4.912e-01,5.217e-02
APOE,613,tau protein binding,GO:0048156,molecular function,116.0,2.0,3.543e-01,1.954e-01,6.424e-01,2.987e-01,1.416e-01,6.300e-01,4.718e-01,3.895e-02
APOE,613,phosphatidylcholine-sterol O-acyltransferase activator activity,GO:0060228,molecular function,116.0,2.0,3.717e-01,2.190e-01,6.310e-01,3.268e-01,1.836e-01,5.817e-01,4.530e-01,3.110e-02
APOE,613,protein-containing complex binding,GO:0044877,molecular function,116.0,76.0,3.742e-01,2.670e-01,5.243e-01,3.056e-01,2.388e-01,3.911e-01,4.715e-01,1.339e-02
AQP1,633,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043154,biological process,73.0,8.0,1.427e-01,4.754e-02,4.281e-01,8.692e-03,3.099e-03,2.438e-02,9.178e-01,1.411e-02
AQP1,633,water transport,GO:0006833,biological process,73.0,7.0,1.427e-01,4.754e-02,4.281e-01,1.211e-02,3.651e-03,4.018e-02,8.950e-01,2.051e-02
AQP1,633,glycerol transport,GO:0015793,biological process,73.0,4.0,1.427e-01,4.754e-02,4.281e-01,1.766e-02,5.709e-03,5.465e-02,8.668e-01,2.647e-02
AQP1,633,cellular response to inorganic substance,GO:0071241,biological process,73.0,18.0,1.529e-01,4.753e-02,4.922e-01,2.032e-02,3.700e-03,1.116e-01,8.471e-01,3.604e-02
AQP1,633,carbon dioxide transmembrane transport,GO:0035378,biological process,73.0,3.0,1.529e-01,4.753e-02,4.922e-01,2.948e-02,1.354e-02,6.416e-02,8.177e-01,2.027e-02
AQP1,633,carbon dioxide transport,GO:0015670,biological process,73.0,5.0,1.529e-01,4.753e-02,4.922e-01,3.133e-02,1.606e-02,6.114e-02,8.114e-01,1.756e-02
AQP1,633,cellular hyperosmotic response,GO:0071474,biological process,73.0,4.0,1.639e-01,4.565e-02,5.882e-01,3.496e-02,1.844e-02,6.631e-02,7.995e-01,1.672e-02
AQP1,633,cell volume homeostasis,GO:0006884,biological process,73.0,6.0,1.639e-01,4.565e-02,5.882e-01,4.169e-02,2.987e-02,5.819e-02,7.805e-01,8.974e-03
AQP1,633,cellular water homeostasis,GO:0009992,biological process,73.0,4.0,1.639e-01,4.565e-02,5.882e-01,4.166e-02,9.725e-03,1.784e-01,7.773e-01,3.844e-02
AQP1,633,hyperosmotic response,GO:0006972,biological process,73.0,4.0,1.639e-01,4.565e-02,5.882e-01,4.604e-02,1.297e-02,1.634e-01,7.666e-01,3.404e-02
AQP1,633,transepithelial water transport,GO:0035377,biological process,73.0,3.0,1.639e-01,4.565e-02,5.882e-01,4.711e-02,9.396e-03,2.362e-01,7.621e-01,4.393e-02
AQP1,633,cellular response to nitric oxide,GO:0071732,biological process,73.0,6.0,1.639e-01,4.565e-02,5.882e-01,6.487e-02,1.773e-02,2.374e-01,7.236e-01,3.987e-02
AQP1,633,cellular response to mechanical stimulus,GO:0071260,biological process,73.0,5.0,1.644e-01,4.557e-02,5.927e-01,6.259e-02,9.760e-03,4.014e-01,7.235e-01,5.597e-02
AQP1,633,renal water transport,GO:0003097,biological process,73.0,4.0,1.644e-01,4.557e-02,5.927e-01,7.614e-02,1.744e-02,3.324e-01,7.012e-01,4.605e-02
AQP1,633,cellular response to mercury ion,GO:0071288,biological process,73.0,3.0,1.652e-01,4.533e-02,6.022e-01,7.234e-02,1.892e-02,2.766e-01,7.101e-01,3.955e-02
AQP1,633,cellular response to copper ion,GO:0071280,biological process,73.0,3.0,1.657e-01,4.521e-02,6.077e-01,8.057e-02,1.757e-02,3.694e-01,6.937e-01,4.624e-02
AQP1,633,cellular response to salt stress,GO:0071472,biological process,73.0,7.0,1.663e-01,4.506e-02,6.138e-01,7.913e-02,1.592e-02,3.933e-01,6.952e-01,4.912e-02
AQP1,633,cellular response to UV,GO:0034644,biological process,73.0,10.0,1.668e-01,4.500e-02,6.184e-01,8.348e-02,7.775e-03,8.964e-01,6.782e-01,7.290e-02
AQP1,633,positive regulation of fibroblast proliferation,GO:0048146,biological process,73.0,6.0,1.812e-01,4.228e-02,7.764e-01,1.004e-01,1.360e-02,7.416e-01,6.550e-01,6.603e-02
AQP1,633,cellular homeostasis,GO:0019725,biological process,73.0,10.0,1.821e-01,4.156e-02,7.976e-01,8.517e-02,1.059e-02,6.850e-01,6.768e-01,7.170e-02
AQP1,633,cellular response to cAMP,GO:0071320,biological process,73.0,5.0,1.934e-01,9.304e-02,4.019e-01,1.012e-01,5.846e-02,1.753e-01,6.684e-01,1.933e-02
AQP1,633,nitric oxide transport,GO:0030185,biological process,73.0,4.0,1.944e-01,9.244e-02,4.088e-01,8.920e-02,6.205e-02,1.282e-01,6.871e-01,1.208e-02
AQP1,633,response to drug,GO:0042493,biological process,73.0,75.0,1.988e-01,6.887e-02,5.740e-01,1.236e-01,3.228e-02,4.735e-01,6.312e-01,4.754e-02
AQP1,633,cellular response to hypoxia,GO:0071456,biological process,73.0,5.0,2.005e-01,8.922e-02,4.504e-01,1.176e-01,3.968e-02,3.484e-01,6.416e-01,4.213e-02
AQP1,633,odontogenesis,GO:0042476,biological process,73.0,4.0,2.144e-01,7.063e-02,6.505e-01,1.496e-01,3.271e-02,6.846e-01,5.973e-01,5.664e-02
AQP1,633,cGMP-mediated signaling,GO:0019934,biological process,73.0,5.0,2.239e-01,9.067e-02,5.530e-01,1.685e-01,5.168e-02,5.496e-01,5.804e-01,5.208e-02
AQP1,633,ammonium transport,GO:0015696,biological process,73.0,23.0,2.273e-01,1.061e-01,4.870e-01,1.806e-01,9.631e-02,3.388e-01,5.745e-01,2.644e-02
AQP1,633,cellular response to hydrogen peroxide,GO:0070301,biological process,73.0,7.0,2.275e-01,7.861e-02,6.585e-01,1.654e-01,4.281e-02,6.391e-01,5.818e-01,5.619e-02
AQP1,633,establishment or maintenance of actin cytoskeleton polarity,GO:0030950,biological process,73.0,3.0,2.295e-01,7.133e-02,7.382e-01,1.598e-01,3.015e-02,8.467e-01,5.802e-01,7.593e-02
AQP1,633,maintenance of symbiont-containing vacuole by host,GO:0085018,biological process,73.0,2.0,2.395e-01,9.748e-02,5.886e-01,1.967e-01,7.987e-02,4.845e-01,5.562e-01,4.093e-02
AQP1,633,cerebrospinal fluid secretion,GO:0033326,biological process,73.0,3.0,2.494e-01,9.101e-02,6.837e-01,2.019e-01,6.463e-02,6.308e-01,5.486e-01,4.851e-02
AQP1,633,cellular response to retinoic acid,GO:0071300,biological process,73.0,5.0,2.538e-01,1.020e-01,6.315e-01,2.109e-01,8.415e-02,5.287e-01,5.421e-01,4.445e-02
AQP1,633,cellular response to dexamethasone stimulus,GO:0071549,biological process,73.0,6.0,2.571e-01,7.035e-02,9.395e-01,2.028e-01,3.622e-02,1.135e+00,5.355e-01,7.694e-02
AQP1,633,positive regulation of saliva secretion,GO:0046878,biological process,73.0,4.0,2.717e-01,7.478e-02,9.872e-01,2.281e-01,4.314e-02,1.206e+00,5.143e-01,7.307e-02
AQP1,633,positive regulation of angiogenesis,GO:0045766,biological process,73.0,12.0,2.746e-01,9.095e-02,8.292e-01,2.488e-01,8.163e-02,7.586e-01,5.063e-01,5.351e-02
AQP1,633,pancreatic juice secretion,GO:0030157,biological process,73.0,4.0,2.806e-01,1.102e-01,7.143e-01,2.601e-01,1.059e-01,6.390e-01,5.003e-01,4.347e-02
AQP1,633,multicellular organismal water homeostasis,GO:0050891,biological process,73.0,6.0,2.915e-01,6.479e-02,1.311e+00,2.433e-01,3.794e-02,1.560e+00,4.895e-01,9.582e-02
AQP1,633,negative regulation of apoptotic process,GO:0043066,biological process,73.0,25.0,3.495e-01,1.739e-01,7.024e-01,3.352e-01,1.687e-01,6.657e-01,4.450e-01,4.049e-02
AQP1,633,lateral ventricle development,GO:0021670,biological process,73.0,2.0,3.533e-01,1.171e-01,1.066e+00,3.036e-01,7.279e-02,1.267e+00,4.462e-01,8.976e-02
AQP1,633,sarcolemma,GO:0042383,cellular component,73.0,3.0,1.639e-01,4.565e-02,5.882e-01,2.975e-02,7.107e-03,1.246e-01,8.134e-01,3.504e-02
AQP1,633,brush border,GO:0005903,cellular component,73.0,2.0,1.639e-01,4.565e-02,5.882e-01,2.892e-02,3.395e-03,2.464e-01,8.084e-01,4.780e-02
AQP1,633,brush border membrane,GO:0031526,cellular component,73.0,2.0,1.639e-01,4.565e-02,5.882e-01,5.364e-02,5.672e-03,5.073e-01,7.408e-01,6.106e-02
AQP1,633,apical plasma membrane,GO:0016324,cellular component,73.0,4.0,1.639e-01,4.565e-02,5.882e-01,5.775e-02,2.147e-02,1.554e-01,7.408e-01,2.809e-02
AQP1,633,basal plasma membrane,GO:0009925,cellular component,73.0,2.0,1.657e-01,4.521e-02,6.077e-01,6.927e-02,2.057e-02,2.333e-01,7.161e-01,3.705e-02
AQP1,633,basolateral plasma membrane,GO:0016323,cellular component,73.0,4.0,1.843e-01,7.067e-02,4.807e-01,9.210e-02,2.465e-02,3.441e-01,6.751e-01,4.710e-02
AQP1,633,plasma membrane,GO:0005886,cellular component,73.0,67.0,1.957e-01,9.181e-02,4.171e-01,1.075e-01,5.309e-02,2.177e-01,6.586e-01,2.573e-02
AQP1,633,extracellular exosome,GO:0070062,cellular component,73.0,39.0,1.977e-01,1.040e-01,3.757e-01,7.358e-02,3.977e-02,1.361e-01,7.117e-01,1.858e-02
AQP1,633,cytoplasm,GO:0005737,cellular component,73.0,72.0,2.028e-01,1.074e-01,3.832e-01,1.207e-01,8.094e-02,1.801e-01,6.429e-01,1.521e-02
AQP1,633,apical part of cell,GO:0045177,cellular component,73.0,4.0,2.053e-01,1.154e-01,3.654e-01,9.600e-02,3.975e-02,2.319e-01,6.742e-01,2.860e-02
AQP1,633,integral component of membrane,GO:0016021,cellular component,73.0,19.0,2.060e-01,1.149e-01,3.694e-01,1.398e-01,8.491e-02,2.300e-01,6.194e-01,1.999e-02
AQP1,633,nuclear membrane,GO:0031965,cellular component,73.0,4.0,2.118e-01,1.029e-01,4.359e-01,1.387e-01,7.765e-02,2.479e-01,6.199e-01,2.278e-02
AQP1,633,nucleus,GO:0005634,cellular component,73.0,86.0,2.129e-01,1.324e-01,3.422e-01,1.560e-01,1.011e-01,2.406e-01,6.013e-01,1.784e-02
AQP1,633,symbiont-containing vacuole membrane,GO:0020005,cellular component,73.0,2.0,2.568e-01,9.055e-02,7.285e-01,2.172e-01,6.663e-02,7.082e-01,5.334e-01,5.337e-02
AQP1,633,carbon dioxide transmembrane transporter activity,GO:0035379,molecular function,73.0,2.0,1.427e-01,4.754e-02,4.281e-01,1.039e-02,2.789e-03,3.870e-02,9.044e-01,2.083e-02
AQP1,633,water channel activity,GO:0015250,molecular function,73.0,4.0,1.427e-01,4.754e-02,4.281e-01,1.546e-02,7.373e-03,3.242e-02,8.807e-01,1.631e-02
AQP1,633,water transmembrane transporter activity,GO:0005372,molecular function,73.0,3.0,1.639e-01,4.565e-02,5.882e-01,4.092e-02,6.565e-03,2.551e-01,7.767e-01,4.710e-02
AQP1,633,transmembrane transporter activity,GO:0022857,molecular function,73.0,42.0,1.643e-01,4.615e-02,5.848e-01,6.976e-02,2.451e-02,1.985e-01,7.167e-01,3.072e-02
AQP1,633,nitric oxide transmembrane transporter activity,GO:0030184,molecular function,73.0,3.0,1.657e-01,4.521e-02,6.077e-01,5.804e-02,7.083e-03,4.756e-01,7.322e-01,5.837e-02
AQP1,633,ammonium transmembrane transporter activity,GO:0008519,molecular function,73.0,22.0,1.696e-01,4.463e-02,6.446e-01,8.688e-02,1.817e-02,4.154e-01,6.822e-01,4.992e-02
AQP1,633,glycerol transmembrane transporter activity,GO:0015168,molecular function,73.0,5.0,1.823e-01,5.326e-02,6.240e-01,1.078e-01,2.347e-02,4.949e-01,6.505e-01,5.092e-02
AQP1,633,identical protein binding,GO:0042802,molecular function,73.0,24.0,2.028e-01,1.074e-01,3.832e-01,1.396e-01,7.825e-02,2.489e-01,6.191e-01,2.314e-02
AQP1,633,protein binding,GO:0005515,molecular function,73.0,318.0,2.066e-01,1.148e-01,3.718e-01,1.564e-01,1.097e-01,2.229e-01,6.012e-01,1.458e-02
AQP1,633,potassium channel activity,GO:0005267,molecular function,73.0,12.0,2.633e-01,8.380e-02,8.276e-01,2.273e-01,6.327e-02,8.163e-01,5.220e-01,6.060e-02
AQP1,633,intracellular cGMP-activated cation channel activity,GO:0005223,molecular function,73.0,2.0,2.662e-01,1.138e-01,6.225e-01,2.406e-01,1.164e-01,4.973e-01,5.189e-01,3.363e-02
AQP7,640,glycerol transport,GO:0015793,biological process,12.0,4.0,7.986e-02,2.814e-02,2.266e-01,5.468e-02,1.248e-02,2.396e-01,7.431e-01,4.549e-02
AQP7,640,water transport,GO:0006833,biological process,12.0,7.0,8.257e-02,2.600e-02,2.623e-01,6.916e-02,1.539e-02,3.107e-01,7.127e-01,4.906e-02
AQP7,640,integral component of plasma membrane,GO:0005887,cellular component,12.0,39.0,6.428e-02,3.582e-02,1.153e-01,2.385e-02,9.303e-03,6.115e-02,8.389e-01,2.226e-02
AQP7,640,cell-cell junction,GO:0005911,cellular component,12.0,18.0,6.892e-02,3.970e-02,1.197e-01,5.039e-02,2.841e-02,8.938e-02,7.585e-01,1.584e-02
AQP7,640,plasma membrane,GO:0005886,cellular component,12.0,67.0,7.586e-02,5.096e-02,1.129e-01,5.464e-02,3.619e-02,8.250e-02,7.490e-01,1.159e-02
AQP7,640,cytoplasm,GO:0005737,cellular component,12.0,72.0,1.201e-01,6.500e-02,2.219e-01,1.134e-01,6.668e-02,1.930e-01,6.518e-01,1.878e-02
AQP7,640,water channel activity,GO:0015250,molecular function,12.0,4.0,6.428e-02,3.582e-02,1.153e-01,2.336e-02,1.207e-02,4.520e-02,8.425e-01,1.651e-02
AQP7,640,urea transmembrane transporter activity,GO:0015204,molecular function,12.0,5.0,6.515e-02,3.469e-02,1.223e-01,2.441e-02,7.496e-03,7.951e-02,8.353e-01,2.871e-02
AQP7,640,glycerol channel activity,GO:0015254,molecular function,12.0,3.0,6.800e-02,4.093e-02,1.130e-01,3.014e-02,9.907e-03,9.172e-02,8.141e-01,2.765e-02
ARAP3,24097,ruffle,GO:0001726,cellular component,12.0,2.0,2.009e-02,6.094e-03,6.622e-02,1.098e-02,1.136e-03,1.061e-01,8.885e-01,2.974e-02
ARAP3,24097,"phosphatidylinositol-3,4,5-trisphosphate binding",GO:0005547,molecular function,12.0,2.0,8.658e-03,6.612e-03,1.134e-02,3.178e-03,7.446e-04,1.356e-02,9.555e-01,1.052e-02
ARAP3,24097,"phosphatidylinositol-3,4-bisphosphate binding",GO:0043325,molecular function,12.0,2.0,1.010e-02,5.639e-03,1.808e-02,5.133e-03,2.866e-03,9.193e-03,9.434e-01,4.903e-03
ARAP3,24097,protein binding,GO:0005515,molecular function,12.0,318.0,7.381e-02,4.419e-02,1.233e-01,7.381e-02,4.419e-02,1.233e-01,7.117e-01,1.617e-02
ARHGEF15,15590,regulation of catalytic activity,GO:0050790,biological process,7.0,15.0,6.422e-02,3.634e-02,1.135e-01,6.422e-02,3.634e-02,1.135e-01,7.292e-01,1.692e-02
ARHGEF15,15590,protein binding,GO:0005515,molecular function,7.0,318.0,5.451e-02,2.423e-02,1.226e-01,2.952e-02,5.805e-03,1.501e-01,8.127e-01,3.845e-02
ARHGEF15,15590,Rho guanyl-nucleotide exchange factor activity,GO:0005089,molecular function,7.0,5.0,5.755e-02,3.979e-02,8.326e-02,2.648e-02,1.793e-02,3.911e-02,8.300e-01,9.854e-03
ART3,725,,,,nan,nan,,,,,,,,
ASAP3,14987,,,,nan,nan,,,,,,,,
ASPHD1,27380,,,,nan,nan,,,,,,,,
ATOH8,24126,positive regulation of pri-miRNA transcription by RNA polymerase II,GO:1902895,biological process,15.0,4.0,7.748e-02,4.882e-02,1.230e-01,2.015e-02,1.377e-02,2.947e-02,8.574e-01,8.787e-03
ATOH8,24126,positive regulation of endothelial cell differentiation,GO:0045603,biological process,15.0,5.0,7.748e-02,4.882e-02,1.230e-01,2.469e-02,7.971e-03,7.649e-02,8.346e-01,2.772e-02
ATOH8,24126,positive regulation of endothelial cell migration,GO:0010595,biological process,15.0,8.0,7.748e-02,4.882e-02,1.230e-01,3.893e-02,1.948e-02,7.779e-02,7.875e-01,1.828e-02
ATOH8,24126,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,15.0,41.0,8.208e-02,5.916e-02,1.139e-01,4.186e-02,2.759e-02,6.353e-02,7.797e-01,1.131e-02
ATOH8,24126,negative regulation of endothelial cell proliferation,GO:0001937,biological process,15.0,6.0,1.050e-01,2.421e-02,4.551e-01,6.398e-02,7.246e-03,5.650e-01,7.151e-01,7.055e-02
ATOH8,24126,negative regulation of gene expression,GO:0010629,biological process,15.0,26.0,1.062e-01,5.324e-02,2.120e-01,6.845e-02,3.873e-02,1.210e-01,7.212e-01,1.698e-02
ATOH8,24126,SMAD protein signal transduction,GO:0060395,biological process,15.0,3.0,1.452e-01,5.136e-02,4.107e-01,1.206e-01,3.584e-02,4.061e-01,6.360e-01,4.815e-02
ATOH8,24126,tube formation,GO:0035148,biological process,15.0,7.0,1.793e-01,3.645e-02,8.821e-01,1.407e-01,1.305e-02,1.517e+00,5.910e-01,8.923e-02
ATOH8,24126,nucleus,GO:0005634,cellular component,15.0,86.0,1.486e-01,8.717e-02,2.532e-01,1.194e-01,9.447e-02,1.509e-01,6.453e-01,8.847e-03
ATOH8,24126,nucleoplasm,GO:0005654,cellular component,15.0,47.0,1.639e-01,1.139e-01,2.360e-01,1.447e-01,1.176e-01,1.780e-01,6.146e-01,8.252e-03
ATOH8,24126,E-box binding,GO:0070888,molecular function,15.0,5.0,7.748e-02,4.882e-02,1.230e-01,1.155e-02,6.436e-03,2.072e-02,9.035e-01,1.044e-02
ATOH8,24126,DNA-binding transcription factor activity,GO:0003700,molecular function,15.0,17.0,7.833e-02,5.081e-02,1.207e-01,3.210e-02,2.477e-02,4.159e-02,8.094e-01,6.734e-03
AZIN2,29957,putrescine biosynthetic process from ornithine,GO:0033387,biological process,18.0,3.0,6.387e-01,3.405e-01,1.198e+00,4.301e-01,1.333e-01,1.387e+00,3.640e-01,7.534e-02
AZIN2,29957,negative regulation of protein catabolic process,GO:0042177,biological process,18.0,9.0,6.390e-01,3.499e-01,1.167e+00,3.979e-01,2.924e-01,5.416e-01,4.066e-01,1.903e-02
AZIN2,29957,trans-Golgi network membrane organization,GO:0098629,biological process,18.0,2.0,7.138e-01,3.590e-01,1.419e+00,6.527e-01,2.426e-01,1.756e+00,2.016e-01,9.430e-02
AZIN2,29957,positive regulation of catalytic activity,GO:0043085,biological process,18.0,12.0,8.344e-01,7.674e-01,9.073e-01,8.014e-01,7.654e-01,8.391e-01,1.467e-01,6.478e-03
AZIN2,29957,transport vesicle,GO:0030133,cellular component,18.0,9.0,6.334e-01,3.379e-01,1.187e+00,1.952e-01,2.573e-02,1.481e+00,5.277e-01,1.053e-01
AZIN2,29957,granular vesicle,GO:1990005,cellular component,18.0,3.0,6.334e-01,3.379e-01,1.187e+00,2.035e-01,1.781e-02,2.326e+00,4.927e-01,1.416e-01
AZIN2,29957,perinuclear region of cytoplasm,GO:0048471,cellular component,18.0,8.0,6.334e-01,3.379e-01,1.187e+00,2.937e-01,1.430e-01,6.033e-01,4.751e-01,4.082e-02
AZIN2,29957,cytosol,GO:0005829,cellular component,18.0,50.0,6.334e-01,3.379e-01,1.187e+00,2.938e-01,1.136e-01,7.598e-01,4.725e-01,4.845e-02
AZIN2,29957,cytoplasm,GO:0005737,cellular component,18.0,72.0,6.334e-01,3.379e-01,1.187e+00,2.985e-01,1.184e-01,7.529e-01,4.691e-01,4.838e-02
AZIN2,29957,cytoplasmic vesicle,GO:0031410,cellular component,18.0,29.0,6.334e-01,3.379e-01,1.187e+00,2.845e-01,5.693e-02,1.422e+00,4.534e-01,1.016e-01
AZIN2,29957,nucleus,GO:0005634,cellular component,18.0,86.0,6.334e-01,3.379e-01,1.187e+00,3.582e-01,1.692e-01,7.582e-01,4.276e-01,4.351e-02
AZIN2,29957,trans-Golgi network,GO:0005802,cellular component,18.0,4.0,6.390e-01,3.499e-01,1.167e+00,4.245e-01,1.739e-01,1.036e+00,3.732e-01,6.831e-02
AZIN2,29957,perikaryon,GO:0043204,cellular component,18.0,3.0,6.390e-01,3.499e-01,1.167e+00,4.370e-01,1.769e-01,1.080e+00,3.639e-01,7.013e-02
AZIN2,29957,dendrite,GO:0030425,cellular component,18.0,13.0,6.585e-01,3.923e-01,1.105e+00,4.675e-01,2.941e-01,7.432e-01,3.582e-01,3.526e-02
AZIN2,29957,axon,GO:0030424,cellular component,18.0,12.0,6.867e-01,4.489e-01,1.051e+00,5.397e-01,4.180e-01,6.968e-01,3.159e-01,2.156e-02
AZIN2,29957,protein binding,GO:0005515,molecular function,18.0,318.0,6.334e-01,3.379e-01,1.187e+00,3.560e-01,1.857e-01,6.827e-01,4.312e-01,3.675e-02
AZIN2,29957,ornithine decarboxylase activator activity,GO:0042978,molecular function,18.0,3.0,7.757e-01,5.679e-01,1.060e+00,7.139e-01,5.332e-01,9.558e-01,2.020e-01,3.308e-02
B3GNT3,13528,protein O-linked glycosylation,GO:0006493,biological process,12.0,10.0,8.976e-02,5.180e-02,1.555e-01,2.693e-02,1.178e-02,6.161e-02,8.268e-01,2.026e-02
B3GNT3,13528,poly-N-acetyllactosamine biosynthetic process,GO:0030311,biological process,12.0,4.0,9.882e-02,6.656e-02,1.467e-01,5.195e-02,2.647e-02,1.020e-01,7.544e-01,1.922e-02
B3GNT3,13528,protein glycosylation,GO:0006486,biological process,12.0,17.0,1.100e-01,4.544e-02,2.663e-01,5.582e-02,1.378e-02,2.262e-01,7.417e-01,4.229e-02
B3GNT3,13528,endoplasmic reticulum,GO:0005783,cellular component,12.0,16.0,1.380e-01,2.804e-02,6.788e-01,9.267e-02,1.036e-02,8.293e-01,6.605e-01,8.138e-02
B3GNT3,13528,Golgi apparatus,GO:0005794,cellular component,12.0,16.0,1.747e-01,3.273e-02,9.320e-01,1.544e-01,2.277e-02,1.048e+00,5.805e-01,8.596e-02
B3GNT3,13528,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity",GO:0008532,molecular function,12.0,2.0,8.976e-02,5.180e-02,1.555e-01,2.101e-02,7.320e-03,6.030e-02,8.513e-01,2.561e-02
B3GNT3,13528,acetylgalactosaminyltransferase activity,GO:0008376,molecular function,12.0,14.0,9.676e-02,6.185e-02,1.514e-01,5.206e-02,4.710e-02,5.755e-02,7.551e-01,2.817e-03
B3GNT3,13528,acetylglucosaminyltransferase activity,GO:0008375,molecular function,12.0,36.0,1.108e-01,4.627e-02,2.653e-01,7.293e-02,3.178e-02,1.674e-01,7.117e-01,2.642e-02
B3GNT3,13528,"transferase activity, transferring hexosyl groups",GO:0016758,molecular function,12.0,205.0,1.914e-01,8.240e-02,4.447e-01,1.760e-01,9.357e-02,3.312e-01,5.791e-01,2.630e-02
BAALC,14333,,,,nan,nan,,,,,,,,
BAIAP2L2,26203,actin crosslink formation,GO:0051764,biological process,10.0,2.0,2.824e-01,2.095e-01,3.807e-01,6.601e-02,4.266e-02,1.021e-01,7.261e-01,1.303e-02
BAIAP2L2,26203,actin filament bundle assembly,GO:0051017,biological process,10.0,7.0,3.172e-01,2.735e-01,3.680e-01,1.313e-01,7.307e-02,2.361e-01,6.289e-01,2.246e-02
BAIAP2L2,26203,positive regulation of actin filament polymerization,GO:0030838,biological process,10.0,11.0,3.651e-01,2.283e-01,5.839e-01,2.993e-01,1.587e-01,5.646e-01,4.722e-01,3.598e-02
BAIAP2L2,26203,positive regulation of actin cytoskeleton reorganization,GO:2000251,biological process,10.0,4.0,3.724e-01,2.484e-01,5.584e-01,3.103e-01,2.126e-01,4.528e-01,4.671e-01,2.097e-02
BAIAP2L2,26203,cell-cell contact zone,GO:0044291,cellular component,10.0,5.0,2.798e-01,2.012e-01,3.890e-01,4.933e-02,1.484e-02,1.639e-01,7.585e-01,3.349e-02
BAIAP2L2,26203,cytosol,GO:0005829,cellular component,10.0,50.0,3.196e-01,2.819e-01,3.624e-01,1.655e-01,1.280e-01,2.139e-01,5.919e-01,1.063e-02
BAIAP2L2,26203,nucleoplasm,GO:0005654,cellular component,10.0,47.0,3.196e-01,2.819e-01,3.624e-01,1.706e-01,1.139e-01,2.554e-01,5.860e-01,1.664e-02
BAIAP2L2,26203,clathrin complex,GO:0071439,cellular component,10.0,2.0,3.651e-01,2.283e-01,5.839e-01,3.240e-01,1.683e-01,6.239e-01,4.533e-01,3.911e-02
BAIAP2L2,26203,vesicle membrane,GO:0012506,cellular component,10.0,5.0,3.866e-01,2.702e-01,5.529e-01,3.429e-01,2.761e-01,4.258e-01,4.448e-01,1.237e-02
BAIAP3,948,,,,nan,nan,,,,,,,,
BATF2,25163,regulation of transcription by RNA polymerase II,GO:0006357,biological process,8.0,51.0,3.487e-02,1.787e-02,6.805e-02,2.699e-02,1.024e-02,7.115e-02,8.262e-01,2.429e-02
BATF2,25163,nucleus,GO:0005634,cellular component,8.0,86.0,3.266e-02,2.022e-02,5.273e-02,1.774e-02,1.419e-02,2.218e-02,8.702e-01,4.972e-03
BATF2,25163,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,8.0,17.0,3.266e-02,2.022e-02,5.273e-02,9.964e-03,7.432e-03,1.336e-02,9.143e-01,3.997e-03
BATF2,25163,RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,molecular function,8.0,30.0,3.266e-02,2.022e-02,5.273e-02,2.223e-02,1.834e-02,2.695e-02,8.481e-01,4.779e-03
BATF2,25163,protein binding,GO:0005515,molecular function,8.0,318.0,3.994e-02,2.742e-02,5.818e-02,3.994e-02,2.742e-02,5.818e-02,7.852e-01,1.012e-02
BATF3,28915,regulation of transcription by RNA polymerase II,GO:0006357,biological process,9.0,51.0,2.837e-02,1.951e-02,4.126e-02,1.283e-02,4.936e-03,3.334e-02,8.932e-01,1.556e-02
BATF3,28915,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,9.0,55.0,2.837e-02,1.951e-02,4.126e-02,1.578e-02,7.129e-03,3.492e-02,8.780e-01,1.567e-02
BATF3,28915,nucleus,GO:0005634,cellular component,9.0,86.0,2.993e-02,1.869e-02,4.791e-02,2.565e-02,1.602e-02,4.107e-02,8.330e-01,1.180e-02
BATF3,28915,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,9.0,17.0,2.837e-02,1.951e-02,4.126e-02,7.935e-03,4.714e-03,1.336e-02,9.258e-01,5.875e-03
BATF3,28915,"DNA-binding transcription repressor activity, RNA polymerase II-specific",GO:0001227,molecular function,9.0,10.0,2.837e-02,1.951e-02,4.126e-02,1.479e-02,1.289e-02,1.696e-02,8.868e-01,2.981e-03
BATF3,28915,RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,molecular function,9.0,30.0,2.890e-02,1.904e-02,4.387e-02,2.175e-02,1.694e-02,2.794e-02,8.503e-01,6.247e-03
BATF3,28915,protein binding,GO:0005515,molecular function,9.0,318.0,6.001e-02,2.701e-02,1.333e-01,6.001e-02,2.701e-02,1.333e-01,7.365e-01,2.364e-02
BCL6B,1002,regulation of cell population proliferation,GO:0042127,biological process,9.0,37.0,1.178e-01,6.459e-02,2.147e-01,5.415e-02,3.040e-02,9.646e-02,7.498e-01,1.652e-02
BCL6B,1002,regulation of cell differentiation,GO:0045595,biological process,9.0,44.0,1.401e-01,1.086e-01,1.807e-01,6.553e-02,3.564e-02,1.205e-01,7.266e-01,1.825e-02
BCL6B,1002,type 2 immune response,GO:0042092,biological process,9.0,2.0,1.431e-01,1.102e-01,1.858e-01,9.763e-02,3.696e-02,2.579e-01,6.708e-01,3.264e-02
BCL6B,1002,regulation of inflammatory response,GO:0050727,biological process,9.0,15.0,1.550e-01,9.126e-02,2.632e-01,1.288e-01,6.566e-02,2.528e-01,6.313e-01,2.561e-02
BCL6B,1002,nucleus,GO:0005634,cellular component,9.0,86.0,1.798e-01,1.188e-01,2.721e-01,1.662e-01,8.681e-02,3.183e-01,5.892e-01,2.693e-02
BCL6B,1002,RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000977,molecular function,9.0,16.0,1.172e-01,6.342e-02,2.167e-01,3.987e-02,9.920e-03,1.602e-01,7.822e-01,3.859e-02
BCL6B,1002,"DNA-binding transcription repressor activity, RNA polymerase II-specific",GO:0001227,molecular function,9.0,10.0,1.172e-01,6.342e-02,2.167e-01,4.145e-02,8.453e-03,2.033e-01,7.764e-01,4.449e-02
BCL6B,1002,DNA binding,GO:0003677,molecular function,9.0,29.0,1.192e-01,6.315e-02,2.251e-01,7.663e-02,2.679e-02,2.192e-01,7.041e-01,3.242e-02
BCO2,18503,,,,nan,nan,,,,,,,,
BHLHB9,29353,extracellular exosome,GO:0070062,cellular component,8.0,39.0,1.963e-02,1.429e-02,2.697e-02,1.394e-02,9.340e-03,2.082e-02,8.906e-01,7.489e-03
BHLHB9,29353,cytosol,GO:0005829,cellular component,8.0,50.0,1.963e-02,1.429e-02,2.697e-02,1.692e-02,1.292e-02,2.215e-02,8.744e-01,5.993e-03
BHLHB9,29353,nucleoplasm,GO:0005654,cellular component,8.0,47.0,1.963e-02,1.429e-02,2.697e-02,1.956e-02,1.406e-02,2.720e-02,8.604e-01,7.531e-03
BHLHE41,16617,circadian regulation of gene expression,GO:0032922,biological process,15.0,4.0,4.708e-02,2.769e-02,8.006e-02,6.309e-03,2.060e-03,1.932e-02,9.330e-01,1.213e-02
BHLHE41,16617,cell differentiation,GO:0030154,biological process,15.0,91.0,5.758e-02,4.669e-02,7.102e-02,2.853e-02,1.870e-02,4.352e-02,8.219e-01,1.086e-02
BHLHE41,16617,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,15.0,55.0,5.758e-02,4.669e-02,7.102e-02,2.953e-02,1.587e-02,5.495e-02,8.180e-01,1.611e-02
BHLHE41,16617,regulation of neurogenesis,GO:0050767,biological process,15.0,9.0,7.021e-02,4.336e-02,1.137e-01,4.823e-02,2.862e-02,8.128e-02,7.634e-01,1.456e-02
BHLHE41,16617,anterior/posterior pattern specification,GO:0009952,biological process,15.0,18.0,1.003e-01,3.708e-02,2.715e-01,9.256e-02,3.420e-02,2.505e-01,6.780e-01,3.406e-02
BHLHE41,16617,nucleus,GO:0005634,cellular component,15.0,86.0,8.295e-02,4.615e-02,1.491e-01,6.839e-02,3.930e-02,1.190e-01,7.213e-01,1.644e-02
BHLHE41,16617,E-box binding,GO:0070888,molecular function,15.0,5.0,4.773e-02,2.768e-02,8.228e-02,9.207e-03,4.930e-03,1.719e-02,9.175e-01,8.930e-03
BHLHE41,16617,RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000977,molecular function,15.0,16.0,4.773e-02,2.768e-02,8.228e-02,9.023e-03,1.926e-03,4.227e-02,9.117e-01,1.760e-02
BHLHE41,16617,"DNA-binding transcription repressor activity, RNA polymerase II-specific",GO:0001227,molecular function,15.0,10.0,4.880e-02,3.048e-02,7.814e-02,1.666e-02,8.806e-03,3.152e-02,8.744e-01,1.296e-02
BHLHE41,16617,transcription corepressor activity,GO:0003714,molecular function,15.0,5.0,5.559e-02,5.027e-02,6.146e-02,2.876e-02,1.464e-02,5.651e-02,8.206e-01,1.717e-02
BHLHE41,16617,bHLH transcription factor binding,GO:0043425,molecular function,15.0,3.0,5.894e-02,5.131e-02,6.770e-02,3.678e-02,2.728e-02,4.958e-02,7.944e-01,8.026e-03
BHLHE41,16617,protein heterodimerization activity,GO:0046982,molecular function,15.0,8.0,8.295e-02,4.615e-02,1.491e-01,6.840e-02,3.312e-02,1.412e-01,7.207e-01,2.131e-02
BHLHE41,16617,protein binding,GO:0005515,molecular function,15.0,318.0,1.517e-01,8.459e-02,2.720e-01,1.517e-01,8.459e-02,2.720e-01,6.053e-01,2.397e-02
BLCAP,1055,apoptotic nuclear changes,GO:0030262,biological process,5.0,2.0,1.000e-01,3.813e-02,2.625e-01,1.000e-01,3.813e-02,2.625e-01,6.675e-01,3.214e-02
BLCAP,1055,protein binding,GO:0005515,molecular function,5.0,318.0,1.000e-01,3.813e-02,2.625e-01,6.155e-02,2.101e-02,1.803e-01,7.322e-01,3.181e-02
BMP5,1072,positive regulation of epithelial cell proliferation,GO:0050679,biological process,18.0,18.0,6.470e-02,2.183e-02,1.918e-01,1.139e-02,8.144e-03,1.592e-02,9.059e-01,5.273e-03
BMP5,1072,positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0010862,biological process,18.0,4.0,6.470e-02,2.183e-02,1.918e-01,1.860e-02,1.000e-02,3.460e-02,8.646e-01,1.462e-02
BMP5,1072,negative regulation of aldosterone biosynthetic process,GO:0032348,biological process,18.0,5.0,6.595e-02,2.243e-02,1.938e-01,2.078e-02,8.940e-03,4.832e-02,8.526e-01,1.919e-02
BMP5,1072,BMP signaling pathway,GO:0030509,biological process,18.0,18.0,6.615e-02,2.080e-02,2.104e-01,1.940e-02,1.577e-03,2.386e-01,8.429e-01,5.759e-02
BMP5,1072,negative regulation of cortisol biosynthetic process,GO:2000065,biological process,18.0,4.0,6.656e-02,2.200e-02,2.013e-01,2.865e-02,1.069e-02,7.678e-02,8.198e-01,2.479e-02
BMP5,1072,negative regulation of steroid biosynthetic process,GO:0010894,biological process,18.0,14.0,6.742e-02,2.141e-02,2.123e-01,3.010e-02,7.136e-03,1.270e-01,8.131e-01,3.817e-02
BMP5,1072,negative regulation of insulin-like growth factor receptor signaling pathway,GO:0043569,biological process,18.0,3.0,6.753e-02,2.309e-02,1.975e-01,2.975e-02,8.360e-03,1.059e-01,8.148e-01,3.147e-02
BMP5,1072,positive regulation of dendrite development,GO:1900006,biological process,18.0,5.0,7.791e-02,3.442e-02,1.763e-01,2.957e-02,4.171e-03,2.097e-01,8.088e-01,4.541e-02
BMP5,1072,positive regulation of cell population proliferation,GO:0008284,biological process,18.0,38.0,8.007e-02,2.245e-02,2.856e-01,4.895e-02,8.356e-03,2.868e-01,7.543e-01,5.324e-02
BMP5,1072,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,18.0,69.0,8.981e-02,4.565e-02,1.767e-01,4.770e-02,1.452e-02,1.568e-01,7.622e-01,3.443e-02
BMP5,1072,negative regulation of cell population proliferation,GO:0008285,biological process,18.0,34.0,9.720e-02,4.525e-02,2.088e-01,8.045e-02,4.421e-02,1.464e-01,7.001e-01,1.952e-02
BMP5,1072,type B pancreatic cell development,GO:0003323,biological process,18.0,2.0,9.950e-02,4.416e-02,2.242e-01,8.032e-02,3.479e-02,1.854e-01,6.993e-01,2.590e-02
BMP5,1072,SMAD protein signal transduction,GO:0060395,biological process,18.0,3.0,1.012e-01,3.630e-02,2.819e-01,8.636e-02,2.960e-02,2.519e-01,6.868e-01,3.718e-02
BMP5,1072,extracellular space,GO:0005615,cellular component,18.0,24.0,1.685e-01,1.100e-01,2.579e-01,1.649e-01,1.134e-01,2.397e-01,5.921e-01,1.532e-02
BMP5,1072,cytokine activity,GO:0005125,molecular function,18.0,5.0,7.439e-02,3.014e-02,1.836e-01,3.711e-02,1.218e-02,1.131e-01,7.916e-01,3.053e-02
BMP5,1072,BMP receptor binding,GO:0070700,molecular function,18.0,2.0,9.906e-02,2.862e-02,3.429e-01,7.987e-02,1.595e-02,4.000e-01,6.911e-01,5.660e-02
BST2,1119,defense response to virus,GO:0051607,biological process,24.0,11.0,2.963e-01,1.754e-01,5.004e-01,5.157e-02,1.787e-02,1.488e-01,7.540e-01,3.014e-02
BST2,1119,negative regulation of viral genome replication,GO:0045071,biological process,24.0,8.0,2.963e-01,1.754e-01,5.004e-01,1.177e-01,5.471e-02,2.534e-01,6.447e-01,2.839e-02
BST2,1119,positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043123,biological process,24.0,12.0,2.963e-01,1.754e-01,5.004e-01,1.420e-01,5.769e-02,3.495e-01,6.137e-01,3.696e-02
BST2,1119,innate immune response,GO:0045087,biological process,24.0,24.0,2.976e-01,1.753e-01,5.052e-01,1.134e-01,3.477e-02,3.701e-01,6.459e-01,4.564e-02
BST2,1119,response to virus,GO:0009615,biological process,24.0,10.0,3.661e-01,2.846e-01,4.709e-01,2.801e-01,1.815e-01,4.324e-01,4.895e-01,2.174e-02
BST2,1119,negative regulation of cell migration,GO:0030336,biological process,24.0,29.0,3.693e-01,2.027e-01,6.727e-01,3.124e-01,1.590e-01,6.140e-01,4.618e-01,3.896e-02
BST2,1119,negative regulation of plasmacytoid dendritic cell cytokine production,GO:0002737,biological process,24.0,3.0,3.790e-01,1.450e-01,9.908e-01,2.959e-01,8.057e-02,1.087e+00,4.635e-01,6.622e-02
BST2,1119,negative regulation of cell growth,GO:0030308,biological process,24.0,18.0,4.233e-01,2.460e-01,7.285e-01,3.657e-01,2.062e-01,6.488e-01,4.248e-01,3.658e-02
BST2,1119,negative regulation of intracellular transport of viral material,GO:1901253,biological process,24.0,4.0,4.955e-01,1.801e-01,1.363e+00,4.719e-01,1.455e-01,1.531e+00,3.336e-01,7.944e-02
BST2,1119,cell surface,GO:0009986,cellular component,24.0,20.0,2.963e-01,1.754e-01,5.004e-01,1.141e-01,6.769e-02,1.925e-01,6.508e-01,1.956e-02
BST2,1119,plasma membrane,GO:0005886,cellular component,24.0,67.0,2.963e-01,1.754e-01,5.004e-01,1.453e-01,9.311e-02,2.268e-01,6.133e-01,1.818e-02
BST2,1119,extracellular exosome,GO:0070062,cellular component,24.0,39.0,2.963e-01,1.754e-01,5.004e-01,1.475e-01,8.469e-02,2.570e-01,6.101e-01,2.238e-02
BST2,1119,cytosol,GO:0005829,cellular component,24.0,50.0,2.963e-01,1.754e-01,5.004e-01,1.623e-01,1.195e-01,2.206e-01,5.949e-01,1.270e-02
BST2,1119,membrane,GO:0016020,cellular component,24.0,41.0,2.963e-01,1.754e-01,5.004e-01,1.655e-01,9.005e-02,3.043e-01,5.902e-01,2.515e-02
BST2,1119,Golgi apparatus,GO:0005794,cellular component,24.0,16.0,2.963e-01,1.754e-01,5.004e-01,1.761e-01,7.473e-02,4.152e-01,5.772e-01,3.696e-02
BST2,1119,cytoplasm,GO:0005737,cellular component,24.0,72.0,2.981e-01,1.802e-01,4.933e-01,1.828e-01,1.379e-01,2.422e-01,5.741e-01,1.197e-02
BST2,1119,multivesicular body,GO:0005771,cellular component,24.0,2.0,3.515e-01,1.612e-01,7.664e-01,2.765e-01,1.111e-01,6.882e-01,4.870e-01,4.487e-02
BST2,1119,identical protein binding,GO:0042802,molecular function,24.0,24.0,2.963e-01,1.754e-01,5.004e-01,8.303e-02,5.135e-02,1.343e-01,6.964e-01,1.505e-02
BST2,1119,protein homodimerization activity,GO:0042803,molecular function,24.0,23.0,2.963e-01,1.754e-01,5.004e-01,1.379e-01,8.651e-02,2.200e-01,6.217e-01,1.799e-02
BST2,1119,RNA binding,GO:0003723,molecular function,24.0,44.0,2.963e-01,1.754e-01,5.004e-01,1.665e-01,9.452e-02,2.931e-01,5.895e-01,2.327e-02
BST2,1119,protein binding,GO:0005515,molecular function,24.0,318.0,3.018e-01,1.863e-01,4.888e-01,2.175e-01,1.484e-01,3.189e-01,5.414e-01,1.755e-02
BST2,1119,metalloendopeptidase inhibitor activity,GO:0008191,molecular function,24.0,2.0,5.019e-01,2.815e-01,8.951e-01,4.866e-01,2.876e-01,8.235e-01,3.452e-01,3.704e-02
BTNL9,24176,,,,nan,nan,,,,,,,,
C2,1248,,,,nan,nan,,,,,,,,
C2CD3,24564,non-motile cilium assembly,GO:1905515,biological process,11.0,2.0,1.638e-02,7.988e-03,3.359e-02,2.400e-03,1.251e-03,4.605e-03,9.650e-01,3.593e-03
C2CD3,24564,centriole elongation,GO:0061511,biological process,11.0,2.0,2.342e-02,7.143e-03,7.681e-02,1.048e-02,1.286e-03,8.542e-02,8.944e-01,3.150e-02
C2CD3,24564,protein localization to centrosome,GO:0071539,biological process,11.0,4.0,3.750e-02,2.328e-02,6.041e-02,2.150e-02,1.337e-02,3.456e-02,8.512e-01,1.163e-02
C2CD3,24564,centriole,GO:0005814,cellular component,11.0,3.0,2.472e-02,9.038e-03,6.761e-02,1.114e-02,3.641e-03,3.407e-02,9.019e-01,1.639e-02
C2CD3,24564,centrosome,GO:0005813,cellular component,11.0,11.0,4.122e-02,2.558e-02,6.643e-02,2.640e-02,1.080e-02,6.453e-02,8.287e-01,2.214e-02
C2CD3,24564,centriolar satellite,GO:0034451,cellular component,11.0,5.0,4.122e-02,2.558e-02,6.643e-02,3.533e-02,2.192e-02,5.694e-02,7.987e-01,1.271e-02
C2CD3,24564,protein binding,GO:0005515,molecular function,11.0,318.0,5.943e-02,5.554e-02,6.359e-02,5.943e-02,5.554e-02,6.359e-02,7.394e-01,1.982e-03
CABP4,1386,,,,nan,nan,,,,,,,,
CAPN12,13249,cytoplasm,GO:0005737,cellular component,3.0,72.0,4.082e-02,2.284e-02,7.296e-02,4.067e-02,2.276e-02,7.267e-02,7.829e-01,1.574e-02
CAPN12,13249,calcium-dependent cysteine-type endopeptidase activity,GO:0004198,molecular function,3.0,2.0,4.082e-02,2.284e-02,7.296e-02,3.754e-02,2.441e-02,5.773e-02,7.921e-01,1.146e-02
CBX7,1557,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,8.0,55.0,1.060e-01,7.479e-02,1.503e-01,9.567e-02,5.890e-02,1.554e-01,6.769e-01,1.631e-02
CBX7,1557,nuclear chromatin,GO:0000790,cellular component,8.0,11.0,8.059e-02,5.615e-02,1.157e-01,2.472e-02,2.013e-02,3.035e-02,8.370e-01,5.125e-03
CBX7,1557,cytosol,GO:0005829,cellular component,8.0,50.0,8.059e-02,5.615e-02,1.157e-01,4.351e-02,3.381e-02,5.600e-02,7.757e-01,6.768e-03
CBX7,1557,nucleoplasm,GO:0005654,cellular component,8.0,47.0,8.059e-02,5.615e-02,1.157e-01,4.339e-02,2.745e-02,6.860e-02,7.757e-01,1.248e-02
CBX7,1557,nucleus,GO:0005634,cellular component,8.0,86.0,8.059e-02,5.615e-02,1.157e-01,4.872e-02,2.316e-02,1.025e-01,7.618e-01,2.042e-02
CBX7,1557,PcG protein complex,GO:0031519,cellular component,8.0,5.0,2.062e-01,6.223e-02,6.832e-01,1.959e-01,4.986e-02,7.694e-01,5.507e-01,5.794e-02
CBX7,1557,protein binding,GO:0005515,molecular function,8.0,318.0,8.224e-02,6.084e-02,1.112e-01,5.538e-02,3.828e-02,8.012e-02,7.476e-01,1.068e-02
CCDC85B,24926,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,10.0,39.0,1.067e-01,4.768e-02,2.386e-01,9.191e-02,3.199e-02,2.641e-01,6.783e-01,3.735e-02
CCDC85B,24926,negative regulation of cell growth,GO:0030308,biological process,10.0,18.0,1.517e-01,1.039e-01,2.215e-01,1.495e-01,1.048e-01,2.132e-01,6.090e-01,1.402e-02
CCDC85B,24926,nucleus,GO:0005634,cellular component,10.0,86.0,9.155e-02,3.738e-02,2.242e-01,2.762e-02,1.653e-02,4.615e-02,8.253e-01,1.307e-02
CCDC85B,24926,centrosome,GO:0005813,cellular component,10.0,11.0,9.221e-02,3.677e-02,2.313e-01,4.437e-02,1.891e-02,1.041e-01,7.724e-01,2.301e-02
CCDC85B,24926,protein binding,GO:0005515,molecular function,10.0,318.0,9.221e-02,3.677e-02,2.313e-01,4.875e-02,1.594e-02,1.491e-01,7.600e-01,3.248e-02
CCL5,10632,positive regulation of phosphorylation,GO:0042327,biological process,82.0,7.0,9.545e-02,4.895e-02,1.861e-01,9.263e-03,1.656e-03,5.181e-02,9.078e-01,2.111e-02
CCL5,10632,positive regulation of ERK1 and ERK2 cascade,GO:0070374,biological process,82.0,7.0,9.545e-02,4.895e-02,1.861e-01,1.423e-02,7.803e-03,2.596e-02,8.882e-01,1.167e-02
CCL5,10632,positive regulation of smooth muscle cell migration,GO:0014911,biological process,82.0,7.0,9.545e-02,4.895e-02,1.861e-01,1.371e-02,2.840e-03,6.618e-02,8.812e-01,2.517e-02
CCL5,10632,chemokine-mediated signaling pathway,GO:0070098,biological process,82.0,15.0,9.545e-02,4.895e-02,1.861e-01,1.552e-02,5.957e-03,4.043e-02,8.786e-01,2.087e-02
CCL5,10632,positive regulation of T cell chemotaxis,GO:0010820,biological process,82.0,4.0,9.545e-02,4.895e-02,1.861e-01,1.512e-02,3.229e-03,7.080e-02,8.732e-01,2.642e-02
CCL5,10632,positive regulation of cell adhesion,GO:0045785,biological process,82.0,10.0,9.671e-02,4.886e-02,1.914e-01,2.641e-02,2.162e-02,3.225e-02,8.303e-01,4.960e-03
CCL5,10632,positive regulation of smooth muscle cell proliferation,GO:0048661,biological process,82.0,6.0,9.884e-02,5.690e-02,1.717e-01,1.868e-02,4.467e-03,7.811e-02,8.582e-01,3.093e-02
CCL5,10632,positive regulation of T cell migration,GO:2000406,biological process,82.0,8.0,9.990e-02,4.580e-02,2.179e-01,2.615e-02,6.964e-03,9.818e-02,8.286e-01,3.404e-02
CCL5,10632,leukocyte cell-cell adhesion,GO:0007159,biological process,82.0,7.0,1.007e-01,4.784e-02,2.120e-01,2.114e-02,2.990e-03,1.495e-01,8.438e-01,4.792e-02
CCL5,10632,positive regulation of monocyte chemotaxis,GO:0090026,biological process,82.0,7.0,1.022e-01,4.405e-02,2.373e-01,3.362e-02,6.704e-03,1.686e-01,7.998e-01,4.387e-02
CCL5,10632,positive regulation of calcium ion transport,GO:0051928,biological process,82.0,8.0,1.030e-01,4.612e-02,2.301e-01,3.666e-02,1.549e-02,8.675e-02,7.938e-01,2.335e-02
CCL5,10632,lipopolysaccharide-mediated signaling pathway,GO:0031663,biological process,82.0,2.0,1.033e-01,4.612e-02,2.314e-01,4.051e-02,2.066e-02,7.943e-02,7.831e-01,1.846e-02
CCL5,10632,positive regulation of natural killer cell chemotaxis,GO:2000503,biological process,82.0,3.0,1.046e-01,4.606e-02,2.375e-01,3.000e-02,7.170e-03,1.255e-01,8.127e-01,3.493e-02
CCL5,10632,lymphocyte chemotaxis,GO:0048247,biological process,82.0,7.0,1.054e-01,4.598e-02,2.416e-01,4.515e-02,1.526e-02,1.336e-01,7.694e-01,2.950e-02
CCL5,10632,protein kinase B signaling,GO:0043491,biological process,82.0,2.0,1.057e-01,4.559e-02,2.448e-01,4.265e-02,8.741e-03,2.080e-01,7.726e-01,4.591e-02
CCL5,10632,regulation of T cell activation,GO:0050863,biological process,82.0,14.0,1.074e-01,4.566e-02,2.527e-01,4.933e-02,1.372e-02,1.773e-01,7.582e-01,3.564e-02
CCL5,10632,positive regulation of cell-cell adhesion mediated by integrin,GO:0033634,biological process,82.0,4.0,1.079e-01,4.474e-02,2.601e-01,5.234e-02,1.247e-02,2.196e-01,7.504e-01,3.981e-02
CCL5,10632,positive regulation of T cell proliferation,GO:0042102,biological process,82.0,11.0,1.083e-01,4.546e-02,2.581e-01,2.987e-02,1.982e-03,4.503e-01,7.968e-01,6.163e-02
CCL5,10632,positive regulation of cell migration,GO:0030335,biological process,82.0,31.0,1.090e-01,4.899e-02,2.426e-01,5.031e-02,2.041e-02,1.241e-01,7.572e-01,2.601e-02
CCL5,10632,positive regulation of GTPase activity,GO:0043547,biological process,82.0,6.0,1.111e-01,4.300e-02,2.868e-01,6.094e-02,1.635e-02,2.272e-01,7.322e-01,3.824e-02
CCL5,10632,positive regulation of phosphatidylinositol 3-kinase signaling,GO:0014068,biological process,82.0,5.0,1.113e-01,5.834e-02,2.125e-01,5.183e-02,4.168e-02,6.447e-02,7.556e-01,6.021e-03
CCL5,10632,monocyte chemotaxis,GO:0002548,biological process,82.0,5.0,1.124e-01,4.424e-02,2.854e-01,5.709e-02,1.378e-02,2.365e-01,7.396e-01,4.036e-02
CCL5,10632,positive regulation of T cell apoptotic process,GO:0070234,biological process,82.0,8.0,1.125e-01,5.151e-02,2.457e-01,6.531e-02,2.469e-02,1.728e-01,7.255e-01,2.820e-02
CCL5,10632,positive regulation of homotypic cell-cell adhesion,GO:0034112,biological process,82.0,5.0,1.129e-01,4.320e-02,2.951e-01,6.339e-02,1.496e-02,2.687e-01,7.265e-01,4.133e-02
CCL5,10632,exocytosis,GO:0006887,biological process,82.0,8.0,1.137e-01,5.618e-02,2.303e-01,6.288e-02,3.182e-02,1.242e-01,7.314e-01,1.980e-02
CCL5,10632,G protein-coupled receptor signaling pathway,GO:0007186,biological process,82.0,48.0,1.146e-01,4.855e-02,2.707e-01,5.122e-02,7.976e-03,3.289e-01,7.484e-01,5.550e-02
CCL5,10632,neutrophil chemotaxis,GO:0030593,biological process,82.0,5.0,1.155e-01,4.241e-02,3.145e-01,6.266e-02,1.490e-02,2.635e-01,7.266e-01,4.470e-02
CCL5,10632,positive regulation of macrophage chemotaxis,GO:0010759,biological process,82.0,6.0,1.184e-01,4.877e-02,2.874e-01,6.249e-02,1.674e-02,2.333e-01,7.275e-01,4.178e-02
CCL5,10632,cellular calcium ion homeostasis,GO:0006874,biological process,82.0,9.0,1.197e-01,8.624e-02,1.662e-01,4.971e-02,2.367e-02,1.044e-01,7.594e-01,2.072e-02
CCL5,10632,calcium ion transport,GO:0006816,biological process,82.0,11.0,1.205e-01,7.182e-02,2.023e-01,6.888e-02,4.836e-02,9.812e-02,7.208e-01,1.076e-02
CCL5,10632,positive regulation of tyrosine phosphorylation of STAT protein,GO:0042531,biological process,82.0,7.0,1.260e-01,7.047e-02,2.253e-01,7.116e-02,2.937e-02,1.724e-01,7.147e-01,2.782e-02
CCL5,10632,positive regulation of cellular biosynthetic process,GO:0031328,biological process,82.0,107.0,1.299e-01,1.151e-01,1.466e-01,3.317e-02,1.125e-03,9.778e-01,7.734e-01,7.298e-02
CCL5,10632,regulation of insulin secretion,GO:0050796,biological process,82.0,7.0,1.307e-01,9.229e-02,1.850e-01,6.095e-02,1.234e-02,3.012e-01,7.306e-01,4.535e-02
CCL5,10632,negative regulation of T cell apoptotic process,GO:0070233,biological process,82.0,8.0,1.369e-01,5.476e-02,3.424e-01,9.587e-02,3.030e-02,3.033e-01,6.721e-01,3.784e-02
CCL5,10632,eosinophil chemotaxis,GO:0048245,biological process,82.0,3.0,1.440e-01,4.841e-02,4.283e-01,1.047e-01,2.354e-02,4.662e-01,6.554e-01,4.949e-02
CCL5,10632,cellular response to interferon-gamma,GO:0071346,biological process,82.0,3.0,1.570e-01,9.086e-02,2.714e-01,1.204e-01,5.375e-02,2.698e-01,6.408e-01,3.088e-02
CCL5,10632,neutrophil activation,GO:0042119,biological process,82.0,3.0,1.575e-01,6.468e-02,3.836e-01,1.186e-01,3.873e-02,3.630e-01,6.403e-01,4.057e-02
CCL5,10632,activation of phospholipase D activity,GO:0031584,biological process,82.0,2.0,1.630e-01,5.663e-02,4.693e-01,1.301e-01,3.077e-02,5.502e-01,6.219e-01,5.126e-02
CCL5,10632,cellular response to fibroblast growth factor stimulus,GO:0044344,biological process,82.0,4.0,1.691e-01,1.164e-01,2.457e-01,1.336e-01,8.603e-02,2.074e-01,6.267e-01,1.666e-02
CCL5,10632,regulation of neuron death,GO:1901214,biological process,82.0,7.0,1.706e-01,1.009e-01,2.883e-01,1.233e-01,3.834e-02,3.968e-01,6.339e-01,4.106e-02
CCL5,10632,negative regulation of G protein-coupled receptor signaling pathway,GO:0045744,biological process,82.0,18.0,1.726e-01,1.104e-01,2.698e-01,1.390e-01,7.132e-02,2.707e-01,6.192e-01,2.519e-02
CCL5,10632,cellular response to tumor necrosis factor,GO:0071356,biological process,82.0,4.0,1.776e-01,1.311e-01,2.405e-01,1.442e-01,1.064e-01,1.955e-01,6.150e-01,1.211e-02
CCL5,10632,MAPK cascade,GO:0000165,biological process,82.0,10.0,2.013e-01,7.549e-02,5.369e-01,1.593e-01,4.292e-02,5.914e-01,5.883e-01,5.892e-02
CCL5,10632,cellular response to interleukin-1,GO:0071347,biological process,82.0,4.0,2.112e-01,1.610e-01,2.770e-01,1.918e-01,1.372e-01,2.681e-01,5.653e-01,1.482e-02
CCL5,10632,inflammatory response,GO:0006954,biological process,82.0,15.0,2.148e-01,1.696e-01,2.720e-01,1.963e-01,1.579e-01,2.441e-01,5.612e-01,9.677e-03
CCL5,10632,negative regulation of viral genome replication,GO:0045071,biological process,82.0,8.0,2.736e-01,1.936e-01,3.867e-01,2.611e-01,1.875e-01,3.637e-01,5.050e-01,1.654e-02
CCL5,10632,cell-cell signaling,GO:0007267,biological process,82.0,35.0,2.738e-01,1.286e-01,5.832e-01,2.549e-01,1.083e-01,5.999e-01,5.054e-01,4.064e-02
CCL5,10632,negative regulation by host of viral transcription,GO:0043922,biological process,82.0,6.0,3.002e-01,2.147e-01,4.196e-01,2.864e-01,2.149e-01,3.817e-01,4.857e-01,1.469e-02
CCL5,10632,cellular response to organic cyclic compound,GO:0071407,biological process,82.0,99.0,3.725e-01,9.090e-02,1.527e+00,3.512e-01,7.385e-02,1.670e+00,4.118e-01,8.502e-02
CCL5,10632,response to toxic substance,GO:0009636,biological process,82.0,30.0,5.117e-01,1.781e-01,1.470e+00,5.117e-01,1.781e-01,1.470e+00,3.103e-01,7.554e-02
CCL5,10632,extracellular space,GO:0005615,cellular component,82.0,24.0,1.556e-01,1.123e-01,2.155e-01,1.154e-01,8.150e-02,1.635e-01,6.501e-01,1.259e-02
CCL5,10632,chemokine receptor binding,GO:0042379,molecular function,82.0,9.0,9.545e-02,4.895e-02,1.861e-01,1.104e-02,4.074e-03,2.989e-02,9.038e-01,1.384e-02
CCL5,10632,chemokine activity,GO:0008009,molecular function,82.0,7.0,9.545e-02,4.895e-02,1.861e-01,1.191e-02,4.768e-03,2.975e-02,8.990e-01,1.632e-02
CCL5,10632,CCR5 chemokine receptor binding,GO:0031730,molecular function,82.0,2.0,9.545e-02,4.895e-02,1.861e-01,1.429e-02,1.103e-02,1.851e-02,8.892e-01,5.383e-03
CCL5,10632,CCR1 chemokine receptor binding,GO:0031726,molecular function,82.0,2.0,9.545e-02,4.895e-02,1.861e-01,1.430e-02,8.904e-03,2.296e-02,8.886e-01,9.411e-03
CCL5,10632,CCR chemokine receptor binding,GO:0048020,molecular function,82.0,13.0,9.545e-02,4.895e-02,1.861e-01,1.988e-02,6.041e-03,6.542e-02,8.541e-01,2.554e-02
CCL5,10632,protein self-association,GO:0043621,molecular function,82.0,4.0,9.995e-02,4.811e-02,2.076e-01,2.683e-02,9.337e-03,7.711e-02,8.271e-01,2.731e-02
CCL5,10632,protein kinase activity,GO:0004672,molecular function,82.0,29.0,1.007e-01,4.784e-02,2.120e-01,3.788e-02,1.790e-02,8.018e-02,7.903e-01,2.050e-02
CCL5,10632,receptor signaling protein tyrosine kinase activator activity,GO:0030298,molecular function,82.0,2.0,1.043e-01,4.609e-02,2.360e-01,3.806e-02,1.482e-02,9.770e-02,7.894e-01,2.514e-02
CCL5,10632,chemoattractant activity,GO:0042056,molecular function,82.0,6.0,1.054e-01,4.465e-02,2.490e-01,3.784e-02,1.280e-02,1.119e-01,7.896e-01,2.940e-02
CCL5,10632,chemokine receptor antagonist activity,GO:0046817,molecular function,82.0,2.0,1.055e-01,4.598e-02,2.421e-01,3.664e-02,6.617e-03,2.029e-01,7.897e-01,4.432e-02
CCL5,10632,phospholipase activator activity,GO:0016004,molecular function,82.0,5.0,1.080e-01,4.474e-02,2.605e-01,6.006e-02,1.857e-02,1.943e-01,7.350e-01,3.334e-02
CCL5,10632,identical protein binding,GO:0042802,molecular function,82.0,24.0,1.309e-01,9.928e-02,1.725e-01,7.970e-02,7.493e-02,8.478e-02,7.026e-01,1.943e-03
CCL5,10632,phosphatidylinositol phospholipase C activity,GO:0004435,molecular function,82.0,2.0,1.339e-01,1.041e-01,1.722e-01,6.468e-02,2.298e-02,1.820e-01,7.264e-01,3.015e-02
CCL5,10632,protein homodimerization activity,GO:0042803,molecular function,82.0,23.0,1.706e-01,1.210e-01,2.405e-01,1.384e-01,9.988e-02,1.919e-01,6.215e-01,1.270e-02
CCL5,10632,protein binding,GO:0005515,molecular function,82.0,318.0,2.076e-01,1.781e-01,2.418e-01,1.853e-01,1.732e-01,1.982e-01,5.722e-01,2.972e-03
CCM2L,16153,,,,nan,nan,,,,,,,,
CCR2,1603,chemotaxis,GO:0006935,biological process,21.0,16.0,5.922e-02,3.091e-02,1.135e-01,8.159e-03,1.120e-03,5.942e-02,9.127e-01,2.349e-02
CCR2,1603,immune response,GO:0006955,biological process,21.0,17.0,6.927e-02,4.338e-02,1.106e-01,2.455e-02,1.403e-02,4.296e-02,8.375e-01,1.417e-02
CCR2,1603,cell chemotaxis,GO:0060326,biological process,21.0,22.0,8.152e-02,3.668e-02,1.812e-01,3.411e-02,5.921e-03,1.965e-01,7.968e-01,4.310e-02
CCR2,1603,positive regulation of monocyte chemotaxis,GO:0090026,biological process,21.0,7.0,8.283e-02,3.307e-02,2.074e-01,4.146e-02,1.056e-02,1.628e-01,7.775e-01,3.874e-02
CCR2,1603,positive regulation of cytosolic calcium ion concentration,GO:0007204,biological process,21.0,12.0,8.595e-02,3.590e-02,2.058e-01,4.479e-02,1.340e-02,1.497e-01,7.701e-01,3.229e-02
CCR2,1603,positive regulation of astrocyte chemotaxis,GO:2000464,biological process,21.0,4.0,9.403e-02,4.894e-02,1.807e-01,5.436e-02,3.395e-02,8.703e-02,7.494e-01,1.352e-02
CCR2,1603,cytokine-mediated signaling pathway,GO:0019221,biological process,21.0,45.0,1.002e-01,4.257e-02,2.359e-01,7.377e-02,2.683e-02,2.028e-01,7.086e-01,3.307e-02
CCR2,1603,calcium-mediated signaling,GO:0019722,biological process,21.0,15.0,1.040e-01,4.502e-02,2.402e-01,8.221e-02,3.659e-02,1.847e-01,6.960e-01,2.601e-02
CCR2,1603,inflammatory response,GO:0006954,biological process,21.0,15.0,1.699e-01,1.425e-01,2.026e-01,1.674e-01,1.336e-01,2.098e-01,5.899e-01,9.243e-03
CCR2,1603,external side of plasma membrane,GO:0009897,cellular component,21.0,16.0,6.521e-02,4.033e-02,1.054e-01,1.850e-02,1.291e-02,2.652e-02,8.659e-01,8.327e-03
CCR2,1603,plasma membrane,GO:0005886,cellular component,21.0,67.0,9.650e-02,4.750e-02,1.961e-01,6.680e-02,3.510e-02,1.271e-01,7.241e-01,1.923e-02
CCR2,1603,cytoplasm,GO:0005737,cellular component,21.0,72.0,1.641e-01,1.463e-01,1.841e-01,1.494e-01,1.360e-01,1.641e-01,6.093e-01,3.807e-03
CCR2,1603,chemokine binding,GO:0019956,molecular function,21.0,7.0,6.521e-02,4.033e-02,1.054e-01,1.250e-02,5.160e-03,3.030e-02,8.958e-01,1.421e-02
CCR2,1603,CCR2 chemokine receptor binding,GO:0031727,molecular function,21.0,2.0,6.841e-02,3.609e-02,1.297e-01,2.198e-02,1.290e-02,3.745e-02,8.485e-01,1.280e-02
CCR2,1603,C-C chemokine binding,GO:0019957,molecular function,21.0,10.0,6.959e-02,3.467e-02,1.397e-01,2.315e-02,9.611e-03,5.576e-02,8.424e-01,2.151e-02
CCR2,1603,C-C chemokine receptor activity,GO:0016493,molecular function,21.0,8.0,1.000e-01,4.394e-02,2.277e-01,6.904e-02,2.797e-02,1.704e-01,7.184e-01,2.780e-02
CCR2,1603,protein binding,GO:0005515,molecular function,21.0,318.0,1.662e-01,1.442e-01,1.916e-01,1.616e-01,1.439e-01,1.814e-01,5.962e-01,4.698e-03
CD200,7203,heterotypic cell-cell adhesion,GO:0034113,biological process,13.0,8.0,1.958e-01,7.927e-02,4.838e-01,4.797e-02,1.906e-02,1.207e-01,7.632e-01,2.554e-02
CD200,7203,negative regulation of matrix metallopeptidase secretion,GO:1904465,biological process,13.0,3.0,2.121e-01,6.681e-02,6.733e-01,7.507e-02,9.945e-03,5.666e-01,6.943e-01,7.003e-02
CD200,7203,positive regulation of CREB transcription factor activity,GO:0032793,biological process,13.0,3.0,2.238e-01,1.218e-01,4.115e-01,8.391e-02,3.601e-02,1.955e-01,6.928e-01,2.803e-02
CD200,7203,negative regulation of NF-kappaB transcription factor activity,GO:0032088,biological process,13.0,5.0,2.863e-01,1.355e-01,6.048e-01,2.014e-01,8.586e-02,4.722e-01,5.527e-01,3.704e-02
CD200,7203,positive regulation of transforming growth factor beta production,GO:0071636,biological process,13.0,7.0,2.919e-01,1.303e-01,6.537e-01,2.212e-01,9.891e-02,4.947e-01,5.344e-01,3.796e-02
CD200,7203,positive regulation of arginase activity,GO:0150072,biological process,13.0,3.0,3.412e-01,1.868e-01,6.233e-01,2.565e-01,1.107e-01,5.945e-01,5.035e-01,4.342e-02
CD200,7203,positive regulation of protein-glutamine gamma-glutamyltransferase activity,GO:0150074,biological process,13.0,3.0,4.224e-01,1.927e-01,9.260e-01,4.103e-01,1.753e-01,9.606e-01,3.857e-01,6.132e-02
CD200,7203,neuronal cell body,GO:0043025,cellular component,13.0,2.0,8.981e-02,9.509e-03,8.483e-01,7.484e-03,7.924e-04,7.069e-02,9.147e-01,2.406e-02
CD200,7203,cell surface,GO:0009986,cellular component,13.0,20.0,2.238e-01,1.218e-01,4.115e-01,9.331e-02,8.982e-02,9.694e-02,6.814e-01,1.244e-03
CD200,7203,cell body,GO:0044297,cellular component,13.0,4.0,2.238e-01,1.218e-01,4.115e-01,9.764e-02,6.862e-02,1.389e-01,6.746e-01,1.205e-02
CD200,7203,axon,GO:0030424,cellular component,13.0,12.0,3.833e-01,2.063e-01,7.123e-01,3.617e-01,1.988e-01,6.582e-01,4.273e-01,3.698e-02
CD200,7203,protein binding,GO:0005515,molecular function,13.0,318.0,2.820e-01,1.395e-01,5.700e-01,1.828e-01,1.181e-01,2.829e-01,5.734e-01,1.872e-02
CD247,1677,T cell receptor signaling pathway,GO:0050852,biological process,38.0,4.0,2.559e-02,1.838e-02,3.562e-02,8.829e-03,2.826e-03,2.759e-02,9.155e-01,1.682e-02
CD247,1677,protein homotetramerization,GO:0051289,biological process,38.0,3.0,4.177e-02,2.836e-02,6.150e-02,2.753e-02,8.376e-03,9.051e-02,8.230e-01,2.896e-02
CD247,1677,protein homotrimerization,GO:0070207,biological process,38.0,3.0,4.177e-02,2.836e-02,6.150e-02,2.947e-02,9.731e-03,8.925e-02,8.165e-01,2.766e-02
CD247,1677,alpha-beta T cell receptor complex,GO:0042105,cellular component,38.0,4.0,2.403e-02,1.668e-02,3.460e-02,4.259e-03,2.059e-03,8.810e-03,9.494e-01,5.794e-03
CD247,1677,cytoplasm,GO:0005737,cellular component,38.0,72.0,3.273e-02,1.564e-02,6.850e-02,2.127e-02,4.881e-03,9.270e-02,8.479e-01,3.654e-02
CD247,1677,plasma membrane,GO:0005886,cellular component,38.0,67.0,3.314e-02,1.857e-02,5.913e-02,2.232e-02,8.568e-03,5.813e-02,8.460e-01,2.349e-02
CD247,1677,T cell receptor complex,GO:0042101,cellular component,38.0,5.0,4.385e-02,2.540e-02,7.568e-02,3.804e-02,1.821e-02,7.946e-02,7.901e-01,1.971e-02
CD247,1677,identical protein binding,GO:0042802,molecular function,38.0,24.0,2.180e-02,6.662e-03,7.133e-02,3.981e-03,2.443e-04,6.489e-02,9.354e-01,2.815e-02
CD247,1677,protein homodimerization activity,GO:0042803,molecular function,38.0,23.0,2.828e-02,1.223e-02,6.541e-02,1.301e-02,3.249e-03,5.208e-02,8.880e-01,2.811e-02
CD247,1677,protein binding,GO:0005515,molecular function,38.0,318.0,2.831e-02,1.220e-02,6.572e-02,1.502e-02,2.585e-03,8.731e-02,8.735e-01,3.847e-02
CD247,1677,protein tyrosine kinase binding,GO:1990782,molecular function,38.0,4.0,4.146e-02,2.345e-02,7.330e-02,3.082e-02,1.685e-02,5.634e-02,8.132e-01,1.540e-02
CD300C,19320,,,,nan,nan,,,,,,,,
CD300LG,30455,,,,nan,nan,,,,,,,,
CD3E,1674,protein homooligomerization,GO:0051260,biological process,28.0,6.0,6.115e-02,3.946e-02,9.477e-02,5.126e-03,1.671e-03,1.572e-02,9.414e-01,1.067e-02
CD3E,1674,T cell differentiation,GO:0030217,biological process,28.0,11.0,7.759e-02,4.313e-02,1.396e-01,3.790e-02,8.253e-03,1.741e-01,7.872e-01,4.209e-02
CD3E,1674,positive regulation of T cell proliferation,GO:0042102,biological process,28.0,11.0,8.539e-02,6.170e-02,1.182e-01,4.799e-02,2.995e-02,7.689e-02,7.641e-01,1.307e-02
CD3E,1674,positive regulation of gene expression,GO:0010628,biological process,28.0,27.0,9.024e-02,5.723e-02,1.423e-01,7.639e-02,4.636e-02,1.259e-01,7.072e-01,1.543e-02
CD3E,1674,positive thymic T cell selection,GO:0045059,biological process,28.0,4.0,9.315e-02,5.397e-02,1.608e-01,7.363e-02,2.484e-02,2.182e-01,7.093e-01,3.281e-02
CD3E,1674,cell surface receptor signaling pathway,GO:0007166,biological process,28.0,34.0,1.005e-01,4.605e-02,2.194e-01,8.410e-02,2.954e-02,2.394e-01,6.906e-01,3.583e-02
CD3E,1674,negative regulation of gene expression,GO:0010629,biological process,28.0,26.0,1.015e-01,5.262e-02,1.956e-01,8.207e-02,3.172e-02,2.123e-01,6.949e-01,3.115e-02
CD3E,1674,alpha-beta T cell receptor complex,GO:0042105,cellular component,28.0,4.0,6.203e-02,4.372e-02,8.801e-02,6.355e-03,3.568e-03,1.132e-02,9.351e-01,5.420e-03
CD3E,1674,external side of plasma membrane,GO:0009897,cellular component,28.0,16.0,7.228e-02,5.050e-02,1.035e-01,2.284e-02,1.318e-02,3.959e-02,8.448e-01,1.356e-02
CD3E,1674,plasma membrane,GO:0005886,cellular component,28.0,67.0,8.434e-02,6.223e-02,1.143e-01,6.077e-02,4.572e-02,8.077e-02,7.366e-01,8.118e-03
CD3E,1674,T cell receptor complex,GO:0042101,cellular component,28.0,5.0,8.932e-02,5.821e-02,1.371e-01,6.657e-02,4.100e-02,1.081e-01,7.248e-01,1.444e-02
CD3E,1674,transmembrane signaling receptor activity,GO:0004888,molecular function,28.0,39.0,7.228e-02,5.050e-02,1.035e-01,1.766e-02,8.942e-03,3.490e-02,8.691e-01,1.577e-02
CD3E,1674,protein heterodimerization activity,GO:0046982,molecular function,28.0,8.0,8.321e-02,6.248e-02,1.108e-01,4.528e-02,1.898e-02,1.080e-01,7.700e-01,2.346e-02
CD3E,1674,SH3 domain binding,GO:0017124,molecular function,28.0,6.0,8.434e-02,6.223e-02,1.143e-01,5.599e-02,2.772e-02,1.131e-01,7.453e-01,2.071e-02
CD3E,1674,protein homodimerization activity,GO:0042803,molecular function,28.0,23.0,8.434e-02,6.223e-02,1.143e-01,5.912e-02,3.860e-02,9.055e-02,7.397e-01,1.216e-02
CD3E,1674,protein binding,GO:0005515,molecular function,28.0,318.0,8.434e-02,6.223e-02,1.143e-01,6.598e-02,3.758e-02,1.158e-01,7.258e-01,1.666e-02
CD3G,1675,protein homooligomerization,GO:0051260,biological process,36.0,6.0,4.031e-02,2.457e-02,6.615e-02,6.924e-03,5.244e-03,9.143e-03,9.327e-01,2.800e-03
CD3G,1675,T cell differentiation,GO:0030217,biological process,36.0,11.0,5.832e-02,3.765e-02,9.033e-02,2.526e-02,8.434e-03,7.566e-02,8.330e-01,2.803e-02
CD3G,1675,regulation of lymphocyte apoptotic process,GO:0070228,biological process,36.0,7.0,6.446e-02,3.951e-02,1.052e-01,3.323e-02,1.926e-02,5.733e-02,8.053e-01,1.411e-02
CD3G,1675,positive thymic T cell selection,GO:0045059,biological process,36.0,4.0,7.668e-02,3.404e-02,1.727e-01,5.177e-02,1.212e-02,2.211e-01,7.517e-01,3.983e-02
CD3G,1675,cell surface receptor signaling pathway,GO:0007166,biological process,36.0,34.0,8.174e-02,4.747e-02,1.408e-01,4.991e-02,1.645e-02,1.514e-01,7.572e-01,3.243e-02
CD3G,1675,protein transport,GO:0015031,biological process,36.0,24.0,9.037e-02,5.051e-02,1.617e-01,7.728e-02,3.781e-02,1.579e-01,7.048e-01,2.318e-02
CD3G,1675,establishment or maintenance of cell polarity,GO:0007163,biological process,36.0,14.0,3.266e-01,1.066e-01,1.001e+00,3.266e-01,1.066e-01,1.001e+00,4.384e-01,7.234e-02
CD3G,1675,alpha-beta T cell receptor complex,GO:0042105,cellular component,36.0,4.0,4.031e-02,2.457e-02,6.615e-02,6.414e-03,2.503e-03,1.644e-02,9.335e-01,9.721e-03
CD3G,1675,external side of plasma membrane,GO:0009897,cellular component,36.0,16.0,4.694e-02,3.966e-02,5.556e-02,1.231e-02,5.946e-03,2.550e-02,8.983e-01,1.338e-02
CD3G,1675,plasma membrane,GO:0005886,cellular component,36.0,67.0,7.151e-02,6.234e-02,8.202e-02,3.981e-02,3.172e-02,4.997e-02,7.857e-01,6.012e-03
CD3G,1675,cytosol,GO:0005829,cellular component,36.0,50.0,8.474e-02,6.793e-02,1.057e-01,7.210e-02,4.914e-02,1.058e-01,7.151e-01,1.174e-02
CD3G,1675,transmembrane signaling receptor activity,GO:0004888,molecular function,36.0,39.0,4.155e-02,2.334e-02,7.394e-02,1.162e-02,3.952e-03,3.415e-02,8.991e-01,1.754e-02
CD3G,1675,protein heterodimerization activity,GO:0046982,molecular function,36.0,8.0,7.324e-02,6.060e-02,8.852e-02,4.856e-02,3.686e-02,6.396e-02,7.632e-01,7.622e-03
CD3G,1675,protein homodimerization activity,GO:0042803,molecular function,36.0,23.0,7.324e-02,6.060e-02,8.852e-02,5.124e-02,4.071e-02,6.449e-02,7.567e-01,6.425e-03
CD7,1695,,,,nan,nan,,,,,,,,
CD72,1696,integral component of plasma membrane,GO:0005887,cellular component,3.0,39.0,6.590e-02,4.652e-02,9.336e-02,3.716e-02,3.111e-02,4.440e-02,7.933e-01,4.722e-03
CD72,1696,protein binding,GO:0005515,molecular function,3.0,318.0,6.590e-02,4.652e-02,9.336e-02,6.590e-02,4.652e-02,9.336e-02,7.265e-01,1.044e-02
CD74,1697,,,,nan,nan,,,,,,,,
CD83,1703,,,,nan,nan,,,,,,,,
CD8A,1706,cytotoxic T cell differentiation,GO:0045065,biological process,15.0,3.0,5.259e-02,3.497e-02,7.908e-02,2.043e-02,6.536e-03,6.384e-02,8.534e-01,2.744e-02
CD8A,1706,T cell mediated immunity,GO:0002456,biological process,15.0,8.0,6.160e-02,4.265e-02,8.895e-02,4.577e-02,2.624e-02,7.983e-02,7.695e-01,1.513e-02
CD8A,1706,cell surface receptor signaling pathway,GO:0007166,biological process,15.0,34.0,6.170e-02,2.386e-02,1.596e-01,3.881e-02,6.831e-03,2.205e-01,7.826e-01,4.973e-02
CD8A,1706,external side of plasma membrane,GO:0009897,cellular component,15.0,16.0,4.869e-02,4.200e-02,5.643e-02,9.030e-03,4.502e-03,1.811e-02,9.179e-01,9.487e-03
CD8A,1706,plasma membrane raft,GO:0044853,cellular component,15.0,5.0,5.476e-02,3.792e-02,7.908e-02,3.637e-02,2.442e-02,5.418e-02,7.957e-01,1.058e-02
CD8A,1706,plasma membrane,GO:0005886,cellular component,15.0,67.0,6.638e-02,5.095e-02,8.647e-02,5.017e-02,3.105e-02,8.106e-02,7.590e-01,1.354e-02
CD8A,1706,MHC class I protein complex binding,GO:0023024,molecular function,15.0,5.0,5.259e-02,3.497e-02,7.908e-02,2.848e-02,1.542e-02,5.259e-02,8.217e-01,1.578e-02
CD8A,1706,protein binding,GO:0005515,molecular function,15.0,318.0,1.033e-01,8.768e-02,1.216e-01,9.877e-02,7.346e-02,1.328e-01,6.731e-01,9.939e-03
CD93,15855,cell-cell adhesion,GO:0098609,biological process,7.0,26.0,6.018e-02,3.129e-02,1.157e-01,2.963e-02,1.988e-02,4.416e-02,8.178e-01,1.028e-02
CD93,15855,plasma membrane,GO:0005886,cellular component,7.0,67.0,6.018e-02,3.129e-02,1.157e-01,4.002e-02,2.795e-02,5.731e-02,7.850e-01,9.635e-03
CD93,15855,transforming growth factor beta binding,GO:0050431,molecular function,7.0,3.0,6.018e-02,3.129e-02,1.157e-01,2.806e-02,1.567e-02,5.024e-02,8.233e-01,1.499e-02
CD93,15855,complement component C1q complex binding,GO:0001849,molecular function,7.0,5.0,6.622e-02,2.633e-02,1.666e-01,4.027e-02,6.778e-03,2.392e-01,7.786e-01,4.683e-02
CD93,15855,protein binding,GO:0005515,molecular function,7.0,318.0,1.041e-01,7.678e-02,1.411e-01,1.041e-01,7.678e-02,1.411e-01,6.657e-01,1.041e-02
CDC6,1744,mitotic DNA replication checkpoint,GO:0033314,biological process,12.0,4.0,1.673e-01,7.214e-02,3.881e-01,3.588e-02,2.285e-02,5.635e-02,7.969e-01,1.186e-02
CDC6,1744,regulation of mitotic metaphase/anaphase transition,GO:0030071,biological process,12.0,7.0,1.673e-01,7.214e-02,3.881e-01,5.169e-02,2.707e-02,9.871e-02,7.550e-01,1.826e-02
CDC6,1744,positive regulation of chromosome segregation,GO:0051984,biological process,12.0,8.0,1.695e-01,7.055e-02,4.070e-01,7.599e-02,2.125e-02,2.717e-01,7.031e-01,4.010e-02
CDC6,1744,positive regulation of cytokinesis,GO:0032467,biological process,12.0,10.0,1.704e-01,7.777e-02,3.734e-01,7.448e-02,3.640e-02,1.524e-01,7.097e-01,2.199e-02
CDC6,1744,mitotic cell cycle,GO:0000278,biological process,12.0,7.0,2.945e-01,2.111e-01,4.108e-01,2.716e-01,1.809e-01,4.077e-01,4.962e-01,2.135e-02
CDC6,1744,nucleus,GO:0005634,cellular component,12.0,86.0,2.034e-01,1.180e-01,3.506e-01,1.157e-01,7.555e-02,1.772e-01,6.494e-01,1.566e-02
CDC6,1744,spindle midzone,GO:0051233,cellular component,12.0,4.0,2.945e-01,2.111e-01,4.108e-01,2.907e-01,2.082e-01,4.058e-01,4.820e-01,1.758e-02
CDC6,1744,spindle pole,GO:0000922,cellular component,12.0,4.0,2.945e-01,2.111e-01,4.108e-01,2.945e-01,2.111e-01,4.108e-01,4.791e-01,1.760e-02
CDC6,1744,kinase binding,GO:0019900,molecular function,12.0,7.0,1.673e-01,7.214e-02,3.881e-01,5.348e-02,1.216e-02,2.351e-01,7.477e-01,4.093e-02
CDC6,1744,DNA replication origin binding,GO:0003688,molecular function,12.0,2.0,2.006e-01,1.031e-01,3.901e-01,1.254e-01,4.945e-02,3.178e-01,6.334e-01,3.398e-02
CDC6,1744,protein binding,GO:0005515,molecular function,12.0,318.0,2.580e-01,1.433e-01,4.643e-01,1.908e-01,1.002e-01,3.632e-01,5.643e-01,2.850e-02
CDH2,1759,cell-cell adhesion mediated by cadherin,GO:0044331,biological process,43.0,3.0,1.004e-01,9.500e-02,1.061e-01,2.339e-02,1.473e-02,3.715e-02,8.427e-01,1.159e-02
CDH2,1759,cell-cell junction assembly,GO:0007043,biological process,43.0,11.0,1.004e-01,9.500e-02,1.061e-01,4.144e-02,2.244e-02,7.653e-02,7.806e-01,1.691e-02
CDH2,1759,adherens junction organization,GO:0034332,biological process,43.0,6.0,1.004e-01,9.500e-02,1.061e-01,4.280e-02,2.766e-02,6.623e-02,7.773e-01,1.196e-02
CDH2,1759,blood vessel morphogenesis,GO:0048514,biological process,43.0,7.0,1.007e-01,9.540e-02,1.063e-01,5.104e-02,3.420e-02,7.617e-02,7.571e-01,1.126e-02
CDH2,1759,synapse assembly,GO:0007416,biological process,43.0,7.0,1.008e-01,9.553e-02,1.064e-01,4.686e-02,3.618e-02,6.070e-02,7.671e-01,7.181e-03
CDH2,1759,"regulation of synaptic transmission, glutamatergic",GO:0051966,biological process,43.0,5.0,1.009e-01,9.390e-02,1.084e-01,3.739e-02,1.054e-02,1.327e-01,7.901e-01,3.477e-02
CDH2,1759,cell-cell adhesion,GO:0098609,biological process,43.0,26.0,1.012e-01,9.439e-02,1.085e-01,4.687e-02,3.787e-02,5.799e-02,7.671e-01,5.893e-03
CDH2,1759,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0016339,biological process,43.0,3.0,1.073e-01,8.765e-02,1.315e-01,5.966e-02,4.148e-02,8.581e-02,7.387e-01,1.047e-02
CDH2,1759,homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007156,biological process,43.0,4.0,1.086e-01,8.713e-02,1.353e-01,6.552e-02,3.969e-02,1.082e-01,7.270e-01,1.471e-02
CDH2,1759,brain development,GO:0007420,biological process,43.0,2.0,1.106e-01,8.005e-02,1.529e-01,4.855e-02,1.518e-02,1.552e-01,7.604e-01,3.248e-02
CDH2,1759,cell morphogenesis,GO:0000902,biological process,43.0,6.0,1.175e-01,7.073e-02,1.952e-01,6.533e-02,2.063e-02,2.068e-01,7.242e-01,3.404e-02
CDH2,1759,regulation of axonogenesis,GO:0050770,biological process,43.0,9.0,1.403e-01,7.020e-02,2.803e-01,1.038e-01,2.204e-02,4.889e-01,6.559e-01,5.225e-02
CDH2,1759,multicellular organism development,GO:0007275,biological process,43.0,18.0,1.422e-01,7.557e-02,2.675e-01,1.163e-01,4.463e-02,3.029e-01,6.451e-01,3.339e-02
CDH2,1759,neuron projection,GO:0043005,cellular component,43.0,20.0,1.004e-01,9.500e-02,1.061e-01,1.801e-02,1.213e-02,2.674e-02,8.685e-01,9.040e-03
CDH2,1759,intercalated disc,GO:0014704,cellular component,43.0,2.0,1.004e-01,9.500e-02,1.061e-01,3.778e-02,2.256e-02,6.327e-02,7.914e-01,1.376e-02
CDH2,1759,cell-cell junction,GO:0005911,cellular component,43.0,18.0,1.004e-01,9.500e-02,1.061e-01,4.083e-02,1.910e-02,8.728e-02,7.821e-01,2.082e-02
CDH2,1759,adherens junction,GO:0005912,cellular component,43.0,7.0,1.007e-01,9.540e-02,1.063e-01,4.256e-02,2.879e-02,6.291e-02,7.782e-01,1.046e-02
CDH2,1759,lamellipodium,GO:0030027,cellular component,43.0,4.0,1.009e-01,9.390e-02,1.084e-01,4.677e-02,1.953e-02,1.120e-01,7.661e-01,2.441e-02
CDH2,1759,cortical actin cytoskeleton,GO:0030864,cellular component,43.0,4.0,1.012e-01,9.439e-02,1.085e-01,6.595e-02,4.100e-02,1.061e-01,7.261e-01,1.401e-02
CDH2,1759,integral component of presynaptic active zone membrane,GO:0099059,cellular component,43.0,3.0,1.013e-01,9.510e-02,1.079e-01,5.356e-02,2.147e-02,1.336e-01,7.501e-01,2.572e-02
CDH2,1759,integral component of postsynaptic specialization membrane,GO:0099060,cellular component,43.0,5.0,1.018e-01,9.630e-02,1.076e-01,6.423e-02,2.467e-02,1.672e-01,7.277e-01,2.770e-02
CDH2,1759,plasma membrane,GO:0005886,cellular component,43.0,67.0,1.082e-01,8.609e-02,1.360e-01,6.210e-02,4.454e-02,8.657e-02,7.337e-01,9.761e-03
CDH2,1759,catenin complex,GO:0016342,cellular component,43.0,3.0,1.174e-01,7.475e-02,1.845e-01,7.781e-02,2.287e-02,2.647e-01,6.998e-01,4.042e-02
CDH2,1759,collagen-containing extracellular matrix,GO:0062023,cellular component,43.0,20.0,1.188e-01,6.932e-02,2.035e-01,7.505e-02,3.152e-02,1.787e-01,7.077e-01,2.761e-02
CDH2,1759,apical part of cell,GO:0045177,cellular component,43.0,4.0,1.209e-01,6.652e-02,2.196e-01,7.936e-02,2.748e-02,2.292e-01,6.986e-01,3.509e-02
CDH2,1759,focal adhesion,GO:0005925,cellular component,43.0,7.0,1.213e-01,6.732e-02,2.187e-01,9.483e-02,4.795e-02,1.876e-01,6.768e-01,2.376e-02
CDH2,1759,cell surface,GO:0009986,cellular component,43.0,20.0,1.310e-01,7.870e-02,2.181e-01,9.953e-02,4.891e-02,2.025e-01,6.703e-01,2.355e-02
CDH2,1759,cell junction,GO:0030054,cellular component,43.0,7.0,1.351e-01,7.396e-02,2.468e-01,8.455e-02,1.536e-02,4.654e-01,6.848e-01,5.349e-02
CDH2,1759,cytoplasm,GO:0005737,cellular component,43.0,72.0,1.362e-01,7.541e-02,2.461e-01,1.174e-01,5.928e-02,2.324e-01,6.458e-01,2.487e-02
CDH2,1759,synapse,GO:0045202,cellular component,43.0,20.0,1.462e-01,7.534e-02,2.837e-01,1.361e-01,6.292e-02,2.942e-01,6.219e-01,2.864e-02
CDH2,1759,postsynaptic density,GO:0014069,cellular component,43.0,4.0,1.500e-01,7.202e-02,3.122e-01,1.226e-01,3.122e-02,4.810e-01,6.325e-01,4.776e-02
CDH2,1759,alpha-catenin binding,GO:0045294,molecular function,43.0,2.0,1.004e-01,9.500e-02,1.061e-01,1.634e-02,1.280e-02,2.085e-02,8.780e-01,5.265e-03
CDH2,1759,gamma-catenin binding,GO:0045295,molecular function,43.0,3.0,1.004e-01,9.500e-02,1.061e-01,1.747e-02,6.384e-03,4.779e-02,8.677e-01,2.114e-02
CDH2,1759,beta-catenin binding,GO:0008013,molecular function,43.0,5.0,1.004e-01,9.500e-02,1.061e-01,2.130e-02,8.996e-03,5.043e-02,8.503e-01,1.966e-02
CDH2,1759,cytoskeletal protein binding,GO:0008092,molecular function,43.0,24.0,1.004e-01,9.500e-02,1.061e-01,2.639e-02,4.999e-03,1.393e-01,8.253e-01,4.281e-02
CDH2,1759,calcium ion binding,GO:0005509,molecular function,43.0,7.0,1.004e-01,9.500e-02,1.061e-01,2.968e-02,2.160e-02,4.079e-02,8.177e-01,8.093e-03
CDH2,1759,cadherin binding,GO:0045296,molecular function,43.0,9.0,1.256e-01,8.609e-02,1.832e-01,9.203e-02,4.919e-02,1.722e-01,6.818e-01,2.033e-02
CDH2,1759,protein homodimerization activity,GO:0042803,molecular function,43.0,23.0,1.329e-01,7.871e-02,2.244e-01,1.134e-01,7.272e-02,1.768e-01,6.523e-01,1.631e-02
CDH2,1759,protein binding,GO:0005515,molecular function,43.0,318.0,1.443e-01,1.024e-01,2.034e-01,1.321e-01,1.041e-01,1.677e-01,6.294e-01,9.375e-03
CDH23,13733,cell-cell adhesion mediated by cadherin,GO:0044331,biological process,24.0,3.0,1.156e-01,6.554e-02,2.039e-01,2.144e-02,1.266e-02,3.632e-02,8.509e-01,1.245e-02
CDH23,13733,adherens junction organization,GO:0034332,biological process,24.0,6.0,1.156e-01,6.554e-02,2.039e-01,3.086e-02,1.495e-02,6.369e-02,8.130e-01,1.900e-02
CDH23,13733,cell-cell junction assembly,GO:0007043,biological process,24.0,11.0,1.156e-01,6.554e-02,2.039e-01,3.104e-02,1.459e-02,6.608e-02,8.123e-01,1.966e-02
CDH23,13733,cell-cell adhesion,GO:0098609,biological process,24.0,26.0,1.156e-01,6.554e-02,2.039e-01,3.860e-02,2.993e-02,4.979e-02,7.891e-01,6.887e-03
CDH23,13733,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0016339,biological process,24.0,3.0,1.215e-01,6.201e-02,2.379e-01,6.171e-02,2.778e-02,1.371e-01,7.333e-01,2.305e-02
CDH23,13733,sensory perception of sound,GO:0007605,biological process,24.0,2.0,1.238e-01,5.719e-02,2.680e-01,5.911e-02,1.193e-02,2.930e-01,7.318e-01,5.088e-02
CDH23,13733,cell morphogenesis,GO:0000902,biological process,24.0,6.0,1.255e-01,5.817e-02,2.707e-01,7.952e-02,2.143e-02,2.951e-01,6.964e-01,4.215e-02
CDH23,13733,homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007156,biological process,24.0,4.0,1.279e-01,6.845e-02,2.388e-01,7.843e-02,3.307e-02,1.860e-01,7.024e-01,2.636e-02
CDH23,13733,equilibrioception,GO:0050957,biological process,24.0,2.0,1.300e-01,6.653e-02,2.542e-01,7.680e-02,3.166e-02,1.863e-01,7.044e-01,2.905e-02
CDH23,13733,calcium ion transport,GO:0006816,biological process,24.0,11.0,1.316e-01,8.382e-02,2.067e-01,8.138e-02,6.561e-02,1.009e-01,6.997e-01,6.909e-03
CDH23,13733,regulation of cytosolic calcium ion concentration,GO:0051480,biological process,24.0,8.0,1.375e-01,9.576e-02,1.975e-01,7.610e-02,4.839e-02,1.197e-01,7.079e-01,1.417e-02
CDH23,13733,sensory perception of light stimulus,GO:0050953,biological process,24.0,3.0,1.376e-01,7.953e-02,2.380e-01,1.055e-01,5.400e-02,2.062e-01,6.616e-01,2.434e-02
CDH23,13733,multicellular organism development,GO:0007275,biological process,24.0,18.0,1.869e-01,1.544e-01,2.262e-01,1.733e-01,1.290e-01,2.329e-01,5.836e-01,1.233e-02
CDH23,13733,photoreceptor cell maintenance,GO:0045494,biological process,24.0,3.0,2.676e-01,9.202e-02,7.782e-01,2.637e-01,8.727e-02,7.966e-01,4.920e-01,5.977e-02
CDH23,13733,catenin complex,GO:0016342,cellular component,24.0,3.0,1.172e-01,6.613e-02,2.076e-01,4.347e-02,2.162e-02,8.738e-02,7.752e-01,1.915e-02
CDH23,13733,adherens junction,GO:0005912,cellular component,24.0,7.0,1.215e-01,6.201e-02,2.379e-01,4.854e-02,2.582e-02,9.125e-02,7.625e-01,1.738e-02
CDH23,13733,plasma membrane,GO:0005886,cellular component,24.0,67.0,1.245e-01,6.825e-02,2.269e-01,6.771e-02,4.413e-02,1.039e-01,7.229e-01,1.276e-02
CDH23,13733,cell surface,GO:0009986,cellular component,24.0,20.0,1.443e-01,9.195e-02,2.263e-01,1.084e-01,7.049e-02,1.667e-01,6.592e-01,1.504e-02
CDH23,13733,cytoskeletal protein binding,GO:0008092,molecular function,24.0,24.0,1.156e-01,6.554e-02,2.039e-01,1.688e-02,4.206e-03,6.776e-02,8.661e-01,2.609e-02
CDH23,13733,calcium ion binding,GO:0005509,molecular function,24.0,7.0,1.156e-01,6.554e-02,2.039e-01,2.452e-02,9.999e-03,6.012e-02,8.369e-01,2.286e-02
CDH23,13733,cadherin binding,GO:0045296,molecular function,24.0,9.0,1.425e-01,6.750e-02,3.009e-01,1.028e-01,3.638e-02,2.904e-01,6.629e-01,3.471e-02
CDH23,13733,protein homodimerization activity,GO:0042803,molecular function,24.0,23.0,1.630e-01,1.074e-01,2.472e-01,1.437e-01,8.960e-02,2.305e-01,6.149e-01,1.832e-02
CDH23,13733,protein binding,GO:0005515,molecular function,24.0,318.0,1.813e-01,1.344e-01,2.446e-01,1.707e-01,1.191e-01,2.446e-01,5.860e-01,1.490e-02
CDK5R1,1775,peptidyl-serine phosphorylation,GO:0018105,biological process,16.0,13.0,1.418e-01,1.055e-01,1.906e-01,7.430e-02,5.156e-02,1.071e-01,7.113e-01,1.141e-02
CDK5R1,1775,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,16.0,39.0,1.418e-01,1.055e-01,1.906e-01,1.002e-01,5.687e-02,1.765e-01,6.697e-01,2.011e-02
CDK5R1,1775,peptidyl-threonine phosphorylation,GO:0018107,biological process,16.0,9.0,1.977e-01,8.787e-02,4.448e-01,1.659e-01,5.201e-02,5.290e-01,5.838e-01,5.068e-02
CDK5R1,1775,perinuclear region of cytoplasm,GO:0048471,cellular component,16.0,8.0,1.418e-01,1.055e-01,1.906e-01,7.069e-02,2.817e-02,1.774e-01,7.149e-01,2.922e-02
CDK5R1,1775,intracellular membrane-bounded organelle,GO:0043231,cellular component,16.0,40.0,1.418e-01,1.055e-01,1.906e-01,7.345e-02,4.395e-02,1.227e-01,7.123e-01,1.612e-02
CDK5R1,1775,nucleoplasm,GO:0005654,cellular component,16.0,47.0,1.424e-01,1.069e-01,1.895e-01,1.139e-01,8.819e-02,1.471e-01,6.525e-01,9.161e-03
CDK5R1,1775,protein kinase binding,GO:0019901,molecular function,16.0,19.0,1.418e-01,1.055e-01,1.906e-01,7.129e-02,1.812e-02,2.805e-01,7.103e-01,4.392e-02
CDK5R1,1775,protein binding,GO:0005515,molecular function,16.0,318.0,1.418e-01,1.055e-01,1.906e-01,1.051e-01,6.946e-02,1.591e-01,6.637e-01,1.430e-02
CDK5R1,1775,protein serine/threonine kinase activator activity,GO:0043539,molecular function,16.0,4.0,1.577e-01,1.060e-01,2.346e-01,1.503e-01,9.075e-02,2.489e-01,6.072e-01,2.069e-02
CELF3,11967,"regulation of alternative mRNA splicing, via spliceosome",GO:0000381,biological process,12.0,2.0,1.013e-01,6.508e-02,1.578e-01,3.775e-02,2.108e-02,6.759e-02,7.912e-01,1.577e-02
CELF3,11967,"positive regulation of mRNA splicing, via spliceosome",GO:0048026,biological process,12.0,6.0,1.013e-01,6.508e-02,1.578e-01,3.795e-02,2.258e-02,6.378e-02,7.906e-01,1.404e-02
CELF3,11967,RNA splicing,GO:0008380,biological process,12.0,6.0,1.352e-01,8.169e-02,2.239e-01,9.327e-02,4.521e-02,1.924e-01,6.789e-01,2.515e-02
CELF3,11967,mRNA splice site selection,GO:0006376,biological process,12.0,4.0,1.585e-01,8.990e-02,2.795e-01,1.485e-01,7.521e-02,2.931e-01,6.081e-01,2.714e-02
CELF3,11967,cytoplasm,GO:0005737,cellular component,12.0,72.0,1.253e-01,9.806e-02,1.601e-01,8.598e-02,8.104e-02,9.121e-02,6.926e-01,1.898e-03
CELF3,11967,nucleus,GO:0005634,cellular component,12.0,86.0,1.253e-01,9.806e-02,1.601e-01,9.400e-02,8.821e-02,1.002e-01,6.805e-01,2.148e-03
CELF3,11967,ribonucleoprotein complex,GO:1990904,cellular component,12.0,24.0,1.705e-01,1.196e-01,2.429e-01,1.688e-01,1.222e-01,2.332e-01,5.881e-01,1.370e-02
CELF3,11967,mRNA binding,GO:0003729,molecular function,12.0,11.0,1.013e-01,6.508e-02,1.578e-01,2.774e-02,8.542e-03,9.011e-02,8.225e-01,2.975e-02
CELF3,11967,RNA binding,GO:0003723,molecular function,12.0,44.0,1.013e-01,6.508e-02,1.578e-01,3.326e-02,2.589e-02,4.272e-02,8.056e-01,6.641e-03
CELSR2,3231,,,,nan,nan,,,,,,,,
CENPV,29920,,,,nan,nan,,,,,,,,
CEP131,29511,intraciliary transport involved in cilium assembly,GO:0035735,biological process,19.0,3.0,1.541e-01,5.192e-02,4.572e-01,2.625e-02,3.517e-03,1.960e-01,8.218e-01,5.074e-02
CEP131,29511,protein localization to centrosome,GO:0071539,biological process,19.0,4.0,1.541e-01,5.192e-02,4.572e-01,6.264e-02,1.518e-02,2.585e-01,7.263e-01,4.510e-02
CEP131,29511,cilium assembly,GO:0060271,biological process,19.0,8.0,1.581e-01,4.919e-02,5.085e-01,8.155e-02,1.425e-02,4.666e-01,6.866e-01,6.153e-02
CEP131,29511,regulation of centrosome duplication,GO:0010824,biological process,19.0,5.0,1.880e-01,6.317e-02,5.593e-01,1.492e-01,4.858e-02,4.582e-01,6.026e-01,4.821e-02
CEP131,29511,positive regulation of intracellular protein transport,GO:0090316,biological process,19.0,17.0,3.002e-01,3.815e-02,2.362e+00,2.598e-01,2.030e-02,3.324e+00,4.530e-01,1.204e-01
CEP131,29511,positive regulation of cell population proliferation,GO:0008284,biological process,19.0,38.0,3.244e-01,1.028e-01,1.024e+00,2.968e-01,8.368e-02,1.053e+00,4.620e-01,6.841e-02
CEP131,29511,microtubule cytoskeleton,GO:0015630,cellular component,19.0,6.0,1.541e-01,5.192e-02,4.572e-01,5.191e-02,1.041e-02,2.589e-01,7.495e-01,4.666e-02
CEP131,29511,intracellular membrane-bounded organelle,GO:0043231,cellular component,19.0,40.0,1.541e-01,5.192e-02,4.572e-01,7.685e-02,2.853e-02,2.070e-01,7.043e-01,2.990e-02
CEP131,29511,centrosome,GO:0005813,cellular component,19.0,11.0,1.541e-01,5.192e-02,4.572e-01,8.040e-02,2.328e-02,2.776e-01,6.953e-01,4.096e-02
CEP131,29511,intercellular bridge,GO:0045171,cellular component,19.0,6.0,1.541e-01,5.192e-02,4.572e-01,9.051e-02,2.508e-02,3.266e-01,6.780e-01,4.529e-02
CEP131,29511,ciliary transition zone,GO:0035869,cellular component,19.0,3.0,1.541e-01,5.192e-02,4.572e-01,9.901e-02,3.229e-02,3.036e-01,6.675e-01,3.846e-02
CEP131,29511,centriolar satellite,GO:0034451,cellular component,19.0,5.0,1.541e-01,5.192e-02,4.572e-01,1.056e-01,4.068e-02,2.743e-01,6.594e-01,3.440e-02
CEP131,29511,ciliary basal body,GO:0036064,cellular component,19.0,12.0,2.269e-01,7.138e-02,7.211e-01,2.127e-01,6.692e-02,6.760e-01,5.369e-01,5.570e-02
CEP131,29511,protein-containing complex binding,GO:0044877,molecular function,19.0,76.0,1.541e-01,5.192e-02,4.572e-01,3.884e-02,1.738e-02,8.679e-02,7.876e-01,2.130e-02
CEP131,29511,protein homodimerization activity,GO:0042803,molecular function,19.0,23.0,1.541e-01,5.192e-02,4.572e-01,9.200e-02,4.778e-02,1.771e-01,6.817e-01,2.141e-02
CEP131,29511,protein binding,GO:0005515,molecular function,19.0,318.0,1.745e-01,8.068e-02,3.774e-01,1.320e-01,9.227e-02,1.888e-01,6.294e-01,1.407e-02
CFD,2771,extracellular exosome,GO:0070062,cellular component,5.0,39.0,3.019e-02,1.180e-02,7.723e-02,3.019e-02,1.180e-02,7.723e-02,8.148e-01,2.479e-02
CHKB,1938,phosphatidylethanolamine biosynthetic process,GO:0006646,biological process,8.0,5.0,3.765e-02,1.736e-02,8.165e-02,3.028e-02,9.626e-03,9.524e-02,8.139e-01,3.055e-02
CHKB,1938,choline kinase activity,GO:0004103,molecular function,8.0,3.0,3.765e-02,1.736e-02,8.165e-02,3.485e-02,1.587e-02,7.650e-02,7.996e-01,2.099e-02
CHKB,1938,ethanolamine kinase activity,GO:0004305,molecular function,8.0,3.0,3.765e-02,1.736e-02,8.165e-02,3.604e-02,1.850e-02,7.021e-02,7.963e-01,1.806e-02
CHST7,13817,N-acetylglucosamine metabolic process,GO:0006044,biological process,7.0,4.0,8.465e-02,4.180e-02,1.714e-01,3.522e-02,1.771e-02,7.001e-02,7.987e-01,1.851e-02
CHST7,13817,sulfur compound metabolic process,GO:0006790,biological process,7.0,65.0,8.465e-02,4.180e-02,1.714e-01,5.352e-02,1.456e-02,1.968e-01,7.480e-01,3.723e-02
CHST7,13817,chondroitin sulfate biosynthetic process,GO:0030206,biological process,7.0,4.0,9.673e-02,6.597e-02,1.418e-01,6.116e-02,3.633e-02,1.030e-01,7.351e-01,1.542e-02
CHST7,13817,trans-Golgi network,GO:0005802,cellular component,7.0,4.0,2.201e-01,1.513e-01,3.201e-01,2.178e-01,1.479e-01,3.208e-01,5.410e-01,1.827e-02
CHST7,13817,chondroitin 6-sulfotransferase activity,GO:0008459,molecular function,7.0,2.0,9.863e-02,6.881e-02,1.414e-01,6.157e-02,2.720e-02,1.394e-01,7.335e-01,2.338e-02
CHST7,13817,N-acetylglucosamine 6-O-sulfotransferase activity,GO:0001517,molecular function,7.0,2.0,1.136e-01,3.328e-02,3.877e-01,7.679e-02,9.873e-03,5.972e-01,6.929e-01,6.605e-02
CIITA,7067,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,18.0,39.0,2.354e-01,1.363e-01,4.064e-01,7.874e-02,6.095e-02,1.017e-01,7.040e-01,7.948e-03
CIITA,7067,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,18.0,41.0,2.371e-01,1.363e-01,4.124e-01,1.033e-01,5.669e-02,1.884e-01,6.652e-01,2.093e-02
CIITA,7067,response to interferon-gamma,GO:0034341,biological process,18.0,6.0,2.482e-01,1.332e-01,4.625e-01,1.437e-01,6.931e-02,2.980e-01,6.130e-01,2.930e-02
CIITA,7067,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,18.0,55.0,2.696e-01,2.067e-01,3.516e-01,1.740e-01,1.249e-01,2.424e-01,5.827e-01,1.417e-02
CIITA,7067,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,18.0,69.0,2.797e-01,2.222e-01,3.520e-01,1.945e-01,1.527e-01,2.478e-01,5.630e-01,1.083e-02
CIITA,7067,response to antibiotic,GO:0046677,biological process,18.0,46.0,3.126e-01,2.184e-01,4.474e-01,2.622e-01,1.566e-01,4.392e-01,5.031e-01,2.500e-02
CIITA,7067,inflammatory response,GO:0006954,biological process,18.0,15.0,3.194e-01,2.713e-01,3.759e-01,2.522e-01,2.133e-01,2.981e-01,5.130e-01,8.205e-03
CIITA,7067,positive regulation of MHC class II biosynthetic process,GO:0045348,biological process,18.0,3.0,3.633e-01,3.115e-01,4.237e-01,3.270e-01,2.344e-01,4.562e-01,4.552e-01,1.918e-02
CIITA,7067,positive regulation of MHC class I biosynthetic process,GO:0045345,biological process,18.0,4.0,3.760e-01,3.419e-01,4.134e-01,3.582e-01,3.127e-01,4.102e-01,4.346e-01,8.122e-03
CIITA,7067,cytosol,GO:0005829,cellular component,18.0,50.0,2.354e-01,1.363e-01,4.064e-01,9.158e-02,5.709e-02,1.469e-01,6.831e-01,1.535e-02
CIITA,7067,nucleoplasm,GO:0005654,cellular component,18.0,47.0,2.354e-01,1.363e-01,4.064e-01,1.092e-01,8.208e-02,1.451e-01,6.588e-01,9.845e-03
CIITA,7067,PML body,GO:0016605,cellular component,18.0,3.0,2.359e-01,1.359e-01,4.097e-01,1.072e-01,5.581e-02,2.059e-01,6.593e-01,2.394e-02
CIITA,7067,activating transcription factor binding,GO:0033613,molecular function,18.0,5.0,2.354e-01,1.363e-01,4.064e-01,5.125e-02,3.945e-02,6.659e-02,7.569e-01,7.480e-03
CIITA,7067,protein C-terminus binding,GO:0008022,molecular function,18.0,3.0,2.354e-01,1.363e-01,4.064e-01,8.130e-02,2.436e-02,2.713e-01,6.950e-01,3.739e-02
CIITA,7067,protein binding,GO:0005515,molecular function,18.0,318.0,2.354e-01,1.363e-01,4.064e-01,1.178e-01,8.771e-02,1.581e-01,6.472e-01,1.075e-02
CIITA,7067,transcription regulatory region DNA binding,GO:0044212,molecular function,18.0,22.0,2.359e-01,1.359e-01,4.097e-01,1.045e-01,3.794e-02,2.880e-01,6.605e-01,3.628e-02
CIITA,7067,protein-containing complex binding,GO:0044877,molecular function,18.0,76.0,3.887e-01,3.373e-01,4.481e-01,3.729e-01,2.925e-01,4.754e-01,4.240e-01,1.480e-02
CIRBP,1982,"positive regulation of mRNA splicing, via spliceosome",GO:0048026,biological process,17.0,6.0,1.116e-01,7.016e-02,1.774e-01,2.528e-02,1.285e-02,4.975e-02,8.340e-01,1.683e-02
CIRBP,1982,mRNA stabilization,GO:0048255,biological process,17.0,6.0,1.116e-01,7.016e-02,1.774e-01,4.461e-02,2.972e-02,6.696e-02,7.727e-01,1.101e-02
CIRBP,1982,regulation of RNA metabolic process,GO:0051252,biological process,17.0,18.0,1.206e-01,9.653e-02,1.506e-01,4.890e-02,1.039e-02,2.301e-01,7.581e-01,4.184e-02
CIRBP,1982,positive regulation of translation,GO:0045727,biological process,17.0,17.0,1.227e-01,1.024e-01,1.470e-01,5.770e-02,8.710e-03,3.823e-01,7.352e-01,5.311e-02
CIRBP,1982,response to UV,GO:0009411,biological process,17.0,10.0,1.899e-01,1.750e-01,2.061e-01,1.899e-01,1.750e-01,2.061e-01,5.675e-01,3.585e-03
CIRBP,1982,spliceosomal complex,GO:0005681,cellular component,17.0,12.0,1.208e-01,6.551e-02,2.226e-01,6.910e-02,3.569e-02,1.338e-01,7.196e-01,2.020e-02
CIRBP,1982,nucleoplasm,GO:0005654,cellular component,17.0,47.0,1.238e-01,6.253e-02,2.450e-01,5.106e-02,1.309e-02,1.991e-01,7.530e-01,3.984e-02
CIRBP,1982,nucleus,GO:0005634,cellular component,17.0,86.0,1.238e-01,6.253e-02,2.450e-01,6.138e-02,3.342e-02,1.127e-01,7.344e-01,1.821e-02
CIRBP,1982,cytoplasm,GO:0005737,cellular component,17.0,72.0,1.238e-01,6.253e-02,2.450e-01,6.515e-02,2.643e-02,1.606e-01,7.256e-01,2.775e-02
CIRBP,1982,ribonucleoprotein complex,GO:1990904,cellular component,17.0,24.0,1.763e-01,1.471e-01,2.113e-01,1.662e-01,1.347e-01,2.051e-01,5.912e-01,8.579e-03
CIRBP,1982,mRNA 3'-UTR binding,GO:0003730,molecular function,17.0,3.0,1.201e-01,6.548e-02,2.203e-01,3.640e-02,1.313e-02,1.009e-01,7.943e-01,2.697e-02
CIRBP,1982,RNA binding,GO:0003723,molecular function,17.0,44.0,1.275e-01,5.935e-02,2.741e-01,6.523e-02,1.016e-02,4.188e-01,7.175e-01,5.790e-02
CIRBP,1982,protein binding,GO:0005515,molecular function,17.0,318.0,1.279e-01,5.949e-02,2.752e-01,9.321e-02,2.979e-02,2.917e-01,6.757e-01,3.962e-02
CIRBP,1982,small ribosomal subunit rRNA binding,GO:0070181,molecular function,17.0,2.0,1.487e-01,1.024e-01,2.161e-01,1.198e-01,9.183e-02,1.563e-01,6.448e-01,1.006e-02
CLCF1,17412,positive regulation of B cell proliferation,GO:0030890,biological process,14.0,4.0,8.594e-02,4.697e-02,1.572e-01,3.038e-02,1.936e-02,4.766e-02,8.152e-01,1.156e-02
CLCF1,17412,cell surface receptor signaling pathway,GO:0007166,biological process,14.0,34.0,8.594e-02,4.697e-02,1.572e-01,3.719e-02,1.050e-02,1.317e-01,7.908e-01,3.432e-02
CLCF1,17412,negative regulation of neuron apoptotic process,GO:0043524,biological process,14.0,13.0,9.029e-02,5.774e-02,1.412e-01,4.919e-02,3.180e-02,7.609e-02,7.614e-01,1.198e-02
CLCF1,17412,positive regulation of cell population proliferation,GO:0008284,biological process,14.0,38.0,9.029e-02,5.774e-02,1.412e-01,5.086e-02,2.993e-02,8.640e-02,7.573e-01,1.478e-02
CLCF1,17412,positive regulation of tyrosine phosphorylation of STAT protein,GO:0042531,biological process,14.0,7.0,9.508e-02,7.076e-02,1.278e-01,5.915e-02,3.748e-02,9.334e-02,7.393e-01,1.342e-02
CLCF1,17412,extracellular region,GO:0005576,cellular component,14.0,16.0,1.225e-01,8.528e-02,1.758e-01,9.962e-02,8.214e-02,1.208e-01,6.722e-01,6.597e-03
CLCF1,17412,CRLF-CLCF1 complex,GO:0097058,cellular component,14.0,3.0,1.546e-01,5.772e-02,4.142e-01,1.481e-01,5.131e-02,4.275e-01,6.047e-01,4.382e-02
CLCF1,17412,CNTFR-CLCF1 complex,GO:0097059,cellular component,14.0,2.0,1.546e-01,5.772e-02,4.142e-01,1.505e-01,5.242e-02,4.323e-01,6.020e-01,4.381e-02
CLCF1,17412,cytokine activity,GO:0005125,molecular function,14.0,5.0,8.594e-02,4.697e-02,1.572e-01,2.327e-02,8.476e-03,6.389e-02,8.408e-01,2.341e-02
CLCF1,17412,signaling receptor binding,GO:0005102,molecular function,14.0,63.0,8.594e-02,4.697e-02,1.572e-01,2.570e-02,6.114e-03,1.081e-01,8.278e-01,3.304e-02
CLCF1,17412,ciliary neurotrophic factor receptor binding,GO:0005127,molecular function,14.0,3.0,8.594e-02,4.697e-02,1.572e-01,3.478e-02,9.030e-03,1.339e-01,7.976e-01,3.502e-02
CLCF1,17412,protein heterodimerization activity,GO:0046982,molecular function,14.0,8.0,9.646e-02,7.198e-02,1.293e-01,6.015e-02,4.991e-02,7.249e-02,7.379e-01,5.482e-03
CLCF1,17412,protein binding,GO:0005515,molecular function,14.0,318.0,1.416e-01,1.222e-01,1.640e-01,1.300e-01,1.225e-01,1.380e-01,6.323e-01,2.309e-03
CLEC12A,31713,,,,nan,nan,,,,,,,,
CLEC9A,26705,receptor-mediated endocytosis,GO:0006898,biological process,5.0,9.0,1.257e-02,1.163e-03,1.357e-01,4.188e-03,3.877e-04,4.524e-02,9.397e-01,2.107e-02
CLEC9A,26705,positive regulation of cytokine secretion,GO:0050715,biological process,5.0,24.0,5.451e-02,2.201e-02,1.350e-01,3.873e-02,1.417e-02,1.058e-01,7.873e-01,2.640e-02
CLEC9A,26705,cell surface,GO:0009986,cellular component,5.0,20.0,8.630e-02,4.792e-02,1.554e-01,8.630e-02,4.792e-02,1.554e-01,6.907e-01,1.940e-02
CLMN,19972,,,,nan,nan,,,,,,,,
CNGA4,2152,,,,nan,nan,,,,,,,,
COLGALT2,16790,procollagen galactosyltransferase activity,GO:0050211,molecular function,3.0,3.0,2.217e-01,7.222e-02,6.808e-01,1.760e-01,3.340e-02,9.272e-01,5.629e-01,7.569e-02
COLGALT2,16790,protein binding,GO:0005515,molecular function,3.0,318.0,2.489e-01,1.021e-01,6.068e-01,1.961e-01,1.273e-01,3.022e-01,5.606e-01,1.911e-02
CORO1A,2252,actin cytoskeleton organization,GO:0030036,biological process,33.0,14.0,1.100e-01,8.337e-02,1.452e-01,1.897e-02,1.255e-02,2.867e-02,8.635e-01,9.650e-03
CORO1A,2252,actin filament organization,GO:0007015,biological process,33.0,15.0,1.100e-01,8.337e-02,1.452e-01,2.540e-02,1.557e-02,4.142e-02,8.340e-01,1.224e-02
CORO1A,2252,cell migration,GO:0016477,biological process,33.0,41.0,1.107e-01,8.302e-02,1.477e-01,2.652e-02,2.258e-02,3.115e-02,8.297e-01,4.093e-03
CORO1A,2252,phagocytosis,GO:0006909,biological process,33.0,4.0,1.143e-01,8.074e-02,1.618e-01,3.902e-02,2.629e-02,5.792e-02,7.878e-01,1.051e-02
CORO1A,2252,cell-substrate adhesion,GO:0031589,biological process,33.0,10.0,1.193e-01,9.703e-02,1.466e-01,4.229e-02,3.300e-02,5.420e-02,7.789e-01,6.683e-03
CORO1A,2252,regulation of actin cytoskeleton organization,GO:0032956,biological process,33.0,11.0,1.214e-01,7.746e-02,1.902e-01,6.005e-02,1.816e-02,1.986e-01,7.349e-01,3.416e-02
CORO1A,2252,phagolysosome assembly,GO:0001845,biological process,33.0,5.0,1.285e-01,9.906e-02,1.667e-01,7.694e-02,7.129e-02,8.303e-02,7.071e-01,2.383e-03
CORO1A,2252,natural killer cell degranulation,GO:0043320,biological process,33.0,3.0,1.304e-01,9.885e-02,1.720e-01,8.326e-02,4.732e-02,1.465e-01,6.957e-01,1.762e-02
CORO1A,2252,positive chemotaxis,GO:0050918,biological process,33.0,12.0,1.327e-01,9.679e-02,1.820e-01,8.812e-02,5.831e-02,1.332e-01,6.885e-01,1.360e-02
CORO1A,2252,negative regulation of actin nucleation,GO:0051126,biological process,33.0,5.0,1.376e-01,9.521e-02,1.988e-01,1.183e-01,8.270e-02,1.693e-01,6.462e-01,1.296e-02
CORO1A,2252,cortical actin cytoskeleton,GO:0030864,cellular component,33.0,4.0,1.100e-01,8.337e-02,1.452e-01,1.877e-02,8.822e-03,3.995e-02,8.635e-01,1.788e-02
CORO1A,2252,lamellipodium,GO:0030027,cellular component,33.0,4.0,1.112e-01,8.274e-02,1.495e-01,3.132e-02,1.697e-02,5.781e-02,8.117e-01,1.591e-02
CORO1A,2252,phagocytic cup,GO:0001891,cellular component,33.0,3.0,1.285e-01,9.906e-02,1.667e-01,6.674e-02,4.716e-02,9.447e-02,7.250e-01,1.029e-02
CORO1A,2252,phagocytic vesicle,GO:0045335,cellular component,33.0,6.0,1.304e-01,9.889e-02,1.720e-01,7.848e-02,4.533e-02,1.359e-01,7.036e-01,1.691e-02
CORO1A,2252,immunological synapse,GO:0001772,cellular component,33.0,3.0,1.304e-01,9.885e-02,1.720e-01,7.983e-02,5.457e-02,1.168e-01,7.020e-01,1.182e-02
CORO1A,2252,plasma membrane,GO:0005886,cellular component,33.0,67.0,1.311e-01,9.598e-02,1.789e-01,8.329e-02,4.703e-02,1.475e-01,6.956e-01,1.881e-02
CORO1A,2252,extracellular exosome,GO:0070062,cellular component,33.0,39.0,1.327e-01,9.679e-02,1.820e-01,9.559e-02,6.609e-02,1.382e-01,6.775e-01,1.218e-02
CORO1A,2252,membrane,GO:0016020,cellular component,33.0,41.0,1.449e-01,1.022e-01,2.054e-01,1.300e-01,9.023e-02,1.873e-01,6.315e-01,1.392e-02
CORO1A,2252,actin filament,GO:0005884,cellular component,33.0,5.0,1.515e-01,1.379e-01,1.664e-01,1.241e-01,7.242e-02,2.127e-01,6.379e-01,1.970e-02
CORO1A,2252,cytoplasm,GO:0005737,cellular component,33.0,72.0,1.568e-01,1.166e-01,2.108e-01,1.416e-01,1.051e-01,1.908e-01,6.182e-01,1.193e-02
CORO1A,2252,protein-containing complex,GO:0032991,cellular component,33.0,474.0,1.598e-01,6.774e-02,3.768e-01,1.212e-01,2.999e-02,4.901e-01,6.331e-01,5.410e-02
CORO1A,2252,actin filament binding,GO:0051015,molecular function,33.0,8.0,1.100e-01,8.337e-02,1.452e-01,1.208e-02,9.368e-03,1.558e-02,9.023e-01,4.368e-03
CORO1A,2252,actin monomer binding,GO:0003785,molecular function,33.0,2.0,1.100e-01,8.337e-02,1.452e-01,1.287e-02,8.672e-03,1.911e-02,8.971e-01,6.951e-03
CORO1A,2252,actin binding,GO:0003779,molecular function,33.0,7.0,1.112e-01,8.274e-02,1.495e-01,2.720e-02,2.036e-02,3.635e-02,8.272e-01,7.274e-03
CORO1A,2252,phosphatidylinositol 3-kinase binding,GO:0043548,molecular function,33.0,6.0,1.116e-01,8.397e-02,1.483e-01,3.827e-02,2.914e-02,5.026e-02,7.900e-01,7.355e-03
CORO1A,2252,myosin heavy chain binding,GO:0032036,molecular function,33.0,7.0,1.285e-01,9.906e-02,1.667e-01,6.674e-02,5.688e-02,7.831e-02,7.252e-01,4.786e-03
CORO1A,2252,protein C-terminus binding,GO:0008022,molecular function,33.0,3.0,1.285e-01,9.909e-02,1.667e-01,8.332e-02,6.332e-02,1.096e-01,6.965e-01,8.657e-03
CORO1A,2252,protein homodimerization activity,GO:0042803,molecular function,33.0,23.0,1.376e-01,9.521e-02,1.988e-01,1.124e-01,7.866e-02,1.607e-01,6.541e-01,1.256e-02
CORO1A,2252,RNA binding,GO:0003723,molecular function,33.0,44.0,1.615e-01,8.462e-02,3.083e-01,1.500e-01,6.808e-02,3.306e-01,6.056e-01,3.076e-02
CORO1A,2252,protein binding,GO:0005515,molecular function,33.0,318.0,1.915e-01,1.327e-01,2.763e-01,1.872e-01,1.341e-01,2.615e-01,5.696e-01,1.465e-02
CORO2B,2256,,,,nan,nan,,,,,,,,
CORO6,21356,actin filament organization,GO:0007015,biological process,7.0,15.0,2.203e-02,1.589e-02,3.053e-02,1.374e-02,1.163e-02,1.623e-02,8.927e-01,3.251e-03
CORO6,21356,cell migration,GO:0016477,biological process,7.0,41.0,2.562e-02,1.107e-02,5.933e-02,1.852e-02,7.476e-03,4.587e-02,8.641e-01,2.151e-02
CORO6,21356,actin filament binding,GO:0051015,molecular function,7.0,8.0,1.850e-02,1.122e-02,3.050e-02,5.639e-03,2.223e-03,1.431e-02,9.391e-01,8.480e-03
CORO6,21356,protein binding,GO:0005515,molecular function,7.0,318.0,7.287e-02,3.873e-02,1.371e-01,7.287e-02,3.873e-02,1.371e-01,7.129e-01,1.922e-02
COX4I2,16232,,,,nan,nan,,,,,,,,
CPLX1,2309,synaptic vesicle exocytosis,GO:0016079,biological process,11.0,6.0,1.501e-01,1.897e-02,1.187e+00,7.830e-02,6.197e-03,9.894e-01,6.788e-01,9.127e-02
CPLX1,2309,regulation of neurotransmitter secretion,GO:0046928,biological process,11.0,14.0,2.911e-01,6.254e-02,1.355e+00,2.459e-01,5.993e-02,1.009e+00,5.033e-01,6.653e-02
CPLX1,2309,SNARE complex,GO:0031201,cellular component,11.0,21.0,1.608e-01,1.968e-02,1.315e+00,1.156e-01,1.104e-02,1.209e+00,6.188e-01,9.962e-02
CPLX1,2309,terminal bouton,GO:0043195,cellular component,11.0,12.0,1.815e-01,2.883e-02,1.142e+00,1.708e-01,2.383e-02,1.224e+00,5.578e-01,9.702e-02
CPLX1,2309,protein binding,GO:0005515,molecular function,11.0,318.0,9.822e-02,4.310e-02,2.238e-01,2.368e-02,1.513e-02,3.708e-02,8.415e-01,1.124e-02
CPLX1,2309,SNARE binding,GO:0000149,molecular function,11.0,4.0,1.331e-01,2.469e-02,7.176e-01,4.533e-02,8.060e-03,2.549e-01,7.650e-01,4.905e-02
CPXM1,15771,peptide metabolic process,GO:0006518,biological process,5.0,23.0,1.416e-01,6.061e-02,3.307e-01,6.031e-02,2.117e-02,1.718e-01,7.343e-01,3.207e-02
CPXM1,15771,protein processing,GO:0016485,biological process,5.0,21.0,1.492e-01,5.758e-02,3.866e-01,7.887e-02,2.073e-02,3.001e-01,6.972e-01,4.341e-02
CPXM1,15771,extracellular space,GO:0005615,cellular component,5.0,24.0,1.956e-01,1.578e-01,2.425e-01,1.956e-01,1.578e-01,2.425e-01,5.620e-01,9.553e-03
CPXM1,15771,metallocarboxypeptidase activity,GO:0004181,molecular function,5.0,6.0,1.723e-01,1.067e-01,2.781e-01,1.384e-01,7.045e-02,2.720e-01,6.196e-01,2.658e-02
CRLF1,2364,negative regulation of neuron apoptotic process,GO:0043524,biological process,14.0,13.0,1.376e-01,7.325e-02,2.584e-01,7.406e-02,3.789e-02,1.448e-01,7.107e-01,2.015e-02
CRLF1,2364,positive regulation of cell population proliferation,GO:0008284,biological process,14.0,38.0,1.380e-01,7.285e-02,2.616e-01,8.141e-02,3.471e-02,1.909e-01,6.974e-01,2.637e-02
CRLF1,2364,positive regulation of tyrosine phosphorylation of STAT protein,GO:0042531,biological process,14.0,7.0,1.380e-01,7.285e-02,2.616e-01,8.362e-02,3.899e-02,1.793e-01,6.940e-01,2.466e-02
CRLF1,2364,external side of plasma membrane,GO:0009897,cellular component,14.0,16.0,1.136e-01,3.229e-02,3.999e-01,3.214e-02,1.027e-02,1.006e-01,8.074e-01,2.948e-02
CRLF1,2364,receptor complex,GO:0043235,cellular component,14.0,30.0,1.900e-01,8.059e-02,4.480e-01,1.793e-01,7.265e-02,4.425e-01,5.736e-01,3.715e-02
CRLF1,2364,CRLF-CLCF1 complex,GO:0097058,cellular component,14.0,3.0,2.057e-01,7.019e-02,6.028e-01,1.918e-01,5.840e-02,6.301e-01,5.570e-01,5.251e-02
CRLF1,2364,cytokine binding,GO:0019955,molecular function,14.0,40.0,1.136e-01,3.229e-02,3.999e-01,2.136e-02,1.570e-03,2.906e-01,8.288e-01,4.980e-02
CRLF1,2364,cytokine activity,GO:0005125,molecular function,14.0,5.0,1.136e-01,3.229e-02,3.999e-01,3.392e-02,7.830e-03,1.469e-01,8.000e-01,3.676e-02
CRLF1,2364,ciliary neurotrophic factor receptor binding,GO:0005127,molecular function,14.0,3.0,1.136e-01,3.229e-02,3.999e-01,4.538e-02,9.347e-03,2.203e-01,7.666e-01,4.253e-02
CRLF1,2364,protein heterodimerization activity,GO:0046982,molecular function,14.0,8.0,1.407e-01,8.036e-02,2.463e-01,8.251e-02,6.132e-02,1.110e-01,6.978e-01,9.361e-03
CRLF1,2364,protein binding,GO:0005515,molecular function,14.0,318.0,1.790e-01,1.171e-01,2.737e-01,1.478e-01,1.170e-01,1.867e-01,6.111e-01,9.327e-03
CRLF1,2364,cytokine receptor activity,GO:0004896,molecular function,14.0,44.0,1.837e-01,8.238e-02,4.098e-01,1.562e-01,6.414e-02,3.805e-01,5.977e-01,3.465e-02
CRTAC1,14882,extracellular exosome,GO:0070062,cellular component,3.0,39.0,4.634e-02,2.002e-02,1.073e-01,2.693e-02,1.449e-02,5.006e-02,8.278e-01,1.558e-02
CRTAC1,14882,protein binding,GO:0005515,molecular function,3.0,318.0,4.712e-02,1.952e-02,1.137e-01,4.712e-02,1.952e-02,1.137e-01,7.654e-01,2.432e-02
CRYBB3,2400,,,,nan,nan,,,,,,,,
CSF2RB,2436,protein binding,GO:0005515,molecular function,8.0,318.0,2.505e-02,1.948e-02,3.221e-02,2.505e-02,1.948e-02,3.221e-02,8.357e-01,6.227e-03
CTSW,2546,proteolysis involved in cellular protein catabolic process,GO:0051603,biological process,6.0,12.0,2.365e-01,6.938e-02,8.060e-01,2.365e-01,6.938e-02,8.060e-01,5.146e-01,5.928e-02
CTSW,2546,extracellular space,GO:0005615,cellular component,6.0,24.0,1.631e-01,2.645e-02,1.005e+00,8.759e-02,1.720e-02,4.460e-01,6.803e-01,5.189e-02
CTSW,2546,lysosome,GO:0005764,cellular component,6.0,9.0,1.631e-01,2.645e-02,1.005e+00,1.007e-01,1.414e-02,7.168e-01,6.543e-01,6.833e-02
CTSW,2546,membrane,GO:0016020,cellular component,6.0,41.0,1.737e-01,3.457e-02,8.724e-01,1.050e-01,3.596e-02,3.065e-01,6.595e-01,3.601e-02
CTSW,2546,cysteine-type endopeptidase activity,GO:0004197,molecular function,6.0,7.0,1.631e-01,2.645e-02,1.005e+00,8.946e-02,4.156e-03,1.926e+00,6.547e-01,9.709e-02
CUL7,21024,protein ubiquitination,GO:0016567,biological process,22.0,8.0,5.439e-02,4.134e-02,7.155e-02,1.442e-02,1.020e-02,2.040e-02,8.884e-01,7.102e-03
CUL7,21024,regulation of mitotic nuclear division,GO:0007088,biological process,22.0,10.0,5.439e-02,4.134e-02,7.155e-02,1.539e-02,8.946e-03,2.648e-02,8.817e-01,1.060e-02
CUL7,21024,microtubule cytoskeleton organization,GO:0000226,biological process,22.0,21.0,5.439e-02,4.134e-02,7.155e-02,2.082e-02,1.232e-02,3.519e-02,8.540e-01,1.235e-02
CUL7,21024,placenta development,GO:0001890,biological process,22.0,3.0,5.439e-02,4.134e-02,7.155e-02,2.336e-02,1.012e-02,5.395e-02,8.419e-01,2.108e-02
CUL7,21024,mitotic cytokinesis,GO:0000281,biological process,22.0,4.0,5.439e-02,4.134e-02,7.155e-02,3.015e-02,2.426e-02,3.747e-02,8.162e-01,5.595e-03
CUL7,21024,epithelial to mesenchymal transition,GO:0001837,biological process,22.0,8.0,5.439e-02,4.134e-02,7.155e-02,3.147e-02,2.048e-02,4.837e-02,8.114e-01,1.122e-02
CUL7,21024,positive regulation of dendrite morphogenesis,GO:0050775,biological process,22.0,5.0,6.065e-02,4.054e-02,9.075e-02,4.387e-02,2.171e-02,8.865e-02,7.740e-01,1.953e-02
CUL7,21024,Cul7-RING ubiquitin ligase complex,GO:0031467,cellular component,22.0,2.0,5.439e-02,4.134e-02,7.155e-02,2.313e-02,1.049e-02,5.104e-02,8.426e-01,1.885e-02
CUL7,21024,centrosome,GO:0005813,cellular component,22.0,11.0,5.498e-02,4.036e-02,7.490e-02,3.138e-02,1.266e-02,7.777e-02,8.108e-01,2.340e-02
CUL7,21024,perinuclear region of cytoplasm,GO:0048471,cellular component,22.0,8.0,5.622e-02,4.341e-02,7.280e-02,4.216e-02,3.328e-02,5.341e-02,7.793e-01,6.419e-03
CUL7,21024,cytoplasm,GO:0005737,cellular component,22.0,72.0,5.750e-02,4.605e-02,7.180e-02,4.651e-02,3.770e-02,5.736e-02,7.682e-01,5.814e-03
CUL7,21024,Golgi apparatus,GO:0005794,cellular component,22.0,16.0,5.827e-02,3.531e-02,9.616e-02,4.287e-02,2.022e-02,9.089e-02,7.764e-01,2.085e-02
CUL7,21024,3M complex,GO:1990393,cellular component,22.0,2.0,1.579e-01,8.379e-02,2.977e-01,1.579e-01,8.379e-02,2.977e-01,5.980e-01,2.600e-02
CUL7,21024,protein binding,GO:0005515,molecular function,22.0,318.0,8.025e-02,6.159e-02,1.046e-01,7.255e-02,5.112e-02,1.030e-01,7.143e-01,1.059e-02
CXCL10,10637,chemokine-mediated signaling pathway,GO:0070098,biological process,42.0,15.0,9.132e-02,4.937e-02,1.689e-01,1.651e-02,7.235e-03,3.767e-02,8.740e-01,1.730e-02
CXCL10,10637,regulation of apoptotic process,GO:0042981,biological process,42.0,24.0,9.803e-02,5.853e-02,1.642e-01,1.971e-02,7.268e-03,5.345e-02,8.567e-01,2.203e-02
CXCL10,10637,chemotaxis,GO:0006935,biological process,42.0,16.0,9.803e-02,5.853e-02,1.642e-01,2.521e-02,7.456e-03,8.522e-02,8.315e-01,2.855e-02
CXCL10,10637,positive regulation of T cell migration,GO:2000406,biological process,42.0,8.0,9.803e-02,5.853e-02,1.642e-01,3.650e-02,1.674e-02,7.959e-02,7.945e-01,2.100e-02
CXCL10,10637,adenylate cyclase-activating G protein-coupled receptor signaling pathway,GO:0007189,biological process,42.0,15.0,9.803e-02,5.853e-02,1.642e-01,4.311e-02,2.396e-02,7.754e-02,7.762e-01,1.624e-02
CXCL10,10637,leukocyte chemotaxis,GO:0030595,biological process,42.0,12.0,9.803e-02,5.853e-02,1.642e-01,4.397e-02,2.196e-02,8.801e-02,7.739e-01,1.892e-02
CXCL10,10637,regulation of T cell chemotaxis,GO:0010819,biological process,42.0,4.0,9.813e-02,5.839e-02,1.649e-01,4.197e-02,1.770e-02,9.951e-02,7.786e-01,2.351e-02
CXCL10,10637,antimicrobial humoral immune response mediated by antimicrobial peptide,GO:0061844,biological process,42.0,3.0,1.008e-01,6.088e-02,1.667e-01,4.534e-02,1.599e-02,1.285e-01,7.693e-01,2.805e-02
CXCL10,10637,neutrophil chemotaxis,GO:0030593,biological process,42.0,5.0,1.017e-01,5.389e-02,1.918e-01,4.869e-02,1.627e-02,1.457e-01,7.601e-01,3.184e-02
CXCL10,10637,positive regulation of monocyte chemotaxis,GO:0090026,biological process,42.0,7.0,1.017e-01,5.389e-02,1.918e-01,5.447e-02,2.159e-02,1.374e-01,7.477e-01,2.741e-02
CXCL10,10637,regulation of cell population proliferation,GO:0042127,biological process,42.0,37.0,1.035e-01,6.942e-02,1.544e-01,4.379e-02,2.504e-02,7.660e-02,7.745e-01,1.542e-02
CXCL10,10637,immune response,GO:0006955,biological process,42.0,17.0,1.091e-01,6.218e-02,1.913e-01,5.115e-02,1.386e-02,1.888e-01,7.534e-01,3.732e-02
CXCL10,10637,negative regulation of angiogenesis,GO:0016525,biological process,42.0,7.0,1.095e-01,6.506e-02,1.843e-01,6.407e-02,3.315e-02,1.238e-01,7.290e-01,1.993e-02
CXCL10,10637,regulation of endothelial tube morphogenesis,GO:1901509,biological process,42.0,5.0,1.101e-01,7.184e-02,1.687e-01,7.491e-02,6.569e-02,8.542e-02,7.106e-01,4.070e-03
CXCL10,10637,T cell chemotaxis,GO:0010818,biological process,42.0,5.0,1.132e-01,4.428e-02,2.892e-01,7.592e-02,1.726e-02,3.340e-01,7.002e-01,5.080e-02
CXCL10,10637,positive regulation of release of sequestered calcium ion into cytosol,GO:0051281,biological process,42.0,9.0,1.148e-01,6.503e-02,2.026e-01,8.298e-02,5.231e-02,1.316e-01,6.965e-01,1.505e-02
CXCL10,10637,G protein-coupled receptor signaling pathway,GO:0007186,biological process,42.0,48.0,1.223e-01,5.505e-02,2.719e-01,8.731e-02,2.519e-02,3.027e-01,6.836e-01,4.378e-02
CXCL10,10637,endothelial cell activation,GO:0042118,biological process,42.0,3.0,1.692e-01,6.139e-02,4.665e-01,1.512e-01,4.255e-02,5.370e-01,5.991e-01,4.851e-02
CXCL10,10637,inflammatory response,GO:0006954,biological process,42.0,15.0,1.966e-01,1.760e-01,2.195e-01,1.770e-01,1.303e-01,2.403e-01,5.798e-01,1.316e-02
CXCL10,10637,cellular response to lipopolysaccharide,GO:0071222,biological process,42.0,8.0,2.024e-01,4.907e-02,8.347e-01,1.765e-01,3.077e-02,1.013e+00,5.612e-01,7.685e-02
CXCL10,10637,extracellular space,GO:0005615,cellular component,42.0,24.0,1.502e-01,8.464e-02,2.665e-01,1.223e-01,6.875e-02,2.177e-01,6.399e-01,2.102e-02
CXCL10,10637,extracellular region,GO:0005576,cellular component,42.0,16.0,1.527e-01,9.095e-02,2.563e-01,1.286e-01,8.314e-02,1.988e-01,6.328e-01,1.637e-02
CXCL10,10637,CXCR3 chemokine receptor binding,GO:0048248,molecular function,42.0,3.0,9.132e-02,4.937e-02,1.689e-01,6.048e-03,1.882e-03,1.943e-02,9.341e-01,1.253e-02
CXCL10,10637,chemokine activity,GO:0008009,molecular function,42.0,7.0,9.132e-02,4.937e-02,1.689e-01,7.944e-03,4.110e-03,1.536e-02,9.253e-01,7.734e-03
CXCL10,10637,CXCR chemokine receptor binding,GO:0045236,molecular function,42.0,9.0,9.132e-02,4.937e-02,1.689e-01,1.756e-02,4.464e-03,6.906e-02,8.639e-01,2.824e-02
CXCL10,10637,chemoattractant activity,GO:0042056,molecular function,42.0,6.0,9.931e-02,5.684e-02,1.735e-01,4.101e-02,1.259e-02,1.335e-01,7.801e-01,3.193e-02
CXCL10,10637,heparin binding,GO:0008201,molecular function,42.0,6.0,1.466e-01,8.519e-02,2.524e-01,1.244e-01,7.193e-02,2.151e-01,6.378e-01,2.085e-02
CXCL10,10637,protein binding,GO:0005515,molecular function,42.0,318.0,1.995e-01,1.926e-01,2.066e-01,1.861e-01,1.511e-01,2.291e-01,5.712e-01,9.044e-03
CXCL12,10672,chemokine-mediated signaling pathway,GO:0070098,biological process,33.0,15.0,6.726e-02,2.502e-02,1.809e-01,1.794e-02,7.146e-03,4.506e-02,8.663e-01,2.048e-02
CXCL12,10672,positive regulation of cell adhesion,GO:0045785,biological process,33.0,10.0,6.726e-02,2.502e-02,1.809e-01,1.891e-02,1.364e-02,2.620e-02,8.639e-01,7.504e-03
CXCL12,10672,chemokine (C-X-C motif) ligand 12 signaling pathway,GO:0038146,biological process,33.0,3.0,6.726e-02,2.502e-02,1.809e-01,2.560e-02,1.163e-02,5.634e-02,8.329e-01,2.022e-02
CXCL12,10672,positive regulation of T cell migration,GO:2000406,biological process,33.0,8.0,6.820e-02,2.420e-02,1.922e-01,2.860e-02,7.140e-03,1.145e-01,8.192e-01,3.677e-02
CXCL12,10672,integrin activation,GO:0033622,biological process,33.0,2.0,6.902e-02,2.655e-02,1.794e-01,2.629e-02,6.687e-03,1.033e-01,8.270e-01,3.401e-02
CXCL12,10672,positive regulation of monocyte chemotaxis,GO:0090026,biological process,33.0,7.0,6.935e-02,2.382e-02,2.019e-01,3.675e-02,7.354e-03,1.836e-01,7.898e-01,4.507e-02
CXCL12,10672,negative regulation of leukocyte tethering or rolling,GO:1903237,biological process,33.0,4.0,7.143e-02,2.259e-02,2.259e-01,3.170e-02,2.588e-03,3.882e-01,7.951e-01,6.393e-02
CXCL12,10672,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,GO:1902230,biological process,33.0,5.0,7.795e-02,3.452e-02,1.760e-01,3.395e-02,9.945e-03,1.159e-01,8.010e-01,3.205e-02
CXCL12,10672,positive regulation of cell migration,GO:0030335,biological process,33.0,31.0,7.889e-02,3.081e-02,2.020e-01,4.728e-02,1.584e-02,1.411e-01,7.639e-01,3.066e-02
CXCL12,10672,cell chemotaxis,GO:0060326,biological process,33.0,22.0,8.622e-02,3.984e-02,1.866e-01,5.457e-02,3.048e-02,9.771e-02,7.489e-01,1.633e-02
CXCL12,10672,induction of positive chemotaxis,GO:0050930,biological process,33.0,3.0,9.066e-02,4.172e-02,1.970e-01,6.678e-02,2.371e-02,1.881e-01,7.218e-01,3.284e-02
CXCL12,10672,negative regulation of dendritic cell apoptotic process,GO:2000669,biological process,33.0,3.0,9.346e-02,4.800e-02,1.820e-01,5.708e-02,1.961e-02,1.662e-01,7.412e-01,3.160e-02
CXCL12,10672,cellular response to chemokine,GO:1990869,biological process,33.0,3.0,1.166e-01,5.169e-02,2.631e-01,1.021e-01,3.875e-02,2.691e-01,6.640e-01,3.538e-02
CXCL12,10672,axon guidance,GO:0007411,biological process,33.0,22.0,1.420e-01,4.506e-02,4.472e-01,1.268e-01,3.167e-02,5.078e-01,6.263e-01,5.094e-02
CXCL12,10672,external side of plasma membrane,GO:0009897,cellular component,33.0,16.0,8.137e-02,3.232e-02,2.048e-01,3.121e-02,6.218e-03,1.566e-01,8.079e-01,4.259e-02
CXCL12,10672,collagen-containing extracellular matrix,GO:0062023,cellular component,33.0,20.0,8.363e-02,3.183e-02,2.197e-01,5.127e-02,1.218e-02,2.159e-01,7.530e-01,3.952e-02
CXCL12,10672,extracellular exosome,GO:0070062,cellular component,33.0,39.0,1.239e-01,5.932e-02,2.586e-01,1.083e-01,4.833e-02,2.427e-01,6.570e-01,2.835e-02
CXCL12,10672,chemokine receptor binding,GO:0042379,molecular function,33.0,9.0,6.726e-02,2.502e-02,1.809e-01,8.204e-03,1.348e-03,4.992e-02,9.141e-01,2.206e-02
CXCL12,10672,chemokine activity,GO:0008009,molecular function,33.0,7.0,6.726e-02,2.502e-02,1.809e-01,1.241e-02,5.974e-03,2.576e-02,8.977e-01,1.333e-02
CXCL12,10672,CXCR chemokine receptor binding,GO:0045236,molecular function,33.0,9.0,6.902e-02,2.655e-02,1.794e-01,2.804e-02,7.498e-03,1.048e-01,8.210e-01,3.323e-02
CXCL12,10672,integrin binding,GO:0005178,molecular function,33.0,11.0,9.674e-02,3.076e-02,3.043e-01,6.882e-02,1.729e-02,2.739e-01,7.160e-01,4.113e-02
CXCL12,10672,protein binding,GO:0005515,molecular function,33.0,318.0,1.637e-01,1.012e-01,2.648e-01,1.585e-01,9.969e-02,2.522e-01,5.984e-01,1.906e-02
CXCL16,16642,response to tumor necrosis factor,GO:0034612,biological process,12.0,4.0,8.006e-02,2.459e-02,2.606e-01,2.997e-02,1.905e-02,4.716e-02,8.166e-01,1.171e-02
CXCL16,16642,positive regulation of cell migration,GO:0030335,biological process,12.0,31.0,8.006e-02,2.459e-02,2.606e-01,3.063e-02,9.401e-03,9.978e-02,8.125e-01,3.134e-02
CXCL16,16642,response to interferon-gamma,GO:0034341,biological process,12.0,6.0,8.006e-02,2.459e-02,2.606e-01,5.632e-02,3.034e-02,1.046e-01,7.450e-01,1.778e-02
CXCL16,16642,T cell chemotaxis,GO:0010818,biological process,12.0,5.0,8.137e-02,2.372e-02,2.791e-01,5.047e-02,8.463e-03,3.010e-01,7.501e-01,5.519e-02
CXCL16,16642,positive regulation of cell growth,GO:0030307,biological process,12.0,14.0,8.748e-02,2.610e-02,2.932e-01,7.873e-02,2.349e-02,2.639e-01,6.987e-01,3.894e-02
CXCL16,16642,response to cytokine,GO:0034097,biological process,12.0,32.0,1.048e-01,3.925e-02,2.800e-01,9.488e-02,4.426e-02,2.034e-01,6.768e-01,2.463e-02
CXCL16,16642,extracellular space,GO:0005615,cellular component,12.0,24.0,8.006e-02,2.459e-02,2.606e-01,4.988e-02,2.991e-02,8.318e-02,7.596e-01,1.449e-02
CXCL16,16642,chemokine activity,GO:0008009,molecular function,12.0,7.0,8.006e-02,2.459e-02,2.606e-01,2.008e-02,8.827e-03,4.566e-02,8.567e-01,1.984e-02
CXCL16,16642,low-density lipoprotein particle receptor activity,GO:0005041,molecular function,12.0,2.0,8.137e-02,2.372e-02,2.791e-01,5.518e-02,1.690e-02,1.802e-01,7.448e-01,3.487e-02
CXCL16,16642,scavenger receptor activity,GO:0005044,molecular function,12.0,3.0,9.317e-02,1.747e-02,4.969e-01,6.104e-02,5.753e-03,6.476e-01,7.165e-01,8.025e-02
CXCL9,7098,chemokine-mediated signaling pathway,GO:0070098,biological process,28.0,15.0,4.821e-02,2.089e-02,1.112e-01,1.593e-02,5.377e-03,4.720e-02,8.749e-01,2.240e-02
CXCL9,7098,chemotaxis,GO:0006935,biological process,28.0,16.0,5.728e-02,2.827e-02,1.161e-01,1.990e-02,5.705e-03,6.941e-02,8.536e-01,2.607e-02
CXCL9,7098,leukocyte chemotaxis,GO:0030595,biological process,28.0,12.0,5.728e-02,2.827e-02,1.161e-01,3.222e-02,1.590e-02,6.529e-02,8.083e-01,1.825e-02
CXCL9,7098,antimicrobial humoral immune response mediated by antimicrobial peptide,GO:0061844,biological process,28.0,3.0,5.837e-02,2.841e-02,1.199e-01,2.935e-02,1.063e-02,8.102e-02,8.172e-01,2.510e-02
CXCL9,7098,neutrophil chemotaxis,GO:0030593,biological process,28.0,5.0,6.147e-02,2.491e-02,1.517e-01,3.204e-02,9.158e-03,1.121e-01,8.072e-01,3.364e-02
CXCL9,7098,immune response,GO:0006955,biological process,28.0,17.0,6.176e-02,2.799e-02,1.362e-01,3.315e-02,1.011e-02,1.087e-01,8.038e-01,3.122e-02
CXCL9,7098,adenylate cyclase-activating G protein-coupled receptor signaling pathway,GO:0007189,biological process,28.0,15.0,6.347e-02,2.822e-02,1.428e-01,3.560e-02,1.374e-02,9.219e-02,7.967e-01,2.575e-02
CXCL9,7098,regulation of cell population proliferation,GO:0042127,biological process,28.0,37.0,6.681e-02,5.047e-02,8.845e-02,3.809e-02,2.750e-02,5.277e-02,7.906e-01,8.692e-03
CXCL9,7098,positive regulation of release of sequestered calcium ion into cytosol,GO:0051281,biological process,28.0,9.0,8.464e-02,4.058e-02,1.765e-01,6.877e-02,3.297e-02,1.434e-01,7.198e-01,2.274e-02
CXCL9,7098,inflammatory response,GO:0006954,biological process,28.0,15.0,1.269e-01,1.093e-01,1.474e-01,1.216e-01,1.018e-01,1.451e-01,6.427e-01,6.505e-03
CXCL9,7098,cellular response to lipopolysaccharide,GO:0071222,biological process,28.0,8.0,1.516e-01,3.055e-02,7.518e-01,1.285e-01,1.818e-02,9.075e-01,6.132e-01,7.951e-02
CXCL9,7098,extracellular space,GO:0005615,cellular component,28.0,24.0,9.432e-02,4.553e-02,1.954e-01,7.594e-02,3.572e-02,1.614e-01,7.072e-01,2.290e-02
CXCL9,7098,CXCR3 chemokine receptor binding,GO:0048248,molecular function,28.0,3.0,4.144e-02,1.248e-02,1.376e-01,4.783e-03,9.961e-04,2.297e-02,9.413e-01,1.565e-02
CXCL9,7098,chemokine activity,GO:0008009,molecular function,28.0,7.0,4.144e-02,1.248e-02,1.376e-01,6.131e-03,1.377e-03,2.729e-02,9.322e-01,1.473e-02
CXCL9,7098,CXCR chemokine receptor binding,GO:0045236,molecular function,28.0,9.0,4.191e-02,1.302e-02,1.349e-01,1.348e-02,1.856e-03,9.794e-02,8.771e-01,3.358e-02
CXCL9,7098,protein binding,GO:0005515,molecular function,28.0,318.0,1.341e-01,1.251e-01,1.438e-01,1.310e-01,1.199e-01,1.430e-01,6.310e-01,3.493e-03
CXCR3,4540,chemotaxis,GO:0006935,biological process,26.0,16.0,4.892e-02,2.966e-02,8.068e-02,1.527e-02,7.554e-03,3.089e-02,8.819e-01,1.541e-02
CXCR3,4540,immune response,GO:0006955,biological process,26.0,17.0,4.892e-02,2.966e-02,8.068e-02,2.630e-02,1.681e-02,4.114e-02,8.304e-01,1.134e-02
CXCR3,4540,positive regulation of cytosolic calcium ion concentration,GO:0007204,biological process,26.0,12.0,5.269e-02,2.488e-02,1.116e-01,2.880e-02,1.099e-02,7.551e-02,8.198e-01,2.518e-02
CXCR3,4540,cell surface receptor signaling pathway,GO:0007166,biological process,26.0,34.0,5.342e-02,2.408e-02,1.185e-01,3.522e-02,1.085e-02,1.143e-01,7.973e-01,3.167e-02
CXCR3,4540,calcium-mediated signaling,GO:0019722,biological process,26.0,15.0,5.664e-02,2.815e-02,1.140e-01,4.747e-02,1.793e-02,1.257e-01,7.639e-01,2.776e-02
CXCR3,4540,cell chemotaxis,GO:0060326,biological process,26.0,22.0,6.295e-02,3.281e-02,1.208e-01,4.969e-02,2.328e-02,1.061e-01,7.595e-01,2.081e-02
CXCR3,4540,regulation of cell adhesion,GO:0030155,biological process,26.0,11.0,8.508e-02,2.022e-02,3.580e-01,5.825e-02,7.486e-03,4.532e-01,7.279e-01,6.733e-02
CXCR3,4540,external side of plasma membrane,GO:0009897,cellular component,26.0,16.0,4.892e-02,2.966e-02,8.068e-02,1.262e-02,9.645e-03,1.652e-02,8.992e-01,4.646e-03
CXCR3,4540,chemokine binding,GO:0019956,molecular function,26.0,7.0,4.892e-02,2.966e-02,8.068e-02,1.382e-02,1.102e-02,1.731e-02,8.922e-01,4.261e-03
CXCR3,4540,C-C chemokine binding,GO:0019957,molecular function,26.0,10.0,5.073e-02,2.723e-02,9.451e-02,2.590e-02,9.884e-03,6.789e-02,8.306e-01,2.356e-02
CXCR3,4540,identical protein binding,GO:0042802,molecular function,26.0,24.0,5.186e-02,3.461e-02,7.771e-02,2.906e-02,1.807e-02,4.672e-02,8.198e-01,1.231e-02
CXCR3,4540,C-C chemokine receptor activity,GO:0016493,molecular function,26.0,8.0,5.947e-02,3.222e-02,1.098e-01,5.000e-02,2.121e-02,1.179e-01,7.581e-01,2.461e-02
CXCR3,4540,protein binding,GO:0005515,molecular function,26.0,318.0,8.260e-02,5.561e-02,1.227e-01,8.043e-02,4.973e-02,1.301e-01,7.006e-01,1.501e-02
CXXC5,26943,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,10.0,55.0,1.258e-01,8.097e-02,1.955e-01,7.825e-02,2.712e-02,2.258e-01,7.003e-01,3.532e-02
CXXC5,26943,positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043123,biological process,10.0,12.0,1.393e-01,8.294e-02,2.340e-01,1.257e-01,5.898e-02,2.680e-01,6.344e-01,2.825e-02
CXXC5,26943,cytosol,GO:0005829,cellular component,10.0,50.0,1.218e-01,9.480e-02,1.565e-01,9.383e-02,4.184e-02,2.104e-01,6.777e-01,2.700e-02
CXXC5,26943,nucleoplasm,GO:0005654,cellular component,10.0,47.0,1.237e-01,9.580e-02,1.598e-01,1.007e-01,7.233e-02,1.401e-01,6.703e-01,1.130e-02
CXXC5,26943,methyl-CpG binding,GO:0008327,molecular function,10.0,3.0,7.445e-02,4.307e-02,1.287e-01,1.844e-02,1.291e-02,2.633e-02,8.664e-01,8.128e-03
CXXC5,26943,sequence-specific DNA binding,GO:0043565,molecular function,10.0,14.0,7.445e-02,4.307e-02,1.287e-01,2.157e-02,1.533e-02,3.036e-02,8.508e-01,8.355e-03
CXXC5,26943,transcription factor binding,GO:0008134,molecular function,10.0,16.0,7.445e-02,4.307e-02,1.287e-01,2.188e-02,8.267e-03,5.792e-02,8.471e-01,2.211e-02
CXXC5,26943,zinc ion binding,GO:0008270,molecular function,10.0,4.0,1.173e-01,9.521e-02,1.446e-01,7.514e-02,3.919e-02,1.441e-01,7.088e-01,2.007e-02
CXXC5,26943,protein binding,GO:0005515,molecular function,10.0,318.0,1.218e-01,9.480e-02,1.565e-01,9.940e-02,4.968e-02,1.989e-01,6.703e-01,2.342e-02
CYGB,16505,protein binding,GO:0005515,molecular function,2.0,318.0,3.277e-02,1.228e-02,8.748e-02,3.277e-02,1.228e-02,8.748e-02,8.058e-01,2.556e-02
DAPK2,2675,,,,nan,nan,,,,,,,,
DBP,2697,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,19.0,69.0,1.389e-02,1.032e-02,1.869e-02,1.131e-02,7.853e-03,1.628e-02,9.063e-01,5.511e-03
DBP,2697,nucleus,GO:0005634,cellular component,19.0,86.0,1.297e-02,1.166e-02,1.442e-02,6.598e-03,2.873e-03,1.515e-02,9.328e-01,8.080e-03
DBP,2697,"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,molecular function,19.0,11.0,1.297e-02,1.166e-02,1.442e-02,5.667e-03,3.150e-03,1.020e-02,9.395e-01,5.000e-03
DBP,2697,RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000977,molecular function,19.0,16.0,1.600e-02,1.118e-02,2.291e-02,1.600e-02,1.118e-02,2.291e-02,8.794e-01,7.675e-03
DCST1,26539,,,,nan,nan,,,,,,,,
DCST2,26562,,,,nan,nan,,,,,,,,
DDAH2,2716,arginine metabolic process,GO:0006525,biological process,12.0,6.0,1.265e-01,4.097e-02,3.904e-01,6.361e-02,2.516e-02,1.608e-01,7.289e-01,2.711e-02
DDAH2,2716,positive regulation of nitric oxide biosynthetic process,GO:0045429,biological process,12.0,6.0,1.361e-01,3.438e-02,5.387e-01,8.354e-02,1.048e-02,6.657e-01,6.774e-01,7.557e-02
DDAH2,2716,citrulline metabolic process,GO:0000052,biological process,12.0,4.0,1.469e-01,2.864e-02,7.536e-01,9.333e-02,7.325e-03,1.189e+00,6.508e-01,9.827e-02
DDAH2,2716,extracellular exosome,GO:0070062,cellular component,12.0,39.0,1.279e-01,4.213e-02,3.884e-01,6.227e-02,2.307e-02,1.681e-01,7.308e-01,2.984e-02
DDAH2,2716,centriolar satellite,GO:0034451,cellular component,12.0,5.0,1.385e-01,4.944e-02,3.880e-01,1.159e-01,6.409e-02,2.097e-01,6.482e-01,2.186e-02
DDAH2,2716,cytosol,GO:0005829,cellular component,12.0,50.0,1.385e-01,4.944e-02,3.880e-01,1.208e-01,6.142e-02,2.375e-01,6.414e-01,2.480e-02
DDAH2,2716,dimethylargininase activity,GO:0016403,molecular function,12.0,2.0,9.374e-02,2.952e-02,2.976e-01,9.374e-03,2.952e-03,2.976e-02,9.118e-01,1.814e-02
DDAH2,2716,amino acid binding,GO:0016597,molecular function,12.0,14.0,1.279e-01,4.213e-02,3.884e-01,8.714e-02,2.764e-02,2.747e-01,6.851e-01,3.886e-02
DDAH2,2716,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines",GO:0016813,molecular function,12.0,33.0,1.286e-01,4.265e-02,3.877e-01,9.428e-02,3.408e-02,2.608e-01,6.751e-01,3.636e-02
DDAH2,2716,protein binding,GO:0005515,molecular function,12.0,318.0,1.425e-01,4.644e-02,4.370e-01,1.225e-01,4.528e-02,3.311e-01,6.363e-01,3.848e-02
DGKH,2854,protein kinase C-activating G protein-coupled receptor signaling pathway,GO:0007205,biological process,14.0,2.0,1.693e-01,5.730e-02,5.001e-01,3.374e-02,2.550e-02,4.464e-02,8.039e-01,7.390e-03
DGKH,2854,protein complex oligomerization,GO:0051259,biological process,14.0,7.0,1.693e-01,5.730e-02,5.001e-01,5.968e-02,6.223e-03,5.724e-01,7.254e-01,6.647e-02
DGKH,2854,lipid phosphorylation,GO:0046834,biological process,14.0,4.0,1.708e-01,5.662e-02,5.153e-01,6.627e-02,1.329e-02,3.305e-01,7.196e-01,4.622e-02
DGKH,2854,glycerolipid metabolic process,GO:0046486,biological process,14.0,6.0,1.889e-01,4.843e-02,7.364e-01,1.190e-01,2.805e-02,5.047e-01,6.357e-01,5.096e-02
DGKH,2854,phosphatidic acid metabolic process,GO:0046473,biological process,14.0,3.0,1.983e-01,5.910e-02,6.655e-01,1.638e-01,4.175e-02,6.427e-01,5.823e-01,6.142e-02
DGKH,2854,diacylglycerol metabolic process,GO:0046339,biological process,14.0,5.0,2.185e-01,6.130e-02,7.790e-01,1.978e-01,4.641e-02,8.432e-01,5.471e-01,6.223e-02
DGKH,2854,intracellular signal transduction,GO:0035556,biological process,14.0,34.0,2.700e-01,8.215e-02,8.875e-01,2.609e-01,8.289e-02,8.210e-01,4.958e-01,5.502e-02
DGKH,2854,endosome,GO:0005768,cellular component,14.0,11.0,1.889e-01,4.843e-02,7.364e-01,1.299e-01,2.730e-02,6.185e-01,6.200e-01,5.759e-02
DGKH,2854,cytoplasm,GO:0005737,cellular component,14.0,72.0,1.983e-01,5.910e-02,6.655e-01,1.507e-01,6.054e-02,3.754e-01,6.035e-01,3.642e-02
DGKH,2854,diacylglycerol kinase activity,GO:0004143,molecular function,14.0,3.0,1.693e-01,5.730e-02,5.001e-01,6.505e-02,4.317e-02,9.802e-02,7.279e-01,1.202e-02
DIDO1,2680,RNA binding,GO:0003723,molecular function,2.0,44.0,1.729e-02,1.110e-02,2.691e-02,1.729e-02,1.110e-02,2.691e-02,8.722e-01,1.016e-02
DLL1,2908,negative regulation of interleukin-10 production,GO:0032693,biological process,12.0,5.0,1.635e-01,1.278e-01,2.091e-01,9.494e-02,4.177e-02,2.158e-01,6.759e-01,2.758e-02
DLL1,2908,negative regulation of Notch signaling pathway,GO:0045746,biological process,12.0,5.0,1.651e-01,1.473e-01,1.850e-01,9.979e-02,2.912e-02,3.419e-01,6.654e-01,4.035e-02
DLL1,2908,neuronal stem cell population maintenance,GO:0097150,biological process,12.0,2.0,1.664e-01,1.225e-01,2.262e-01,1.383e-01,8.952e-02,2.138e-01,6.213e-01,1.710e-02
DLL1,2908,Notch signaling pathway,GO:0007219,biological process,12.0,10.0,1.939e-01,1.112e-01,3.381e-01,1.321e-01,4.116e-02,4.237e-01,6.223e-01,4.785e-02
DLL1,2908,plasma membrane,GO:0005886,cellular component,12.0,67.0,1.592e-01,1.359e-01,1.866e-01,6.731e-02,6.073e-02,7.460e-02,7.243e-01,3.149e-03
DLL1,2908,Notch binding,GO:0005112,molecular function,12.0,3.0,1.592e-01,1.359e-01,1.866e-01,5.695e-02,2.595e-02,1.249e-01,7.429e-01,2.262e-02
DLL1,2908,Tat protein binding,GO:0030957,molecular function,12.0,2.0,1.628e-01,1.290e-01,2.055e-01,9.510e-02,4.104e-02,2.204e-01,6.758e-01,2.714e-02
DLL1,2908,protein binding,GO:0005515,molecular function,12.0,318.0,1.738e-01,1.319e-01,2.290e-01,1.636e-01,1.048e-01,2.552e-01,5.932e-01,1.843e-02
DNA2,2939,mitochondrial DNA replication,GO:0006264,biological process,32.0,2.0,6.032e-02,5.597e-02,6.501e-02,1.629e-02,7.822e-03,3.391e-02,8.760e-01,1.622e-02
DNA2,2939,base-excision repair,GO:0006284,biological process,32.0,5.0,6.032e-02,5.597e-02,6.501e-02,1.629e-02,7.511e-03,3.532e-02,8.756e-01,1.699e-02
DNA2,2939,mitochondrial DNA repair,GO:0043504,biological process,32.0,3.0,6.032e-02,5.597e-02,6.501e-02,1.813e-02,1.239e-02,2.653e-02,8.676e-01,8.723e-03
DNA2,2939,"DNA replication, removal of RNA primer",GO:0043137,biological process,32.0,4.0,6.032e-02,5.597e-02,6.501e-02,1.980e-02,1.217e-02,3.221e-02,8.591e-01,1.159e-02
DNA2,2939,DNA replication checkpoint,GO:0000076,biological process,32.0,5.0,6.032e-02,5.597e-02,6.501e-02,2.115e-02,9.951e-03,4.495e-02,8.520e-01,1.827e-02
DNA2,2939,replication fork reversal,GO:0071932,biological process,32.0,2.0,6.044e-02,5.572e-02,6.557e-02,2.881e-02,1.893e-02,4.384e-02,8.209e-01,1.081e-02
DNA2,2939,DNA replication,GO:0006260,biological process,32.0,5.0,6.791e-02,4.823e-02,9.562e-02,3.031e-02,6.202e-03,1.481e-01,8.107e-01,3.966e-02
DNA2,2939,"DNA replication, Okazaki fragment processing",GO:0033567,biological process,32.0,3.0,6.808e-02,6.243e-02,7.424e-02,4.474e-02,3.993e-02,5.012e-02,7.727e-01,3.080e-03
DNA2,2939,DNA double-strand break processing,GO:0000729,biological process,32.0,6.0,8.332e-02,6.049e-02,1.148e-01,6.734e-02,3.811e-02,1.190e-01,7.233e-01,1.704e-02
DNA2,2939,positive regulation of DNA replication,GO:0045740,biological process,32.0,5.0,1.367e-01,7.918e-02,2.359e-01,1.331e-01,7.417e-02,2.390e-01,6.267e-01,2.265e-02
DNA2,2939,mitochondrial nucleoid,GO:0042645,cellular component,32.0,3.0,6.040e-02,5.581e-02,6.537e-02,2.637e-02,2.431e-02,2.862e-02,8.302e-01,2.057e-03
DNA2,2939,mitochondrion,GO:0005739,cellular component,32.0,12.0,6.408e-02,5.670e-02,7.242e-02,3.664e-02,2.450e-02,5.478e-02,7.948e-01,1.073e-02
DNA2,2939,"nuclear chromosome, telomeric region",GO:0000784,cellular component,32.0,4.0,7.343e-02,5.966e-02,9.037e-02,5.104e-02,3.696e-02,7.049e-02,7.571e-01,9.018e-03
DNA2,2939,nucleoplasm,GO:0005654,cellular component,32.0,47.0,7.623e-02,6.393e-02,9.090e-02,5.682e-02,4.499e-02,7.177e-02,7.448e-01,6.641e-03
DNA2,2939,nucleus,GO:0005634,cellular component,32.0,86.0,8.181e-02,7.114e-02,9.408e-02,7.006e-02,5.058e-02,9.706e-02,7.187e-01,9.699e-03
DNA2,2939,cytoplasm,GO:0005737,cellular component,32.0,72.0,8.345e-02,8.232e-02,8.459e-02,7.008e-02,6.551e-02,7.497e-02,7.191e-01,2.030e-03
DNA2,2939,gamma DNA polymerase complex,GO:0005760,cellular component,32.0,3.0,1.430e-01,1.076e-01,1.899e-01,1.411e-01,1.022e-01,1.948e-01,6.186e-01,1.269e-02
DNA2,2939,5'-3' DNA helicase activity,GO:0043139,molecular function,32.0,2.0,5.334e-02,3.765e-02,7.556e-02,4.936e-03,1.686e-03,1.445e-02,9.432e-01,9.784e-03
DNA2,2939,single-stranded DNA helicase activity,GO:0017116,molecular function,32.0,3.0,5.334e-02,3.765e-02,7.556e-02,5.981e-03,1.761e-03,2.031e-02,9.349e-01,1.261e-02
DNA2,2939,"site-specific endodeoxyribonuclease activity, specific for altered base",GO:0016890,molecular function,32.0,4.0,6.032e-02,5.597e-02,6.501e-02,2.496e-02,1.500e-02,4.153e-02,8.359e-01,1.275e-02
DNA2,2939,5'-flap endonuclease activity,GO:0017108,molecular function,32.0,3.0,6.040e-02,5.581e-02,6.537e-02,1.976e-02,7.681e-03,5.086e-02,8.569e-01,2.096e-02
DNA2,2939,DNA binding,GO:0003677,molecular function,32.0,29.0,6.040e-02,5.581e-02,6.537e-02,2.348e-02,1.055e-02,5.225e-02,8.410e-01,1.901e-02
DNA2,2939,RNA binding,GO:0003723,molecular function,32.0,44.0,6.230e-02,5.533e-02,7.015e-02,3.003e-02,1.624e-02,5.551e-02,8.162e-01,1.575e-02
DNA2,2939,DNA helicase activity,GO:0003678,molecular function,32.0,10.0,6.392e-02,5.269e-02,7.756e-02,3.530e-02,2.307e-02,5.403e-02,7.989e-01,1.142e-02
DNA2,2939,protein binding,GO:0005515,molecular function,32.0,318.0,8.868e-02,7.621e-02,1.032e-01,7.761e-02,6.980e-02,8.628e-02,7.060e-01,3.326e-03
DNA2,2939,nuclease activity,GO:0004518,molecular function,32.0,7.0,1.011e-01,6.787e-02,1.505e-01,8.923e-02,5.158e-02,1.543e-01,6.865e-01,1.755e-02
DNAH17,2946,,,,nan,nan,,,,,,,,
DNAJC7,12392,chaperone cofactor-dependent protein refolding,GO:0051085,biological process,15.0,3.0,2.242e-02,9.951e-03,5.053e-02,2.051e-02,7.970e-03,5.280e-02,8.538e-01,2.225e-02
DNAJC7,12392,extracellular exosome,GO:0070062,cellular component,15.0,39.0,1.338e-02,5.179e-03,3.456e-02,5.903e-03,1.610e-03,2.164e-02,9.347e-01,1.379e-02
DNAJC7,12392,cytosol,GO:0005829,cellular component,15.0,50.0,1.338e-02,5.179e-03,3.456e-02,6.210e-03,1.996e-03,1.932e-02,9.339e-01,1.134e-02
DNAJC7,12392,cytoplasm,GO:0005737,cellular component,15.0,72.0,1.338e-02,5.179e-03,3.456e-02,7.301e-03,2.758e-03,1.933e-02,9.274e-01,1.077e-02
DNAJC7,12392,nucleoplasm,GO:0005654,cellular component,15.0,47.0,1.338e-02,5.179e-03,3.456e-02,9.674e-03,2.950e-03,3.173e-02,9.098e-01,1.902e-02
DNAJC7,12392,membrane,GO:0016020,cellular component,15.0,41.0,1.386e-02,5.341e-03,3.596e-02,6.962e-03,1.434e-03,3.380e-02,9.265e-01,1.481e-02
DNAJC7,12392,protein binding,GO:0005515,molecular function,15.0,318.0,1.338e-02,5.179e-03,3.456e-02,9.008e-03,3.952e-03,2.053e-02,9.174e-01,1.139e-02
DNAJC7,12392,heat shock protein binding,GO:0031072,molecular function,15.0,5.0,2.348e-02,1.934e-02,2.850e-02,2.157e-02,1.396e-02,3.333e-02,8.506e-01,1.037e-02
DNASE1L3,2959,apoptotic DNA fragmentation,GO:0006309,biological process,11.0,2.0,9.555e-02,6.346e-02,1.439e-01,2.147e-02,1.502e-02,3.069e-02,8.514e-01,8.721e-03
DNASE1L3,2959,"DNA catabolic process, endonucleolytic",GO:0000737,biological process,11.0,4.0,9.797e-02,5.989e-02,1.603e-01,2.333e-02,4.854e-03,1.121e-01,8.381e-01,3.981e-02
DNASE1L3,2959,DNA catabolic process,GO:0006308,biological process,11.0,7.0,1.293e-01,1.016e-01,1.647e-01,1.052e-01,7.208e-02,1.534e-01,6.638e-01,1.338e-02
DNASE1L3,2959,programmed cell death involved in cell development,GO:0010623,biological process,11.0,10.0,4.471e-01,1.470e-01,1.360e+00,4.471e-01,1.470e-01,1.360e+00,3.443e-01,9.134e-02
DNASE1L3,2959,endoplasmic reticulum,GO:0005783,cellular component,11.0,16.0,1.071e-01,7.831e-02,1.466e-01,4.353e-02,1.523e-02,1.244e-01,7.736e-01,2.919e-02
DNASE1L3,2959,nucleus,GO:0005634,cellular component,11.0,86.0,1.293e-01,1.016e-01,1.647e-01,9.780e-02,7.401e-02,1.292e-01,6.746e-01,9.534e-03
DNASE1L3,2959,deoxyribonuclease I activity,GO:0004530,molecular function,11.0,2.0,1.098e-01,7.557e-02,1.597e-01,4.640e-02,2.605e-02,8.266e-02,7.678e-01,1.613e-02
DNASE1L3,2959,DNA binding,GO:0003677,molecular function,11.0,29.0,1.268e-01,1.050e-01,1.531e-01,6.827e-02,4.605e-02,1.012e-01,7.220e-01,1.165e-02
DNASE1L3,2959,deoxyribonuclease activity,GO:0004536,molecular function,11.0,6.0,1.516e-01,1.126e-01,2.041e-01,1.306e-01,9.324e-02,1.830e-01,6.311e-01,1.325e-02
DOCK6,19189,,,,nan,nan,,,,,,,,
DOCK9,14132,membrane,GO:0016020,cellular component,4.0,41.0,6.118e-02,4.312e-02,8.680e-02,5.639e-02,4.899e-02,6.490e-02,7.454e-01,4.011e-03
DOCK9,14132,cadherin binding,GO:0045296,molecular function,4.0,9.0,6.118e-02,4.312e-02,8.680e-02,2.451e-02,1.398e-02,4.297e-02,8.376e-01,1.379e-02
DOCK9,14132,protein binding,GO:0005515,molecular function,4.0,318.0,6.118e-02,4.312e-02,8.680e-02,6.007e-02,4.084e-02,8.836e-02,7.376e-01,1.129e-02
DUSP26,28161,negative regulation of protein kinase activity by regulation of protein phosphorylation,GO:0044387,biological process,24.0,2.0,1.344e-01,9.633e-02,1.875e-01,4.109e-02,8.818e-03,1.915e-01,7.782e-01,4.102e-02
DUSP26,28161,negative regulation of ERK1 and ERK2 cascade,GO:0070373,biological process,24.0,4.0,1.365e-01,1.045e-01,1.782e-01,4.602e-02,2.873e-02,7.373e-02,7.690e-01,1.314e-02
DUSP26,28161,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,24.0,55.0,1.481e-01,1.358e-01,1.616e-01,1.135e-01,1.008e-01,1.278e-01,6.534e-01,4.300e-03
DUSP26,28161,positive regulation of cell adhesion,GO:0045785,biological process,24.0,10.0,1.504e-01,1.339e-01,1.688e-01,8.644e-02,2.579e-02,2.897e-01,6.861e-01,3.887e-02
DUSP26,28161,positive regulation of peptidyl-serine dephosphorylation,GO:1902310,biological process,24.0,3.0,1.546e-01,1.297e-01,1.843e-01,9.824e-02,3.481e-02,2.773e-01,6.695e-01,3.431e-02
DUSP26,28161,protein dephosphorylation,GO:0006470,biological process,24.0,11.0,1.722e-01,6.295e-02,4.711e-01,1.098e-01,1.898e-02,6.353e-01,6.418e-01,7.014e-02
DUSP26,28161,Golgi apparatus,GO:0005794,cellular component,24.0,16.0,1.344e-01,9.633e-02,1.875e-01,5.515e-02,1.752e-02,1.736e-01,7.451e-01,3.390e-02
DUSP26,28161,extracellular exosome,GO:0070062,cellular component,24.0,39.0,1.369e-01,1.040e-01,1.801e-01,6.550e-02,2.944e-02,1.457e-01,7.258e-01,2.371e-02
DUSP26,28161,nucleus,GO:0005634,cellular component,24.0,86.0,1.369e-01,1.040e-01,1.801e-01,8.662e-02,4.299e-02,1.745e-01,6.895e-01,2.308e-02
DUSP26,28161,cytoplasm,GO:0005737,cellular component,24.0,72.0,1.369e-01,1.040e-01,1.801e-01,9.591e-02,4.910e-02,1.873e-01,6.755e-01,2.300e-02
DUSP26,28161,nucleoplasm,GO:0005654,cellular component,24.0,47.0,1.542e-01,1.201e-01,1.980e-01,1.200e-01,6.508e-02,2.213e-01,6.429e-01,2.290e-02
DUSP26,28161,p53 binding,GO:0002039,molecular function,24.0,2.0,1.125e-01,7.322e-02,1.727e-01,1.614e-02,2.422e-03,1.075e-01,8.635e-01,3.321e-02
DUSP26,28161,protein tyrosine phosphatase activity,GO:0004725,molecular function,24.0,8.0,1.340e-01,9.674e-02,1.856e-01,2.854e-02,1.306e-02,6.237e-02,8.215e-01,1.996e-02
DUSP26,28161,RNA polymerase II activating transcription factor binding,GO:0001102,molecular function,24.0,5.0,1.340e-01,9.674e-02,1.856e-01,4.722e-02,1.424e-02,1.566e-01,7.636e-01,3.320e-02
DUSP26,28161,protein binding,GO:0005515,molecular function,24.0,318.0,1.452e-01,1.300e-01,1.622e-01,1.097e-01,7.796e-02,1.545e-01,6.576e-01,1.248e-02
DUSP26,28161,phosphoprotein phosphatase activity,GO:0004721,molecular function,24.0,20.0,1.652e-01,1.364e-01,1.999e-01,1.412e-01,8.154e-02,2.445e-01,6.173e-01,2.157e-02
DUSP26,28161,phosphoserine phosphatase activity,GO:0004647,molecular function,24.0,4.0,1.740e-01,1.362e-01,2.222e-01,1.573e-01,9.733e-02,2.543e-01,5.996e-01,1.963e-02
EBI3,3129,external side of plasma membrane,GO:0009897,cellular component,6.0,16.0,8.300e-02,1.771e-02,3.890e-01,2.176e-02,8.922e-03,5.309e-02,8.487e-01,2.190e-02
EBI3,3129,receptor complex,GO:0043235,cellular component,6.0,30.0,1.963e-01,7.977e-02,4.832e-01,1.912e-01,7.226e-02,5.059e-01,5.607e-01,4.395e-02
EBI3,3129,cytokine binding,GO:0019955,molecular function,6.0,40.0,8.514e-02,1.686e-02,4.299e-01,3.046e-02,4.306e-03,2.154e-01,8.066e-01,4.841e-02
EBI3,3129,protein binding,GO:0005515,molecular function,6.0,318.0,1.554e-01,8.564e-02,2.821e-01,9.609e-02,5.544e-02,1.666e-01,6.758e-01,1.915e-02
EBI3,3129,cytokine receptor activity,GO:0004896,molecular function,6.0,44.0,1.963e-01,7.977e-02,4.832e-01,1.742e-01,8.561e-02,3.545e-01,5.802e-01,3.114e-02
ECHDC2,23408,,,,nan,nan,,,,,,,,
EFS,16898,cell migration,GO:0016477,biological process,9.0,41.0,1.631e-01,1.125e-01,2.363e-01,1.123e-01,6.568e-02,1.921e-01,6.532e-01,1.975e-02
EFS,16898,actin filament reorganization,GO:0090527,biological process,9.0,3.0,1.667e-01,1.068e-01,2.603e-01,1.366e-01,5.844e-02,3.192e-01,6.204e-01,3.367e-02
EFS,16898,transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007169,biological process,9.0,26.0,1.868e-01,1.302e-01,2.682e-01,1.169e-01,2.463e-02,5.545e-01,6.374e-01,5.403e-02
EFS,16898,plasma membrane,GO:0005886,cellular component,9.0,67.0,1.631e-01,1.125e-01,2.363e-01,7.571e-02,5.212e-02,1.100e-01,7.088e-01,1.141e-02
EFS,16898,cytoplasm,GO:0005737,cellular component,9.0,72.0,1.631e-01,1.125e-01,2.363e-01,1.399e-01,9.662e-02,2.025e-01,6.199e-01,1.476e-02
EFS,16898,protein domain specific binding,GO:0019904,molecular function,9.0,78.0,1.631e-01,1.125e-01,2.363e-01,7.166e-02,1.687e-02,3.045e-01,7.102e-01,4.331e-02
EFS,16898,protein binding,GO:0005515,molecular function,9.0,318.0,1.631e-01,1.125e-01,2.363e-01,1.428e-01,1.033e-01,1.973e-01,6.167e-01,1.278e-02
EGFL7,20594,negative regulation of Notch signaling pathway,GO:0045746,biological process,12.0,5.0,7.593e-02,4.915e-02,1.173e-01,3.153e-02,1.701e-02,5.844e-02,8.108e-01,1.590e-02
EGFL7,20594,positive regulation of endothelial cell proliferation,GO:0001938,biological process,12.0,8.0,7.852e-02,4.537e-02,1.359e-01,5.556e-02,2.160e-02,1.430e-01,7.452e-01,2.763e-02
EGFL7,20594,anatomical structure development,GO:0048856,biological process,12.0,198.0,5.592e-01,2.192e-01,1.426e+00,5.592e-01,2.192e-01,1.426e+00,2.794e-01,7.701e-02
EGFL7,20594,cell surface,GO:0009986,cellular component,12.0,20.0,7.593e-02,4.915e-02,1.173e-01,4.366e-02,3.327e-02,5.729e-02,7.752e-01,7.453e-03
EGFL7,20594,extracellular region,GO:0005576,cellular component,12.0,16.0,7.996e-02,5.418e-02,1.180e-01,5.634e-02,5.582e-02,5.686e-02,7.460e-01,2.943e-04
EGFL7,20594,collagen-containing extracellular matrix,GO:0062023,cellular component,12.0,20.0,9.779e-02,4.889e-02,1.956e-01,7.365e-02,2.930e-02,1.851e-01,7.101e-01,2.812e-02
EGFL7,20594,signaling receptor binding,GO:0005102,molecular function,12.0,63.0,7.288e-02,4.312e-02,1.232e-01,2.127e-02,4.297e-03,1.053e-01,8.436e-01,3.321e-02
EGFL8,13944,anatomical structure development,GO:0048856,biological process,6.0,198.0,4.351e-01,4.079e-01,4.641e-01,4.351e-01,4.079e-01,4.641e-01,3.838e-01,4.305e-03
EGFL8,13944,extracellular region,GO:0005576,cellular component,6.0,16.0,4.375e-02,3.330e-02,5.747e-02,2.552e-02,1.720e-02,3.786e-02,8.337e-01,1.002e-02
EGFL8,13944,cell surface,GO:0009986,cellular component,6.0,20.0,4.375e-02,3.330e-02,5.747e-02,3.281e-02,2.498e-02,4.310e-02,8.071e-01,7.251e-03
EGFL8,13944,signaling receptor binding,GO:0005102,molecular function,6.0,63.0,2.344e-02,1.030e-02,5.330e-02,5.859e-03,2.576e-03,1.333e-02,9.375e-01,8.125e-03
ELANE,3309,negative regulation of interleukin-8 biosynthetic process,GO:0045415,biological process,30.0,4.0,1.102e-01,5.570e-02,2.181e-01,1.718e-02,4.664e-03,6.328e-02,8.663e-01,2.677e-02
ELANE,3309,negative regulation of chemokine biosynthetic process,GO:0045079,biological process,30.0,5.0,1.102e-01,5.570e-02,2.181e-01,2.062e-02,3.383e-03,1.257e-01,8.440e-01,3.658e-02
ELANE,3309,positive regulation of interleukin-8 biosynthetic process,GO:0045416,biological process,30.0,4.0,1.155e-01,6.697e-02,1.993e-01,2.015e-02,6.848e-03,5.928e-02,8.551e-01,2.603e-02
ELANE,3309,positive regulation of smooth muscle cell proliferation,GO:0048661,biological process,30.0,6.0,1.255e-01,8.792e-02,1.791e-01,2.140e-02,1.059e-02,4.326e-02,8.509e-01,1.655e-02
ELANE,3309,phagocytosis,GO:0006909,biological process,30.0,4.0,1.675e-01,1.322e-01,2.123e-01,1.064e-01,1.027e-01,1.103e-01,6.629e-01,1.249e-03
ELANE,3309,proteolysis,GO:0006508,biological process,30.0,8.0,1.825e-01,1.208e-01,2.756e-01,1.053e-01,3.560e-02,3.116e-01,6.585e-01,3.858e-02
ELANE,3309,response to UV,GO:0009411,biological process,30.0,10.0,2.030e-01,1.075e-01,3.835e-01,1.334e-01,3.156e-02,5.637e-01,6.176e-01,5.185e-02
ELANE,3309,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,30.0,55.0,2.063e-01,1.540e-01,2.763e-01,1.670e-01,1.396e-01,1.998e-01,5.904e-01,7.279e-03
ELANE,3309,biosynthetic process of antibacterial peptides active against Gram-negative bacteria,GO:0002812,biological process,30.0,2.0,2.108e-01,1.110e-01,4.006e-01,1.648e-01,6.552e-02,4.144e-01,5.883e-01,3.712e-02
ELANE,3309,acute inflammatory response to antigenic stimulus,GO:0002438,biological process,30.0,4.0,2.198e-01,1.119e-01,4.315e-01,1.896e-01,9.398e-02,3.825e-01,5.652e-01,2.980e-02
ELANE,3309,neutrophil mediated killing of gram-negative bacterium,GO:0070945,biological process,30.0,2.0,2.393e-01,1.045e-01,5.478e-01,2.274e-01,9.503e-02,5.441e-01,5.287e-01,3.943e-02
ELANE,3309,defense response to bacterium,GO:0042742,biological process,30.0,14.0,2.548e-01,1.401e-01,4.633e-01,2.483e-01,1.414e-01,4.360e-01,5.141e-01,2.680e-02
ELANE,3309,collagen-containing extracellular matrix,GO:0062023,cellular component,30.0,20.0,1.579e-01,1.204e-01,2.070e-01,5.503e-02,3.774e-02,8.024e-02,7.483e-01,1.083e-02
ELANE,3309,extracellular exosome,GO:0070062,cellular component,30.0,39.0,1.596e-01,1.186e-01,2.147e-01,6.862e-02,5.466e-02,8.615e-02,7.216e-01,6.880e-03
ELANE,3309,extracellular space,GO:0005615,cellular component,30.0,24.0,1.633e-01,1.276e-01,2.090e-01,9.202e-02,7.391e-02,1.146e-01,6.831e-01,7.162e-03
ELANE,3309,cytoplasm,GO:0005737,cellular component,30.0,72.0,1.730e-01,1.124e-01,2.662e-01,1.085e-01,7.198e-02,1.636e-01,6.591e-01,1.452e-02
ELANE,3309,cell surface,GO:0009986,cellular component,30.0,20.0,1.830e-01,1.225e-01,2.734e-01,1.386e-01,1.104e-01,1.739e-01,6.216e-01,8.978e-03
ELANE,3309,secretory granule,GO:0030141,cellular component,30.0,18.0,2.050e-01,1.070e-01,3.926e-01,1.669e-01,7.977e-02,3.491e-01,5.876e-01,3.195e-02
ELANE,3309,transcriptional repressor complex,GO:0017053,cellular component,30.0,6.0,2.238e-01,5.346e-02,9.373e-01,1.361e-01,1.396e-02,1.326e+00,5.901e-01,1.060e-01
ELANE,3309,cytokine binding,GO:0019955,molecular function,30.0,40.0,1.102e-01,5.570e-02,2.181e-01,1.150e-02,2.658e-03,4.978e-02,8.950e-01,2.752e-02
ELANE,3309,protease binding,GO:0002020,molecular function,30.0,6.0,1.274e-01,9.107e-02,1.781e-01,2.624e-02,1.562e-02,4.407e-02,8.306e-01,1.329e-02
ELANE,3309,serine-type endopeptidase activity,GO:0004252,molecular function,30.0,5.0,1.343e-01,9.731e-02,1.853e-01,3.486e-02,1.609e-02,7.555e-02,7.996e-01,2.076e-02
ELANE,3309,endopeptidase activity,GO:0004175,molecular function,30.0,12.0,1.476e-01,9.231e-02,2.362e-01,4.901e-02,1.864e-02,1.289e-01,7.603e-01,2.655e-02
ELANE,3309,transcription corepressor activity,GO:0003714,molecular function,30.0,5.0,1.491e-01,9.082e-02,2.448e-01,5.425e-02,1.539e-02,1.913e-01,7.470e-01,3.551e-02
ELANE,3309,heparin binding,GO:0008201,molecular function,30.0,6.0,1.626e-01,1.265e-01,2.090e-01,7.223e-02,4.108e-02,1.270e-01,7.143e-01,1.688e-02
ELANE,3309,protein binding,GO:0005515,molecular function,30.0,318.0,1.748e-01,1.149e-01,2.658e-01,1.220e-01,7.931e-02,1.875e-01,6.412e-01,1.591e-02
ELANE,3309,peptidase activity,GO:0008233,molecular function,30.0,7.0,1.899e-01,1.235e-01,2.920e-01,1.279e-01,6.744e-02,2.425e-01,6.326e-01,2.349e-02
EMCN,16041,,,,nan,nan,,,,,,,,
EML5,18197,extracellular exosome,GO:0070062,cellular component,3.0,39.0,5.238e-02,2.510e-02,1.093e-01,4.325e-02,3.528e-02,5.300e-02,7.764e-01,5.472e-03
EML5,18197,microtubule binding,GO:0008017,molecular function,3.0,8.0,5.238e-02,2.510e-02,1.093e-01,4.627e-02,1.836e-02,1.166e-01,7.670e-01,2.633e-02
EPHB1,3392,ephrin receptor signaling pathway,GO:0048013,biological process,23.0,3.0,2.173e-01,2.085e-01,2.265e-01,1.665e-02,7.418e-03,3.739e-02,8.734e-01,1.617e-02
EPHB1,3392,regulation of ERK1 and ERK2 cascade,GO:0070372,biological process,23.0,4.0,2.173e-01,2.085e-01,2.265e-01,4.803e-02,3.458e-02,6.670e-02,7.643e-01,9.047e-03
EPHB1,3392,cell-substrate adhesion,GO:0031589,biological process,23.0,10.0,2.173e-01,2.085e-01,2.265e-01,5.969e-02,2.448e-02,1.456e-01,7.369e-01,2.601e-02
EPHB1,3392,transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007169,biological process,23.0,26.0,2.210e-01,2.136e-01,2.287e-01,8.303e-02,3.236e-02,2.130e-01,6.941e-01,2.971e-02
EPHB1,3392,regulation of JNK cascade,GO:0046328,biological process,23.0,5.0,2.238e-01,2.210e-01,2.267e-01,9.804e-02,5.661e-02,1.698e-01,6.733e-01,1.814e-02
EPHB1,3392,cell chemotaxis,GO:0060326,biological process,23.0,22.0,2.238e-01,2.210e-01,2.267e-01,1.229e-01,8.432e-02,1.792e-01,6.403e-01,1.393e-02
EPHB1,3392,protein autophosphorylation,GO:0046777,biological process,23.0,11.0,2.364e-01,1.987e-01,2.811e-01,1.617e-01,1.394e-01,1.876e-01,5.959e-01,6.007e-03
EPHB1,3392,positive regulation of kinase activity,GO:0033674,biological process,23.0,13.0,2.711e-01,1.517e-01,4.845e-01,2.172e-01,9.072e-02,5.201e-01,5.370e-01,4.313e-02
EPHB1,3392,angiogenesis,GO:0001525,biological process,23.0,13.0,2.725e-01,1.832e-01,4.053e-01,1.975e-01,6.409e-02,6.088e-01,5.525e-01,4.991e-02
EPHB1,3392,multicellular organism development,GO:0007275,biological process,23.0,18.0,2.792e-01,2.580e-01,3.022e-01,2.504e-01,2.371e-01,2.646e-01,5.145e-01,2.663e-03
EPHB1,3392,regulation of neuron death,GO:1901214,biological process,23.0,7.0,2.809e-01,1.859e-01,4.242e-01,2.154e-01,6.320e-02,7.340e-01,5.348e-01,5.373e-02
EPHB1,3392,integral component of plasma membrane,GO:0005887,cellular component,23.0,39.0,2.173e-01,2.085e-01,2.265e-01,4.870e-02,2.965e-02,7.997e-02,7.624e-01,1.371e-02
EPHB1,3392,plasma membrane,GO:0005886,cellular component,23.0,67.0,2.238e-01,2.210e-01,2.267e-01,9.057e-02,6.952e-02,1.180e-01,6.853e-01,8.684e-03
EPHB1,3392,early endosome membrane,GO:0031901,cellular component,23.0,3.0,2.238e-01,2.210e-01,2.267e-01,1.467e-01,1.112e-01,1.936e-01,6.122e-01,1.104e-02
EPHB1,3392,extracellular exosome,GO:0070062,cellular component,23.0,39.0,2.354e-01,2.006e-01,2.763e-01,1.376e-01,1.063e-01,1.781e-01,6.228e-01,1.026e-02
EPHB1,3392,endoplasmic reticulum,GO:0005783,cellular component,23.0,16.0,2.384e-01,1.947e-01,2.920e-01,1.486e-01,7.065e-02,3.125e-01,6.076e-01,2.912e-02
EPHB1,3392,cytosol,GO:0005829,cellular component,23.0,50.0,2.531e-01,2.238e-01,2.862e-01,2.088e-01,1.809e-01,2.411e-01,5.497e-01,6.536e-03
EPHB1,3392,receptor complex,GO:0043235,cellular component,23.0,30.0,3.272e-01,2.438e-01,4.392e-01,3.114e-01,2.111e-01,4.593e-01,4.662e-01,2.172e-02
EPHB1,3392,transmembrane-ephrin receptor activity,GO:0005005,molecular function,23.0,2.0,2.173e-01,2.085e-01,2.265e-01,4.029e-02,2.889e-02,5.620e-02,7.841e-01,8.922e-03
EPHB1,3392,transmembrane receptor protein tyrosine kinase activity,GO:0004714,molecular function,23.0,20.0,2.238e-01,2.210e-01,2.267e-01,1.230e-01,7.006e-02,2.161e-01,6.393e-01,2.160e-02
EPHB1,3392,protein binding,GO:0005515,molecular function,23.0,318.0,2.511e-01,2.145e-01,2.940e-01,2.034e-01,1.564e-01,2.646e-01,5.546e-01,1.196e-02
EPHB4,3395,ephrin receptor signaling pathway,GO:0048013,biological process,14.0,3.0,9.067e-02,3.755e-02,2.189e-01,1.395e-02,5.777e-03,3.368e-02,8.871e-01,1.556e-02
EPHB4,3395,cell adhesion,GO:0007155,biological process,14.0,14.0,1.827e-01,1.053e-01,3.169e-01,7.190e-02,4.512e-02,1.146e-01,7.153e-01,1.414e-02
EPHB4,3395,transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007169,biological process,14.0,26.0,1.899e-01,9.927e-02,3.632e-01,7.741e-02,2.678e-02,2.237e-01,7.025e-01,3.300e-02
EPHB4,3395,cell migration involved in sprouting angiogenesis,GO:0002042,biological process,14.0,2.0,1.899e-01,9.927e-02,3.632e-01,1.024e-01,4.276e-02,2.453e-01,6.648e-01,2.913e-02
EPHB4,3395,protein autophosphorylation,GO:0046777,biological process,14.0,11.0,2.212e-01,1.613e-01,3.032e-01,1.668e-01,1.392e-01,1.999e-01,5.906e-01,7.575e-03
EPHB4,3395,positive regulation of kinase activity,GO:0033674,biological process,14.0,13.0,2.447e-01,1.258e-01,4.757e-01,1.933e-01,7.160e-02,5.219e-01,5.576e-01,4.696e-02
EPHB4,3395,multicellular organism development,GO:0007275,biological process,14.0,18.0,2.580e-01,1.926e-01,3.457e-01,2.329e-01,2.015e-01,2.693e-01,5.288e-01,6.845e-03
EPHB4,3395,integral component of plasma membrane,GO:0005887,cellular component,14.0,39.0,1.541e-01,1.171e-01,2.027e-01,3.934e-02,3.364e-02,4.601e-02,7.871e-01,4.156e-03
EPHB4,3395,extracellular exosome,GO:0070062,cellular component,14.0,39.0,2.159e-01,1.605e-01,2.903e-01,1.400e-01,1.069e-01,1.833e-01,6.200e-01,1.060e-02
EPHB4,3395,receptor complex,GO:0043235,cellular component,14.0,30.0,2.750e-01,1.644e-01,4.602e-01,2.678e-01,1.482e-01,4.837e-01,4.976e-01,3.015e-02
EPHB4,3395,ephrin receptor activity,GO:0005003,molecular function,14.0,4.0,7.805e-02,3.233e-02,1.884e-01,8.433e-03,3.156e-03,2.253e-02,9.201e-01,1.258e-02
EPHB4,3395,transmembrane receptor protein tyrosine kinase activity,GO:0004714,molecular function,14.0,20.0,1.885e-01,1.203e-01,2.953e-01,9.988e-02,5.341e-02,1.868e-01,6.698e-01,2.225e-02
EPHB4,3395,protein binding,GO:0005515,molecular function,14.0,318.0,2.443e-01,1.708e-01,3.495e-01,2.067e-01,1.445e-01,2.957e-01,5.513e-01,1.629e-02
EPHX2,3402,,,,nan,nan,,,,,,,,
EPOR,3416,nuclear speck,GO:0016607,cellular component,15.0,7.0,2.966e-02,1.893e-02,4.647e-02,2.364e-02,1.021e-02,5.475e-02,8.402e-01,2.015e-02
EPOR,3416,plasma membrane,GO:0005886,cellular component,15.0,67.0,2.966e-02,1.893e-02,4.647e-02,2.713e-02,1.418e-02,5.191e-02,8.269e-01,1.635e-02
EPOR,3416,erythropoietin receptor activity,GO:0004900,molecular function,15.0,2.0,1.342e-02,1.751e-03,1.028e-01,2.892e-03,3.369e-04,2.482e-02,9.555e-01,1.065e-02
EPOR,3416,identical protein binding,GO:0042802,molecular function,15.0,24.0,2.906e-02,1.734e-02,4.870e-02,1.574e-02,5.577e-03,4.441e-02,8.760e-01,1.954e-02
EPOR,3416,protein binding,GO:0005515,molecular function,15.0,318.0,2.966e-02,1.893e-02,4.647e-02,2.966e-02,1.893e-02,4.647e-02,8.177e-01,1.149e-02
ESR1,3467,negative regulation of gene expression,GO:0010629,biological process,100.0,26.0,5.018e-02,4.649e-02,5.417e-02,7.578e-03,2.184e-03,2.629e-02,9.241e-01,1.298e-02
ESR1,3467,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,100.0,41.0,5.677e-02,3.967e-02,8.124e-02,1.860e-02,1.057e-02,3.274e-02,8.649e-01,1.296e-02
ESR1,3467,response to estrogen,GO:0043627,biological process,100.0,4.0,6.179e-02,3.242e-02,1.178e-01,2.660e-02,1.037e-02,6.822e-02,8.284e-01,2.440e-02
ESR1,3467,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,GO:0045899,biological process,100.0,4.0,6.229e-02,4.143e-02,9.366e-02,3.123e-02,1.718e-02,5.675e-02,8.120e-01,1.538e-02
ESR1,3467,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,100.0,69.0,6.503e-02,3.719e-02,1.137e-01,3.675e-02,3.082e-02,4.381e-02,7.946e-01,4.633e-03
ESR1,3467,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,100.0,55.0,6.511e-02,3.730e-02,1.137e-01,3.896e-02,3.282e-02,4.626e-02,7.881e-01,4.599e-03
ESR1,3467,response to estradiol,GO:0032355,biological process,100.0,6.0,6.640e-02,2.731e-02,1.614e-01,2.978e-02,5.784e-03,1.533e-01,8.132e-01,4.413e-02
ESR1,3467,cellular response to estradiol stimulus,GO:0071392,biological process,100.0,6.0,7.132e-02,2.302e-02,2.210e-01,3.580e-02,4.135e-03,3.100e-01,7.876e-01,6.145e-02
ESR1,3467,negative regulation of production of miRNAs involved in gene silencing by miRNA,GO:1903799,biological process,100.0,7.0,7.861e-02,3.669e-02,1.684e-01,6.067e-02,2.671e-02,1.378e-01,7.349e-01,2.467e-02
ESR1,3467,negative regulation of DNA-binding transcription factor activity,GO:0043433,biological process,100.0,10.0,9.102e-02,6.771e-02,1.224e-01,6.773e-02,5.889e-02,7.791e-02,7.235e-01,4.258e-03
ESR1,3467,positive regulation of DNA-binding transcription factor activity,GO:0051091,biological process,100.0,12.0,9.687e-02,7.242e-02,1.296e-01,7.961e-02,6.973e-02,9.090e-02,7.027e-01,4.170e-03
ESR1,3467,negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043124,biological process,100.0,6.0,1.081e-01,8.037e-02,1.454e-01,9.236e-02,6.281e-02,1.358e-01,6.823e-01,1.289e-02
ESR1,3467,transcription by RNA polymerase II,GO:0006366,biological process,100.0,15.0,1.191e-01,5.529e-02,2.564e-01,1.068e-01,4.701e-02,2.428e-01,6.588e-01,2.999e-02
ESR1,3467,intracellular estrogen receptor signaling pathway,GO:0030520,biological process,100.0,2.0,1.529e-01,8.427e-02,2.774e-01,1.437e-01,7.753e-02,2.665e-01,6.140e-01,2.513e-02
ESR1,3467,protein localization to chromatin,GO:0071168,biological process,100.0,7.0,2.310e-01,1.564e-01,3.412e-01,2.251e-01,1.524e-01,3.324e-01,5.346e-01,1.867e-02
ESR1,3467,cytoplasm,GO:0005737,cellular component,100.0,72.0,5.018e-02,4.649e-02,5.417e-02,5.347e-03,1.786e-03,1.600e-02,9.404e-01,1.021e-02
ESR1,3467,nucleus,GO:0005634,cellular component,100.0,86.0,5.018e-02,4.649e-02,5.417e-02,7.209e-03,1.697e-03,3.061e-02,9.256e-01,1.459e-02
ESR1,3467,plasma membrane,GO:0005886,cellular component,100.0,67.0,5.677e-02,3.967e-02,8.124e-02,1.702e-02,1.121e-02,2.585e-02,8.735e-01,9.520e-03
ESR1,3467,nuclear chromatin,GO:0000790,cellular component,100.0,11.0,6.842e-02,3.139e-02,1.491e-01,4.205e-02,1.579e-02,1.120e-01,7.778e-01,2.701e-02
ESR1,3467,transcriptionally active chromatin,GO:0035327,cellular component,100.0,2.0,7.566e-02,2.701e-02,2.120e-01,5.876e-02,1.706e-02,2.024e-01,7.362e-01,3.819e-02
ESR1,3467,transcriptional preinitiation complex,GO:0097550,cellular component,100.0,2.0,1.069e-01,8.345e-02,1.369e-01,9.493e-02,7.749e-02,1.163e-01,6.788e-01,6.691e-03
ESR1,3467,protein-containing complex,GO:0032991,cellular component,100.0,474.0,4.139e-01,2.074e-01,8.260e-01,4.139e-01,2.074e-01,8.260e-01,3.890e-01,4.701e-02
ESR1,3467,protein binding,GO:0005515,molecular function,100.0,318.0,5.034e-02,4.702e-02,5.389e-02,5.536e-03,3.787e-03,8.093e-03,9.410e-01,3.500e-03
ESR1,3467,identical protein binding,GO:0042802,molecular function,100.0,24.0,5.034e-02,4.702e-02,5.389e-02,5.390e-03,1.191e-03,2.440e-02,9.379e-01,1.301e-02
ESR1,3467,ATPase binding,GO:0051117,molecular function,100.0,3.0,5.677e-02,3.967e-02,8.124e-02,9.076e-03,5.636e-03,1.462e-02,9.190e-01,5.610e-03
ESR1,3467,transcription factor binding,GO:0008134,molecular function,100.0,16.0,5.912e-02,3.603e-02,9.701e-02,1.567e-02,7.265e-03,3.380e-02,8.786e-01,1.522e-02
ESR1,3467,protein kinase binding,GO:0019901,molecular function,100.0,19.0,5.912e-02,3.603e-02,9.701e-02,2.359e-02,1.933e-02,2.878e-02,8.420e-01,5.010e-03
ESR1,3467,estrogen response element binding,GO:0034056,molecular function,100.0,2.0,6.018e-02,3.454e-02,1.048e-01,1.874e-02,9.314e-03,3.772e-02,8.634e-01,1.568e-02
ESR1,3467,"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,molecular function,100.0,11.0,6.048e-02,3.413e-02,1.072e-01,2.178e-02,1.248e-02,3.802e-02,8.494e-01,1.321e-02
ESR1,3467,nuclear receptor activity,GO:0004879,molecular function,100.0,4.0,6.179e-02,3.242e-02,1.178e-01,2.557e-02,1.037e-02,6.305e-02,8.324e-01,2.303e-02
ESR1,3467,estrogen receptor binding,GO:0030331,molecular function,100.0,3.0,6.179e-02,3.242e-02,1.178e-01,2.587e-02,1.568e-02,4.268e-02,8.322e-01,1.279e-02
ESR1,3467,beta-catenin binding,GO:0008013,molecular function,100.0,5.0,6.292e-02,3.402e-02,1.164e-01,3.389e-02,2.463e-02,4.662e-02,8.036e-01,8.483e-03
ESR1,3467,TFIIB-class transcription factor binding,GO:0001093,molecular function,100.0,2.0,6.292e-02,3.402e-02,1.164e-01,3.564e-02,2.404e-02,5.284e-02,7.978e-01,1.053e-02
ESR1,3467,chromatin binding,GO:0003682,molecular function,100.0,11.0,6.454e-02,2.923e-02,1.425e-01,3.277e-02,1.242e-02,8.649e-02,8.056e-01,2.601e-02
ESR1,3467,transcription coactivator binding,GO:0001223,molecular function,100.0,4.0,6.481e-02,2.958e-02,1.420e-01,3.279e-02,1.311e-02,8.201e-02,8.060e-01,2.439e-02
ESR1,3467,RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,molecular function,100.0,30.0,6.620e-02,2.890e-02,1.517e-01,3.671e-02,1.294e-02,1.042e-01,7.932e-01,2.812e-02
ESR1,3467,TBP-class protein binding,GO:0017025,molecular function,100.0,2.0,6.725e-02,3.000e-02,1.507e-01,4.340e-02,1.804e-02,1.044e-01,7.748e-01,2.438e-02
ESR1,3467,estrogen receptor activity,GO:0030284,molecular function,100.0,3.0,8.084e-02,3.669e-02,1.781e-01,6.197e-02,2.311e-02,1.662e-01,7.317e-01,2.927e-02
ESR1,3467,enzyme binding,GO:0019899,molecular function,100.0,35.0,9.608e-02,7.383e-02,1.250e-01,7.723e-02,7.119e-02,8.378e-02,7.067e-01,2.501e-03
ETS1,3488,positive regulation of gene expression,GO:0010628,biological process,46.0,27.0,4.663e-02,3.956e-02,5.497e-02,3.672e-03,1.321e-03,1.020e-02,9.530e-01,6.917e-03
ETS1,3488,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,46.0,41.0,4.663e-02,3.956e-02,5.497e-02,9.495e-03,6.339e-03,1.422e-02,9.170e-01,5.110e-03
ETS1,3488,positive regulation of blood vessel endothelial cell migration,GO:0043536,biological process,46.0,7.0,5.189e-02,4.039e-02,6.666e-02,1.566e-02,6.802e-03,3.604e-02,8.783e-01,1.650e-02
ETS1,3488,positive regulation of endothelial cell migration,GO:0010595,biological process,46.0,8.0,5.413e-02,3.877e-02,7.559e-02,2.100e-02,6.631e-03,6.648e-02,8.495e-01,2.541e-02
ETS1,3488,pri-miRNA transcription by RNA polymerase II,GO:0061614,biological process,46.0,2.0,5.525e-02,4.058e-02,7.524e-02,2.613e-02,1.401e-02,4.876e-02,8.309e-01,1.601e-02
ETS1,3488,positive regulation of angiogenesis,GO:0045766,biological process,46.0,12.0,5.710e-02,3.952e-02,8.252e-02,2.265e-02,8.811e-03,5.822e-02,8.439e-01,2.226e-02
ETS1,3488,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,46.0,69.0,5.710e-02,3.952e-02,8.252e-02,2.697e-02,2.221e-02,3.276e-02,8.282e-01,4.866e-03
ETS1,3488,positive regulation of cellular component movement,GO:0051272,biological process,46.0,14.0,6.373e-02,4.823e-02,8.422e-02,3.791e-02,3.152e-02,4.559e-02,7.913e-01,4.886e-03
ETS1,3488,cell motility,GO:0048870,biological process,46.0,16.0,7.061e-02,3.896e-02,1.280e-01,4.526e-02,2.394e-02,8.556e-02,7.706e-01,1.770e-02
ETS1,3488,regulation of angiogenesis,GO:0045765,biological process,46.0,9.0,9.049e-02,3.383e-02,2.420e-01,7.203e-02,2.541e-02,2.042e-01,7.115e-01,3.387e-02
ETS1,3488,positive regulation of erythrocyte differentiation,GO:0045648,biological process,46.0,5.0,9.653e-02,2.867e-02,3.249e-01,8.077e-02,1.928e-02,3.384e-01,6.922e-01,4.913e-02
ETS1,3488,regulation of transcription by RNA polymerase II,GO:0006357,biological process,46.0,51.0,1.009e-01,3.853e-02,2.640e-01,8.212e-02,2.625e-02,2.569e-01,6.942e-01,3.540e-02
ETS1,3488,positive regulation of inflammatory response,GO:0050729,biological process,46.0,13.0,1.076e-01,7.495e-02,1.545e-01,9.281e-02,7.369e-02,1.169e-01,6.820e-01,7.626e-03
ETS1,3488,PML body organization,GO:0030578,biological process,46.0,2.0,1.220e-01,6.395e-02,2.327e-01,1.096e-01,6.050e-02,1.985e-01,6.565e-01,2.160e-02
ETS1,3488,positive regulation of leukocyte adhesion to vascular endothelial cell,GO:1904996,biological process,46.0,5.0,1.247e-01,4.525e-02,3.437e-01,1.136e-01,3.521e-02,3.666e-01,6.457e-01,4.542e-02
ETS1,3488,cell differentiation,GO:0030154,biological process,46.0,91.0,1.452e-01,8.656e-02,2.436e-01,1.409e-01,9.118e-02,2.176e-01,6.184e-01,1.690e-02
ETS1,3488,nucleoplasm,GO:0005654,cellular component,46.0,47.0,4.663e-02,3.956e-02,5.497e-02,1.165e-02,5.496e-03,2.468e-02,9.022e-01,1.120e-02
ETS1,3488,nucleus,GO:0005634,cellular component,46.0,86.0,4.663e-02,3.956e-02,5.497e-02,1.234e-02,4.932e-03,3.086e-02,8.962e-01,1.430e-02
ETS1,3488,identical protein binding,GO:0042802,molecular function,46.0,24.0,5.079e-02,4.217e-02,6.118e-02,1.091e-02,6.686e-03,1.780e-02,9.082e-01,7.085e-03
ETS1,3488,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,46.0,17.0,5.210e-02,4.061e-02,6.685e-02,1.967e-02,1.500e-02,2.579e-02,8.603e-01,6.508e-03
ETS1,3488,protein binding,GO:0005515,molecular function,46.0,318.0,5.525e-02,4.058e-02,7.524e-02,2.251e-02,1.138e-02,4.454e-02,8.457e-01,1.644e-02
ETS1,3488,RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,molecular function,46.0,30.0,6.540e-02,3.323e-02,1.287e-01,3.722e-02,1.406e-02,9.853e-02,7.919e-01,2.553e-02
ETS1,3488,DNA-binding transcription factor activity,GO:0003700,molecular function,46.0,17.0,7.376e-02,3.918e-02,1.389e-01,5.010e-02,2.504e-02,1.002e-01,7.587e-01,1.970e-02
ETS2,3489,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,74.0,41.0,2.896e-02,1.805e-02,4.648e-02,1.156e-02,7.702e-03,1.735e-02,9.046e-01,6.213e-03
ETS2,3489,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,74.0,55.0,4.683e-02,3.130e-02,7.005e-02,2.998e-02,2.161e-02,4.159e-02,8.165e-01,8.430e-03
ETS2,3489,regulation of transcription by RNA polymerase II,GO:0006357,biological process,74.0,51.0,1.315e-01,4.682e-02,3.692e-01,1.135e-01,3.972e-02,3.245e-01,6.479e-01,3.672e-02
ETS2,3489,cell differentiation,GO:0030154,biological process,74.0,91.0,1.712e-01,1.143e-01,2.565e-01,1.664e-01,1.156e-01,2.395e-01,5.905e-01,1.490e-02
ETS2,3489,cytosol,GO:0005829,cellular component,74.0,50.0,1.877e-02,5.669e-03,6.217e-02,3.145e-03,1.355e-03,7.302e-03,9.580e-01,5.368e-03
ETS2,3489,nucleoplasm,GO:0005654,cellular component,74.0,47.0,1.877e-02,5.669e-03,6.217e-02,3.794e-03,1.118e-03,1.287e-02,9.520e-01,7.846e-03
ETS2,3489,nucleus,GO:0005634,cellular component,74.0,86.0,1.877e-02,5.669e-03,6.217e-02,4.418e-03,8.058e-04,2.422e-02,9.449e-01,1.193e-02
ETS2,3489,plasma membrane,GO:0005886,cellular component,74.0,67.0,2.932e-02,1.761e-02,4.881e-02,1.230e-02,7.321e-03,2.066e-02,8.995e-01,9.526e-03
ETS2,3489,protein binding,GO:0005515,molecular function,74.0,318.0,2.137e-02,9.885e-03,4.619e-02,6.105e-03,2.824e-03,1.320e-02,9.361e-01,7.022e-03
ETS2,3489,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,74.0,17.0,3.741e-02,2.399e-02,5.834e-02,1.953e-02,1.445e-02,2.638e-02,8.608e-01,6.794e-03
ETS2,3489,"DNA-binding transcription repressor activity, RNA polymerase II-specific",GO:0001227,molecular function,74.0,10.0,4.457e-02,2.096e-02,9.478e-02,2.766e-02,1.104e-02,6.930e-02,8.240e-01,2.299e-02
ETS2,3489,RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,molecular function,74.0,30.0,5.168e-02,1.855e-02,1.440e-01,3.557e-02,1.140e-02,1.110e-01,7.964e-01,2.963e-02
ETS2,3489,DNA-binding transcription factor activity,GO:0003700,molecular function,74.0,17.0,6.089e-02,2.622e-02,1.414e-01,4.784e-02,2.061e-02,1.111e-01,7.638e-01,2.320e-02
ETS2,3489,protein domain specific binding,GO:0019904,molecular function,74.0,78.0,1.833e-01,8.559e-02,3.926e-01,1.788e-01,8.100e-02,3.948e-01,5.746e-01,3.553e-02
EVA1B,25558,,,,nan,nan,,,,,,,,
EVL,20234,positive regulation of stress fiber assembly,GO:0051496,biological process,11.0,3.0,1.264e-01,5.008e-02,3.191e-01,3.986e-02,5.943e-03,2.674e-01,7.780e-01,5.336e-02
EVL,20234,actin polymerization or depolymerization,GO:0008154,biological process,11.0,4.0,1.276e-01,5.213e-02,3.122e-01,3.944e-02,1.867e-02,8.330e-02,7.859e-01,1.970e-02
EVL,20234,positive regulation of actin filament polymerization,GO:0030838,biological process,11.0,11.0,1.562e-01,5.128e-02,4.760e-01,1.093e-01,1.988e-02,6.012e-01,6.460e-01,5.763e-02
EVL,20234,negative regulation of epithelial cell migration,GO:0010633,biological process,11.0,7.0,1.782e-01,8.695e-02,3.650e-01,1.401e-01,5.951e-02,3.297e-01,6.163e-01,3.529e-02
EVL,20234,negative regulation of ruffle assembly,GO:1900028,biological process,11.0,3.0,2.489e-01,8.254e-02,7.506e-01,2.489e-01,8.254e-02,7.506e-01,5.061e-01,5.376e-02
EVL,20234,membrane,GO:0016020,cellular component,11.0,41.0,1.385e-01,6.008e-02,3.195e-01,9.594e-02,3.676e-02,2.504e-01,6.735e-01,3.207e-02
EVL,20234,profilin binding,GO:0005522,molecular function,11.0,2.0,1.223e-01,4.986e-02,3.000e-01,1.702e-02,1.024e-02,2.828e-02,8.735e-01,1.162e-02
EVL,20234,protein binding,GO:0005515,molecular function,11.0,318.0,1.385e-01,6.008e-02,3.195e-01,7.820e-02,3.571e-02,1.712e-01,7.032e-01,2.395e-02
EVL,20234,SH3 domain binding,GO:0017124,molecular function,11.0,6.0,1.521e-01,9.043e-02,2.558e-01,1.165e-01,6.835e-02,1.986e-01,6.477e-01,1.934e-02
F2RL3,3540,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway,GO:0051482,biological process,12.0,4.0,1.080e-01,7.802e-02,1.496e-01,2.016e-02,1.404e-02,2.894e-02,8.576e-01,8.291e-03
F2RL3,3540,positive regulation of release of sequestered calcium ion into cytosol,GO:0051281,biological process,12.0,9.0,1.177e-01,6.674e-02,2.074e-01,6.898e-02,3.774e-02,1.261e-01,7.199e-01,1.864e-02
F2RL3,3540,positive regulation of Rho protein signal transduction,GO:0035025,biological process,12.0,6.0,1.235e-01,6.952e-02,2.192e-01,1.105e-01,5.278e-02,2.315e-01,6.544e-01,2.637e-02
F2RL3,3540,integral component of plasma membrane,GO:0005887,cellular component,12.0,39.0,1.080e-01,7.802e-02,1.496e-01,3.767e-02,2.972e-02,4.775e-02,7.917e-01,6.386e-03
F2RL3,3540,plasma membrane,GO:0005886,cellular component,12.0,67.0,1.177e-01,6.674e-02,2.074e-01,6.970e-02,5.993e-02,8.106e-02,7.199e-01,4.610e-03
F2RL3,3540,cytosol,GO:0005829,cellular component,12.0,50.0,1.526e-01,1.324e-01,1.757e-01,1.453e-01,1.252e-01,1.687e-01,6.139e-01,5.934e-03
F2RL3,3540,G protein-coupled receptor activity,GO:0004930,molecular function,12.0,47.0,1.177e-01,6.674e-02,2.074e-01,9.348e-02,5.280e-02,1.655e-01,6.796e-01,1.970e-02
F3,3541,activation of plasma proteins involved in acute inflammatory response,GO:0002541,biological process,21.0,2.0,2.865e-01,2.093e-01,3.922e-01,3.003e-02,8.164e-03,1.104e-01,8.144e-01,3.473e-02
F3,3541,protein processing,GO:0016485,biological process,21.0,21.0,2.865e-01,2.093e-01,3.922e-01,1.145e-01,2.641e-02,4.969e-01,6.420e-01,4.996e-02
F3,3541,positive regulation of endothelial cell proliferation,GO:0001938,biological process,21.0,8.0,2.865e-01,2.093e-01,3.922e-01,1.235e-01,3.227e-02,4.726e-01,6.315e-01,4.731e-02
F3,3541,positive regulation of platelet-derived growth factor receptor signaling pathway,GO:0010641,biological process,21.0,5.0,2.882e-01,2.136e-01,3.888e-01,1.519e-01,9.600e-02,2.404e-01,6.056e-01,1.875e-02
F3,3541,cytokine-mediated signaling pathway,GO:0019221,biological process,21.0,45.0,2.896e-01,2.044e-01,4.102e-01,1.628e-01,6.157e-02,4.305e-01,5.898e-01,4.034e-02
F3,3541,positive regulation of angiogenesis,GO:0045766,biological process,21.0,12.0,2.913e-01,2.085e-01,4.068e-01,1.989e-01,1.210e-01,3.269e-01,5.577e-01,2.197e-02
F3,3541,activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,biological process,21.0,3.0,2.999e-01,2.400e-01,3.749e-01,1.570e-01,8.550e-02,2.883e-01,5.993e-01,2.435e-02
F3,3541,positive regulation of protein kinase B signaling,GO:0051897,biological process,21.0,5.0,3.171e-01,2.240e-01,4.488e-01,2.495e-01,1.482e-01,4.201e-01,5.133e-01,2.492e-02
F3,3541,blood coagulation,GO:0007596,biological process,21.0,3.0,3.797e-01,2.510e-01,5.745e-01,3.604e-01,2.389e-01,5.438e-01,4.312e-01,2.370e-02
F3,3541,integral component of membrane,GO:0016021,cellular component,21.0,19.0,2.865e-01,2.093e-01,3.922e-01,1.170e-01,4.899e-02,2.794e-01,6.449e-01,3.145e-02
F3,3541,collagen-containing extracellular matrix,GO:0062023,cellular component,21.0,20.0,2.865e-01,2.093e-01,3.922e-01,1.259e-01,8.681e-02,1.825e-01,6.367e-01,1.439e-02
F3,3541,plasma membrane,GO:0005886,cellular component,21.0,67.0,2.882e-01,2.136e-01,3.888e-01,1.484e-01,1.252e-01,1.760e-01,6.105e-01,6.788e-03
F3,3541,cell surface,GO:0009986,cellular component,21.0,20.0,2.913e-01,2.213e-01,3.833e-01,1.721e-01,1.208e-01,2.450e-01,5.847e-01,1.497e-02
F3,3541,extracellular space,GO:0005615,cellular component,21.0,24.0,3.151e-01,2.606e-01,3.812e-01,2.443e-01,2.393e-01,2.495e-01,5.195e-01,1.034e-03
F3,3541,serine-type peptidase complex,GO:1905286,cellular component,21.0,3.0,4.443e-01,2.261e-01,8.729e-01,4.367e-01,2.196e-01,8.686e-01,3.729e-01,5.052e-02
F3,3541,serine-type endopeptidase activity,GO:0004252,molecular function,21.0,5.0,2.865e-01,2.093e-01,3.922e-01,1.425e-01,9.042e-02,2.245e-01,6.164e-01,1.788e-02
F3,3541,phospholipid binding,GO:0005543,molecular function,21.0,16.0,2.865e-01,2.093e-01,3.922e-01,1.451e-01,8.827e-02,2.386e-01,6.131e-01,1.951e-02
F3,3541,protease binding,GO:0002020,molecular function,21.0,6.0,2.896e-01,2.044e-01,4.102e-01,1.257e-01,3.832e-02,4.126e-01,6.301e-01,4.604e-02
F3,3541,protein binding,GO:0005515,molecular function,21.0,318.0,3.329e-01,2.286e-01,4.848e-01,2.936e-01,2.106e-01,4.092e-01,4.799e-01,1.788e-02
F3,3541,cytokine receptor activity,GO:0004896,molecular function,21.0,44.0,4.006e-01,2.005e-01,8.001e-01,3.492e-01,1.450e-01,8.408e-01,4.300e-01,5.459e-02
FAM181B,28512,,,,nan,nan,,,,,,,,
FAM193B,25524,nuclear speck,GO:0016607,cellular component,6.0,7.0,7.353e-02,4.427e-02,1.221e-01,2.726e-02,1.362e-02,5.457e-02,8.262e-01,1.773e-02
FAM193B,25524,nucleolus,GO:0005730,cellular component,6.0,5.0,7.353e-02,4.427e-02,1.221e-01,5.245e-02,4.190e-02,6.566e-02,7.541e-01,6.476e-03
FAM193B,25524,cytoplasm,GO:0005737,cellular component,6.0,72.0,7.353e-02,4.427e-02,1.221e-01,6.004e-02,4.031e-02,8.944e-02,7.379e-01,1.162e-02
FAM193B,25524,nucleoplasm,GO:0005654,cellular component,6.0,47.0,7.353e-02,4.427e-02,1.221e-01,6.407e-02,3.736e-02,1.099e-01,7.294e-01,1.625e-02
FAM193B,25524,nucleus,GO:0005634,cellular component,6.0,86.0,7.494e-02,4.466e-02,1.258e-01,7.494e-02,4.466e-02,1.258e-01,7.098e-01,1.586e-02
FAM227A,44197,,,,nan,nan,,,,,,,,
FAM43A,26888,,,,nan,nan,,,,,,,,
FAM89A,25057,,,,nan,nan,,,,,,,,
FAM98C,27119,,,,nan,nan,,,,,,,,
FBXL12,13611,regulation of cell cycle,GO:0051726,biological process,10.0,11.0,9.143e-02,5.898e-02,1.417e-01,6.453e-02,3.389e-02,1.229e-01,7.283e-01,1.868e-02
FBXL12,13611,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0031146,biological process,10.0,2.0,9.233e-02,6.744e-02,1.264e-01,6.494e-02,3.795e-02,1.111e-01,7.278e-01,1.589e-02
FBXL12,13611,G2/M transition of mitotic cell cycle,GO:0000086,biological process,10.0,4.0,1.110e-01,7.430e-02,1.659e-01,9.228e-02,5.195e-02,1.639e-01,6.818e-01,1.855e-02
FBXL12,13611,cytosol,GO:0005829,cellular component,10.0,50.0,7.720e-02,4.403e-02,1.354e-01,2.704e-02,1.383e-02,5.286e-02,8.271e-01,1.724e-02
FBXL12,13611,nucleus,GO:0005634,cellular component,10.0,86.0,7.720e-02,4.403e-02,1.354e-01,2.781e-02,1.370e-02,5.644e-02,8.241e-01,1.815e-02
FBXL12,13611,SCF ubiquitin ligase complex,GO:0019005,cellular component,10.0,20.0,3.036e-01,1.993e-01,4.625e-01,3.036e-01,1.993e-01,4.625e-01,4.717e-01,2.202e-02
FBXL12,13611,ubiquitin protein ligase activity,GO:0061630,molecular function,10.0,8.0,7.720e-02,4.403e-02,1.354e-01,3.026e-02,1.046e-02,8.757e-02,8.142e-01,2.749e-02
FBXL12,13611,protein binding,GO:0005515,molecular function,10.0,318.0,8.152e-02,5.190e-02,1.280e-01,4.644e-02,2.045e-02,1.055e-01,7.670e-01,2.327e-02
FGD5,19117,,,,nan,nan,,,,,,,,
FLI1,3749,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,14.0,41.0,2.521e-02,1.502e-02,4.232e-02,6.633e-03,2.673e-03,1.646e-02,9.321e-01,9.763e-03
FLI1,3749,cell differentiation,GO:0030154,biological process,14.0,91.0,4.209e-02,2.497e-02,7.095e-02,4.047e-02,2.468e-02,6.634e-02,7.835e-01,1.333e-02
FLI1,3749,regulation of transcription by RNA polymerase II,GO:0006357,biological process,14.0,51.0,4.472e-02,1.646e-02,1.215e-01,3.977e-02,1.144e-02,1.382e-01,7.835e-01,3.305e-02
FLI1,3749,nucleus,GO:0005634,cellular component,14.0,86.0,2.521e-02,1.502e-02,4.232e-02,1.063e-02,4.066e-03,2.777e-02,9.065e-01,1.358e-02
FLI1,3749,nucleoplasm,GO:0005654,cellular component,14.0,47.0,2.521e-02,1.502e-02,4.232e-02,1.136e-02,6.877e-03,1.877e-02,9.054e-01,7.504e-03
FLI1,3749,cytosol,GO:0005829,cellular component,14.0,50.0,2.585e-02,1.657e-02,4.033e-02,1.692e-02,1.035e-02,2.768e-02,8.736e-01,1.088e-02
FLI1,3749,nuclear body,GO:0016604,cellular component,14.0,18.0,2.585e-02,1.657e-02,4.033e-02,1.784e-02,1.157e-02,2.749e-02,8.695e-01,9.461e-03
FLI1,3749,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,14.0,17.0,2.521e-02,1.502e-02,4.232e-02,6.248e-03,3.898e-03,1.001e-02,9.366e-01,4.773e-03
FLI1,3749,protein binding,GO:0005515,molecular function,14.0,318.0,2.927e-02,1.391e-02,6.159e-02,2.381e-02,1.140e-02,4.971e-02,8.398e-01,1.794e-02
FLT3,3765,lymphocyte differentiation,GO:0030098,biological process,21.0,6.0,1.065e-01,5.933e-02,1.912e-01,2.362e-02,8.569e-03,6.513e-02,8.393e-01,2.368e-02
FLT3,3765,B cell differentiation,GO:0030183,biological process,21.0,5.0,1.295e-01,4.557e-02,3.680e-01,4.006e-02,1.196e-02,1.341e-01,7.826e-01,3.270e-02
FLT3,3765,leukocyte differentiation,GO:0002521,biological process,21.0,6.0,1.586e-01,7.115e-02,3.538e-01,8.636e-02,4.556e-02,1.637e-01,6.905e-01,2.031e-02
FLT3,3765,transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007169,biological process,21.0,26.0,1.629e-01,6.848e-02,3.877e-01,8.599e-02,3.083e-02,2.399e-01,6.884e-01,3.332e-02
FLT3,3765,cytokine-mediated signaling pathway,GO:0019221,biological process,21.0,45.0,1.629e-01,6.848e-02,3.877e-01,1.095e-01,4.087e-02,2.936e-01,6.539e-01,3.405e-02
FLT3,3765,hematopoietic progenitor cell differentiation,GO:0002244,biological process,21.0,5.0,1.692e-01,8.018e-02,3.569e-01,1.410e-01,7.363e-02,2.700e-01,6.168e-01,2.482e-02
FLT3,3765,positive regulation of kinase activity,GO:0033674,biological process,21.0,13.0,1.848e-01,6.816e-02,5.011e-01,1.615e-01,5.749e-02,4.536e-01,5.901e-01,4.487e-02
FLT3,3765,multicellular organism development,GO:0007275,biological process,21.0,18.0,2.140e-01,1.784e-01,2.566e-01,1.774e-01,1.241e-01,2.537e-01,5.791e-01,1.510e-02
FLT3,3765,hemopoiesis,GO:0030097,biological process,21.0,5.0,2.209e-01,6.902e-02,7.071e-01,2.041e-01,4.887e-02,8.524e-01,5.418e-01,6.074e-02
FLT3,3765,integral component of plasma membrane,GO:0005887,cellular component,21.0,39.0,1.065e-01,5.933e-02,1.912e-01,2.522e-02,2.179e-02,2.919e-02,8.349e-01,3.705e-03
FLT3,3765,endoplasmic reticulum,GO:0005783,cellular component,21.0,16.0,1.665e-01,6.618e-02,4.190e-01,1.079e-01,2.445e-02,4.764e-01,6.505e-01,5.289e-02
FLT3,3765,receptor complex,GO:0043235,cellular component,21.0,30.0,1.692e-01,8.018e-02,3.569e-01,1.432e-01,7.182e-02,2.854e-01,6.141e-01,2.670e-02
FLT3,3765,growth factor binding,GO:0019838,molecular function,21.0,21.0,6.625e-02,1.244e-02,3.528e-01,6.393e-03,5.547e-04,7.368e-02,9.215e-01,2.351e-02
FLT3,3765,protein self-association,GO:0043621,molecular function,21.0,4.0,9.582e-02,5.993e-02,1.532e-01,1.574e-02,8.118e-03,3.052e-02,8.796e-01,1.444e-02
FLT3,3765,transmembrane receptor protein tyrosine kinase activity,GO:0004714,molecular function,21.0,20.0,1.586e-01,7.115e-02,3.538e-01,7.452e-02,3.905e-02,1.422e-01,7.099e-01,1.954e-02
FLT3,3765,protein binding,GO:0005515,molecular function,21.0,318.0,1.692e-01,8.018e-02,3.569e-01,1.251e-01,8.633e-02,1.813e-01,6.374e-01,1.397e-02
FMNL1,1212,cortical actin cytoskeleton organization,GO:0030866,biological process,14.0,8.0,4.146e-02,2.380e-02,7.221e-02,2.385e-02,5.601e-03,1.015e-01,8.357e-01,3.419e-02
FMNL1,1212,cell migration,GO:0016477,biological process,14.0,41.0,4.807e-02,2.722e-02,8.486e-02,2.953e-02,9.026e-03,9.664e-02,8.159e-01,2.969e-02
FMNL1,1212,regulation of cell shape,GO:0008360,biological process,14.0,8.0,1.175e-01,3.550e-02,3.891e-01,1.175e-01,3.550e-02,3.891e-01,6.409e-01,4.136e-02
FMNL1,1212,extracellular exosome,GO:0070062,cellular component,14.0,39.0,5.209e-02,2.705e-02,1.003e-01,2.281e-02,7.173e-03,7.256e-02,8.419e-01,2.693e-02
FMNL1,1212,membrane,GO:0016020,cellular component,14.0,41.0,5.502e-02,2.639e-02,1.147e-01,3.328e-02,9.612e-03,1.152e-01,8.030e-01,3.225e-02
FMNL1,1212,cytosol,GO:0005829,cellular component,14.0,50.0,5.502e-02,2.639e-02,1.147e-01,3.756e-02,1.362e-02,1.036e-01,7.909e-01,2.673e-02
FMNL1,1212,actin filament binding,GO:0051015,molecular function,14.0,8.0,2.988e-02,2.451e-02,3.642e-02,5.671e-03,3.803e-03,8.458e-03,9.400e-01,3.365e-03
FMNL1,1212,GTPase activating protein binding,GO:0032794,molecular function,14.0,2.0,2.988e-02,2.451e-02,3.642e-02,7.002e-03,4.624e-03,1.060e-02,9.318e-01,4.470e-03
FMNL1,1212,protein binding,GO:0005515,molecular function,14.0,318.0,6.022e-02,2.380e-02,1.523e-01,5.119e-02,1.783e-02,1.470e-01,7.547e-01,3.009e-02
FMNL3,23698,cortical actin cytoskeleton organization,GO:0030866,biological process,11.0,8.0,8.365e-02,7.214e-02,9.700e-02,2.343e-02,7.942e-03,6.913e-02,8.403e-01,2.644e-02
FMNL3,23698,cell migration,GO:0016477,biological process,11.0,41.0,8.365e-02,7.214e-02,9.700e-02,3.537e-02,1.491e-02,8.390e-02,7.976e-01,2.338e-02
FMNL3,23698,cytoskeleton organization,GO:0007010,biological process,11.0,14.0,8.533e-02,6.977e-02,1.043e-01,4.753e-02,3.471e-02,6.508e-02,7.657e-01,8.693e-03
FMNL3,23698,regulation of cell shape,GO:0008360,biological process,11.0,8.0,1.073e-01,7.026e-02,1.638e-01,1.053e-01,6.498e-02,1.705e-01,6.632e-01,1.668e-02
FMNL3,23698,intracellular membrane-bounded organelle,GO:0043231,cellular component,11.0,40.0,8.533e-02,6.977e-02,1.043e-01,5.010e-02,2.953e-02,8.500e-02,7.591e-01,1.498e-02
FMNL3,23698,plasma membrane,GO:0005886,cellular component,11.0,67.0,8.870e-02,6.435e-02,1.223e-01,5.315e-02,2.916e-02,9.686e-02,7.520e-01,1.726e-02
FMNL3,23698,Golgi apparatus,GO:0005794,cellular component,11.0,16.0,8.870e-02,6.435e-02,1.223e-01,5.799e-02,4.589e-02,7.327e-02,7.423e-01,6.764e-03
FMNL3,23698,cytoplasm,GO:0005737,cellular component,11.0,72.0,1.002e-01,7.076e-02,1.419e-01,8.694e-02,5.915e-02,1.278e-01,6.904e-01,1.274e-02
FMNL3,23698,cytosol,GO:0005829,cellular component,11.0,50.0,1.009e-01,7.146e-02,1.424e-01,9.404e-02,7.265e-02,1.217e-01,6.800e-01,8.726e-03
FMNL3,23698,actin filament binding,GO:0051015,molecular function,11.0,8.0,8.136e-02,6.979e-02,9.483e-02,1.318e-02,5.398e-03,3.219e-02,8.919e-01,1.503e-02
FNDC5,20240,positive regulation of brown fat cell differentiation,GO:0090336,biological process,4.0,3.0,2.472e-01,4.883e-02,1.252e+00,2.204e-01,3.433e-02,1.415e+00,5.081e-01,9.960e-02
FNDC5,20240,plasma membrane,GO:0005886,cellular component,4.0,67.0,1.655e-01,9.639e-02,2.841e-01,1.308e-01,7.511e-02,2.278e-01,6.299e-01,2.182e-02
FNDC5,20240,extracellular region,GO:0005576,cellular component,4.0,16.0,1.655e-01,9.639e-02,2.841e-01,1.446e-01,8.067e-02,2.591e-01,6.133e-01,2.401e-02
FOXS1,3735,,,,nan,nan,,,,,,,,
GAS2,4167,,,,nan,nan,,,,,,,,
GATM,4175,creatine metabolic process,GO:0006600,biological process,12.0,6.0,4.442e-02,2.779e-02,7.100e-02,1.803e-02,6.822e-03,4.763e-02,8.651e-01,2.046e-02
GATM,4175,learning or memory,GO:0007611,biological process,12.0,6.0,4.446e-02,2.789e-02,7.087e-02,1.973e-02,1.079e-02,3.605e-02,8.591e-01,1.449e-02
GATM,4175,creatine biosynthetic process,GO:0006601,biological process,12.0,4.0,4.446e-02,2.789e-02,7.087e-02,2.170e-02,1.978e-02,2.380e-02,8.508e-01,2.334e-03
GATM,4175,muscle atrophy,GO:0014889,biological process,12.0,4.0,5.477e-02,2.340e-02,1.282e-01,2.870e-02,4.574e-03,1.801e-01,8.136e-01,4.393e-02
GATM,4175,multicellular organism development,GO:0007275,biological process,12.0,18.0,1.119e-01,8.939e-02,1.402e-01,1.044e-01,7.398e-02,1.472e-01,6.651e-01,1.223e-02
GATM,4175,mitochondrial intermembrane space,GO:0005758,cellular component,12.0,2.0,5.136e-02,2.636e-02,1.001e-01,3.621e-02,1.426e-02,9.195e-02,7.951e-01,2.443e-02
GATM,4175,mitochondrion,GO:0005739,cellular component,12.0,12.0,6.290e-02,5.032e-02,7.863e-02,3.131e-02,7.163e-03,1.368e-01,8.081e-01,3.648e-02
GATM,4175,extracellular exosome,GO:0070062,cellular component,12.0,39.0,9.171e-02,4.601e-02,1.828e-01,8.854e-02,3.945e-02,1.987e-01,6.862e-01,2.554e-02
GATM,4175,glycine amidinotransferase activity,GO:0015068,molecular function,12.0,2.0,3.681e-02,2.925e-02,4.633e-02,3.728e-03,3.010e-03,4.617e-03,9.541e-01,1.627e-03
GATM,4175,amidinotransferase activity,GO:0015067,molecular function,12.0,6.0,4.586e-02,2.629e-02,8.000e-02,2.937e-02,9.923e-03,8.696e-02,8.174e-01,2.850e-02
GBP3,4184,,,,nan,nan,,,,,,,,
GBP4,20480,,,,nan,nan,,,,,,,,
GBP5,19895,,,,nan,nan,,,,,,,,
GBP7,29606,,,,nan,nan,,,,,,,,
GDPD3,28638,,,,nan,nan,,,,,,,,
GIMAP1,23237,endoplasmic reticulum,GO:0005783,cellular component,2.0,16.0,2.808e-02,2.477e-02,3.183e-02,2.808e-02,2.477e-02,3.183e-02,8.237e-01,3.123e-03
GIMAP4,21872,cytosol,GO:0005829,cellular component,2.0,50.0,6.186e-02,3.563e-02,1.074e-01,6.186e-02,3.563e-02,1.074e-01,7.338e-01,1.587e-02
GIMAP5,18005,protein binding,GO:0005515,molecular function,2.0,318.0,6.352e-02,4.708e-02,8.569e-02,6.352e-02,4.708e-02,8.569e-02,7.312e-01,8.868e-03
GIMAP8,21792,,,,nan,nan,,,,,,,,
GIPR,4271,gastric inhibitory peptide receptor activity,GO:0016519,molecular function,7.0,2.0,5.315e-02,2.085e-02,1.355e-01,1.386e-02,5.838e-03,3.290e-02,8.884e-01,1.797e-02
GIPR,4271,G protein-coupled peptide receptor activity,GO:0008528,molecular function,7.0,28.0,5.332e-02,2.068e-02,1.375e-01,2.666e-02,1.034e-02,6.874e-02,8.281e-01,2.455e-02
GIPR,4271,peptide hormone binding,GO:0017046,molecular function,7.0,13.0,6.894e-02,3.522e-02,1.349e-01,5.170e-02,2.641e-02,1.012e-01,7.549e-01,1.907e-02
GIPR,4271,protein binding,GO:0005515,molecular function,7.0,318.0,9.970e-02,7.538e-02,1.319e-01,9.970e-02,7.538e-02,1.319e-01,6.719e-01,9.560e-03
GJA4,4278,,,,nan,nan,,,,,,,,
GNG11,4403,G protein-coupled receptor signaling pathway,GO:0007186,biological process,51.0,48.0,5.023e-02,3.109e-02,8.115e-02,3.036e-02,5.770e-03,1.597e-01,8.095e-01,3.960e-02
GNG11,4403,G-protein beta/gamma-subunit complex,GO:0031680,cellular component,51.0,2.0,4.810e-02,3.018e-02,7.665e-02,3.107e-02,1.490e-02,6.479e-02,8.123e-01,1.886e-02
GNG11,4403,heterotrimeric G-protein complex,GO:0005834,cellular component,51.0,3.0,4.898e-02,2.634e-02,9.108e-02,4.043e-02,1.575e-02,1.038e-01,7.826e-01,2.614e-02
GNG11,4403,G-protein beta-subunit binding,GO:0031681,molecular function,51.0,2.0,4.728e-02,2.861e-02,7.816e-02,2.645e-02,1.474e-02,4.745e-02,8.296e-01,1.485e-02
GP5,4443,,,,nan,nan,,,,,,,,
GPR4,4497,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway,GO:0051482,biological process,6.0,4.0,5.614e-02,3.137e-02,1.005e-01,1.404e-02,7.842e-03,2.512e-02,8.895e-01,1.185e-02
GPR4,4497,positive regulation of Rho protein signal transduction,GO:0035025,biological process,6.0,6.0,8.579e-02,5.482e-02,1.342e-01,6.598e-02,3.984e-02,1.093e-01,7.259e-01,1.512e-02
GPR4,4497,integral component of plasma membrane,GO:0005887,cellular component,6.0,39.0,8.068e-02,6.254e-02,1.041e-01,5.663e-02,3.150e-02,1.018e-01,7.443e-01,1.723e-02
GPR4,4497,G protein-coupled receptor activity,GO:0004930,molecular function,6.0,47.0,8.579e-02,5.482e-02,1.342e-01,8.579e-02,5.482e-02,1.342e-01,6.921e-01,1.467e-02
GPR68,4519,cellular response to pH,GO:0071467,biological process,2.0,6.0,1.145e-01,3.823e-02,3.431e-01,1.145e-01,3.823e-02,3.431e-01,6.453e-01,4.249e-02
GPX1,4553,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043154,biological process,25.0,8.0,1.240e-01,9.304e-02,1.653e-01,4.135e-02,2.030e-02,8.425e-02,7.808e-01,1.952e-02
GPX1,4553,hydrogen peroxide catabolic process,GO:0042744,biological process,25.0,6.0,1.255e-01,9.051e-02,1.741e-01,5.205e-02,1.948e-02,1.390e-01,7.529e-01,2.855e-02
GPX1,4553,glutathione metabolic process,GO:0006749,biological process,25.0,10.0,1.343e-01,9.529e-02,1.893e-01,6.110e-02,2.724e-02,1.370e-01,7.344e-01,2.452e-02
GPX1,4553,UV protection,GO:0009650,biological process,25.0,2.0,1.343e-01,9.529e-02,1.893e-01,6.952e-02,5.963e-02,8.106e-02,7.202e-01,4.636e-03
GPX1,4553,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902042,biological process,25.0,4.0,1.374e-01,1.075e-01,1.757e-01,5.461e-02,1.573e-02,1.896e-01,7.454e-01,3.734e-02
GPX1,4553,"regulation of gene expression, epigenetic",GO:0040029,biological process,25.0,7.0,1.413e-01,1.037e-01,1.924e-01,7.408e-02,2.104e-02,2.609e-01,7.064e-01,4.020e-02
GPX1,4553,response to hydrogen peroxide,GO:0042542,biological process,25.0,7.0,1.486e-01,1.436e-01,1.538e-01,7.364e-02,3.870e-02,1.401e-01,7.114e-01,2.004e-02
GPX1,4553,response to selenium ion,GO:0010269,biological process,25.0,3.0,1.486e-01,1.436e-01,1.538e-01,7.679e-02,4.367e-02,1.350e-01,7.064e-01,1.739e-02
GPX1,4553,negative regulation of release of cytochrome c from mitochondria,GO:0090201,biological process,25.0,4.0,1.698e-01,7.986e-02,3.611e-01,1.143e-01,2.348e-02,5.563e-01,6.405e-01,5.430e-02
GPX1,4553,regulation of mammary gland epithelial cell proliferation,GO:0033599,biological process,25.0,6.0,1.755e-01,5.593e-02,5.509e-01,7.673e-02,5.832e-03,1.009e+00,6.794e-01,9.517e-02
GPX1,4553,regulation of proteasomal protein catabolic process,GO:0061136,biological process,25.0,8.0,1.789e-01,1.210e-01,2.643e-01,1.515e-01,8.496e-02,2.702e-01,6.054e-01,2.407e-02
GPX1,4553,heart contraction,GO:0060047,biological process,25.0,2.0,2.252e-01,2.202e-01,2.304e-01,2.173e-01,2.031e-01,2.323e-01,5.423e-01,3.076e-03
GPX1,4553,cell redox homeostasis,GO:0045454,biological process,25.0,3.0,2.496e-01,1.258e-01,4.952e-01,2.338e-01,1.019e-01,5.364e-01,5.227e-01,4.103e-02
GPX1,4553,mitochondrion,GO:0005739,cellular component,25.0,12.0,1.422e-01,9.066e-02,2.232e-01,8.732e-02,3.205e-02,2.379e-01,6.866e-01,3.213e-02
GPX1,4553,cytosol,GO:0005829,cellular component,25.0,50.0,1.442e-01,8.794e-02,2.366e-01,8.737e-02,3.811e-02,2.003e-01,6.877e-01,2.669e-02
GPX1,4553,cytoplasm,GO:0005737,cellular component,25.0,72.0,1.519e-01,8.517e-02,2.709e-01,1.040e-01,4.591e-02,2.354e-01,6.630e-01,2.804e-02
GPX1,4553,Lewy body,GO:0097413,cellular component,25.0,4.0,1.761e-01,1.176e-01,2.638e-01,1.410e-01,6.265e-02,3.175e-01,6.154e-01,3.170e-02
GPX1,4553,glutathione peroxidase activity,GO:0004602,molecular function,25.0,3.0,1.206e-01,8.413e-02,1.730e-01,1.254e-02,8.422e-03,1.867e-02,8.988e-01,6.895e-03
GPX1,4553,peroxidase activity,GO:0004601,molecular function,25.0,19.0,1.206e-01,8.413e-02,1.730e-01,1.634e-02,3.287e-03,8.118e-02,8.688e-01,3.609e-02
GPX1,4553,SH3 domain binding,GO:0017124,molecular function,25.0,6.0,1.255e-01,9.051e-02,1.741e-01,4.826e-02,1.746e-02,1.334e-01,7.618e-01,2.924e-02
GRASP,18707,,,,nan,nan,,,,,,,,
GRB14,4565,insulin receptor signaling pathway,GO:0008286,biological process,14.0,6.0,4.298e-02,1.265e-02,1.460e-01,1.783e-02,8.701e-03,3.655e-02,8.683e-01,1.680e-02
GRB14,4565,negative regulation of insulin receptor signaling pathway,GO:0046627,biological process,14.0,6.0,6.661e-02,1.994e-02,2.225e-01,6.661e-02,1.994e-02,2.225e-01,7.208e-01,3.743e-02
GRB14,4565,plasma membrane,GO:0005886,cellular component,14.0,67.0,4.011e-02,1.062e-02,1.515e-01,2.600e-02,7.569e-03,8.934e-02,8.296e-01,3.196e-02
GRB14,4565,intracellular membrane-bounded organelle,GO:0043231,cellular component,14.0,40.0,4.048e-02,1.088e-02,1.506e-01,2.876e-02,7.574e-03,1.092e-01,8.182e-01,3.451e-02
GRB14,4565,cytoplasm,GO:0005737,cellular component,14.0,72.0,4.048e-02,1.088e-02,1.506e-01,3.037e-02,5.929e-03,1.555e-01,8.107e-01,4.360e-02
GRB14,4565,receptor tyrosine kinase binding,GO:0030971,molecular function,14.0,5.0,4.011e-02,1.062e-02,1.515e-01,1.505e-02,8.411e-03,2.693e-02,8.839e-01,1.212e-02
GRB14,4565,identical protein binding,GO:0042802,molecular function,14.0,24.0,4.011e-02,1.062e-02,1.515e-01,1.649e-02,2.783e-03,9.769e-02,8.665e-01,4.052e-02
GRB14,4565,protein homodimerization activity,GO:0042803,molecular function,14.0,23.0,4.011e-02,1.062e-02,1.515e-01,2.416e-02,3.718e-03,1.570e-01,8.320e-01,4.749e-02
GRB14,4565,SH3/SH2 adaptor activity,GO:0005070,molecular function,14.0,3.0,4.298e-02,1.265e-02,1.460e-01,2.877e-02,1.043e-02,7.936e-02,8.196e-01,2.568e-02
GREM2,17655,,,,nan,nan,,,,,,,,
GRID2,4576,"synaptic transmission, glutamatergic",GO:0035249,biological process,16.0,2.0,3.155e-01,1.766e-01,5.635e-01,7.831e-02,4.355e-02,1.408e-01,7.036e-01,1.882e-02
GRID2,4576,positive regulation of long-term synaptic depression,GO:1900454,biological process,16.0,3.0,3.155e-01,1.766e-01,5.635e-01,1.176e-01,4.433e-02,3.117e-01,6.428e-01,3.746e-02
GRID2,4576,excitatory synapse assembly,GO:1904861,biological process,16.0,2.0,3.293e-01,1.623e-01,6.683e-01,1.542e-01,1.834e-02,1.297e+00,5.787e-01,8.561e-02
GRID2,4576,modulation of chemical synaptic transmission,GO:0050804,biological process,16.0,30.0,4.502e-01,2.280e-01,8.889e-01,4.043e-01,1.613e-01,1.014e+00,3.896e-01,6.100e-02
GRID2,4576,positive regulation of synapse assembly,GO:0051965,biological process,16.0,9.0,5.116e-01,3.698e-01,7.077e-01,4.981e-01,3.939e-01,6.300e-01,3.425e-01,1.831e-02
GRID2,4576,plasma membrane,GO:0005886,cellular component,16.0,67.0,3.155e-01,1.766e-01,5.635e-01,9.978e-02,6.035e-02,1.650e-01,6.708e-01,1.749e-02
GRID2,4576,postsynaptic membrane,GO:0045211,cellular component,16.0,3.0,3.155e-01,1.766e-01,5.635e-01,2.075e-01,8.848e-02,4.866e-01,5.470e-01,3.711e-02
GRID2,4576,postsynaptic density membrane,GO:0098839,cellular component,16.0,2.0,3.221e-01,1.811e-01,5.728e-01,2.236e-01,1.093e-01,4.572e-01,5.333e-01,3.470e-02
GRID2,4576,signaling receptor activity,GO:0038023,molecular function,16.0,28.0,3.155e-01,1.766e-01,5.635e-01,1.339e-01,6.027e-02,2.975e-01,6.241e-01,3.165e-02
GRID2,4576,ligand-gated ion channel activity,GO:0015276,molecular function,16.0,9.0,3.155e-01,1.766e-01,5.635e-01,1.695e-01,8.305e-02,3.460e-01,5.852e-01,2.902e-02
GRID2,4576,protein binding,GO:0005515,molecular function,16.0,318.0,3.180e-01,1.822e-01,5.549e-01,2.260e-01,1.582e-01,3.228e-01,5.341e-01,1.641e-02
GRID2,4576,glutamate receptor activity,GO:0008066,molecular function,16.0,4.0,3.180e-01,1.822e-01,5.549e-01,2.258e-01,1.332e-01,3.828e-01,5.332e-01,2.489e-02
GRID2,4576,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,GO:1904315,molecular function,16.0,4.0,3.211e-01,1.789e-01,5.763e-01,2.180e-01,1.046e-01,4.545e-01,5.382e-01,3.404e-02
GSC,4612,neural crest cell fate specification,GO:0014036,biological process,2.0,2.0,5.451e-01,4.771e-01,6.228e-01,5.451e-01,4.771e-01,6.228e-01,3.139e-01,1.079e-02
GSTT1,4641,glutathione metabolic process,GO:0006749,biological process,16.0,10.0,1.110e-01,1.038e-01,1.187e-01,1.110e-01,1.038e-01,1.187e-01,6.567e-01,2.389e-03
GSTT1,4641,cytosol,GO:0005829,cellular component,16.0,50.0,2.482e-02,1.354e-02,4.550e-02,1.247e-02,4.367e-03,3.561e-02,8.943e-01,1.733e-02
GSTT1,4641,cytoplasm,GO:0005737,cellular component,16.0,72.0,2.482e-02,1.354e-02,4.550e-02,1.349e-02,5.456e-03,3.336e-02,8.900e-01,1.769e-02
GSTT1,4641,extracellular exosome,GO:0070062,cellular component,16.0,39.0,2.482e-02,1.354e-02,4.550e-02,1.500e-02,7.102e-03,3.169e-02,8.830e-01,1.597e-02
GSTT1,4641,protein binding,GO:0005515,molecular function,16.0,318.0,2.482e-02,1.354e-02,4.550e-02,8.443e-03,3.607e-03,1.977e-02,9.210e-01,1.101e-02
GSTT1,4641,glutathione peroxidase activity,GO:0004602,molecular function,16.0,3.0,2.490e-02,1.359e-02,4.560e-02,1.698e-02,8.079e-03,3.567e-02,8.720e-01,1.593e-02
GSTT1,4641,glutathione transferase activity,GO:0004364,molecular function,16.0,2.0,4.392e-02,1.506e-02,1.281e-01,3.765e-02,1.290e-02,1.098e-01,7.905e-01,2.800e-02
GSTT2,4642,,,,nan,nan,,,,,,,,
GUCA2B,4683,,,,nan,nan,,,,,,,,
GZMA,4708,,,,nan,nan,,,,,,,,
HCAR2,24827,neutrophil apoptotic process,GO:0001781,biological process,12.0,4.0,6.823e-02,1.607e-02,2.897e-01,2.985e-02,2.601e-03,3.426e-01,8.020e-01,5.921e-02
HCAR2,24827,positive regulation of neutrophil apoptotic process,GO:0033031,biological process,12.0,5.0,7.769e-02,1.739e-02,3.472e-01,6.180e-02,1.082e-02,3.529e-01,7.277e-01,4.939e-02
HCAR2,24827,plasma membrane,GO:0005886,cellular component,12.0,67.0,6.914e-02,1.692e-02,2.825e-01,4.125e-02,2.133e-02,7.977e-02,7.810e-01,1.815e-02
HCAR2,24827,cell junction,GO:0030054,cellular component,12.0,7.0,7.058e-02,1.520e-02,3.278e-01,5.826e-02,9.333e-03,3.637e-01,7.318e-01,5.683e-02
HCST,16977,positive regulation of phosphatidylinositol 3-kinase signaling,GO:0014068,biological process,9.0,5.0,4.057e-02,2.980e-02,5.523e-02,1.481e-02,6.371e-03,3.444e-02,8.825e-01,1.609e-02
HCST,16977,protein phosphorylation,GO:0006468,biological process,9.0,25.0,4.057e-02,2.980e-02,5.523e-02,2.311e-02,1.330e-02,4.014e-02,8.437e-01,1.362e-02
HCST,16977,cell surface,GO:0009986,cellular component,9.0,20.0,4.512e-02,2.399e-02,8.486e-02,3.760e-02,1.999e-02,7.071e-02,7.917e-01,1.711e-02
HCST,16977,signaling receptor binding,GO:0005102,molecular function,9.0,63.0,4.057e-02,2.980e-02,5.523e-02,1.596e-02,6.815e-03,3.739e-02,8.765e-01,1.704e-02
HCST,16977,phosphatidylinositol 3-kinase binding,GO:0043548,molecular function,9.0,6.0,4.057e-02,2.980e-02,5.523e-02,2.866e-02,1.983e-02,4.143e-02,8.215e-01,9.321e-03
HCST,16977,protein binding,GO:0005515,molecular function,9.0,318.0,7.398e-02,5.293e-02,1.034e-01,7.398e-02,5.293e-02,1.034e-01,7.119e-01,1.018e-02
HDGFL2,14680,,,,nan,nan,,,,,,,,
HERC6,26072,cytosol,GO:0005829,cellular component,3.0,50.0,4.115e-02,3.152e-02,5.372e-02,3.538e-02,2.889e-02,4.332e-02,7.987e-01,5.374e-03
HERC6,26072,nucleoplasm,GO:0005654,cellular component,3.0,47.0,4.115e-02,3.152e-02,5.372e-02,4.098e-02,3.129e-02,5.367e-02,7.825e-01,7.280e-03
HHEX,4901,poly(A)+ mRNA export from nucleus,GO:0016973,biological process,25.0,2.0,8.893e-02,6.676e-02,1.185e-01,1.981e-02,1.474e-02,2.663e-02,8.595e-01,7.079e-03
HHEX,4901,cell differentiation,GO:0030154,biological process,25.0,91.0,9.326e-02,7.944e-02,1.095e-01,3.953e-02,2.626e-02,5.951e-02,7.864e-01,1.097e-02
HHEX,4901,negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045736,biological process,25.0,7.0,9.406e-02,6.612e-02,1.338e-01,4.205e-02,2.489e-02,7.103e-02,7.791e-01,1.414e-02
HHEX,4901,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,25.0,55.0,9.729e-02,6.332e-02,1.495e-01,4.341e-02,1.879e-02,1.003e-01,7.750e-01,2.261e-02
HHEX,4901,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,25.0,69.0,1.032e-01,5.699e-02,1.868e-01,5.824e-02,1.879e-02,1.805e-01,7.389e-01,3.265e-02
HHEX,4901,mRNA export from nucleus,GO:0006406,biological process,25.0,5.0,1.038e-01,7.703e-02,1.398e-01,5.445e-02,2.828e-02,1.049e-01,7.489e-01,1.842e-02
HHEX,4901,regulation of leukocyte proliferation,GO:0070663,biological process,25.0,8.0,1.416e-01,6.774e-02,2.959e-01,8.546e-02,2.043e-02,3.574e-01,6.847e-01,4.907e-02
HHEX,4901,DNA conformation change,GO:0071103,biological process,25.0,5.0,1.457e-01,8.847e-02,2.401e-01,1.047e-01,5.900e-02,1.859e-01,6.633e-01,2.067e-02
HHEX,4901,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,25.0,39.0,1.477e-01,7.283e-02,2.995e-01,1.075e-01,4.361e-02,2.651e-01,6.569e-01,3.365e-02
HHEX,4901,protein localization to nucleus,GO:0034504,biological process,25.0,10.0,2.280e-01,1.701e-01,3.056e-01,2.160e-01,1.668e-01,2.798e-01,5.432e-01,1.204e-02
HHEX,4901,nucleus,GO:0005634,cellular component,25.0,86.0,1.299e-01,1.013e-01,1.666e-01,8.908e-02,6.844e-02,1.159e-01,6.876e-01,8.567e-03
HHEX,4901,protein-DNA complex,GO:0032993,cellular component,25.0,21.0,1.821e-01,7.638e-02,4.343e-01,1.477e-01,4.901e-02,4.453e-01,6.047e-01,4.414e-02
HHEX,4901,cytoplasm,GO:0005737,cellular component,25.0,72.0,1.877e-01,1.298e-01,2.714e-01,1.515e-01,1.016e-01,2.260e-01,6.063e-01,1.641e-02
HHEX,4901,RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000977,molecular function,25.0,16.0,8.893e-02,6.676e-02,1.185e-01,2.250e-02,1.955e-02,2.590e-02,8.471e-01,3.563e-03
HHEX,4901,sequence-specific DNA binding,GO:0043565,molecular function,25.0,14.0,8.893e-02,6.676e-02,1.185e-01,2.563e-02,1.095e-02,5.999e-02,8.326e-01,2.176e-02
HHEX,4901,repressing transcription factor binding,GO:0070491,molecular function,25.0,3.0,8.893e-02,6.676e-02,1.185e-01,2.606e-02,1.562e-02,4.346e-02,8.312e-01,1.301e-02
HHEX,4901,"DNA binding, bending",GO:0008301,molecular function,25.0,5.0,8.893e-02,6.676e-02,1.185e-01,2.690e-02,1.307e-02,5.536e-02,8.277e-01,1.854e-02
HHEX,4901,transcription factor binding,GO:0008134,molecular function,25.0,16.0,8.893e-02,6.676e-02,1.185e-01,2.928e-02,1.689e-02,5.077e-02,8.189e-01,1.425e-02
HHEX,4901,transcription regulatory region DNA binding,GO:0044212,molecular function,25.0,22.0,8.893e-02,6.676e-02,1.185e-01,4.015e-02,1.792e-02,8.991e-02,7.839e-01,2.208e-02
HHEX,4901,"DNA-binding transcription repressor activity, RNA polymerase II-specific",GO:0001227,molecular function,25.0,10.0,9.271e-02,7.799e-02,1.102e-01,3.545e-02,2.358e-02,5.330e-02,7.984e-01,1.088e-02
HHEX,4901,RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,molecular function,25.0,30.0,9.406e-02,6.612e-02,1.338e-01,4.586e-02,2.850e-02,7.381e-02,7.693e-01,1.294e-02
HHEX,4901,protein homodimerization activity,GO:0042803,molecular function,25.0,23.0,1.951e-01,1.453e-01,2.620e-01,1.679e-01,1.294e-01,2.178e-01,5.892e-01,1.096e-02
HHEX,4901,protein binding,GO:0005515,molecular function,25.0,318.0,2.062e-01,1.381e-01,3.079e-01,1.874e-01,1.191e-01,2.949e-01,5.688e-01,1.979e-02
HHEX,4901,eukaryotic initiation factor 4E binding,GO:0008190,molecular function,25.0,2.0,2.648e-01,1.601e-01,4.378e-01,2.648e-01,1.601e-01,4.378e-01,5.010e-01,2.480e-02
HID1,15736,cytoplasmic microtubule,GO:0005881,cellular component,13.0,5.0,9.768e-02,3.969e-02,2.404e-01,4.942e-02,1.472e-02,1.659e-01,7.586e-01,3.299e-02
HID1,15736,extracellular exosome,GO:0070062,cellular component,13.0,39.0,9.768e-02,3.969e-02,2.404e-01,5.104e-02,2.089e-02,1.247e-01,7.557e-01,2.565e-02
HID1,15736,cytoplasm,GO:0005737,cellular component,13.0,72.0,9.768e-02,3.969e-02,2.404e-01,5.949e-02,2.900e-02,1.220e-01,7.378e-01,2.125e-02
HID1,15736,cytosol,GO:0005829,cellular component,13.0,50.0,9.768e-02,3.969e-02,2.404e-01,6.095e-02,2.632e-02,1.412e-01,7.344e-01,2.511e-02
HID1,15736,Golgi apparatus,GO:0005794,cellular component,13.0,16.0,9.768e-02,3.969e-02,2.404e-01,6.804e-02,1.824e-02,2.538e-01,7.169e-01,4.165e-02
HID1,15736,Golgi medial cisterna,GO:0005797,cellular component,13.0,2.0,1.012e-01,4.090e-02,2.506e-01,6.252e-02,2.167e-02,1.804e-01,7.305e-01,3.043e-02
HID1,15736,Golgi trans cisterna,GO:0000138,cellular component,13.0,2.0,1.012e-01,4.090e-02,2.506e-01,6.427e-02,2.248e-02,1.838e-01,7.270e-01,3.049e-02
HID1,15736,membrane,GO:0016020,cellular component,13.0,41.0,1.020e-01,4.689e-02,2.220e-01,8.084e-02,3.335e-02,1.959e-01,6.974e-01,2.970e-02
HID1,15736,extrinsic component of Golgi membrane,GO:0090498,cellular component,13.0,2.0,1.593e-01,5.810e-02,4.371e-01,1.593e-01,5.810e-02,4.371e-01,5.928e-01,4.392e-02
HID1,15736,protein binding,GO:0005515,molecular function,13.0,318.0,1.020e-01,4.689e-02,2.220e-01,7.758e-02,3.961e-02,1.520e-01,7.046e-01,2.181e-02
HMCES,24446,,,,nan,nan,,,,,,,,
HMGA2,5009,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,GO:0045869,biological process,62.0,3.0,2.027e-01,1.324e-01,3.101e-01,1.912e-02,5.304e-03,6.890e-02,8.584e-01,3.027e-02
HMGA2,5009,senescence-associated heterochromatin focus assembly,GO:0035986,biological process,62.0,2.0,2.027e-01,1.324e-01,3.101e-01,2.513e-02,1.168e-02,5.407e-02,8.342e-01,1.883e-02
HMGA2,5009,positive regulation of transcription regulatory region DNA binding,GO:2000679,biological process,62.0,5.0,2.027e-01,1.324e-01,3.101e-01,3.359e-02,5.896e-03,1.914e-01,7.986e-01,4.256e-02
HMGA2,5009,mesenchymal cell differentiation,GO:0048762,biological process,62.0,10.0,2.027e-01,1.324e-01,3.101e-01,3.621e-02,1.181e-02,1.111e-01,7.944e-01,3.033e-02
HMGA2,5009,regulation of cell cycle process,GO:0010564,biological process,62.0,28.0,2.027e-01,1.324e-01,3.101e-01,3.918e-02,2.228e-02,6.890e-02,7.872e-01,1.511e-02
HMGA2,5009,epithelial to mesenchymal transition,GO:0001837,biological process,62.0,8.0,2.027e-01,1.324e-01,3.101e-01,4.084e-02,3.559e-02,4.685e-02,7.828e-01,3.732e-03
HMGA2,5009,"regulation of transcription, DNA-templated",GO:0006355,biological process,62.0,35.0,2.027e-01,1.324e-01,3.101e-01,4.467e-02,9.531e-03,2.093e-01,7.686e-01,4.163e-02
HMGA2,5009,endodermal cell differentiation,GO:0035987,biological process,62.0,3.0,2.027e-01,1.324e-01,3.101e-01,5.044e-02,3.843e-02,6.620e-02,7.585e-01,7.529e-03
HMGA2,5009,base-excision repair,GO:0006284,biological process,62.0,5.0,2.027e-01,1.324e-01,3.101e-01,6.060e-02,5.426e-02,6.768e-02,7.369e-01,3.100e-03
HMGA2,5009,chondrocyte differentiation,GO:0002062,biological process,62.0,3.0,2.027e-01,1.324e-01,3.101e-01,6.831e-02,2.788e-02,1.673e-01,7.200e-01,2.681e-02
HMGA2,5009,positive regulation of cell cycle arrest,GO:0071158,biological process,62.0,5.0,2.027e-01,1.324e-01,3.101e-01,7.278e-02,4.471e-02,1.185e-01,7.135e-01,1.504e-02
HMGA2,5009,stem cell differentiation,GO:0048863,biological process,62.0,12.0,2.027e-01,1.324e-01,3.101e-01,7.626e-02,3.352e-02,1.735e-01,7.063e-01,2.508e-02
HMGA2,5009,heterochromatin assembly,GO:0031507,biological process,62.0,11.0,2.042e-01,1.315e-01,3.171e-01,7.893e-02,3.373e-02,1.847e-01,7.012e-01,2.691e-02
HMGA2,5009,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,62.0,41.0,2.060e-01,1.422e-01,2.984e-01,5.799e-02,3.272e-02,1.028e-01,7.417e-01,1.632e-02
HMGA2,5009,fat cell differentiation,GO:0045444,biological process,62.0,6.0,2.066e-01,1.308e-01,3.264e-01,8.397e-02,1.750e-02,4.028e-01,6.870e-01,4.936e-02
HMGA2,5009,mesodermal cell differentiation,GO:0048333,biological process,62.0,7.0,2.066e-01,1.308e-01,3.264e-01,9.138e-02,2.995e-02,2.787e-01,6.789e-01,3.709e-02
HMGA2,5009,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,62.0,55.0,2.070e-01,1.342e-01,3.193e-01,8.958e-02,3.857e-02,2.081e-01,6.838e-01,2.902e-02
HMGA2,5009,negative regulation of double-strand break repair via nonhomologous end joining,GO:2001033,biological process,62.0,3.0,2.232e-01,1.259e-01,3.956e-01,9.020e-02,3.507e-02,2.320e-01,6.819e-01,3.306e-02
HMGA2,5009,positive regulation of gene expression,GO:0010628,biological process,62.0,27.0,2.299e-01,2.224e-01,2.377e-01,9.939e-02,5.139e-02,1.922e-01,6.703e-01,2.329e-02
HMGA2,5009,mitotic G2 DNA damage checkpoint,GO:0007095,biological process,62.0,4.0,2.306e-01,1.314e-01,4.045e-01,1.232e-01,5.635e-02,2.694e-01,6.374e-01,2.914e-02
HMGA2,5009,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,62.0,39.0,2.306e-01,2.248e-01,2.366e-01,1.174e-01,6.902e-02,1.998e-01,6.466e-01,1.965e-02
HMGA2,5009,negative regulation of DNA binding,GO:0043392,biological process,62.0,12.0,2.317e-01,2.191e-01,2.449e-01,1.182e-01,8.833e-02,1.580e-01,6.467e-01,1.073e-02
HMGA2,5009,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,62.0,69.0,2.516e-01,1.911e-01,3.313e-01,1.414e-01,6.725e-02,2.973e-01,6.156e-01,2.987e-02
HMGA2,5009,positive regulation of stem cell proliferation,GO:2000648,biological process,62.0,7.0,2.535e-01,1.391e-01,4.620e-01,1.584e-01,5.790e-02,4.331e-01,5.942e-01,3.924e-02
HMGA2,5009,response to virus,GO:0009615,biological process,62.0,10.0,2.723e-01,2.007e-01,3.694e-01,1.685e-01,8.919e-02,3.183e-01,5.869e-01,2.656e-02
HMGA2,5009,oncogene-induced cell senescence,GO:0090402,biological process,62.0,2.0,2.822e-01,1.510e-01,5.276e-01,1.980e-01,8.386e-02,4.674e-01,5.550e-01,4.046e-02
HMGA2,5009,negative regulation by host of viral transcription,GO:0043922,biological process,62.0,6.0,2.855e-01,1.853e-01,4.398e-01,1.795e-01,5.388e-02,5.979e-01,5.698e-01,4.872e-02
HMGA2,5009,"DNA damage response, detection of DNA damage",GO:0042769,biological process,62.0,5.0,2.871e-01,1.561e-01,5.279e-01,1.857e-01,5.787e-02,5.962e-01,5.634e-01,5.062e-02
HMGA2,5009,positive regulation of protein serine/threonine kinase activity,GO:0071902,biological process,62.0,8.0,2.932e-01,2.307e-01,3.726e-01,2.146e-01,1.594e-01,2.889e-01,5.444e-01,1.351e-02
HMGA2,5009,histone H2A-S139 phosphorylation,GO:0035978,biological process,62.0,3.0,3.018e-01,2.256e-01,4.039e-01,2.328e-01,1.548e-01,3.503e-01,5.277e-01,1.981e-02
HMGA2,5009,chromosome breakage,GO:0031052,biological process,62.0,2.0,3.051e-01,1.787e-01,5.209e-01,2.225e-01,9.654e-02,5.129e-01,5.326e-01,4.039e-02
HMGA2,5009,positive regulation of response to DNA damage stimulus,GO:2001022,biological process,62.0,9.0,3.150e-01,2.529e-01,3.923e-01,2.418e-01,1.879e-01,3.111e-01,5.210e-01,1.213e-02
HMGA2,5009,positive regulation of cellular response to X-ray,GO:2000685,biological process,62.0,4.0,3.598e-01,2.657e-01,4.870e-01,3.024e-01,2.256e-01,4.052e-01,4.736e-01,1.582e-02
HMGA2,5009,positive regulation of cellular senescence,GO:2000774,biological process,62.0,4.0,3.653e-01,2.648e-01,5.040e-01,3.108e-01,2.217e-01,4.357e-01,4.671e-01,1.847e-02
HMGA2,5009,regulation of stem cell population maintenance,GO:2000036,biological process,62.0,6.0,3.806e-01,2.077e-01,6.974e-01,3.325e-01,1.682e-01,6.572e-01,4.466e-01,4.135e-02
HMGA2,5009,regulation of cellular response to drug,GO:2001038,biological process,62.0,8.0,4.186e-01,2.941e-01,5.958e-01,3.697e-01,2.324e-01,5.880e-01,4.243e-01,2.702e-02
HMGA2,5009,mesodermal-endodermal cell signaling,GO:0003131,biological process,62.0,3.0,4.523e-01,2.049e-01,9.986e-01,4.201e-01,1.714e-01,1.030e+00,3.775e-01,6.495e-02
HMGA2,5009,positive regulation of apoptotic process,GO:0043065,biological process,62.0,28.0,4.595e-01,2.980e-01,7.087e-01,4.276e-01,2.683e-01,6.815e-01,3.842e-01,3.305e-02
HMGA2,5009,negative regulation of apoptotic process,GO:0043066,biological process,62.0,25.0,5.004e-01,3.698e-01,6.771e-01,4.811e-01,3.652e-01,6.338e-01,3.529e-01,1.979e-02
HMGA2,5009,chondrocyte proliferation,GO:0035988,biological process,62.0,2.0,6.501e-01,4.170e-01,1.014e+00,6.501e-01,4.170e-01,1.014e+00,2.370e-01,5.012e-02
HMGA2,5009,nucleus,GO:0005634,cellular component,62.0,86.0,2.292e-01,1.684e-01,3.119e-01,1.317e-01,7.681e-02,2.260e-01,6.288e-01,2.124e-02
HMGA2,5009,senescence-associated heterochromatin focus,GO:0035985,cellular component,62.0,2.0,2.537e-01,1.799e-01,3.577e-01,1.608e-01,9.518e-02,2.717e-01,5.954e-01,2.229e-02
HMGA2,5009,protein-DNA complex,GO:0032993,cellular component,62.0,21.0,3.835e-01,1.934e-01,7.603e-01,3.254e-01,1.307e-01,8.103e-01,4.491e-01,4.831e-02
HMGA2,5009,SMAD protein complex,GO:0071141,cellular component,62.0,5.0,4.535e-01,2.113e-01,9.735e-01,4.197e-01,1.692e-01,1.041e+00,3.804e-01,5.788e-02
HMGA2,5009,cAMP response element binding,GO:0035497,molecular function,62.0,2.0,2.027e-01,1.324e-01,3.101e-01,1.690e-02,9.540e-03,2.993e-02,8.735e-01,1.227e-02
HMGA2,5009,"DNA binding, bending",GO:0008301,molecular function,62.0,5.0,2.027e-01,1.324e-01,3.101e-01,3.826e-02,1.809e-02,8.093e-02,7.894e-01,2.051e-02
HMGA2,5009,transcription regulatory region DNA binding,GO:0044212,molecular function,62.0,22.0,2.027e-01,1.324e-01,3.101e-01,5.052e-02,2.523e-02,1.012e-01,7.577e-01,1.919e-02
HMGA2,5009,"DNA-binding transcription repressor activity, RNA polymerase II-specific",GO:0001227,molecular function,62.0,10.0,2.027e-01,1.324e-01,3.101e-01,5.148e-02,1.994e-02,1.329e-01,7.550e-01,2.621e-02
HMGA2,5009,SMAD binding,GO:0046332,molecular function,62.0,5.0,2.027e-01,1.324e-01,3.101e-01,5.467e-02,1.989e-02,1.502e-01,7.472e-01,2.898e-02
HMGA2,5009,"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,molecular function,62.0,11.0,2.027e-01,1.324e-01,3.101e-01,5.955e-02,2.570e-02,1.379e-01,7.375e-01,2.438e-02
HMGA2,5009,transcription factor binding,GO:0008134,molecular function,62.0,16.0,2.027e-01,1.324e-01,3.101e-01,6.341e-02,2.267e-02,1.774e-01,7.289e-01,2.992e-02
HMGA2,5009,RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,molecular function,62.0,30.0,2.027e-01,1.324e-01,3.101e-01,7.721e-02,4.705e-02,1.267e-01,7.059e-01,1.537e-02
HMGA2,5009,transcription coregulator activity,GO:0003712,molecular function,62.0,5.0,2.044e-01,1.353e-01,3.088e-01,9.273e-02,4.657e-02,1.847e-01,6.801e-01,2.321e-02
HMGA2,5009,AT DNA binding,GO:0003680,molecular function,62.0,2.0,2.276e-01,1.348e-01,3.844e-01,1.214e-01,6.190e-02,2.381e-01,6.405e-01,2.437e-02
HMGA2,5009,MH2 domain binding,GO:0035500,molecular function,62.0,2.0,2.366e-01,1.457e-01,3.842e-01,1.291e-01,5.936e-02,2.806e-01,6.302e-01,3.091e-02
HMGA2,5009,MH1 domain binding,GO:0035501,molecular function,62.0,2.0,2.368e-01,1.459e-01,3.844e-01,1.303e-01,6.065e-02,2.799e-01,6.288e-01,3.049e-02
HMGA2,5009,C2H2 zinc finger domain binding,GO:0070742,molecular function,62.0,2.0,2.368e-01,1.459e-01,3.844e-01,1.333e-01,6.275e-02,2.833e-01,6.252e-01,3.026e-02
HMGA2,5009,DNA-(apurinic or apyrimidinic site) endonuclease activity,GO:0003906,molecular function,62.0,6.0,2.638e-01,2.041e-01,3.409e-01,1.652e-01,1.363e-01,2.002e-01,5.922e-01,7.818e-03
HMGA2,5009,protein binding,GO:0005515,molecular function,62.0,318.0,3.132e-01,2.820e-01,3.479e-01,2.472e-01,2.195e-01,2.785e-01,5.171e-01,5.712e-03
HMGA2,5009,nucleosomal DNA binding,GO:0031492,molecular function,62.0,3.0,3.768e-01,1.931e-01,7.353e-01,3.208e-01,1.331e-01,7.734e-01,4.531e-01,4.657e-02
HMGA2,5009,5'-deoxyribose-5-phosphate lyase activity,GO:0051575,molecular function,62.0,3.0,4.248e-01,3.099e-01,5.824e-01,3.851e-01,2.777e-01,5.340e-01,4.150e-01,2.056e-02
HOXA3,5104,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,12.0,69.0,1.484e-01,9.574e-02,2.299e-01,6.269e-02,3.038e-02,1.294e-01,7.313e-01,2.163e-02
HOXA3,5104,embryonic skeletal system morphogenesis,GO:0048704,biological process,12.0,6.0,1.568e-01,1.047e-01,2.350e-01,9.782e-02,6.578e-02,1.455e-01,6.741e-01,1.373e-02
HOXA3,5104,anterior/posterior pattern specification,GO:0009952,biological process,12.0,18.0,1.620e-01,9.819e-02,2.674e-01,1.195e-01,6.283e-02,2.273e-01,6.434e-01,2.421e-02
HOXA3,5104,angiogenesis,GO:0001525,biological process,12.0,13.0,1.930e-01,1.383e-01,2.694e-01,1.706e-01,9.466e-02,3.075e-01,5.849e-01,2.435e-02
HOXA3,5104,nucleus,GO:0005634,cellular component,12.0,86.0,1.568e-01,1.047e-01,2.350e-01,9.703e-02,6.662e-02,1.413e-01,6.755e-01,1.242e-02
HOXA3,5104,nucleoplasm,GO:0005654,cellular component,12.0,47.0,1.651e-01,1.001e-01,2.722e-01,1.311e-01,8.093e-02,2.124e-01,6.295e-01,1.807e-02
HOXA3,5104,DNA-binding transcription factor activity,GO:0003700,molecular function,12.0,17.0,1.105e-01,5.038e-02,2.426e-01,1.627e-02,7.959e-03,3.327e-02,8.764e-01,1.591e-02
HOXA3,5104,RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,molecular function,12.0,30.0,1.105e-01,5.038e-02,2.426e-01,2.600e-02,1.097e-02,6.166e-02,8.304e-01,2.101e-02
HOXA3,5104,protein binding,GO:0005515,molecular function,12.0,318.0,1.822e-01,1.403e-01,2.367e-01,1.752e-01,1.211e-01,2.534e-01,5.814e-01,1.574e-02
HOXC4,5126,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,15.0,69.0,1.442e-01,1.027e-01,2.024e-01,7.230e-02,4.114e-02,1.270e-01,7.141e-01,1.769e-02
HOXC4,5126,embryonic skeletal system morphogenesis,GO:0048704,biological process,15.0,6.0,1.652e-01,1.079e-01,2.529e-01,1.197e-01,6.810e-02,2.105e-01,6.435e-01,2.140e-02
HOXC4,5126,anterior/posterior pattern specification,GO:0009952,biological process,15.0,18.0,1.786e-01,1.009e-01,3.160e-01,1.334e-01,7.398e-02,2.407e-01,6.264e-01,2.340e-02
HOXC4,5126,skeletal system development,GO:0001501,biological process,15.0,3.0,2.051e-01,1.556e-01,2.703e-01,2.051e-01,1.556e-01,2.703e-01,5.530e-01,1.251e-02
HOXC4,5126,nucleus,GO:0005634,cellular component,15.0,86.0,1.635e-01,1.094e-01,2.443e-01,1.054e-01,7.370e-02,1.508e-01,6.636e-01,1.229e-02
HOXC4,5126,nucleoplasm,GO:0005654,cellular component,15.0,47.0,1.755e-01,1.046e-01,2.944e-01,1.337e-01,8.397e-02,2.128e-01,6.266e-01,1.754e-02
HOXC4,5126,RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000977,molecular function,15.0,16.0,8.954e-02,4.094e-02,1.958e-01,1.259e-02,8.128e-03,1.950e-02,8.983e-01,7.596e-03
HOXC4,5126,"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,molecular function,15.0,11.0,8.954e-02,4.094e-02,1.958e-01,2.048e-02,1.132e-02,3.705e-02,8.554e-01,1.378e-02
HOXC4,5126,RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,molecular function,15.0,30.0,8.954e-02,4.094e-02,1.958e-01,2.443e-02,1.116e-02,5.350e-02,8.372e-01,1.885e-02
HOXC4,5126,activating transcription factor binding,GO:0033613,molecular function,15.0,5.0,1.113e-01,7.806e-02,1.588e-01,4.770e-02,2.036e-02,1.118e-01,7.638e-01,2.411e-02
HOXC4,5126,protein binding,GO:0005515,molecular function,15.0,318.0,1.996e-01,1.488e-01,2.676e-01,1.814e-01,1.353e-01,2.433e-01,5.755e-01,1.271e-02
HPCA,5144,cellular response to calcium ion,GO:0071277,biological process,11.0,4.0,9.568e-02,5.697e-02,1.607e-01,4.517e-02,3.126e-02,6.527e-02,7.713e-01,1.005e-02
HPCA,5144,regulation of voltage-gated calcium channel activity,GO:1901385,biological process,11.0,7.0,9.568e-02,5.697e-02,1.607e-01,5.464e-02,2.837e-02,1.053e-01,7.485e-01,1.882e-02
HPCA,5144,cytoplasm,GO:0005737,cellular component,11.0,72.0,1.620e-01,1.148e-01,2.286e-01,1.620e-01,1.148e-01,2.286e-01,5.950e-01,1.449e-02
HPCA,5144,identical protein binding,GO:0042802,molecular function,11.0,24.0,9.568e-02,5.697e-02,1.607e-01,6.048e-02,2.854e-02,1.282e-01,7.358e-01,2.232e-02
HPCA,5144,actin binding,GO:0003779,molecular function,11.0,7.0,9.885e-02,6.084e-02,1.606e-01,7.647e-02,3.815e-02,1.533e-01,7.063e-01,2.165e-02
HPCA,5144,calcium ion binding,GO:0005509,molecular function,11.0,7.0,1.034e-01,6.804e-02,1.572e-01,6.177e-02,3.558e-02,1.072e-01,7.338e-01,1.642e-02
HPGDS,17890,,,,nan,nan,,,,,,,,
HSPA12B,16193,protein binding,GO:0005515,molecular function,2.0,318.0,3.239e-02,2.431e-02,4.317e-02,3.239e-02,2.431e-02,4.317e-02,8.082e-01,7.428e-03
HTR7,5302,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",GO:0007187,biological process,11.0,4.0,1.882e-01,1.385e-01,2.557e-01,4.610e-02,2.386e-02,8.905e-02,7.687e-01,1.813e-02
HTR7,5302,chemical synaptic transmission,GO:0007268,biological process,11.0,15.0,2.902e-01,1.521e-01,5.537e-01,2.487e-01,1.072e-01,5.769e-01,5.102e-01,4.150e-02
HTR7,5302,integral component of plasma membrane,GO:0005887,cellular component,11.0,39.0,1.882e-01,1.385e-01,2.557e-01,5.145e-02,4.286e-02,6.175e-02,7.565e-01,5.081e-03
HTR7,5302,dendrite,GO:0030425,cellular component,11.0,13.0,4.226e-01,3.542e-01,5.041e-01,4.226e-01,3.542e-01,5.041e-01,3.915e-01,1.189e-02
HTR7,5302,neurotransmitter receptor activity,GO:0030594,molecular function,11.0,7.0,1.886e-01,1.381e-01,2.576e-01,8.761e-02,6.716e-02,1.143e-01,6.897e-01,8.543e-03
HTR7,5302,G protein-coupled receptor activity,GO:0004930,molecular function,11.0,47.0,1.886e-01,1.381e-01,2.576e-01,9.506e-02,6.833e-02,1.323e-01,6.784e-01,1.090e-02
HTR7,5302,protein binding,GO:0005515,molecular function,11.0,318.0,2.269e-01,1.755e-01,2.933e-01,1.558e-01,1.187e-01,2.043e-01,6.023e-01,1.086e-02
HTR7,5302,G protein-coupled serotonin receptor activity,GO:0004993,molecular function,11.0,6.0,2.467e-01,1.788e-01,3.404e-01,1.948e-01,1.623e-01,2.337e-01,5.628e-01,8.212e-03
ICOS,5351,cell-cell adhesion,GO:0098609,biological process,8.0,26.0,9.244e-02,6.459e-02,1.323e-01,3.777e-02,3.395e-02,4.202e-02,7.916e-01,2.853e-03
ICOS,5351,T cell costimulation,GO:0031295,biological process,8.0,4.0,9.244e-02,6.459e-02,1.323e-01,4.622e-02,3.230e-02,6.614e-02,7.688e-01,9.782e-03
ICOS,5351,T cell tolerance induction,GO:0002517,biological process,8.0,5.0,1.604e-01,1.279e-01,2.012e-01,1.324e-01,1.000e-01,1.754e-01,6.288e-01,1.084e-02
ICOS,5351,protein binding,GO:0005515,molecular function,8.0,318.0,1.621e-01,1.301e-01,2.021e-01,1.555e-01,1.118e-01,2.161e-01,6.023e-01,1.348e-02
ID1,5360,negative regulation of neuron differentiation,GO:0045665,biological process,17.0,13.0,9.922e-02,7.437e-02,1.324e-01,4.003e-02,1.242e-02,1.291e-01,7.827e-01,3.274e-02
ID1,5360,negative regulation of DNA-binding transcription factor activity,GO:0043433,biological process,17.0,10.0,1.123e-01,6.956e-02,1.812e-01,4.434e-02,9.514e-03,2.066e-01,7.697e-01,4.085e-02
ID1,5360,negative regulation of DNA binding,GO:0043392,biological process,17.0,12.0,1.134e-01,6.990e-02,1.840e-01,6.664e-02,2.193e-02,2.025e-01,7.222e-01,3.225e-02
ID1,5360,neuron differentiation,GO:0030182,biological process,17.0,19.0,1.232e-01,7.218e-02,2.104e-01,4.625e-02,1.157e-02,1.849e-01,7.647e-01,4.051e-02
ID1,5360,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,17.0,39.0,1.292e-01,1.065e-01,1.567e-01,6.529e-02,4.102e-02,1.039e-01,7.272e-01,1.397e-02
ID1,5360,regulation of cell cycle,GO:0051726,biological process,17.0,11.0,1.573e-01,9.281e-02,2.665e-01,1.312e-01,5.715e-02,3.012e-01,6.271e-01,3.055e-02
ID1,5360,circadian rhythm,GO:0007623,biological process,17.0,10.0,2.941e-01,1.665e-01,5.194e-01,2.941e-01,1.665e-01,5.194e-01,4.774e-01,2.971e-02
ID1,5360,nucleus,GO:0005634,cellular component,17.0,86.0,1.394e-01,9.814e-02,1.981e-01,7.516e-02,5.052e-02,1.118e-01,7.097e-01,1.252e-02
ID1,5360,nucleoplasm,GO:0005654,cellular component,17.0,47.0,1.394e-01,9.814e-02,1.981e-01,9.549e-02,7.009e-02,1.301e-01,6.778e-01,1.030e-02
ID1,5360,Golgi apparatus,GO:0005794,cellular component,17.0,16.0,1.397e-01,9.778e-02,1.996e-01,1.025e-01,7.171e-02,1.464e-01,6.677e-01,1.228e-02
ID1,5360,cytoplasm,GO:0005737,cellular component,17.0,72.0,1.516e-01,1.032e-01,2.229e-01,1.270e-01,9.045e-02,1.784e-01,6.353e-01,1.279e-02
ID1,5360,RNA polymerase II transcription factor binding,GO:0001085,molecular function,17.0,4.0,9.922e-02,7.437e-02,1.324e-01,2.350e-02,1.619e-02,3.410e-02,8.426e-01,9.356e-03
ID1,5360,DNA-binding transcription factor activity,GO:0003700,molecular function,17.0,17.0,9.922e-02,7.437e-02,1.324e-01,2.603e-02,1.510e-02,4.487e-02,8.316e-01,1.366e-02
ID1,5360,transcription factor binding,GO:0008134,molecular function,17.0,16.0,9.922e-02,7.437e-02,1.324e-01,2.702e-02,1.424e-02,5.126e-02,8.273e-01,1.626e-02
ID1,5360,protein binding,GO:0005515,molecular function,17.0,318.0,1.667e-01,1.297e-01,2.142e-01,1.518e-01,1.242e-01,1.855e-01,6.066e-01,7.975e-03
IFT81,14313,intraciliary transport involved in cilium assembly,GO:0035735,biological process,11.0,3.0,6.769e-02,5.108e-02,8.968e-02,1.333e-02,6.554e-03,2.713e-02,8.923e-01,1.245e-02
IFT81,14313,intraciliary transport,GO:0042073,biological process,11.0,6.0,7.971e-02,3.638e-02,1.747e-01,2.346e-02,1.023e-02,5.384e-02,8.413e-01,2.063e-02
IFT81,14313,cilium assembly,GO:0060271,biological process,11.0,8.0,1.073e-01,4.603e-02,2.500e-01,5.022e-02,2.467e-02,1.023e-01,7.584e-01,1.967e-02
IFT81,14313,regulation of smoothened signaling pathway,GO:0008589,biological process,11.0,5.0,2.368e-01,1.719e-01,3.261e-01,2.207e-01,1.554e-01,3.135e-01,5.389e-01,1.607e-02
IFT81,14313,cilium,GO:0005929,cellular component,11.0,6.0,1.055e-01,4.296e-02,2.592e-01,5.205e-02,1.427e-02,1.898e-01,7.515e-01,3.636e-02
IFT81,14313,centrosome,GO:0005813,cellular component,11.0,11.0,1.214e-01,5.497e-02,2.681e-01,7.263e-02,3.306e-02,1.596e-01,7.128e-01,2.342e-02
IFT81,14313,ciliary basal body,GO:0036064,cellular component,11.0,12.0,1.949e-01,1.549e-01,2.453e-01,1.513e-01,1.006e-01,2.276e-01,6.067e-01,1.618e-02
IFT81,14313,intraciliary transport particle B,GO:0030992,cellular component,11.0,2.0,3.524e-01,1.365e-01,9.100e-01,3.402e-01,1.178e-01,9.829e-01,4.338e-01,6.037e-02
IFT81,14313,tubulin binding,GO:0015631,molecular function,11.0,6.0,6.769e-02,5.108e-02,8.968e-02,1.728e-02,1.361e-02,2.192e-02,8.728e-01,5.201e-03
IFT81,14313,protein binding,GO:0005515,molecular function,11.0,318.0,1.952e-01,1.560e-01,2.443e-01,1.516e-01,1.273e-01,1.805e-01,6.069e-01,6.931e-03
IGFLR1,23620,,,,nan,nan,,,,,,,,
IL2RB,6009,interleukin-15-mediated signaling pathway,GO:0035723,biological process,23.0,2.0,1.701e-02,6.080e-03,4.761e-02,5.104e-03,1.824e-03,1.428e-02,9.419e-01,9.653e-03
IL2RB,6009,cytokine-mediated signaling pathway,GO:0019221,biological process,23.0,45.0,1.318e-01,1.215e-01,1.430e-01,8.912e-02,6.096e-02,1.303e-01,6.871e-01,1.256e-02
IL2RB,6009,positive regulation of phagocytosis,GO:0050766,biological process,23.0,9.0,1.320e-01,1.211e-01,1.439e-01,1.160e-01,9.888e-02,1.361e-01,6.499e-01,5.794e-03
IL2RB,6009,negative regulation of apoptotic process,GO:0043066,biological process,23.0,25.0,1.515e-01,1.078e-01,2.130e-01,1.479e-01,9.746e-02,2.243e-01,6.106e-01,1.659e-02
IL2RB,6009,cell surface,GO:0009986,cellular component,23.0,20.0,1.318e-01,1.215e-01,1.430e-01,8.722e-02,6.860e-02,1.109e-01,6.904e-01,7.839e-03
IL2RB,6009,membrane,GO:0016020,cellular component,23.0,41.0,1.318e-01,1.215e-01,1.430e-01,9.652e-02,5.719e-02,1.629e-01,6.756e-01,1.721e-02
IL2RB,6009,interleukin-15 receptor activity,GO:0042010,molecular function,23.0,2.0,1.198e-02,3.984e-03,3.604e-02,2.367e-03,8.864e-04,6.323e-03,9.648e-01,5.223e-03
IL2RB,6009,interleukin-2 receptor activity,GO:0004911,molecular function,23.0,2.0,1.198e-02,3.984e-03,3.604e-02,2.562e-03,7.525e-04,8.720e-03,9.624e-01,6.520e-03
IL2RB,6009,interleukin-2 binding,GO:0019976,molecular function,23.0,3.0,4.092e-02,2.638e-02,6.348e-02,1.637e-02,1.055e-02,2.539e-02,8.768e-01,9.319e-03
IL2RB,6009,protein binding,GO:0005515,molecular function,23.0,318.0,1.318e-01,1.215e-01,1.430e-01,1.042e-01,7.431e-02,1.461e-01,6.653e-01,1.197e-02
INSL3,6086,positive regulation of epithelial cell migration,GO:0010634,biological process,7.0,7.0,1.696e-01,7.263e-02,3.962e-01,3.369e-02,8.086e-03,1.404e-01,8.009e-01,3.882e-02
INSL3,6086,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,GO:0007193,biological process,7.0,9.0,2.204e-01,1.444e-01,3.365e-01,1.293e-01,9.886e-02,1.691e-01,6.328e-01,1.030e-02
INSL3,6086,positive regulation of wound healing,GO:0090303,biological process,7.0,11.0,2.291e-01,1.335e-01,3.931e-01,1.646e-01,7.619e-02,3.556e-01,5.898e-01,3.321e-02
INSL3,6086,extracellular space,GO:0005615,cellular component,7.0,24.0,2.291e-01,1.335e-01,3.931e-01,1.754e-01,1.222e-01,2.517e-01,5.812e-01,1.538e-02
INSL3,6086,protease binding,GO:0002020,molecular function,7.0,6.0,2.291e-01,1.469e-01,3.572e-01,1.371e-01,6.160e-02,3.053e-01,6.201e-01,3.126e-02
INSL3,6086,G protein-coupled receptor binding,GO:0001664,molecular function,7.0,46.0,2.878e-01,1.244e-01,6.656e-01,2.762e-01,1.041e-01,7.327e-01,4.861e-01,4.808e-02
IQCB1,28949,photoreceptor cell maintenance,GO:0045494,biological process,16.0,3.0,9.201e-02,2.618e-02,3.234e-01,6.754e-02,8.665e-03,5.265e-01,7.105e-01,6.454e-02
IQCB1,28949,maintenance of animal organ identity,GO:0048496,biological process,16.0,3.0,1.172e-01,5.320e-02,2.581e-01,1.148e-01,5.590e-02,2.357e-01,6.488e-01,2.721e-02
IQCB1,28949,photoreceptor connecting cilium,GO:0032391,cellular component,16.0,2.0,3.763e-02,1.534e-02,9.232e-02,5.131e-03,9.481e-04,2.777e-02,9.386e-01,1.420e-02
IQCB1,28949,mitotic spindle,GO:0072686,cellular component,16.0,3.0,7.087e-02,2.623e-02,1.915e-01,3.694e-02,1.019e-02,1.339e-01,7.912e-01,3.558e-02
IQCB1,28949,microtubule cytoskeleton,GO:0015630,cellular component,16.0,6.0,7.087e-02,2.623e-02,1.915e-01,3.823e-02,9.462e-03,1.545e-01,7.869e-01,3.872e-02
IQCB1,28949,extracellular exosome,GO:0070062,cellular component,16.0,39.0,7.087e-02,2.623e-02,1.915e-01,3.961e-02,1.554e-02,1.009e-01,7.849e-01,2.513e-02
IQCB1,28949,centrosome,GO:0005813,cellular component,16.0,11.0,7.087e-02,2.623e-02,1.915e-01,4.623e-02,1.322e-02,1.616e-01,7.656e-01,3.616e-02
IQCB1,28949,intercellular bridge,GO:0045171,cellular component,16.0,6.0,7.087e-02,2.623e-02,1.915e-01,4.886e-02,1.599e-02,1.493e-01,7.596e-01,3.253e-02
IQCB1,28949,nucleoplasm,GO:0005654,cellular component,16.0,47.0,8.181e-02,3.806e-02,1.759e-01,6.817e-02,3.171e-02,1.465e-01,7.205e-01,2.373e-02
IQCB1,28949,calmodulin binding,GO:0005516,molecular function,16.0,4.0,4.895e-02,2.925e-02,8.193e-02,9.228e-03,3.399e-03,2.506e-02,9.149e-01,1.356e-02
IQCB1,28949,enzyme binding,GO:0019899,molecular function,16.0,35.0,5.528e-02,4.754e-02,6.427e-02,1.856e-02,6.985e-03,4.930e-02,8.636e-01,2.330e-02
IQCB1,28949,protein binding,GO:0005515,molecular function,16.0,318.0,8.519e-02,4.025e-02,1.803e-01,6.969e-02,3.086e-02,1.574e-01,7.178e-01,2.446e-02
IRF1,6116,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,55.0,41.0,3.462e-02,2.650e-02,4.523e-02,1.244e-02,9.207e-03,1.680e-02,9.001e-01,5.376e-03
IRF1,6116,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,55.0,39.0,3.462e-02,2.650e-02,4.523e-02,1.179e-02,4.805e-03,2.891e-02,8.998e-01,1.324e-02
IRF1,6116,cellular response to interferon-beta,GO:0035458,biological process,55.0,3.0,3.462e-02,2.650e-02,4.523e-02,1.298e-02,4.313e-03,3.907e-02,8.909e-01,2.225e-02
IRF1,6116,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,55.0,69.0,4.188e-02,2.093e-02,8.380e-02,2.329e-02,1.157e-02,4.689e-02,8.422e-01,1.728e-02
IRF1,6116,defense response to virus,GO:0051607,biological process,55.0,11.0,4.238e-02,2.186e-02,8.216e-02,2.428e-02,1.454e-02,4.055e-02,8.388e-01,1.288e-02
IRF1,6116,cell cycle arrest,GO:0007050,biological process,55.0,7.0,8.948e-02,4.109e-02,1.948e-01,6.711e-02,3.082e-02,1.461e-01,7.229e-01,2.277e-02
IRF1,6116,cellular response to mechanical stimulus,GO:0071260,biological process,55.0,5.0,1.246e-01,1.395e-02,1.112e+00,1.004e-01,8.299e-03,1.215e+00,6.447e-01,8.901e-02
IRF1,6116,apoptotic process,GO:0006915,biological process,55.0,20.0,1.317e-01,4.984e-02,3.478e-01,1.132e-01,4.486e-02,2.855e-01,6.494e-01,3.257e-02
IRF1,6116,positive regulation of interferon-beta production,GO:0032728,biological process,55.0,5.0,1.836e-01,1.507e-01,2.237e-01,1.682e-01,1.488e-01,1.902e-01,5.894e-01,5.077e-03
IRF1,6116,immune system process,GO:0002376,biological process,55.0,21.0,5.442e-01,2.315e-01,1.279e+00,5.442e-01,2.315e-01,1.279e+00,2.907e-01,7.589e-02
IRF1,6116,nucleus,GO:0005634,cellular component,55.0,86.0,2.086e-02,9.739e-03,4.470e-02,1.571e-03,4.139e-04,5.963e-03,9.719e-01,5.787e-03
IRF1,6116,nuclear chromatin,GO:0000790,cellular component,55.0,11.0,7.077e-02,3.522e-02,1.422e-01,5.144e-02,2.648e-02,9.991e-02,7.556e-01,1.877e-02
IRF1,6116,protein binding,GO:0005515,molecular function,55.0,318.0,2.957e-02,2.795e-02,3.129e-02,3.748e-03,3.408e-03,4.122e-03,9.538e-01,7.364e-04
IRF1,6116,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,55.0,17.0,4.177e-02,2.104e-02,8.294e-02,1.785e-02,1.185e-02,2.690e-02,8.692e-01,9.446e-03
IRF1,6116,"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,molecular function,55.0,11.0,4.188e-02,2.093e-02,8.380e-02,1.672e-02,6.256e-03,4.468e-02,8.720e-01,2.131e-02
IRF1,6116,RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,molecular function,55.0,30.0,4.796e-02,1.545e-02,1.489e-01,2.744e-02,7.591e-03,9.921e-02,8.234e-01,3.324e-02
IRS2,6126,insulin receptor signaling pathway,GO:0008286,biological process,21.0,6.0,2.894e-02,6.497e-03,1.289e-01,2.442e-03,5.274e-04,1.131e-02,9.623e-01,8.873e-03
IRS2,6126,positive regulation of glucose metabolic process,GO:0010907,biological process,21.0,7.0,7.428e-02,5.316e-02,1.038e-01,1.574e-02,8.360e-03,2.964e-02,8.796e-01,1.369e-02
IRS2,6126,negative regulation of long-chain fatty acid import across plasma membrane,GO:0010748,biological process,21.0,4.0,8.795e-02,7.504e-02,1.031e-01,3.041e-02,1.550e-02,5.964e-02,8.147e-01,1.732e-02
IRS2,6126,cellular response to insulin stimulus,GO:0032869,biological process,21.0,3.0,9.949e-02,4.419e-02,2.240e-01,4.845e-02,7.276e-03,3.226e-01,7.564e-01,5.094e-02
IRS2,6126,positive regulation of fatty acid beta-oxidation,GO:0032000,biological process,21.0,8.0,1.035e-01,5.654e-02,1.895e-01,6.163e-02,1.733e-02,2.192e-01,7.304e-01,3.854e-02
IRS2,6126,positive regulation of glycogen biosynthetic process,GO:0045725,biological process,21.0,5.0,1.073e-01,6.351e-02,1.814e-01,7.379e-02,3.304e-02,1.648e-01,7.103e-01,2.546e-02
IRS2,6126,positive regulation of glucose import,GO:0046326,biological process,21.0,3.0,1.155e-01,6.898e-02,1.935e-01,9.549e-02,4.142e-02,2.201e-01,6.747e-01,2.961e-02
IRS2,6126,plasma membrane,GO:0005886,cellular component,21.0,67.0,1.215e-01,8.741e-02,1.689e-01,9.625e-02,7.893e-02,1.174e-01,6.771e-01,6.681e-03
IRS2,6126,cytosol,GO:0005829,cellular component,21.0,50.0,1.362e-01,1.170e-01,1.586e-01,1.323e-01,1.252e-01,1.399e-01,6.294e-01,2.232e-03
IRS2,6126,insulin receptor binding,GO:0005158,molecular function,21.0,3.0,8.691e-02,4.803e-02,1.573e-01,2.688e-02,1.190e-02,6.072e-02,8.275e-01,2.105e-02
IRS2,6126,phosphatidylinositol 3-kinase binding,GO:0043548,molecular function,21.0,6.0,9.890e-02,6.834e-02,1.431e-01,5.065e-02,3.534e-02,7.260e-02,7.581e-01,1.015e-02
IRS2,6126,protein binding,GO:0005515,molecular function,21.0,318.0,1.226e-01,9.029e-02,1.666e-01,1.069e-01,9.193e-02,1.243e-01,6.622e-01,5.249e-03
ISG15,4053,ISG15-protein conjugation,GO:0032020,biological process,25.0,3.0,1.296e-01,5.882e-02,2.857e-01,2.079e-02,6.390e-03,6.764e-02,8.503e-01,2.621e-02
ISG15,4053,negative regulation of viral genome replication,GO:0045071,biological process,25.0,8.0,1.329e-01,5.949e-02,2.969e-01,5.740e-02,2.889e-02,1.140e-01,7.425e-01,1.962e-02
ISG15,4053,response to type I interferon,GO:0034340,biological process,25.0,4.0,1.329e-01,5.949e-02,2.969e-01,6.901e-02,1.655e-02,2.877e-01,7.142e-01,4.512e-02
ISG15,4053,modification-dependent protein catabolic process,GO:0019941,biological process,25.0,7.0,1.361e-01,6.568e-02,2.819e-01,4.498e-02,1.123e-02,1.801e-01,7.688e-01,3.779e-02
ISG15,4053,regulation of interferon-gamma production,GO:0032649,biological process,25.0,6.0,1.367e-01,5.965e-02,3.131e-01,5.686e-02,9.079e-03,3.562e-01,7.370e-01,5.247e-02
ISG15,4053,defense response to virus,GO:0051607,biological process,25.0,11.0,1.395e-01,6.602e-02,2.950e-01,9.276e-02,3.598e-02,2.391e-01,6.784e-01,3.147e-02
ISG15,4053,negative regulation of protein ubiquitination,GO:0031397,biological process,25.0,11.0,1.448e-01,5.610e-02,3.736e-01,1.003e-01,2.106e-02,4.775e-01,6.611e-01,5.122e-02
ISG15,4053,integrin-mediated signaling pathway,GO:0007229,biological process,25.0,5.0,1.604e-01,1.170e-01,2.198e-01,1.113e-01,8.289e-02,1.495e-01,6.559e-01,1.032e-02
ISG15,4053,defense response to bacterium,GO:0042742,biological process,25.0,14.0,2.271e-01,1.408e-01,3.663e-01,2.061e-01,1.357e-01,3.132e-01,5.515e-01,1.909e-02
ISG15,4053,interferon-gamma secretion,GO:0072643,biological process,25.0,2.0,2.468e-01,1.394e-01,4.369e-01,2.445e-01,1.411e-01,4.239e-01,5.173e-01,2.607e-02
ISG15,4053,interleukin-10 secretion,GO:0072608,biological process,25.0,2.0,2.468e-01,1.394e-01,4.369e-01,2.446e-01,1.377e-01,4.344e-01,5.170e-01,2.732e-02
ISG15,4053,extracellular region,GO:0005576,cellular component,25.0,16.0,1.329e-01,5.949e-02,2.969e-01,6.761e-02,2.646e-02,1.727e-01,7.210e-01,2.863e-02
ISG15,4053,cytoplasm,GO:0005737,cellular component,25.0,72.0,1.560e-01,1.120e-01,2.172e-01,9.178e-02,5.978e-02,1.409e-01,6.830e-01,1.393e-02
ISG15,4053,nucleus,GO:0005634,cellular component,25.0,86.0,1.580e-01,1.166e-01,2.140e-01,9.915e-02,5.278e-02,1.863e-01,6.712e-01,2.103e-02
ISG15,4053,protein tag,GO:0031386,molecular function,25.0,2.0,1.296e-01,5.882e-02,2.857e-01,3.224e-02,1.381e-02,7.527e-02,8.079e-01,2.252e-02
ISG15,4053,ubiquitin protein ligase binding,GO:0031625,molecular function,25.0,6.0,1.296e-01,5.882e-02,2.857e-01,3.668e-02,1.222e-02,1.101e-01,7.928e-01,3.002e-02
ISG15,4053,integrin binding,GO:0005178,molecular function,25.0,11.0,1.296e-01,5.882e-02,2.857e-01,3.900e-02,2.514e-02,6.049e-02,7.879e-01,1.169e-02
ISG15,4053,protein binding,GO:0005515,molecular function,25.0,318.0,1.683e-01,1.386e-01,2.044e-01,1.250e-01,9.365e-02,1.668e-01,6.380e-01,1.079e-02
ITGAL,6148,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007157,biological process,27.0,3.0,3.164e-02,1.985e-02,5.041e-02,7.810e-03,4.336e-03,1.407e-02,9.265e-01,6.750e-03
ITGAL,6148,receptor clustering,GO:0043113,biological process,27.0,8.0,3.958e-02,1.830e-02,8.563e-02,2.528e-02,1.179e-02,5.422e-02,8.336e-01,1.888e-02
ITGAL,6148,cell-matrix adhesion,GO:0007160,biological process,27.0,11.0,4.076e-02,1.718e-02,9.673e-02,3.019e-02,1.102e-02,8.272e-02,8.145e-01,2.656e-02
ITGAL,6148,leukocyte cell-cell adhesion,GO:0007159,biological process,27.0,7.0,4.329e-02,1.839e-02,1.019e-01,3.231e-02,1.156e-02,9.031e-02,8.074e-01,2.696e-02
ITGAL,6148,memory T cell extravasation,GO:0035683,biological process,27.0,2.0,5.501e-02,1.677e-02,1.804e-01,5.129e-02,1.746e-02,1.506e-01,7.547e-01,2.964e-02
ITGAL,6148,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,GO:0002291,biological process,27.0,2.0,6.083e-02,1.472e-02,2.514e-01,5.452e-02,1.029e-02,2.888e-01,7.436e-01,4.726e-02
ITGAL,6148,cell surface,GO:0009986,cellular component,27.0,20.0,3.164e-02,1.985e-02,5.041e-02,7.085e-03,3.897e-03,1.288e-02,9.309e-01,5.901e-03
ITGAL,6148,extracellular exosome,GO:0070062,cellular component,27.0,39.0,3.164e-02,1.985e-02,5.041e-02,9.830e-03,6.367e-03,1.518e-02,9.149e-01,5.861e-03
ITGAL,6148,membrane,GO:0016020,cellular component,27.0,41.0,3.641e-02,1.914e-02,6.928e-02,2.036e-02,1.338e-02,3.098e-02,8.564e-01,9.721e-03
ITGAL,6148,integrin alphaL-beta2 complex,GO:0034687,cellular component,27.0,2.0,5.743e-02,9.208e-03,3.581e-01,3.398e-02,2.108e-03,5.476e-01,7.830e-01,7.659e-02
ITGAL,6148,cell adhesion molecule binding,GO:0050839,molecular function,27.0,6.0,3.164e-02,1.985e-02,5.041e-02,6.726e-03,5.872e-03,7.704e-03,9.336e-01,1.324e-03
ITGAL,6148,protein binding,GO:0005515,molecular function,27.0,318.0,3.402e-02,2.120e-02,5.460e-02,1.545e-02,1.172e-02,2.036e-02,8.827e-01,5.771e-03
ITGAL,6148,ICAM-3 receptor activity,GO:0030369,molecular function,27.0,2.0,4.658e-02,1.705e-02,1.272e-01,3.212e-02,8.440e-03,1.222e-01,8.063e-01,3.332e-02
IVNS1ABP,16951,negative regulation of protein ubiquitination,GO:0031397,biological process,6.0,11.0,2.272e-01,2.137e-01,2.416e-01,1.302e-01,5.499e-02,3.082e-01,6.280e-01,3.160e-02
IVNS1ABP,16951,response to virus,GO:0009615,biological process,6.0,10.0,2.272e-01,2.137e-01,2.416e-01,1.506e-01,1.131e-01,2.006e-01,6.077e-01,1.155e-02
IVNS1ABP,16951,RNA splicing,GO:0008380,biological process,6.0,6.0,3.235e-01,1.624e-01,6.444e-01,3.235e-01,1.624e-01,6.444e-01,4.538e-01,3.770e-02
IVNS1ABP,16951,cytosol,GO:0005829,cellular component,6.0,50.0,2.272e-01,2.137e-01,2.416e-01,1.282e-01,1.076e-01,1.528e-01,6.344e-01,6.792e-03
IVNS1ABP,16951,protein binding,GO:0005515,molecular function,6.0,318.0,2.272e-01,2.137e-01,2.416e-01,1.792e-01,1.550e-01,2.072e-01,5.782e-01,6.249e-03
JAM2,14686,,,,nan,nan,,,,,,,,
KANK3,24796,,,,nan,nan,,,,,,,,
KCNC2,6234,,,,nan,nan,,,,,,,,
KCNJ8,6269,,,,nan,nan,,,,,,,,
KCNQ3,6297,potassium ion transmembrane transport,GO:0071805,biological process,10.0,6.0,4.102e-02,3.184e-02,5.284e-02,1.879e-02,1.061e-02,3.329e-02,8.638e-01,1.302e-02
KCNQ3,6297,voltage-gated potassium channel complex,GO:0008076,cellular component,10.0,16.0,4.249e-02,2.927e-02,6.167e-02,2.164e-02,1.118e-02,4.190e-02,8.495e-01,1.552e-02
KCNQ3,6297,integral component of plasma membrane,GO:0005887,cellular component,10.0,39.0,4.249e-02,2.927e-02,6.167e-02,2.833e-02,1.985e-02,4.045e-02,8.227e-01,9.018e-03
KCNQ3,6297,integral component of membrane,GO:0016021,cellular component,10.0,19.0,4.937e-02,3.177e-02,7.671e-02,3.341e-02,1.539e-02,7.253e-02,8.042e-01,2.002e-02
KCNQ3,6297,axon initial segment,GO:0043194,cellular component,10.0,2.0,1.219e-01,6.951e-02,2.139e-01,1.089e-01,6.122e-02,1.936e-01,6.577e-01,2.067e-02
KCNQ3,6297,delayed rectifier potassium channel activity,GO:0005251,molecular function,10.0,2.0,3.968e-02,3.445e-02,4.571e-02,5.346e-03,3.608e-03,7.922e-03,9.420e-01,3.501e-03
KCNQ3,6297,voltage-gated potassium channel activity,GO:0005249,molecular function,10.0,9.0,4.102e-02,3.184e-02,5.284e-02,1.701e-02,1.074e-02,2.692e-02,8.737e-01,1.047e-02
KCNQ3,6297,calmodulin binding,GO:0005516,molecular function,10.0,4.0,4.249e-02,2.927e-02,6.167e-02,2.732e-02,1.167e-02,6.396e-02,8.256e-01,2.138e-02
KCNQ3,6297,protein binding,GO:0005515,molecular function,10.0,318.0,1.490e-01,1.155e-01,1.922e-01,1.490e-01,1.155e-01,1.922e-01,6.097e-01,1.012e-02
KHK,6315,response to insulin,GO:0032868,biological process,13.0,3.0,1.049e-01,4.971e-02,2.215e-01,2.639e-02,7.397e-03,9.416e-02,8.275e-01,3.224e-02
KHK,6315,response to zinc ion,GO:0010043,biological process,13.0,4.0,1.049e-01,4.971e-02,2.215e-01,3.215e-02,1.331e-02,7.762e-02,8.081e-01,2.339e-02
KHK,6315,regulation of glycogen metabolic process,GO:0070873,biological process,13.0,8.0,1.360e-01,7.106e-02,2.605e-01,6.087e-02,2.178e-02,1.701e-01,7.334e-01,3.151e-02
KHK,6315,response to sucrose,GO:0009744,biological process,13.0,4.0,1.520e-01,4.436e-02,5.210e-01,8.276e-02,1.372e-02,4.994e-01,6.854e-01,5.952e-02
KHK,6315,fructose metabolic process,GO:0006000,biological process,13.0,4.0,1.632e-01,3.909e-02,6.817e-01,8.649e-02,5.579e-03,1.341e+00,6.627e-01,9.568e-02
KHK,6315,response to fructose,GO:0009750,biological process,13.0,3.0,2.138e-01,1.033e-01,4.424e-01,1.885e-01,8.530e-02,4.167e-01,5.648e-01,3.639e-02
KHK,6315,response to glucose,GO:0009749,biological process,13.0,4.0,2.138e-01,1.033e-01,4.424e-01,2.005e-01,1.033e-01,3.893e-01,5.548e-01,3.092e-02
KHK,6315,extracellular exosome,GO:0070062,cellular component,13.0,39.0,1.843e-01,1.474e-01,2.304e-01,1.367e-01,8.731e-02,2.141e-01,6.230e-01,1.715e-02
KHK,6315,cytoplasm,GO:0005737,cellular component,13.0,72.0,1.876e-01,1.361e-01,2.585e-01,1.415e-01,9.432e-02,2.123e-01,6.177e-01,1.575e-02
KHK,6315,ketohexokinase activity,GO:0004454,molecular function,13.0,3.0,6.883e-02,3.332e-02,1.422e-01,1.195e-02,1.635e-03,8.728e-02,8.859e-01,2.911e-02
KHK,6315,protein binding,GO:0005515,molecular function,13.0,318.0,1.854e-01,1.321e-01,2.603e-01,1.129e-01,7.009e-02,1.817e-01,6.529e-01,1.728e-02
KHK,6315,carbohydrate kinase activity,GO:0019200,molecular function,13.0,21.0,2.577e-01,2.780e-02,2.389e+00,1.645e-01,9.134e-03,2.961e+00,5.059e-01,1.721e-01
KIF26A,20226,,,,nan,nan,,,,,,,,
KIRREL3,23204,protein binding,GO:0005515,molecular function,3.0,318.0,5.272e-02,2.560e-02,1.086e-01,5.272e-02,2.560e-02,1.086e-01,7.526e-01,2.026e-02
KISS1R,4510,neuropeptide signaling pathway,GO:0007218,biological process,10.0,3.0,6.223e-02,5.499e-02,7.043e-02,2.130e-02,1.216e-02,3.731e-02,8.521e-01,1.369e-02
KISS1R,4510,integral component of plasma membrane,GO:0005887,cellular component,10.0,39.0,6.223e-02,5.499e-02,7.043e-02,1.394e-02,7.948e-03,2.445e-02,8.902e-01,1.106e-02
KISS1R,4510,integral component of membrane,GO:0016021,cellular component,10.0,19.0,6.223e-02,5.499e-02,7.043e-02,2.627e-02,1.337e-02,5.163e-02,8.302e-01,1.714e-02
KISS1R,4510,plasma membrane,GO:0005886,cellular component,10.0,67.0,6.223e-02,5.499e-02,7.043e-02,2.872e-02,1.965e-02,4.198e-02,8.211e-01,9.793e-03
KISS1R,4510,cilium,GO:0005929,cellular component,10.0,6.0,6.557e-02,5.059e-02,8.499e-02,3.909e-02,3.104e-02,4.924e-02,7.877e-01,6.160e-03
KISS1R,4510,intracellular membrane-bounded organelle,GO:0043231,cellular component,10.0,40.0,1.525e-01,9.473e-02,2.456e-01,1.466e-01,8.240e-02,2.610e-01,6.108e-01,2.337e-02
KISS1R,4510,G protein-coupled peptide receptor activity,GO:0008528,molecular function,10.0,28.0,7.365e-02,3.836e-02,1.414e-01,4.132e-02,1.439e-02,1.187e-01,7.796e-01,2.885e-02
KISS1R,4510,neuropeptide receptor activity,GO:0008188,molecular function,10.0,17.0,9.446e-02,5.720e-02,1.560e-01,7.347e-02,4.449e-02,1.213e-01,7.124e-01,1.519e-02
KISS1R,4510,protein binding,GO:0005515,molecular function,10.0,318.0,1.231e-01,1.147e-01,1.322e-01,1.138e-01,9.455e-02,1.371e-01,6.528e-01,6.781e-03
KLHDC8B,28557,,,,nan,nan,,,,,,,,
KLHDC9,28489,,,,nan,nan,,,,,,,,
KLHL2,6353,actin cytoskeleton,GO:0015629,cellular component,6.0,6.0,5.519e-02,5.049e-02,6.033e-02,3.078e-02,1.125e-02,8.418e-02,8.125e-01,2.569e-02
KLHL2,6353,actin binding,GO:0003779,molecular function,6.0,7.0,5.519e-02,5.049e-02,6.033e-02,2.361e-02,1.072e-02,5.201e-02,8.405e-01,1.893e-02
KLHL2,6353,identical protein binding,GO:0042802,molecular function,6.0,24.0,5.519e-02,5.049e-02,6.033e-02,3.639e-02,2.568e-02,5.157e-02,7.958e-01,9.256e-03
KLHL2,6353,protein binding,GO:0005515,molecular function,6.0,318.0,6.776e-02,5.134e-02,8.944e-02,6.776e-02,5.134e-02,8.944e-02,7.231e-01,8.195e-03
KLRC1,6374,receptor complex,GO:0043235,cellular component,8.0,30.0,1.271e-01,5.754e-02,2.808e-01,1.271e-01,5.754e-02,2.808e-01,6.324e-01,2.992e-02
KLRC1,6374,MHC class I protein complex binding,GO:0023024,molecular function,8.0,5.0,5.072e-02,4.240e-02,6.067e-02,1.691e-02,1.413e-02,2.022e-02,8.747e-01,3.841e-03
KLRC1,6374,protein binding,GO:0005515,molecular function,8.0,318.0,8.361e-02,7.912e-02,8.836e-02,5.709e-02,5.110e-02,6.378e-02,7.442e-01,3.203e-03
KLRC2,6375,natural killer cell mediated immunity,GO:0002228,biological process,12.0,7.0,7.417e-02,6.109e-02,9.004e-02,4.450e-02,3.666e-02,5.402e-02,7.731e-01,5.281e-03
KLRC2,6375,receptor complex,GO:0043235,cellular component,12.0,30.0,1.378e-01,8.333e-02,2.280e-01,1.378e-01,8.333e-02,2.280e-01,6.216e-01,1.955e-02
KLRC2,6375,protein antigen binding,GO:1990405,molecular function,12.0,4.0,2.430e-02,1.797e-02,3.288e-02,4.861e-03,3.594e-03,6.575e-03,9.456e-01,2.291e-03
KLRC2,6375,MHC class I protein complex binding,GO:0023024,molecular function,12.0,5.0,5.417e-02,4.490e-02,6.534e-02,2.167e-02,1.796e-02,2.614e-02,8.508e-01,4.569e-03
KLRC2,6375,protein binding,GO:0005515,molecular function,12.0,318.0,8.622e-02,7.188e-02,1.034e-01,6.898e-02,5.751e-02,8.273e-02,7.211e-01,5.520e-03
KLRD1,6378,natural killer cell mediated immunity,GO:0002228,biological process,12.0,7.0,5.283e-02,3.616e-02,7.717e-02,3.522e-02,2.411e-02,5.145e-02,7.992e-01,1.015e-02
KLRD1,6378,receptor complex,GO:0043235,cellular component,12.0,30.0,9.572e-02,6.272e-02,1.461e-01,9.527e-02,6.155e-02,1.474e-01,6.778e-01,1.463e-02
KLRD1,6378,protein antigen binding,GO:1990405,molecular function,12.0,4.0,1.241e-02,5.396e-03,2.852e-02,2.068e-03,8.994e-04,4.754e-03,9.683e-01,4.496e-03
KLRD1,6378,"MHC class Ib protein binding, via antigen binding groove",GO:0023030,molecular function,12.0,2.0,2.299e-02,8.745e-03,6.042e-02,8.547e-03,2.460e-03,2.970e-02,9.170e-01,1.573e-02
KLRD1,6378,MHC class I protein complex binding,GO:0023024,molecular function,12.0,5.0,3.634e-02,3.139e-02,4.208e-02,1.817e-02,1.569e-02,2.104e-02,8.681e-01,3.150e-03
KLRD1,6378,protein binding,GO:0005515,molecular function,12.0,318.0,8.771e-02,6.766e-02,1.137e-01,7.767e-02,6.736e-02,8.956e-02,7.060e-01,4.482e-03
KLRK1,18788,positive regulation of natural killer cell mediated cytotoxicity,GO:0045954,biological process,14.0,7.0,5.335e-02,2.500e-02,1.138e-01,9.311e-03,2.135e-03,4.060e-02,9.100e-01,1.893e-02
KLRK1,18788,negative regulation of natural killer cell chemotaxis,GO:2000502,biological process,14.0,3.0,8.197e-02,3.547e-02,1.895e-01,3.167e-02,1.150e-02,8.723e-02,8.095e-01,2.662e-02
KLRK1,18788,natural killer cell mediated cytotoxicity,GO:0042267,biological process,14.0,4.0,8.264e-02,3.636e-02,1.878e-01,3.272e-02,1.660e-02,6.451e-02,8.067e-01,1.742e-02
KLRK1,18788,negative regulation of GTPase activity,GO:0034260,biological process,14.0,5.0,1.403e-01,8.140e-02,2.417e-01,1.188e-01,5.149e-02,2.742e-01,6.428e-01,3.063e-02
KLRK1,18788,external side of plasma membrane,GO:0009897,cellular component,14.0,16.0,7.088e-02,4.213e-02,1.192e-01,1.945e-02,1.008e-02,3.754e-02,8.600e-01,1.474e-02
KLRK1,18788,cell surface,GO:0009986,cellular component,14.0,20.0,9.345e-02,4.324e-02,2.020e-01,6.453e-02,2.126e-02,1.959e-01,7.263e-01,3.200e-02
KLRK1,18788,plasma membrane,GO:0005886,cellular component,14.0,67.0,1.030e-01,7.234e-02,1.465e-01,6.731e-02,4.922e-02,9.206e-02,7.239e-01,9.369e-03
KLRK1,18788,signaling receptor activity,GO:0038023,molecular function,14.0,28.0,1.437e-01,8.185e-02,2.524e-01,1.341e-01,6.368e-02,2.826e-01,6.243e-01,2.767e-02
KLRK1,18788,protein binding,GO:0005515,molecular function,14.0,318.0,1.493e-01,1.046e-01,2.130e-01,1.341e-01,1.144e-01,1.571e-01,6.272e-01,6.252e-03
LAMA5,6485,substrate adhesion-dependent cell spreading,GO:0034446,biological process,17.0,3.0,1.386e-01,1.038e-01,1.851e-01,1.817e-02,1.370e-02,2.411e-02,8.677e-01,6.424e-03
LAMA5,6485,cell-cell adhesion,GO:0098609,biological process,17.0,26.0,1.717e-01,1.126e-01,2.618e-01,6.289e-02,4.152e-02,9.526e-02,7.320e-01,1.225e-02
LAMA5,6485,cell migration,GO:0016477,biological process,17.0,41.0,1.717e-01,1.126e-01,2.618e-01,6.910e-02,5.974e-02,7.993e-02,7.209e-01,4.434e-03
LAMA5,6485,animal organ morphogenesis,GO:0009887,biological process,17.0,29.0,1.717e-01,1.126e-01,2.618e-01,8.614e-02,3.967e-02,1.871e-01,6.900e-01,2.498e-02
LAMA5,6485,morphogenesis of a polarized epithelium,GO:0001738,biological process,17.0,2.0,1.736e-01,1.106e-01,2.725e-01,1.132e-01,5.435e-02,2.360e-01,6.508e-01,2.738e-02
LAMA5,6485,tissue development,GO:0009888,biological process,17.0,31.0,1.840e-01,1.388e-01,2.439e-01,1.742e-01,1.240e-01,2.447e-01,5.824e-01,1.457e-02
LAMA5,6485,integrin-mediated signaling pathway,GO:0007229,biological process,17.0,5.0,2.323e-01,1.563e-01,3.453e-01,2.266e-01,1.468e-01,3.499e-01,5.328e-01,2.102e-02
LAMA5,6485,basement membrane,GO:0005604,cellular component,17.0,2.0,1.386e-01,1.038e-01,1.851e-01,1.747e-02,1.172e-02,2.602e-02,8.711e-01,9.075e-03
LAMA5,6485,collagen-containing extracellular matrix,GO:0062023,cellular component,17.0,20.0,1.583e-01,1.156e-01,2.167e-01,3.899e-02,1.651e-02,9.209e-02,7.869e-01,2.346e-02
LAMA5,6485,extracellular exosome,GO:0070062,cellular component,17.0,39.0,1.717e-01,1.126e-01,2.618e-01,1.087e-01,6.165e-02,1.915e-01,6.581e-01,1.950e-02
LAMA5,6485,extracellular space,GO:0005615,cellular component,17.0,24.0,1.722e-01,1.127e-01,2.631e-01,1.221e-01,7.903e-02,1.885e-01,6.411e-01,1.623e-02
LAMA5,6485,laminin-10 complex,GO:0043259,cellular component,17.0,2.0,1.736e-01,1.106e-01,2.725e-01,1.397e-01,7.042e-02,2.770e-01,6.183e-01,2.803e-02
LAMA5,6485,laminin-5 complex,GO:0005610,cellular component,17.0,2.0,1.736e-01,1.106e-01,2.725e-01,1.432e-01,7.290e-02,2.814e-01,6.143e-01,2.792e-02
LAMA5,6485,nucleus,GO:0005634,cellular component,17.0,86.0,1.741e-01,1.108e-01,2.736e-01,1.496e-01,7.321e-02,3.056e-01,6.067e-01,2.784e-02
LAMA5,6485,integrin binding,GO:0005178,molecular function,17.0,11.0,1.705e-01,1.093e-01,2.659e-01,8.050e-02,1.985e-02,3.265e-01,6.949e-01,4.260e-02
LAT,18874,regulation of T cell activation,GO:0050863,biological process,40.0,14.0,7.622e-02,6.844e-02,8.488e-02,1.633e-02,6.246e-03,4.271e-02,8.735e-01,1.851e-02
LAT,18874,positive regulation of protein kinase activity,GO:0045860,biological process,40.0,11.0,7.937e-02,6.783e-02,9.288e-02,1.723e-02,5.763e-03,5.153e-02,8.691e-01,2.532e-02
LAT,18874,immune response,GO:0006955,biological process,40.0,17.0,7.937e-02,6.783e-02,9.288e-02,2.691e-02,2.051e-02,3.531e-02,8.284e-01,6.764e-03
LAT,18874,integrin-mediated signaling pathway,GO:0007229,biological process,40.0,5.0,7.937e-02,6.783e-02,9.288e-02,4.654e-02,2.861e-02,7.570e-02,7.677e-01,1.330e-02
LAT,18874,Ras protein signal transduction,GO:0007265,biological process,40.0,11.0,8.145e-02,6.472e-02,1.025e-01,5.497e-02,4.156e-02,7.271e-02,7.485e-01,7.981e-03
LAT,18874,calcium-mediated signaling,GO:0019722,biological process,40.0,15.0,8.496e-02,6.506e-02,1.109e-01,6.276e-02,3.538e-02,1.113e-01,7.320e-01,1.651e-02
LAT,18874,inflammatory response,GO:0006954,biological process,40.0,15.0,1.200e-01,9.550e-02,1.509e-01,1.135e-01,8.640e-02,1.491e-01,6.529e-01,1.006e-02
LAT,18874,intracellular signal transduction,GO:0035556,biological process,40.0,34.0,1.264e-01,1.005e-01,1.589e-01,1.205e-01,8.158e-02,1.779e-01,6.433e-01,1.417e-02
LAT,18874,plasma membrane,GO:0005886,cellular component,40.0,67.0,7.937e-02,6.783e-02,9.288e-02,3.875e-02,2.961e-02,5.070e-02,7.886e-01,7.263e-03
LAT,18874,integral component of membrane,GO:0016021,cellular component,40.0,19.0,7.937e-02,6.783e-02,9.288e-02,3.946e-02,2.379e-02,6.546e-02,7.863e-01,1.367e-02
LAT,18874,immunological synapse,GO:0001772,cellular component,40.0,3.0,7.937e-02,6.783e-02,9.288e-02,4.462e-02,2.111e-02,9.433e-02,7.720e-01,2.036e-02
LAT,18874,Golgi apparatus,GO:0005794,cellular component,40.0,16.0,9.782e-02,6.391e-02,1.497e-01,8.411e-02,4.073e-02,1.737e-01,6.933e-01,2.364e-02
LAT,18874,SH3/SH2 adaptor activity,GO:0005070,molecular function,40.0,3.0,7.622e-02,6.844e-02,8.488e-02,8.622e-03,6.577e-03,1.130e-02,9.223e-01,3.359e-03
LAT,18874,protein kinase binding,GO:0019901,molecular function,40.0,19.0,7.937e-02,6.783e-02,9.288e-02,3.786e-02,2.660e-02,5.389e-02,7.912e-01,9.497e-03
LAT,18874,protein binding,GO:0005515,molecular function,40.0,318.0,9.869e-02,8.139e-02,1.197e-01,8.043e-02,6.637e-02,9.747e-02,7.013e-01,6.038e-03
LBH,29532,,,,nan,nan,,,,,,,,
LDB2,6533,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,16.0,39.0,9.150e-02,6.721e-02,1.246e-01,6.130e-02,4.343e-02,8.651e-02,7.353e-01,9.986e-03
LDB2,6533,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,16.0,55.0,9.555e-02,6.505e-02,1.404e-01,7.627e-02,4.976e-02,1.169e-01,7.077e-01,1.351e-02
LDB2,6533,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,16.0,69.0,1.070e-01,5.558e-02,2.059e-01,1.000e-01,4.624e-02,2.163e-01,6.687e-01,2.728e-02
LDB2,6533,multicellular organism development,GO:0007275,biological process,16.0,18.0,1.324e-01,3.770e-02,4.648e-01,1.017e-01,1.915e-02,5.407e-01,6.550e-01,6.419e-02
LDB2,6533,nucleolus,GO:0005730,cellular component,16.0,5.0,9.150e-02,6.721e-02,1.246e-01,3.402e-02,3.170e-02,3.651e-02,8.031e-01,1.929e-03
LDB2,6533,nucleus,GO:0005634,cellular component,16.0,86.0,9.150e-02,6.721e-02,1.246e-01,5.457e-02,3.653e-02,8.153e-02,7.491e-01,1.147e-02
LDB2,6533,nucleoplasm,GO:0005654,cellular component,16.0,47.0,9.150e-02,6.721e-02,1.246e-01,5.764e-02,3.422e-02,9.710e-02,7.426e-01,1.478e-02
LDB2,6533,transcription factor complex,GO:0005667,cellular component,16.0,8.0,9.526e-02,6.898e-02,1.315e-01,6.507e-02,3.698e-02,1.145e-01,7.275e-01,1.718e-02
LDB2,6533,plasma membrane,GO:0005886,cellular component,16.0,67.0,9.709e-02,6.073e-02,1.552e-01,8.239e-02,4.387e-02,1.547e-01,6.967e-01,2.035e-02
LDB2,6533,RNA polymerase II activating transcription factor binding,GO:0001102,molecular function,16.0,5.0,9.150e-02,6.721e-02,1.246e-01,3.304e-02,3.240e-02,3.370e-02,8.063e-01,5.122e-04
LDB2,6533,LIM domain binding,GO:0030274,molecular function,16.0,2.0,9.150e-02,6.721e-02,1.246e-01,4.335e-02,2.199e-02,8.545e-02,7.755e-01,1.877e-02
LDB2,6533,protein binding,GO:0005515,molecular function,16.0,318.0,9.263e-02,6.546e-02,1.311e-01,6.992e-02,4.241e-02,1.153e-01,7.185e-01,1.488e-02
LGALS4,6565,collagen-containing extracellular matrix,GO:0062023,cellular component,2.0,20.0,3.986e-02,1.303e-02,1.219e-01,3.986e-02,1.303e-02,1.219e-01,7.835e-01,3.045e-02
LIME1,26016,regulation of MAP kinase activity,GO:0043405,biological process,14.0,9.0,6.000e-02,2.352e-02,1.531e-01,1.241e-02,3.932e-03,3.915e-02,8.936e-01,2.101e-02
LIME1,26016,regulation of phosphatidylinositol 3-kinase signaling,GO:0014066,biological process,14.0,4.0,1.077e-01,4.826e-02,2.405e-01,5.232e-02,1.917e-02,1.428e-01,7.522e-01,2.948e-02
LIME1,26016,regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043122,biological process,14.0,6.0,1.147e-01,4.965e-02,2.649e-01,6.609e-02,1.740e-02,2.511e-01,7.207e-01,4.151e-02
LIME1,26016,B cell receptor signaling pathway,GO:0050853,biological process,14.0,4.0,1.254e-01,7.615e-02,2.064e-01,7.356e-02,3.150e-02,1.718e-01,7.103e-01,2.729e-02
LIME1,26016,regulation of NIK/NF-kappaB signaling,GO:1901222,biological process,14.0,5.0,1.522e-01,8.018e-02,2.887e-01,1.199e-01,4.936e-02,2.914e-01,6.407e-01,3.354e-02
LIME1,26016,regulation of transcription by RNA polymerase II,GO:0006357,biological process,14.0,51.0,1.552e-01,1.359e-01,1.771e-01,1.192e-01,7.070e-02,2.010e-01,6.444e-01,1.953e-02
LIME1,26016,regulation of release of sequestered calcium ion into cytosol,GO:0051279,biological process,14.0,10.0,1.768e-01,1.024e-01,3.053e-01,1.664e-01,8.661e-02,3.196e-01,5.888e-01,2.816e-02
LIME1,26016,extracellular space,GO:0005615,cellular component,14.0,24.0,6.000e-02,2.352e-02,1.531e-01,1.378e-02,3.550e-03,5.349e-02,8.842e-01,2.702e-02
LIME1,26016,B cell receptor complex,GO:0019815,cellular component,14.0,8.0,1.686e-01,1.380e-01,2.060e-01,1.388e-01,8.190e-02,2.354e-01,6.204e-01,2.128e-02
LIME1,26016,protein kinase binding,GO:0019901,molecular function,14.0,19.0,4.214e-02,2.082e-02,8.528e-02,8.765e-03,1.300e-03,5.910e-02,9.095e-01,2.203e-02
LONRF1,26302,protein binding,GO:0005515,molecular function,3.0,318.0,2.891e-02,2.064e-02,4.050e-02,2.891e-02,2.064e-02,4.050e-02,8.205e-01,8.606e-03
LPAR6,15520,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway,GO:0051482,biological process,6.0,4.0,5.966e-02,3.917e-02,9.087e-02,1.316e-02,6.522e-03,2.656e-02,8.936e-01,1.321e-02
LPAR6,15520,positive regulation of Rho protein signal transduction,GO:0035025,biological process,6.0,6.0,8.337e-02,5.715e-02,1.216e-01,8.113e-02,5.194e-02,1.267e-01,6.996e-01,1.431e-02
LPAR6,15520,integral component of plasma membrane,GO:0005887,cellular component,6.0,39.0,8.029e-02,6.221e-02,1.036e-01,4.141e-02,2.474e-02,6.931e-02,7.809e-01,1.404e-02
LPAR6,15520,plasma membrane,GO:0005886,cellular component,6.0,67.0,8.337e-02,5.715e-02,1.216e-01,6.672e-02,5.878e-02,7.573e-02,7.253e-01,3.832e-03
LPAR6,15520,G protein-coupled receptor activity,GO:0004930,molecular function,6.0,47.0,8.337e-02,5.715e-02,1.216e-01,7.536e-02,4.863e-02,1.168e-01,7.092e-01,1.374e-02
LRIG1,17360,,,,nan,nan,,,,,,,,
LRRC29,13605,,,,nan,nan,,,,,,,,
LRRC3B,28105,,,,nan,nan,,,,,,,,
LRRC4,15586,,,,nan,nan,,,,,,,,
LST1,14189,dendrite development,GO:0016358,biological process,5.0,7.0,5.116e-01,3.544e-01,7.385e-01,4.127e-01,2.467e-01,6.905e-01,3.941e-01,3.325e-02
LST1,14189,negative regulation of lymphocyte proliferation,GO:0050672,biological process,5.0,8.0,5.293e-01,3.414e-01,8.208e-01,5.293e-01,3.414e-01,8.208e-01,3.193e-01,3.391e-02
LST1,14189,integral component of membrane,GO:0016021,cellular component,5.0,19.0,4.464e-01,3.164e-01,6.300e-01,1.994e-01,1.292e-01,3.077e-01,5.577e-01,1.972e-02
LST1,14189,cytoplasm,GO:0005737,cellular component,5.0,72.0,4.464e-01,3.164e-01,6.300e-01,2.197e-01,1.518e-01,3.178e-01,5.395e-01,1.748e-02
LY6H,6728,,,,nan,nan,,,,,,,,
MAPK12,6874,regulation of gene expression,GO:0010468,biological process,15.0,23.0,8.565e-02,4.901e-02,1.497e-01,2.366e-02,7.793e-03,7.181e-02,8.386e-01,2.579e-02
MAPK12,6874,myoblast differentiation,GO:0045445,biological process,15.0,4.0,1.021e-01,9.671e-02,1.079e-01,6.110e-02,3.218e-02,1.160e-01,7.349e-01,1.926e-02
MAPK12,6874,peptidyl-serine phosphorylation,GO:0018105,biological process,15.0,13.0,1.022e-01,8.859e-02,1.179e-01,5.493e-02,1.655e-02,1.823e-01,7.450e-01,3.617e-02
MAPK12,6874,intracellular signal transduction,GO:0035556,biological process,15.0,34.0,1.207e-01,7.989e-02,1.824e-01,1.103e-01,6.270e-02,1.939e-01,6.557e-01,2.091e-02
MAPK12,6874,nucleus,GO:0005634,cellular component,15.0,86.0,1.003e-01,9.259e-02,1.086e-01,4.331e-02,3.566e-02,5.261e-02,7.762e-01,5.217e-03
MAPK12,6874,cytoplasm,GO:0005737,cellular component,15.0,72.0,1.025e-01,9.812e-02,1.071e-01,5.611e-02,4.267e-02,7.378e-02,7.462e-01,7.822e-03
MAPK12,6874,MAP kinase activity,GO:0004707,molecular function,15.0,3.0,8.140e-02,3.925e-02,1.688e-01,1.144e-02,3.048e-03,4.291e-02,8.981e-01,1.908e-02
MAPK12,6874,protein binding,GO:0005515,molecular function,15.0,318.0,1.051e-01,9.780e-02,1.129e-01,6.867e-02,4.436e-02,1.063e-01,7.211e-01,1.301e-02
MAPK12,6874,magnesium ion binding,GO:0000287,molecular function,15.0,2.0,1.051e-01,9.780e-02,1.129e-01,8.356e-02,6.247e-02,1.118e-01,6.961e-01,9.354e-03
MAPK12,6874,protein serine/threonine kinase activity,GO:0004674,molecular function,15.0,28.0,1.114e-01,9.613e-02,1.291e-01,1.003e-01,7.070e-02,1.423e-01,6.708e-01,1.203e-02
MARCKS,6759,extracellular exosome,GO:0070062,cellular component,3.0,39.0,6.315e-02,2.748e-02,1.451e-01,5.585e-02,2.825e-02,1.104e-01,7.457e-01,1.996e-02
MARCKS,6759,focal adhesion,GO:0005925,cellular component,3.0,7.0,6.315e-02,2.748e-02,1.451e-01,5.827e-02,2.008e-02,1.691e-01,7.390e-01,3.104e-02
MC3R,6931,adenylate cyclase-activating G protein-coupled receptor signaling pathway,GO:0007189,biological process,5.0,15.0,1.113e-01,4.678e-02,2.650e-01,3.318e-02,1.743e-02,6.317e-02,8.053e-01,1.690e-02
MC3R,6931,neuropeptide binding,GO:0042923,molecular function,5.0,3.0,1.158e-01,5.008e-02,2.678e-01,6.045e-02,2.917e-02,1.253e-01,7.358e-01,2.177e-02
MC3R,6931,melanocyte-stimulating hormone receptor activity,GO:0004980,molecular function,5.0,2.0,1.255e-01,5.209e-02,3.024e-01,9.881e-02,3.568e-02,2.736e-01,6.686e-01,3.516e-02
MC3R,6931,protein binding,GO:0005515,molecular function,5.0,318.0,1.752e-01,1.485e-01,2.066e-01,1.752e-01,1.485e-01,2.066e-01,5.822e-01,7.097e-03
MEGF10,29634,positive regulation of cell-cell adhesion,GO:0022409,biological process,16.0,14.0,1.625e-01,3.604e-02,7.326e-01,3.241e-02,9.753e-04,1.077e+00,7.721e-01,7.969e-02
MEGF10,29634,apoptotic cell clearance,GO:0043277,biological process,16.0,2.0,1.656e-01,3.914e-02,7.007e-01,3.217e-02,7.332e-03,1.411e-01,8.055e-01,3.871e-02
MEGF10,29634,homotypic cell-cell adhesion,GO:0034109,biological process,16.0,6.0,1.656e-01,3.914e-02,7.007e-01,5.513e-02,2.750e-02,1.105e-01,7.473e-01,1.992e-02
MEGF10,29634,muscle cell development,GO:0055001,biological process,16.0,4.0,1.656e-01,3.914e-02,7.007e-01,5.282e-02,8.737e-03,3.194e-01,7.468e-01,5.019e-02
MEGF10,29634,myoblast migration,GO:0051451,biological process,16.0,3.0,1.656e-01,3.914e-02,7.007e-01,9.317e-02,2.412e-02,3.598e-01,6.744e-01,4.360e-02
MEGF10,29634,positive regulation of myoblast proliferation,GO:2000288,biological process,16.0,4.0,1.848e-01,3.349e-02,1.020e+00,1.067e-01,6.812e-03,1.673e+00,6.319e-01,9.334e-02
MEGF10,29634,regulation of skeletal muscle tissue development,GO:0048641,biological process,16.0,9.0,1.875e-01,3.635e-02,9.669e-01,1.195e-01,1.289e-02,1.108e+00,6.239e-01,7.570e-02
MEGF10,29634,regulation of muscle cell differentiation,GO:0051147,biological process,16.0,6.0,1.882e-01,3.251e-02,1.090e+00,1.113e-01,8.069e-03,1.536e+00,6.239e-01,9.810e-02
MEGF10,29634,skeletal muscle satellite cell differentiation,GO:0014816,biological process,16.0,2.0,2.193e-01,4.222e-02,1.139e+00,1.904e-01,4.273e-02,8.483e-01,5.541e-01,6.110e-02
MEGF10,29634,muscle cell proliferation,GO:0033002,biological process,16.0,4.0,2.399e-01,4.026e-02,1.429e+00,2.295e-01,4.157e-02,1.267e+00,5.121e-01,7.505e-02
MEGF10,29634,phagocytic cup,GO:0001891,cellular component,16.0,3.0,1.719e-01,4.601e-02,6.423e-01,1.097e-01,4.102e-02,2.935e-01,6.535e-01,3.365e-02
MEGF10,29634,plasma membrane,GO:0005886,cellular component,16.0,67.0,1.719e-01,4.601e-02,6.423e-01,1.190e-01,4.588e-02,3.084e-01,6.414e-01,3.336e-02
MEGF10,29634,Notch binding,GO:0005112,molecular function,16.0,3.0,1.719e-01,4.601e-02,6.423e-01,1.106e-01,3.625e-02,3.376e-01,6.510e-01,3.822e-02
MEGF10,29634,complement component C1q complex binding,GO:0001849,molecular function,16.0,5.0,1.719e-01,4.601e-02,6.423e-01,1.153e-01,4.793e-02,2.776e-01,6.469e-01,3.081e-02
MEGF10,29634,scavenger receptor activity,GO:0005044,molecular function,16.0,3.0,1.916e-01,3.155e-02,1.164e+00,1.500e-01,1.496e-02,1.504e+00,5.785e-01,9.420e-02
MEOX2,7014,negative regulation of cell migration involved in sprouting angiogenesis,GO:0090051,biological process,16.0,4.0,5.886e-02,3.748e-02,9.244e-02,2.315e-02,1.379e-02,3.886e-02,8.439e-01,1.305e-02
MEOX2,7014,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,16.0,69.0,6.246e-02,4.493e-02,8.683e-02,4.706e-02,4.170e-02,5.312e-02,7.668e-01,3.345e-03
MEOX2,7014,somite development,GO:0061053,biological process,16.0,2.0,9.710e-02,6.263e-02,1.506e-01,9.710e-02,6.263e-02,1.506e-01,6.751e-01,1.458e-02
MEOX2,7014,nucleus,GO:0005634,cellular component,16.0,86.0,5.886e-02,3.748e-02,9.244e-02,2.489e-02,8.693e-03,7.125e-02,8.339e-01,2.495e-02
MEOX2,7014,cytoplasm,GO:0005737,cellular component,16.0,72.0,5.886e-02,3.748e-02,9.244e-02,2.938e-02,9.148e-03,9.435e-02,8.165e-01,2.890e-02
MEOX2,7014,"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,molecular function,16.0,11.0,5.886e-02,3.748e-02,9.244e-02,2.843e-02,1.952e-02,4.140e-02,8.223e-01,9.684e-03
MEOX2,7014,protein binding,GO:0005515,molecular function,16.0,318.0,5.886e-02,3.748e-02,9.244e-02,3.256e-02,8.004e-03,1.325e-01,8.045e-01,3.586e-02
MEOX2,7014,sequence-specific DNA binding,GO:0043565,molecular function,16.0,14.0,6.246e-02,4.493e-02,8.683e-02,3.356e-02,1.851e-02,6.084e-02,8.041e-01,1.554e-02
MEOX2,7014,DNA-binding transcription factor activity,GO:0003700,molecular function,16.0,17.0,6.246e-02,4.493e-02,8.683e-02,4.415e-02,2.608e-02,7.472e-02,7.737e-01,1.428e-02
MEOX2,7014,RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,molecular function,16.0,30.0,6.445e-02,4.767e-02,8.714e-02,5.877e-02,3.716e-02,9.295e-02,7.403e-01,1.343e-02
MEPCE,20247,snRNA metabolic process,GO:0016073,biological process,10.0,5.0,1.868e-01,1.247e-01,2.797e-01,7.382e-02,3.805e-02,1.432e-01,7.110e-01,2.026e-02
MEPCE,20247,snRNA modification,GO:0040031,biological process,10.0,6.0,2.005e-01,1.440e-01,2.791e-01,9.027e-02,6.619e-02,1.231e-01,6.856e-01,1.031e-02
MEPCE,20247,RNA methylation,GO:0001510,biological process,10.0,11.0,2.908e-01,1.741e-01,4.857e-01,2.348e-01,1.804e-01,3.058e-01,5.270e-01,1.228e-02
MEPCE,20247,snRNA binding,GO:0017069,molecular function,10.0,15.0,1.413e-01,5.352e-02,3.729e-01,2.443e-02,1.195e-02,4.993e-02,8.374e-01,1.713e-02
MEPCE,20247,RNA binding,GO:0003723,molecular function,10.0,44.0,1.413e-01,5.352e-02,3.729e-01,2.868e-02,6.498e-03,1.266e-01,8.170e-01,3.688e-02
MEPCE,20247,protein binding,GO:0005515,molecular function,10.0,318.0,1.753e-01,5.130e-02,5.991e-01,8.366e-02,7.525e-03,9.302e-01,6.767e-01,7.651e-02
MEPCE,20247,RNA methyltransferase activity,GO:0008173,molecular function,10.0,10.0,3.195e-01,1.419e-01,7.195e-01,2.608e-01,1.207e-01,5.635e-01,5.011e-01,3.969e-02
MEPCE,20247,O-methyltransferase activity,GO:0008171,molecular function,10.0,31.0,3.202e-01,1.412e-01,7.261e-01,2.765e-01,1.165e-01,6.565e-01,4.863e-01,4.745e-02
MEPCE,20247,S-adenosylmethionine-dependent methyltransferase activity,GO:0008757,molecular function,10.0,134.0,4.072e-01,2.400e-01,6.907e-01,4.072e-01,2.400e-01,6.907e-01,3.969e-01,3.624e-02
MFSD2B,37207,,,,nan,nan,,,,,,,,
MKRN3,7114,identical protein binding,GO:0042802,molecular function,10.0,24.0,2.185e-04,5.183e-05,9.214e-04,1.093e-04,2.591e-05,4.607e-04,9.917e-01,9.225e-04
MKRN3,7114,protein binding,GO:0005515,molecular function,10.0,318.0,1.830e-03,2.901e-04,1.154e-02,1.830e-03,2.901e-04,1.154e-02,9.673e-01,9.443e-03
MMP11,7157,,,,nan,nan,,,,,,,,
MOV10,7200,gene silencing by miRNA,GO:0035195,biological process,27.0,2.0,2.021e-02,1.217e-02,3.356e-02,2.848e-03,1.543e-03,5.256e-03,9.609e-01,3.774e-03
MOV10,7200,defense response to virus,GO:0051607,biological process,27.0,11.0,2.021e-02,1.217e-02,3.356e-02,8.374e-03,3.487e-03,2.011e-02,9.207e-01,1.187e-02
MOV10,7200,posttranscriptional gene silencing by RNA,GO:0035194,biological process,27.0,5.0,2.112e-02,1.106e-02,4.033e-02,1.131e-02,4.884e-03,2.620e-02,9.031e-01,1.491e-02
MOV10,7200,"negative regulation of transposition, RNA-mediated",GO:0010526,biological process,27.0,3.0,2.113e-02,1.106e-02,4.034e-02,1.357e-02,9.660e-03,1.906e-02,8.932e-01,6.185e-03
MOV10,7200,3'-UTR-mediated mRNA destabilization,GO:0061158,biological process,27.0,2.0,2.189e-02,1.019e-02,4.702e-02,1.367e-02,3.146e-03,5.940e-02,8.832e-01,2.787e-02
MOV10,7200,mRNA cleavage involved in gene silencing by miRNA,GO:0035279,biological process,27.0,2.0,2.189e-02,1.019e-02,4.702e-02,1.517e-02,5.119e-03,4.494e-02,8.798e-01,2.371e-02
MOV10,7200,positive regulation of mRNA catabolic process,GO:0061014,biological process,27.0,12.0,2.729e-02,9.574e-03,7.781e-02,2.555e-02,8.207e-03,7.954e-02,8.316e-01,2.882e-02
MOV10,7200,P-body,GO:0000932,cellular component,27.0,3.0,2.021e-02,1.217e-02,3.356e-02,6.557e-03,3.185e-03,1.350e-02,9.337e-01,6.512e-03
MOV10,7200,P granule,GO:0043186,cellular component,27.0,4.0,2.112e-02,1.106e-02,4.033e-02,1.076e-02,3.364e-03,3.439e-02,9.032e-01,1.998e-02
MOV10,7200,viral replication complex,GO:0019034,cellular component,27.0,2.0,2.112e-02,1.106e-02,4.033e-02,1.196e-02,6.205e-03,2.306e-02,9.007e-01,1.206e-02
MOV10,7200,cytosol,GO:0005829,cellular component,27.0,50.0,2.144e-02,1.279e-02,3.593e-02,1.062e-02,4.041e-03,2.790e-02,9.062e-01,1.656e-02
MOV10,7200,cytoplasmic ribonucleoprotein granule,GO:0036464,cellular component,27.0,11.0,2.189e-02,1.019e-02,4.702e-02,1.505e-02,5.542e-03,4.089e-02,8.808e-01,2.113e-02
MOV10,7200,extracellular space,GO:0005615,cellular component,27.0,24.0,2.695e-02,2.038e-02,3.564e-02,2.312e-02,1.601e-02,3.338e-02,8.440e-01,9.150e-03
MOV10,7200,RNA binding,GO:0003723,molecular function,27.0,44.0,2.021e-02,1.217e-02,3.356e-02,8.566e-03,4.518e-03,1.624e-02,9.214e-01,7.608e-03
MOV10,7200,5'-3' RNA helicase activity,GO:0032574,molecular function,27.0,2.0,2.281e-02,9.261e-03,5.619e-02,1.754e-02,5.089e-03,6.047e-02,8.665e-01,2.863e-02
MOV10,7200,protein binding,GO:0005515,molecular function,27.0,318.0,2.289e-02,1.247e-02,4.204e-02,1.468e-02,5.593e-03,3.856e-02,8.831e-01,2.068e-02
MPP4,13680,,,,nan,nan,,,,,,,,
MRGBP,15866,regulation of transcription by RNA polymerase II,GO:0006357,biological process,6.0,51.0,1.859e-01,6.513e-02,5.308e-01,1.158e-01,3.703e-02,3.621e-01,6.438e-01,4.040e-02
MRGBP,15866,histone acetylation,GO:0016573,biological process,6.0,7.0,4.129e-01,1.833e-01,9.301e-01,3.558e-01,1.242e-01,1.019e+00,4.189e-01,6.986e-02
MRGBP,15866,nucleoplasm,GO:0005654,cellular component,6.0,47.0,1.087e-01,7.346e-02,1.607e-01,3.025e-02,2.698e-02,3.391e-02,8.161e-01,3.034e-03
MRGBP,15866,NuA4 histone acetyltransferase complex,GO:0035267,cellular component,6.0,3.0,4.468e-01,2.360e-01,8.458e-01,4.285e-01,2.600e-01,7.062e-01,3.832e-01,3.527e-02
MRGBP,15866,protein binding,GO:0005515,molecular function,6.0,318.0,1.087e-01,7.346e-02,1.607e-01,4.346e-02,2.938e-02,6.429e-02,7.757e-01,1.075e-02
MX2,7533,defense response to virus,GO:0051607,biological process,33.0,11.0,3.962e-01,1.616e-01,9.709e-01,8.647e-02,4.038e-02,1.852e-01,6.896e-01,2.445e-02
MX2,7533,organelle fission,GO:0048285,biological process,33.0,7.0,3.962e-01,1.616e-01,9.709e-01,1.212e-01,4.551e-02,3.226e-01,6.383e-01,3.666e-02
MX2,7533,response to interferon-alpha,GO:0035455,biological process,33.0,3.0,3.962e-01,1.616e-01,9.709e-01,1.205e-01,2.919e-02,4.978e-01,6.341e-01,5.191e-02
MX2,7533,mitochondrial fission,GO:0000266,biological process,33.0,3.0,3.986e-01,1.595e-01,9.965e-01,1.500e-01,1.487e-02,1.513e+00,5.718e-01,1.091e-01
MX2,7533,synaptic vesicle budding from presynaptic endocytic zone membrane,GO:0016185,biological process,33.0,2.0,4.018e-01,1.701e-01,9.489e-01,2.656e-01,9.035e-02,7.806e-01,4.914e-01,5.746e-02
MX2,7533,response to virus,GO:0009615,biological process,33.0,10.0,4.238e-01,2.040e-01,8.804e-01,2.701e-01,2.514e-01,2.902e-01,4.989e-01,3.634e-03
MX2,7533,regulation of cell cycle,GO:0051726,biological process,33.0,11.0,4.238e-01,2.040e-01,8.804e-01,2.919e-01,2.500e-01,3.407e-01,4.821e-01,8.039e-03
MX2,7533,membrane fusion,GO:0061025,biological process,33.0,6.0,4.238e-01,2.040e-01,8.804e-01,2.924e-01,1.495e-01,5.719e-01,4.770e-01,3.739e-02
MX2,7533,postsynaptic neurotransmitter receptor internalization,GO:0098884,biological process,33.0,4.0,4.238e-01,2.040e-01,8.804e-01,3.244e-01,1.339e-01,7.860e-01,4.491e-01,5.130e-02
MX2,7533,regulation of synapse structure or activity,GO:0050803,biological process,33.0,2.0,4.284e-01,2.110e-01,8.695e-01,3.075e-01,1.566e-01,6.036e-01,4.655e-01,3.802e-02
MX2,7533,regulation of nucleocytoplasmic transport,GO:0046822,biological process,33.0,8.0,4.842e-01,2.326e-01,1.008e+00,4.403e-01,1.891e-01,1.025e+00,3.650e-01,6.353e-02
MX2,7533,receptor internalization,GO:0031623,biological process,33.0,11.0,5.543e-01,1.547e-01,1.986e+00,3.921e-01,3.387e-02,4.541e+00,3.217e-01,1.479e-01
MX2,7533,postsynaptic density,GO:0014069,cellular component,33.0,4.0,3.962e-01,1.616e-01,9.709e-01,7.778e-02,7.631e-03,7.928e-01,6.867e-01,7.682e-02
MX2,7533,dendritic spine,GO:0043197,cellular component,33.0,4.0,3.962e-01,1.616e-01,9.709e-01,9.600e-02,1.729e-02,5.331e-01,6.636e-01,6.326e-02
MX2,7533,microtubule cytoskeleton,GO:0015630,cellular component,33.0,6.0,3.962e-01,1.616e-01,9.709e-01,1.065e-01,1.277e-02,8.878e-01,6.386e-01,8.609e-02
MX2,7533,synapse,GO:0045202,cellular component,33.0,20.0,3.962e-01,1.616e-01,9.709e-01,1.202e-01,8.743e-03,1.653e+00,6.068e-01,1.084e-01
MX2,7533,plasma membrane,GO:0005886,cellular component,33.0,67.0,3.964e-01,1.619e-01,9.701e-01,1.576e-01,8.956e-02,2.775e-01,5.990e-01,2.275e-02
MX2,7533,nucleus,GO:0005634,cellular component,33.0,86.0,3.964e-01,1.619e-01,9.701e-01,2.314e-01,7.542e-02,7.099e-01,5.213e-01,5.291e-02
MX2,7533,membrane,GO:0016020,cellular component,33.0,41.0,4.018e-01,1.701e-01,9.489e-01,2.023e-01,9.953e-02,4.112e-01,5.527e-01,3.308e-02
MX2,7533,cytoplasm,GO:0005737,cellular component,33.0,72.0,4.018e-01,1.701e-01,9.489e-01,2.216e-01,1.061e-01,4.628e-01,5.348e-01,3.493e-02
MX2,7533,cytoplasmic vesicle,GO:0031410,cellular component,33.0,29.0,4.024e-01,1.562e-01,1.037e+00,2.118e-01,3.236e-02,1.387e+00,5.167e-01,9.802e-02
MX2,7533,dendritic spine head,GO:0044327,cellular component,33.0,2.0,4.090e-01,1.812e-01,9.234e-01,2.972e-01,1.025e-01,8.616e-01,4.659e-01,6.010e-02
MX2,7533,postsynaptic endocytic zone membrane,GO:0098844,cellular component,33.0,2.0,4.238e-01,2.040e-01,8.804e-01,2.135e-01,1.261e-01,3.615e-01,5.441e-01,2.378e-02
MX2,7533,axon,GO:0030424,cellular component,33.0,12.0,4.554e-01,2.504e-01,8.281e-01,3.954e-01,2.486e-01,6.289e-01,4.061e-01,3.089e-02
MX2,7533,postsynaptic membrane,GO:0045211,cellular component,33.0,3.0,4.615e-01,2.567e-01,8.297e-01,3.007e-01,1.927e-01,4.691e-01,4.736e-01,2.457e-02
MX2,7533,mitochondrial membrane,GO:0031966,cellular component,33.0,4.0,5.135e-01,2.230e-01,1.182e+00,4.558e-01,1.780e-01,1.167e+00,3.540e-01,6.337e-02
MX2,7533,nuclear pore,GO:0005643,cellular component,33.0,2.0,6.425e-01,3.884e-01,1.063e+00,6.287e-01,3.944e-01,1.002e+00,2.542e-01,4.195e-02
MX2,7533,microtubule binding,GO:0008017,molecular function,33.0,8.0,3.962e-01,1.616e-01,9.709e-01,1.686e-01,5.611e-02,5.068e-01,5.821e-01,4.470e-02
MX2,7533,GTPase activity,GO:0003924,molecular function,33.0,6.0,3.964e-01,1.619e-01,9.701e-01,1.017e-01,5.872e-02,1.762e-01,6.680e-01,1.833e-02
MX2,7533,GTP binding,GO:0005525,molecular function,33.0,6.0,3.964e-01,1.619e-01,9.701e-01,1.568e-01,7.959e-02,3.091e-01,5.989e-01,2.889e-02
MX2,7533,protein binding,GO:0005515,molecular function,33.0,318.0,4.238e-01,2.040e-01,8.804e-01,3.133e-01,1.804e-01,5.441e-01,4.632e-01,3.043e-02
MYCT1,23172,nucleoplasm,GO:0005654,cellular component,3.0,47.0,3.495e-02,2.941e-02,4.154e-02,3.177e-02,2.730e-02,3.697e-02,8.107e-01,4.049e-03
MYCT1,23172,intracellular membrane-bounded organelle,GO:0043231,cellular component,3.0,40.0,3.495e-02,2.941e-02,4.154e-02,3.480e-02,2.919e-02,4.149e-02,8.006e-01,4.678e-03
N4BP2L1,25037,,,,nan,nan,,,,,,,,
NCR1,6731,protein binding,GO:0005515,molecular function,4.0,318.0,7.144e-03,5.012e-03,1.018e-02,7.144e-03,5.012e-03,1.018e-02,9.309e-01,3.853e-03
NDRG1,7679,"DNA damage response, signal transduction by p53 class mediator",GO:0030330,biological process,20.0,5.0,2.300e-01,1.842e-01,2.872e-01,1.261e-01,7.024e-02,2.265e-01,6.351e-01,2.146e-02
NDRG1,7679,cellular response to hypoxia,GO:0071456,biological process,20.0,5.0,3.032e-01,1.640e-01,5.604e-01,2.821e-01,1.447e-01,5.498e-01,4.854e-01,3.489e-02
NDRG1,7679,signal transduction,GO:0007165,biological process,20.0,48.0,4.296e-01,1.117e-01,1.652e+00,4.067e-01,9.029e-02,1.832e+00,3.526e-01,1.155e-01
NDRG1,7679,adherens junction,GO:0005912,cellular component,20.0,7.0,2.300e-01,1.842e-01,2.872e-01,6.510e-02,3.060e-02,1.385e-01,7.266e-01,2.322e-02
NDRG1,7679,microtubule cytoskeleton,GO:0015630,cellular component,20.0,6.0,2.300e-01,1.842e-01,2.872e-01,7.907e-02,2.059e-02,3.036e-01,6.961e-01,4.611e-02
NDRG1,7679,extracellular exosome,GO:0070062,cellular component,20.0,39.0,2.300e-01,1.842e-01,2.872e-01,1.168e-01,7.475e-02,1.825e-01,6.477e-01,1.671e-02
NDRG1,7679,centrosome,GO:0005813,cellular component,20.0,11.0,2.300e-01,1.842e-01,2.872e-01,1.298e-01,9.318e-02,1.809e-01,6.320e-01,1.295e-02
NDRG1,7679,microtubule,GO:0005874,cellular component,20.0,9.0,2.300e-01,1.842e-01,2.872e-01,1.415e-01,1.061e-01,1.887e-01,6.182e-01,1.132e-02
NDRG1,7679,plasma membrane,GO:0005886,cellular component,20.0,67.0,2.300e-01,1.842e-01,2.872e-01,1.443e-01,9.869e-02,2.109e-01,6.147e-01,1.485e-02
NDRG1,7679,cytosol,GO:0005829,cellular component,20.0,50.0,2.300e-01,1.842e-01,2.872e-01,1.591e-01,1.297e-01,1.950e-01,5.988e-01,8.341e-03
NDRG1,7679,cytoplasm,GO:0005737,cellular component,20.0,72.0,2.300e-01,1.842e-01,2.872e-01,1.662e-01,1.500e-01,1.841e-01,5.915e-01,4.250e-03
NDRG1,7679,perinuclear region of cytoplasm,GO:0048471,cellular component,20.0,8.0,2.320e-01,1.806e-01,2.982e-01,1.868e-01,1.208e-01,2.888e-01,5.696e-01,1.935e-02
NDRG1,7679,nucleus,GO:0005634,cellular component,20.0,86.0,2.329e-01,1.828e-01,2.967e-01,1.940e-01,1.683e-01,2.236e-01,5.637e-01,6.325e-03
NDRG1,7679,recycling endosome membrane,GO:0055038,cellular component,20.0,2.0,2.494e-01,1.855e-01,3.354e-01,2.132e-01,1.291e-01,3.522e-01,5.445e-01,2.315e-02
NDRG1,7679,Rab GTPase binding,GO:0017137,molecular function,20.0,3.0,2.300e-01,1.842e-01,2.872e-01,5.290e-02,3.611e-02,7.749e-02,7.529e-01,1.076e-02
NDRG1,7679,cadherin binding,GO:0045296,molecular function,20.0,9.0,2.300e-01,1.842e-01,2.872e-01,6.704e-02,5.561e-02,8.082e-02,7.245e-01,5.575e-03
NDRG1,7679,gamma-tubulin binding,GO:0043015,molecular function,20.0,2.0,2.300e-01,1.842e-01,2.872e-01,7.319e-02,6.674e-02,8.026e-02,7.136e-01,2.849e-03
NDRG1,7679,microtubule binding,GO:0008017,molecular function,20.0,8.0,2.300e-01,1.842e-01,2.872e-01,1.119e-01,9.739e-02,1.286e-01,6.554e-01,5.001e-03
NDRG1,7679,protein binding,GO:0005515,molecular function,20.0,318.0,2.360e-01,1.903e-01,2.928e-01,2.152e-01,1.773e-01,2.613e-01,5.441e-01,8.951e-03
NEIL2,18956,base-excision repair,GO:0006284,biological process,7.0,5.0,1.302e-01,6.670e-02,2.543e-01,3.913e-02,1.492e-02,1.026e-01,7.864e-01,2.545e-02
NEIL2,18956,nucleoplasm,GO:0005654,cellular component,7.0,47.0,1.302e-01,6.670e-02,2.543e-01,7.072e-02,4.585e-02,1.091e-01,7.174e-01,1.342e-02
NEIL2,18956,intracellular membrane-bounded organelle,GO:0043231,cellular component,7.0,40.0,1.316e-01,6.745e-02,2.567e-01,8.575e-02,4.694e-02,1.566e-01,6.916e-01,1.941e-02
NEIL2,18956,protein binding,GO:0005515,molecular function,7.0,318.0,1.376e-01,8.158e-02,2.321e-01,8.476e-02,3.701e-02,1.941e-01,6.918e-01,2.638e-02
NEIL2,18956,DNA-(apurinic or apyrimidinic site) endonuclease activity,GO:0003906,molecular function,7.0,6.0,1.568e-01,6.365e-02,3.865e-01,1.182e-01,3.437e-02,4.066e-01,6.394e-01,4.309e-02
NEIL2,18956,DNA N-glycosylase activity,GO:0019104,molecular function,7.0,8.0,3.312e-01,2.031e-01,5.401e-01,3.312e-01,2.031e-01,5.401e-01,4.506e-01,2.889e-02
NEMP2,33700,,,,nan,nan,,,,,,,,
NES,7756,negative regulation of protein binding,GO:0032091,biological process,10.0,14.0,2.551e-01,2.284e-01,2.848e-01,3.815e-02,3.147e-02,4.623e-02,7.905e-01,5.111e-03
NES,7756,G2/M transition of mitotic cell cycle,GO:0000086,biological process,10.0,4.0,4.560e-01,3.536e-01,5.882e-01,3.327e-01,1.797e-01,6.161e-01,4.483e-01,3.361e-02
NES,7756,negative regulation of catalytic activity,GO:0043086,biological process,10.0,12.0,4.592e-01,3.622e-01,5.821e-01,3.884e-01,2.313e-01,6.523e-01,4.101e-01,3.427e-02
NES,7756,stem cell proliferation,GO:0072089,biological process,10.0,5.0,4.672e-01,3.709e-01,5.883e-01,4.358e-01,3.520e-01,5.394e-01,3.827e-01,1.406e-02
NES,7756,cytoplasm,GO:0005737,cellular component,10.0,72.0,2.755e-01,2.366e-01,3.208e-01,1.185e-01,9.098e-02,1.542e-01,6.465e-01,9.574e-03
NES,7756,intermediate filament cytoskeleton,GO:0045111,cellular component,10.0,5.0,3.065e-01,1.833e-01,5.125e-01,1.806e-01,4.082e-02,7.991e-01,5.616e-01,6.940e-02
NES,7756,protein binding,GO:0005515,molecular function,10.0,318.0,2.755e-01,2.366e-01,3.208e-01,1.392e-01,1.203e-01,1.611e-01,6.210e-01,5.847e-03
NET1,14592,positive regulation of Rho protein signal transduction,GO:0035025,biological process,8.0,6.0,3.494e-01,1.086e-01,1.124e+00,1.692e-01,3.863e-02,7.412e-01,5.746e-01,6.473e-02
NET1,14592,positive regulation of GTPase activity,GO:0043547,biological process,8.0,6.0,3.494e-01,1.086e-01,1.124e+00,1.760e-01,2.582e-02,1.199e+00,5.583e-01,8.240e-02
NET1,14592,cellular response to hydrogen peroxide,GO:0070301,biological process,8.0,7.0,3.774e-01,1.333e-01,1.068e+00,3.142e-01,6.225e-02,1.586e+00,4.371e-01,8.925e-02
NET1,14592,cellular response to ionizing radiation,GO:0071479,biological process,8.0,5.0,3.972e-01,1.633e-01,9.664e-01,3.494e-01,1.508e-01,8.096e-01,4.321e-01,4.820e-02
NET1,14592,positive regulation of apoptotic process,GO:0043065,biological process,8.0,28.0,4.297e-01,2.180e-01,8.469e-01,4.161e-01,2.100e-01,8.246e-01,3.870e-01,4.899e-02
NET1,14592,Rho guanyl-nucleotide exchange factor activity,GO:0005089,molecular function,8.0,5.0,3.391e-01,9.640e-02,1.193e+00,9.785e-02,8.020e-03,1.194e+00,6.493e-01,8.711e-02
NET1,14592,protein binding,GO:0005515,molecular function,8.0,318.0,3.651e-01,1.290e-01,1.034e+00,1.689e-01,9.574e-02,2.981e-01,5.867e-01,2.440e-02
NEURL1B,35422,ubiquitin-dependent endocytosis,GO:0070086,biological process,5.0,4.0,5.346e-02,1.618e-02,1.767e-01,2.390e-02,6.075e-03,9.403e-02,8.355e-01,3.090e-02
NEURL1B,35422,early endosome,GO:0005769,cellular component,5.0,4.0,5.346e-02,1.618e-02,1.767e-01,2.514e-02,7.607e-03,8.307e-02,8.323e-01,2.907e-02
NEURL1B,35422,protein binding,GO:0005515,molecular function,5.0,318.0,6.657e-02,3.591e-02,1.234e-01,5.410e-02,3.828e-02,7.647e-02,7.502e-01,9.748e-03
NEURL1B,35422,ubiquitin protein ligase activity,GO:0061630,molecular function,5.0,8.0,8.608e-02,2.680e-02,2.765e-01,8.608e-02,2.680e-02,2.765e-01,6.869e-01,3.822e-02
NEURL3,25162,,,,nan,nan,,,,,,,,
NKG7,7830,plasma membrane,GO:0005886,cellular component,5.0,67.0,1.035e-02,4.979e-03,2.151e-02,5.175e-03,2.490e-03,1.076e-02,9.428e-01,6.265e-03
NKG7,7830,protein binding,GO:0005515,molecular function,5.0,318.0,1.493e-02,1.287e-02,1.732e-02,1.493e-02,1.287e-02,1.732e-02,8.859e-01,3.100e-03
NLRC5,29933,defense response to virus,GO:0051607,biological process,17.0,11.0,3.219e-01,2.361e-01,4.390e-01,4.806e-02,1.656e-02,1.395e-01,7.620e-01,3.057e-02
NLRC5,29933,negative regulation of NF-kappaB transcription factor activity,GO:0032088,biological process,17.0,5.0,3.219e-01,2.361e-01,4.390e-01,1.607e-01,8.888e-02,2.905e-01,5.953e-01,2.460e-02
NLRC5,29933,innate immune response,GO:0045087,biological process,17.0,24.0,3.244e-01,2.341e-01,4.496e-01,1.509e-01,5.971e-02,3.813e-01,6.033e-01,3.658e-02
NLRC5,29933,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,17.0,69.0,3.279e-01,2.333e-01,4.608e-01,2.083e-01,1.490e-01,2.912e-01,5.499e-01,1.521e-02
NLRC5,29933,intracellular signal transduction,GO:0035556,biological process,17.0,34.0,3.670e-01,2.493e-01,5.403e-01,2.338e-01,1.022e-01,5.349e-01,5.233e-01,3.898e-02
NLRC5,29933,regulation of kinase activity,GO:0043549,biological process,17.0,11.0,3.774e-01,2.114e-01,6.736e-01,2.363e-01,6.515e-02,8.572e-01,5.148e-01,5.820e-02
NLRC5,29933,positive regulation of interferon-gamma-mediated signaling pathway,GO:0060335,biological process,17.0,4.0,3.951e-01,2.296e-01,6.799e-01,3.278e-01,1.580e-01,6.801e-01,4.491e-01,4.427e-02
NLRC5,29933,positive regulation of MHC class I biosynthetic process,GO:0045345,biological process,17.0,4.0,4.491e-01,2.996e-01,6.733e-01,4.017e-01,2.616e-01,6.169e-01,4.030e-01,2.655e-02
NLRC5,29933,negative regulation of type I interferon-mediated signaling pathway,GO:0060339,biological process,17.0,5.0,4.810e-01,3.971e-01,5.826e-01,4.540e-01,4.004e-01,5.149e-01,3.715e-01,8.886e-03
NLRC5,29933,positive regulation of type I interferon-mediated signaling pathway,GO:0060340,biological process,17.0,4.0,4.894e-01,3.291e-01,7.278e-01,4.688e-01,2.940e-01,7.474e-01,3.573e-01,3.519e-02
NLRC5,29933,cytosol,GO:0005829,cellular component,17.0,50.0,3.219e-01,2.361e-01,4.390e-01,1.293e-01,1.152e-01,1.453e-01,6.330e-01,4.543e-03
NLRC5,29933,nucleus,GO:0005634,cellular component,17.0,86.0,3.219e-01,2.361e-01,4.390e-01,1.408e-01,9.113e-02,2.177e-01,6.185e-01,1.750e-02
NLRC5,29933,cytoplasm,GO:0005737,cellular component,17.0,72.0,3.219e-01,2.361e-01,4.390e-01,1.412e-01,1.069e-01,1.865e-01,6.184e-01,1.093e-02
NLRC5,29933,centrosome,GO:0005813,cellular component,17.0,11.0,3.219e-01,2.361e-01,4.390e-01,1.480e-01,8.576e-02,2.553e-01,6.098e-01,2.122e-02
NLRC5,29933,RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,molecular function,17.0,30.0,3.219e-01,2.361e-01,4.390e-01,1.306e-01,9.888e-02,1.725e-01,6.310e-01,1.057e-02
NLRC5,29933,protein binding,GO:0005515,molecular function,17.0,318.0,3.219e-01,2.361e-01,4.390e-01,1.916e-01,1.603e-01,2.289e-01,5.659e-01,7.971e-03
NNAT,7860,,,,nan,nan,,,,,,,,
NOD2,5331,positive regulation of interleukin-1 beta production,GO:0032731,biological process,49.0,5.0,3.713e-01,1.898e-01,7.262e-01,7.115e-02,2.196e-02,2.305e-01,7.129e-01,3.583e-02
NOD2,5331,positive regulation of NF-kappaB transcription factor activity,GO:0051092,biological process,49.0,6.0,3.713e-01,1.898e-01,7.262e-01,7.530e-02,2.361e-02,2.402e-01,7.050e-01,3.718e-02
NOD2,5331,positive regulation of stress-activated MAPK cascade,GO:0032874,biological process,49.0,7.0,3.713e-01,1.898e-01,7.262e-01,7.720e-02,1.857e-02,3.208e-01,6.994e-01,4.571e-02
NOD2,5331,positive regulation of JNK cascade,GO:0046330,biological process,49.0,4.0,3.713e-01,1.898e-01,7.262e-01,8.227e-02,4.121e-02,1.642e-01,6.965e-01,2.246e-02
NOD2,5331,response to muramyl dipeptide,GO:0032495,biological process,49.0,5.0,3.713e-01,1.898e-01,7.262e-01,1.088e-01,6.303e-02,1.878e-01,6.579e-01,1.949e-02
NOD2,5331,positive regulation of interleukin-1 beta secretion,GO:0050718,biological process,49.0,4.0,3.713e-01,1.898e-01,7.262e-01,1.590e-01,4.136e-02,6.113e-01,5.879e-01,6.061e-02
NOD2,5331,detection of muramyl dipeptide,GO:0032498,biological process,49.0,3.0,3.753e-01,1.937e-01,7.273e-01,1.177e-01,2.092e-02,6.625e-01,6.340e-01,5.947e-02
NOD2,5331,positive regulation of type 2 immune response,GO:0002830,biological process,49.0,5.0,3.753e-01,1.937e-01,7.273e-01,1.887e-01,5.764e-02,6.175e-01,5.600e-01,5.272e-02
NOD2,5331,intracellular signal transduction,GO:0035556,biological process,49.0,34.0,3.753e-01,1.937e-01,7.273e-01,1.880e-01,5.104e-02,6.927e-01,5.582e-01,6.046e-02
NOD2,5331,defense response to bacterium,GO:0042742,biological process,49.0,14.0,3.840e-01,2.058e-01,7.164e-01,2.329e-01,1.348e-01,4.022e-01,5.270e-01,2.633e-02
NOD2,5331,positive regulation of interleukin-8 production,GO:0032757,biological process,49.0,6.0,3.900e-01,2.199e-01,6.920e-01,2.581e-01,1.260e-01,5.288e-01,5.036e-01,3.765e-02
NOD2,5331,innate immune response,GO:0045087,biological process,49.0,24.0,3.923e-01,2.060e-01,7.471e-01,2.164e-01,7.329e-02,6.393e-01,5.358e-01,4.841e-02
NOD2,5331,positive regulation of cytokine production involved in inflammatory response,GO:1900017,biological process,49.0,4.0,3.923e-01,2.060e-01,7.471e-01,2.406e-01,7.653e-02,7.562e-01,5.130e-01,5.411e-02
NOD2,5331,positive regulation of tumor necrosis factor production,GO:0032760,biological process,49.0,5.0,3.985e-01,2.127e-01,7.464e-01,2.632e-01,1.008e-01,6.871e-01,4.965e-01,4.796e-02
NOD2,5331,positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043123,biological process,49.0,12.0,4.051e-01,2.446e-01,6.710e-01,2.193e-01,1.140e-01,4.219e-01,5.380e-01,2.922e-02
NOD2,5331,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,49.0,69.0,4.104e-01,2.523e-01,6.677e-01,2.511e-01,1.165e-01,5.414e-01,5.095e-01,3.639e-02
NOD2,5331,cellular response to muramyl dipeptide,GO:0071225,biological process,49.0,4.0,4.294e-01,2.105e-01,8.760e-01,2.765e-01,6.801e-02,1.124e+00,4.778e-01,6.807e-02
NOD2,5331,cellular response to lipopolysaccharide,GO:0071222,biological process,49.0,8.0,4.339e-01,2.205e-01,8.541e-01,2.897e-01,1.036e-01,8.100e-01,4.736e-01,5.486e-02
NOD2,5331,positive regulation of NIK/NF-kappaB signaling,GO:1901224,biological process,49.0,4.0,4.373e-01,2.723e-01,7.023e-01,3.285e-01,1.629e-01,6.624e-01,4.501e-01,3.819e-02
NOD2,5331,positive regulation of protein K63-linked ubiquitination,GO:1902523,biological process,49.0,4.0,4.392e-01,2.377e-01,8.116e-01,2.495e-01,3.812e-02,1.633e+00,4.881e-01,8.746e-02
NOD2,5331,nucleotide-binding oligomerization domain containing 2 signaling pathway,GO:0070431,biological process,49.0,2.0,4.544e-01,1.967e-01,1.050e+00,3.020e-01,5.661e-02,1.611e+00,4.483e-01,8.532e-02
NOD2,5331,positive regulation of B cell activation,GO:0050871,biological process,49.0,8.0,4.837e-01,2.676e-01,8.743e-01,4.020e-01,1.878e-01,8.603e-01,3.971e-01,4.593e-02
NOD2,5331,detection of bacterium,GO:0016045,biological process,49.0,4.0,5.402e-01,2.834e-01,1.030e+00,4.768e-01,2.283e-01,9.957e-01,3.443e-01,5.668e-02
NOD2,5331,cytokine production involved in immune response,GO:0002367,biological process,49.0,8.0,5.511e-01,3.047e-01,9.969e-01,5.071e-01,2.834e-01,9.072e-01,3.291e-01,4.744e-02
NOD2,5331,positive regulation of interleukin-17 production,GO:0032740,biological process,49.0,5.0,5.717e-01,3.147e-01,1.039e+00,5.148e-01,2.690e-01,9.854e-01,3.202e-01,5.722e-02
NOD2,5331,cytokine secretion involved in immune response,GO:0002374,biological process,49.0,2.0,5.846e-01,4.213e-01,8.112e-01,5.506e-01,4.491e-01,6.750e-01,3.098e-01,1.709e-02
NOD2,5331,positive regulation of interleukin-6 production,GO:0032755,biological process,49.0,5.0,5.864e-01,3.054e-01,1.126e+00,5.560e-01,2.763e-01,1.119e+00,2.880e-01,6.906e-02
NOD2,5331,maintenance of gastrointestinal epithelium,GO:0030277,biological process,49.0,4.0,7.217e-01,5.040e-01,1.034e+00,7.217e-01,5.040e-01,1.034e+00,1.920e-01,4.432e-02
NOD2,5331,cytoskeleton,GO:0005856,cellular component,49.0,11.0,3.713e-01,1.898e-01,7.262e-01,4.761e-02,1.245e-02,1.821e-01,7.615e-01,3.936e-02
NOD2,5331,vesicle,GO:0031982,cellular component,49.0,5.0,3.713e-01,1.898e-01,7.262e-01,8.180e-02,4.414e-02,1.516e-01,6.978e-01,2.023e-02
NOD2,5331,plasma membrane,GO:0005886,cellular component,49.0,67.0,3.713e-01,1.898e-01,7.262e-01,1.271e-01,6.102e-02,2.647e-01,6.331e-01,2.863e-02
NOD2,5331,cell surface,GO:0009986,cellular component,49.0,20.0,3.752e-01,1.966e-01,7.162e-01,1.436e-01,7.547e-02,2.733e-01,6.140e-01,2.471e-02
NOD2,5331,basolateral plasma membrane,GO:0016323,cellular component,49.0,4.0,3.753e-01,1.937e-01,7.273e-01,1.945e-01,5.793e-02,6.528e-01,5.537e-01,5.562e-02
NOD2,5331,cytosol,GO:0005829,cellular component,49.0,50.0,3.757e-01,1.943e-01,7.264e-01,1.619e-01,1.124e-01,2.332e-01,5.952e-01,1.506e-02
NOD2,5331,Golgi apparatus,GO:0005794,cellular component,49.0,16.0,3.757e-01,1.974e-01,7.151e-01,1.212e-01,4.758e-02,3.088e-01,6.386e-01,3.359e-02
NOD2,5331,cytoplasm,GO:0005737,cellular component,49.0,72.0,3.794e-01,2.009e-01,7.163e-01,1.629e-01,1.121e-01,2.367e-01,5.940e-01,1.571e-02
NOD2,5331,protein-containing complex,GO:0032991,cellular component,49.0,474.0,5.028e-01,2.080e-01,1.215e+00,4.185e-01,1.373e-01,1.276e+00,3.644e-01,9.048e-02
NOD2,5331,muramyl dipeptide binding,GO:0032500,molecular function,49.0,4.0,3.713e-01,1.898e-01,7.262e-01,7.595e-02,1.843e-02,3.130e-01,7.007e-01,4.818e-02
NOD2,5331,enzyme binding,GO:0019899,molecular function,49.0,35.0,3.713e-01,1.898e-01,7.262e-01,9.688e-02,3.811e-02,2.463e-01,6.721e-01,3.290e-02
NOD2,5331,protein kinase binding,GO:0019901,molecular function,49.0,19.0,3.713e-01,1.898e-01,7.262e-01,9.993e-02,2.977e-02,3.355e-01,6.645e-01,4.462e-02
NOD2,5331,actin binding,GO:0003779,molecular function,49.0,7.0,3.713e-01,1.898e-01,7.262e-01,1.160e-01,4.596e-02,2.927e-01,6.456e-01,3.483e-02
NOD2,5331,protein binding,GO:0005515,molecular function,49.0,318.0,3.895e-01,2.161e-01,7.020e-01,2.207e-01,1.861e-01,2.617e-01,5.393e-01,7.910e-03
NOD2,5331,CARD domain binding,GO:0050700,molecular function,49.0,2.0,3.927e-01,2.067e-01,7.459e-01,2.057e-01,1.039e-01,4.072e-01,5.500e-01,2.998e-02
NOD2,5331,Hsp70 protein binding,GO:0030544,molecular function,49.0,2.0,4.081e-01,2.313e-01,7.199e-01,2.881e-01,1.632e-01,5.086e-01,4.822e-01,2.901e-02
NOD2,5331,Hsp90 protein binding,GO:0051879,molecular function,49.0,2.0,4.081e-01,2.313e-01,7.199e-01,2.890e-01,1.598e-01,5.228e-01,4.812e-01,3.022e-02
NOD2,5331,peptidoglycan binding,GO:0042834,molecular function,49.0,2.0,4.104e-01,2.054e-01,8.202e-01,2.860e-01,1.046e-01,7.821e-01,4.753e-01,5.779e-02
NOD2,5331,protein-containing complex binding,GO:0044877,molecular function,49.0,76.0,4.262e-01,2.703e-01,6.720e-01,2.657e-01,1.147e-01,6.157e-01,4.968e-01,4.067e-02
NOS2,7873,regulation of cytokine production involved in inflammatory response,GO:1900015,biological process,34.0,5.0,1.900e-01,1.398e-01,2.581e-01,1.297e-02,3.525e-03,4.775e-02,8.888e-01,2.507e-02
NOS2,7873,prostaglandin secretion,GO:0032310,biological process,34.0,5.0,2.033e-01,1.309e-01,3.158e-01,4.097e-02,3.621e-03,4.636e-01,7.693e-01,6.033e-02
NOS2,7873,response to lipopolysaccharide,GO:0032496,biological process,34.0,6.0,2.292e-01,1.986e-01,2.645e-01,4.050e-02,2.278e-02,7.200e-02,7.835e-01,1.550e-02
NOS2,7873,arginine catabolic process,GO:0006527,biological process,34.0,10.0,2.292e-01,1.986e-01,2.645e-01,7.454e-02,4.012e-02,1.385e-01,7.101e-01,1.950e-02
NOS2,7873,response to hormone,GO:0009725,biological process,34.0,32.0,2.292e-01,1.986e-01,2.645e-01,8.073e-02,2.976e-02,2.190e-01,6.972e-01,3.209e-02
NOS2,7873,regulation of insulin secretion,GO:0050796,biological process,34.0,7.0,2.292e-01,1.986e-01,2.645e-01,9.039e-02,2.742e-02,2.979e-01,6.800e-01,3.936e-02
NOS2,7873,positive regulation of killing of cells of other organism,GO:0051712,biological process,34.0,8.0,2.323e-01,2.005e-01,2.692e-01,8.640e-02,3.630e-02,2.057e-01,6.890e-01,2.792e-02
NOS2,7873,defense response to bacterium,GO:0042742,biological process,34.0,14.0,2.323e-01,2.005e-01,2.692e-01,1.381e-01,7.411e-02,2.573e-01,6.205e-01,2.423e-02
NOS2,7873,negative regulation of gene expression,GO:0010629,biological process,34.0,26.0,2.323e-01,2.005e-01,2.692e-01,1.416e-01,5.396e-02,3.717e-01,6.136e-01,3.617e-02
NOS2,7873,interleukin-6 secretion,GO:0072604,biological process,34.0,2.0,2.323e-01,2.005e-01,2.692e-01,1.915e-01,1.533e-01,2.393e-01,5.659e-01,9.886e-03
NOS2,7873,interleukin-8 secretion,GO:0072606,biological process,34.0,2.0,2.323e-01,2.005e-01,2.692e-01,1.965e-01,1.566e-01,2.465e-01,5.611e-01,1.011e-02
NOS2,7873,nitric oxide biosynthetic process,GO:0006809,biological process,34.0,5.0,2.490e-01,2.247e-01,2.759e-01,2.070e-01,1.489e-01,2.879e-01,5.511e-01,1.481e-02
NOS2,7873,nitric oxide mediated signal transduction,GO:0007263,biological process,34.0,4.0,2.504e-01,2.220e-01,2.824e-01,2.079e-01,1.519e-01,2.846e-01,5.502e-01,1.442e-02
NOS2,7873,negative regulation of blood pressure,GO:0045776,biological process,34.0,4.0,2.949e-01,1.673e-01,5.197e-01,2.624e-01,1.159e-01,5.944e-01,4.988e-01,4.283e-02
NOS2,7873,positive regulation of guanylate cyclase activity,GO:0031284,biological process,34.0,5.0,2.952e-01,1.847e-01,4.719e-01,2.737e-01,1.532e-01,4.890e-01,4.930e-01,2.991e-02
NOS2,7873,plasma membrane,GO:0005886,cellular component,34.0,67.0,2.323e-01,2.005e-01,2.692e-01,1.113e-01,6.085e-02,2.036e-01,6.542e-01,2.206e-02
NOS2,7873,cytosol,GO:0005829,cellular component,34.0,50.0,2.323e-01,2.005e-01,2.692e-01,1.414e-01,7.162e-02,2.790e-01,6.162e-01,2.707e-02
NOS2,7873,peroxisome,GO:0005777,cellular component,34.0,12.0,2.323e-01,2.005e-01,2.692e-01,1.745e-01,1.371e-01,2.221e-01,5.825e-01,1.008e-02
NOS2,7873,cytoplasm,GO:0005737,cellular component,34.0,72.0,2.352e-01,1.999e-01,2.767e-01,1.638e-01,8.788e-02,3.053e-01,5.918e-01,2.621e-02
NOS2,7873,vesicle membrane,GO:0012506,cellular component,34.0,5.0,2.352e-01,1.999e-01,2.767e-01,1.797e-01,1.112e-01,2.905e-01,5.763e-01,2.060e-02
NOS2,7873,nucleus,GO:0005634,cellular component,34.0,86.0,2.647e-01,1.823e-01,3.842e-01,2.365e-01,1.248e-01,4.481e-01,5.234e-01,2.988e-02
NOS2,7873,NADPH-hemoprotein reductase activity,GO:0003958,molecular function,34.0,2.0,2.292e-01,1.986e-01,2.645e-01,6.606e-02,4.375e-02,9.974e-02,7.260e-01,1.218e-02
NOS2,7873,nitric-oxide synthase activity,GO:0004517,molecular function,34.0,2.0,2.323e-01,2.005e-01,2.692e-01,7.374e-02,2.244e-02,2.423e-01,7.075e-01,3.847e-02
NOS2,7873,oxidoreductase activity,GO:0016491,molecular function,34.0,90.0,2.323e-01,2.005e-01,2.692e-01,1.259e-01,6.887e-02,2.303e-01,6.355e-01,2.313e-02
NOS2,7873,flavin adenine dinucleotide binding,GO:0050660,molecular function,34.0,6.0,2.323e-01,2.005e-01,2.692e-01,1.399e-01,1.030e-01,1.900e-01,6.199e-01,1.199e-02
NOS2,7873,protein binding,GO:0005515,molecular function,34.0,318.0,2.323e-01,2.005e-01,2.692e-01,1.487e-01,1.028e-01,2.152e-01,6.098e-01,1.459e-02
NOS2,7873,FMN binding,GO:0010181,molecular function,34.0,4.0,2.323e-01,2.005e-01,2.692e-01,1.571e-01,1.172e-01,2.105e-01,6.006e-01,1.195e-02
NOS2,7873,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen",GO:0016709,molecular function,34.0,305.0,2.463e-01,1.690e-01,3.590e-01,1.484e-01,3.227e-02,6.828e-01,5.981e-01,6.054e-02
NOVA2,7887,RNA binding,GO:0003723,molecular function,2.0,44.0,2.902e-02,8.324e-03,1.012e-01,2.902e-02,8.324e-03,1.012e-01,8.177e-01,3.169e-02
NPFF,7901,excitatory postsynaptic potential,GO:0060079,biological process,8.0,4.0,3.182e-01,2.544e-01,3.980e-01,3.029e-01,2.363e-01,3.883e-01,4.734e-01,1.365e-02
NPFF,7901,axon terminus,GO:0043679,cellular component,8.0,7.0,3.079e-01,2.622e-01,3.616e-01,6.461e-02,4.468e-02,9.343e-02,7.288e-01,1.106e-02
NPFF,7901,extracellular space,GO:0005615,cellular component,8.0,24.0,3.079e-01,2.622e-01,3.616e-01,1.279e-01,9.842e-02,1.663e-01,6.344e-01,9.892e-03
NPFF,7901,dendrite,GO:0030425,cellular component,8.0,13.0,3.182e-01,2.544e-01,3.980e-01,2.405e-01,1.228e-01,4.708e-01,5.196e-01,3.187e-02
NPFF,7901,perikaryon,GO:0043204,cellular component,8.0,3.0,3.182e-01,2.544e-01,3.980e-01,2.845e-01,1.950e-01,4.151e-01,4.864e-01,2.018e-02
NPFF,7901,neuropeptide hormone activity,GO:0005184,molecular function,8.0,7.0,3.079e-01,2.622e-01,3.616e-01,1.328e-01,7.799e-02,2.263e-01,6.274e-01,2.114e-02
NPFF,7901,G protein-coupled receptor binding,GO:0001664,molecular function,8.0,46.0,3.182e-01,2.544e-01,3.980e-01,2.251e-01,1.671e-01,3.032e-01,5.352e-01,1.391e-02
NPR2,7944,cGMP biosynthetic process,GO:0006182,biological process,18.0,4.0,5.770e-02,2.616e-02,1.273e-01,2.611e-02,8.438e-03,8.080e-02,8.287e-01,2.696e-02
NPR2,7944,cellular response to granulocyte macrophage colony-stimulating factor stimulus,GO:0097011,biological process,18.0,3.0,2.009e-01,6.432e-02,6.273e-01,1.707e-01,4.914e-02,5.932e-01,5.771e-01,5.541e-02
NPR2,7944,receptor guanylyl cyclase signaling pathway,GO:0007168,biological process,18.0,2.0,2.159e-01,1.799e-01,2.591e-01,1.851e-01,1.431e-01,2.394e-01,5.720e-01,1.139e-02
NPR2,7944,signal transduction,GO:0007165,biological process,18.0,48.0,4.306e-01,1.033e-01,1.795e+00,4.052e-01,7.907e-02,2.077e+00,3.648e-01,9.749e-02
NPR2,7944,plasma membrane,GO:0005886,cellular component,18.0,67.0,5.770e-02,2.616e-02,1.273e-01,2.264e-02,1.132e-02,4.527e-02,8.451e-01,1.636e-02
NPR2,7944,integral component of plasma membrane,GO:0005887,cellular component,18.0,39.0,6.184e-02,3.548e-02,1.078e-01,2.983e-02,1.951e-02,4.561e-02,8.171e-01,1.079e-02
NPR2,7944,peptide receptor activity,GO:0001653,molecular function,18.0,5.0,5.770e-02,2.616e-02,1.273e-01,9.402e-03,4.771e-03,1.853e-02,9.158e-01,9.774e-03
NPR2,7944,natriuretic peptide receptor activity,GO:0016941,molecular function,18.0,2.0,5.770e-02,2.616e-02,1.273e-01,1.212e-02,6.602e-03,2.224e-02,8.999e-01,1.010e-02
NPR2,7944,peptide hormone binding,GO:0017046,molecular function,18.0,13.0,5.770e-02,2.616e-02,1.273e-01,2.311e-02,1.037e-02,5.152e-02,8.426e-01,1.933e-02
NPR2,7944,protein binding,GO:0005515,molecular function,18.0,318.0,7.331e-02,3.014e-02,1.783e-01,4.561e-02,1.954e-02,1.064e-01,7.694e-01,2.335e-02
NPR2,7944,hormone binding,GO:0042562,molecular function,18.0,22.0,8.234e-02,2.902e-02,2.337e-01,5.489e-02,1.934e-02,1.558e-01,7.468e-01,2.914e-02
NPR2,7944,guanylate cyclase activity,GO:0004383,molecular function,18.0,3.0,1.751e-01,4.759e-02,6.441e-01,1.497e-01,3.378e-02,6.635e-01,5.977e-01,5.584e-02
NR1D1,7962,cell differentiation,GO:0030154,biological process,35.0,91.0,1.019e-01,8.836e-02,1.176e-01,4.098e-02,2.415e-02,6.954e-02,7.822e-01,1.437e-02
NR1D1,7962,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,35.0,39.0,1.069e-01,7.967e-02,1.435e-01,4.525e-02,1.851e-02,1.106e-01,7.698e-01,2.525e-02
NR1D1,7962,response to leptin,GO:0044321,biological process,35.0,3.0,1.070e-01,9.157e-02,1.251e-01,4.468e-02,1.506e-02,1.326e-01,7.709e-01,2.922e-02
NR1D1,7962,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,35.0,55.0,1.124e-01,8.800e-02,1.435e-01,5.714e-02,2.914e-02,1.120e-01,7.431e-01,1.911e-02
NR1D1,7962,regulation of circadian rhythm,GO:0042752,biological process,35.0,10.0,1.354e-01,5.539e-02,3.309e-01,7.187e-02,1.015e-02,5.091e-01,7.025e-01,6.396e-02
NR1D1,7962,negative regulation of toll-like receptor 4 signaling pathway,GO:0034144,biological process,35.0,3.0,1.384e-01,7.927e-02,2.417e-01,9.379e-02,3.527e-02,2.494e-01,6.761e-01,3.473e-02
NR1D1,7962,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,35.0,69.0,1.385e-01,9.397e-02,2.042e-01,9.146e-02,4.050e-02,2.065e-01,6.817e-01,2.596e-02
NR1D1,7962,negative regulation of receptor biosynthetic process,GO:0010871,biological process,35.0,6.0,1.456e-01,8.699e-02,2.437e-01,1.022e-01,4.446e-02,2.349e-01,6.653e-01,2.852e-02
NR1D1,7962,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,GO:0035947,biological process,35.0,5.0,1.482e-01,8.750e-02,2.511e-01,1.099e-01,4.507e-02,2.681e-01,6.541e-01,3.076e-02
NR1D1,7962,response to lipid,GO:0033993,biological process,35.0,38.0,1.538e-01,9.503e-02,2.491e-01,1.100e-01,5.018e-02,2.411e-01,6.547e-01,2.916e-02
NR1D1,7962,multicellular organism development,GO:0007275,biological process,35.0,18.0,2.351e-01,9.661e-02,5.722e-01,2.078e-01,6.918e-02,6.243e-01,5.418e-01,5.437e-02
NR1D1,7962,cellular response to lipopolysaccharide,GO:0071222,biological process,35.0,8.0,2.476e-01,1.107e-01,5.540e-01,2.150e-01,6.819e-02,6.776e-01,5.360e-01,5.158e-02
NR1D1,7962,hormone-mediated signaling pathway,GO:0009755,biological process,35.0,17.0,3.273e-01,2.408e-01,4.448e-01,3.132e-01,2.209e-01,4.441e-01,4.652e-01,1.867e-02
NR1D1,7962,nuclear chromatin,GO:0000790,cellular component,35.0,11.0,9.360e-02,8.672e-02,1.010e-01,1.975e-02,9.915e-03,3.932e-02,8.588e-01,1.603e-02
NR1D1,7962,nuclear body,GO:0016604,cellular component,35.0,18.0,1.310e-01,7.317e-02,2.346e-01,6.690e-02,2.110e-02,2.121e-01,7.205e-01,3.657e-02
NR1D1,7962,nucleus,GO:0005634,cellular component,35.0,86.0,1.320e-01,1.071e-01,1.627e-01,8.135e-02,4.903e-02,1.350e-01,6.990e-01,1.601e-02
NR1D1,7962,RNA polymerase II transcription factor complex,GO:0090575,cellular component,35.0,45.0,1.952e-01,1.180e-01,3.230e-01,1.635e-01,8.894e-02,3.005e-01,5.922e-01,2.611e-02
NR1D1,7962,ligand-activated transcription factor activity,GO:0098531,molecular function,35.0,5.0,9.157e-02,8.131e-02,1.031e-01,6.636e-03,1.393e-03,3.161e-02,9.273e-01,1.791e-02
NR1D1,7962,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,35.0,17.0,9.157e-02,8.131e-02,1.031e-01,1.615e-02,1.204e-02,2.166e-02,8.790e-01,6.358e-03
NR1D1,7962,RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000977,molecular function,35.0,16.0,9.157e-02,8.131e-02,1.031e-01,1.761e-02,1.110e-02,2.793e-02,8.705e-01,1.051e-02
NR1D1,7962,transcription factor binding,GO:0008134,molecular function,35.0,16.0,9.157e-02,8.131e-02,1.031e-01,1.896e-02,1.340e-02,2.683e-02,8.635e-01,8.199e-03
NR1D1,7962,transcription regulatory region sequence-specific DNA binding,GO:0000976,molecular function,35.0,10.0,9.157e-02,8.131e-02,1.031e-01,2.001e-02,9.767e-03,4.099e-02,8.577e-01,1.693e-02
NR1D1,7962,transcription regulatory region DNA binding,GO:0044212,molecular function,35.0,22.0,9.360e-02,8.672e-02,1.010e-01,2.263e-02,1.727e-02,2.965e-02,8.463e-01,6.768e-03
NR1D1,7962,"DNA-binding transcription repressor activity, RNA polymerase II-specific",GO:0001227,molecular function,35.0,10.0,9.360e-02,8.672e-02,1.010e-01,2.524e-02,1.919e-02,3.319e-02,8.347e-01,6.810e-03
NR1D1,7962,nuclear receptor transcription coactivator activity,GO:0030374,molecular function,35.0,5.0,9.621e-02,7.999e-02,1.157e-01,2.913e-02,9.391e-03,9.033e-02,8.175e-01,2.805e-02
NR1D1,7962,RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,molecular function,35.0,30.0,1.004e-01,9.365e-02,1.077e-01,4.103e-02,3.456e-02,4.870e-02,7.823e-01,4.693e-03
NR1D1,7962,transcription corepressor binding,GO:0001222,molecular function,35.0,3.0,1.148e-01,1.016e-01,1.297e-01,5.885e-02,3.317e-02,1.044e-01,7.397e-01,1.700e-02
NR1D1,7962,heme binding,GO:0020037,molecular function,35.0,3.0,1.639e-01,1.336e-01,2.011e-01,1.261e-01,9.549e-02,1.665e-01,6.367e-01,1.067e-02
NR1D1,7962,protein binding,GO:0005515,molecular function,35.0,318.0,1.715e-01,9.587e-02,3.068e-01,1.307e-01,4.713e-02,3.627e-01,6.259e-01,3.740e-02
NR1D1,7962,signaling receptor activity,GO:0038023,molecular function,35.0,28.0,3.884e-01,1.313e-01,1.149e+00,3.777e-01,1.215e-01,1.174e+00,3.971e-01,8.230e-02
NR1D2,7963,cell differentiation,GO:0030154,biological process,23.0,91.0,1.007e-01,8.948e-02,1.134e-01,3.779e-02,2.216e-02,6.445e-02,7.914e-01,1.432e-02
NR1D2,7963,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,23.0,39.0,1.097e-01,7.710e-02,1.561e-01,4.544e-02,2.077e-02,9.938e-02,7.697e-01,2.195e-02
NR1D2,7963,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,23.0,55.0,1.144e-01,8.601e-02,1.522e-01,6.760e-02,4.592e-02,9.952e-02,7.232e-01,1.143e-02
NR1D2,7963,regulation of circadian rhythm,GO:0042752,biological process,23.0,10.0,1.355e-01,5.173e-02,3.548e-01,8.345e-02,1.477e-02,4.717e-01,6.841e-01,5.993e-02
NR1D2,7963,response to lipid,GO:0033993,biological process,23.0,38.0,1.488e-01,7.299e-02,3.036e-01,1.056e-01,4.201e-02,2.653e-01,6.596e-01,3.376e-02
NR1D2,7963,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,23.0,69.0,1.606e-01,1.408e-01,1.832e-01,1.134e-01,7.005e-02,1.836e-01,6.521e-01,1.708e-02
NR1D2,7963,multicellular organism development,GO:0007275,biological process,23.0,18.0,2.442e-01,1.055e-01,5.653e-01,2.133e-01,7.230e-02,6.291e-01,5.373e-01,5.309e-02
NR1D2,7963,hormone-mediated signaling pathway,GO:0009755,biological process,23.0,17.0,3.700e-01,2.346e-01,5.837e-01,3.512e-01,2.048e-01,6.021e-01,4.362e-01,3.033e-02
NR1D2,7963,nucleus,GO:0005634,cellular component,23.0,86.0,1.362e-01,8.445e-02,2.197e-01,8.416e-02,5.033e-02,1.407e-01,6.945e-01,1.611e-02
NR1D2,7963,nucleoplasm,GO:0005654,cellular component,23.0,47.0,1.533e-01,7.665e-02,3.066e-01,9.866e-02,4.052e-02,2.402e-01,6.701e-01,2.907e-02
NR1D2,7963,RNA polymerase II transcription factor complex,GO:0090575,cellular component,23.0,45.0,2.185e-01,1.595e-01,2.992e-01,1.886e-01,1.440e-01,2.471e-01,5.686e-01,1.209e-02
NR1D2,7963,ligand-activated transcription factor activity,GO:0098531,molecular function,23.0,5.0,7.629e-02,4.710e-02,1.236e-01,6.937e-03,1.737e-03,2.771e-02,9.261e-01,1.675e-02
NR1D2,7963,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,23.0,17.0,7.868e-02,4.854e-02,1.275e-01,1.591e-02,1.114e-02,2.271e-02,8.801e-01,7.852e-03
NR1D2,7963,RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000977,molecular function,23.0,16.0,7.868e-02,4.854e-02,1.275e-01,1.803e-02,1.175e-02,2.768e-02,8.682e-01,9.695e-03
NR1D2,7963,transcription factor binding,GO:0008134,molecular function,23.0,16.0,7.868e-02,4.854e-02,1.275e-01,1.860e-02,1.350e-02,2.561e-02,8.655e-01,7.359e-03
NR1D2,7963,transcription regulatory region sequence-specific DNA binding,GO:0000976,molecular function,23.0,10.0,7.868e-02,4.854e-02,1.275e-01,2.040e-02,1.122e-02,3.712e-02,8.559e-01,1.423e-02
NR1D2,7963,nuclear receptor transcription coactivator activity,GO:0030374,molecular function,23.0,5.0,8.462e-02,4.798e-02,1.493e-01,3.200e-02,1.181e-02,8.669e-02,8.083e-01,2.531e-02
NR1D2,7963,RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,molecular function,23.0,30.0,9.964e-02,9.711e-02,1.022e-01,4.169e-02,3.582e-02,4.852e-02,7.806e-01,4.171e-03
NR1D2,7963,protein binding,GO:0005515,molecular function,23.0,318.0,1.605e-01,7.478e-02,3.446e-01,1.264e-01,4.805e-02,3.326e-01,6.320e-01,3.453e-02
NR1D2,7963,signaling receptor activity,GO:0038023,molecular function,23.0,28.0,3.925e-01,1.292e-01,1.192e+00,3.794e-01,1.179e-01,1.220e+00,3.935e-01,8.626e-02
NR5A2,7984,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,21.0,41.0,1.227e-01,1.016e-01,1.483e-01,4.641e-02,3.664e-02,5.878e-02,7.684e-01,6.464e-03
NR5A2,7984,"regulation of transcription, DNA-templated",GO:0006355,biological process,21.0,35.0,1.310e-01,9.364e-02,1.832e-01,4.784e-02,1.448e-02,1.581e-01,7.623e-01,3.269e-02
NR5A2,7984,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,21.0,69.0,1.670e-01,1.137e-01,2.452e-01,1.003e-01,5.238e-02,1.922e-01,6.689e-01,2.329e-02
NR5A2,7984,positive regulation of viral genome replication,GO:0045070,biological process,21.0,5.0,2.517e-01,2.217e-01,2.857e-01,2.045e-01,1.685e-01,2.482e-01,5.537e-01,8.676e-03
NR5A2,7984,tissue development,GO:0009888,biological process,21.0,31.0,3.182e-01,1.973e-01,5.134e-01,2.946e-01,1.793e-01,4.838e-01,4.776e-01,2.731e-02
NR5A2,7984,hormone-mediated signaling pathway,GO:0009755,biological process,21.0,17.0,4.261e-01,3.920e-01,4.630e-01,4.261e-01,3.920e-01,4.630e-01,3.897e-01,5.459e-03
NR5A2,7984,nucleus,GO:0005634,cellular component,21.0,86.0,1.694e-01,1.151e-01,2.494e-01,9.622e-02,6.962e-02,1.330e-01,6.767e-01,1.092e-02
NR5A2,7984,cytoplasm,GO:0005737,cellular component,21.0,72.0,2.087e-01,1.369e-01,3.180e-01,1.361e-01,9.704e-02,1.908e-01,6.244e-01,1.313e-02
NR5A2,7984,RNA polymerase II transcription factor complex,GO:0090575,cellular component,21.0,45.0,3.051e-01,2.165e-01,4.300e-01,2.708e-01,1.945e-01,3.769e-01,4.974e-01,1.642e-02
NR5A2,7984,transcription regulatory region sequence-specific DNA binding,GO:0000976,molecular function,21.0,10.0,1.227e-01,1.016e-01,1.483e-01,2.439e-02,1.483e-02,4.013e-02,8.383e-01,1.249e-02
NR5A2,7984,nuclear receptor activity,GO:0004879,molecular function,21.0,4.0,1.227e-01,1.016e-01,1.483e-01,2.505e-02,1.772e-02,3.541e-02,8.357e-01,8.695e-03
NR5A2,7984,transcription regulatory region DNA binding,GO:0044212,molecular function,21.0,22.0,1.227e-01,1.016e-01,1.483e-01,3.703e-02,2.568e-02,5.340e-02,7.936e-01,9.793e-03
NR5A2,7984,sequence-specific DNA binding,GO:0043565,molecular function,21.0,14.0,1.227e-01,1.016e-01,1.483e-01,3.717e-02,3.287e-02,4.204e-02,7.933e-01,3.260e-03
NR5A2,7984,DNA-binding transcription factor activity,GO:0003700,molecular function,21.0,17.0,1.227e-01,1.016e-01,1.483e-01,3.968e-02,2.226e-02,7.073e-02,7.857e-01,1.557e-02
NR5A2,7984,DNA binding,GO:0003677,molecular function,21.0,29.0,1.265e-01,1.157e-01,1.382e-01,4.449e-02,3.197e-02,6.192e-02,7.730e-01,9.108e-03
NR5A2,7984,chromatin binding,GO:0003682,molecular function,21.0,11.0,1.795e-01,8.967e-02,3.592e-01,1.069e-01,3.359e-02,3.401e-01,6.551e-01,4.356e-02
NR5A2,7984,protein binding,GO:0005515,molecular function,21.0,318.0,2.197e-01,1.550e-01,3.113e-01,1.617e-01,1.070e-01,2.445e-01,5.949e-01,1.742e-02
NR5A2,7984,phospholipid binding,GO:0005543,molecular function,21.0,16.0,3.050e-01,1.894e-01,4.910e-01,2.546e-01,1.405e-01,4.613e-01,5.081e-01,3.036e-02
NRBP2,19339,,,,nan,nan,,,,,,,,
NRCAM,7994,clustering of voltage-gated sodium channels,GO:0045162,biological process,6.0,2.0,3.695e-02,1.379e-02,9.901e-02,1.847e-02,6.893e-03,4.951e-02,8.632e-01,2.265e-02
NRCAM,7994,angiogenesis,GO:0001525,biological process,6.0,13.0,1.290e-01,8.948e-02,1.860e-01,1.213e-01,7.895e-02,1.865e-01,6.421e-01,1.646e-02
NRCAM,7994,ankyrin binding,GO:0030506,molecular function,6.0,2.0,3.548e-02,1.504e-02,8.372e-02,1.183e-02,5.481e-03,2.555e-02,9.009e-01,1.169e-02
NRCAM,7994,protein binding,GO:0005515,molecular function,6.0,318.0,1.223e-01,7.691e-02,1.945e-01,1.010e-01,5.503e-02,1.852e-01,6.688e-01,2.029e-02
NREP,16834,regulation of neuron differentiation,GO:0045664,biological process,8.0,16.0,3.055e-01,1.389e-01,6.718e-01,1.182e-01,1.805e-02,7.740e-01,6.281e-01,7.525e-02
NREP,16834,regulation of transforming growth factor beta receptor signaling pathway,GO:0017015,biological process,8.0,8.0,3.055e-01,1.389e-01,6.718e-01,1.565e-01,2.955e-02,8.286e-01,5.858e-01,6.900e-02
NREP,16834,axon regeneration,GO:0031103,biological process,8.0,8.0,4.797e-01,1.658e-01,1.388e+00,4.797e-01,1.658e-01,1.388e+00,3.156e-01,1.014e-01
NREP,16834,nucleus,GO:0005634,cellular component,8.0,86.0,3.248e-01,1.796e-01,5.872e-01,1.694e-01,1.072e-01,2.677e-01,5.869e-01,1.929e-02
NREP,16834,cytoplasm,GO:0005737,cellular component,8.0,72.0,3.276e-01,1.804e-01,5.951e-01,2.141e-01,1.449e-01,3.165e-01,5.444e-01,1.762e-02
NREP,16834,protein binding,GO:0005515,molecular function,8.0,318.0,3.276e-01,1.804e-01,5.951e-01,2.538e-01,1.637e-01,3.934e-01,5.103e-01,2.108e-02
NTF3,8023,positive regulation of peptidyl-tyrosine phosphorylation,GO:0050731,biological process,38.0,11.0,1.400e-01,5.921e-02,3.310e-01,1.271e-02,4.133e-03,3.908e-02,8.924e-01,2.137e-02
NTF3,8023,negative regulation of peptidyl-tyrosine phosphorylation,GO:0050732,biological process,38.0,7.0,1.400e-01,5.921e-02,3.310e-01,1.228e-02,2.119e-03,7.111e-02,8.877e-01,3.329e-02
NTF3,8023,activation of GTPase activity,GO:0090630,biological process,38.0,2.0,1.400e-01,5.921e-02,3.310e-01,2.156e-02,5.644e-03,8.236e-02,8.452e-01,2.896e-02
NTF3,8023,activation of protein kinase B activity,GO:0032148,biological process,38.0,3.0,1.400e-01,5.921e-02,3.310e-01,2.479e-02,1.548e-02,3.968e-02,8.367e-01,1.193e-02
NTF3,8023,nerve growth factor signaling pathway,GO:0038180,biological process,38.0,2.0,1.400e-01,5.921e-02,3.310e-01,3.340e-02,1.240e-02,8.999e-02,8.036e-01,2.644e-02
NTF3,8023,regulation of apoptotic process,GO:0042981,biological process,38.0,24.0,1.400e-01,5.921e-02,3.310e-01,3.415e-02,4.537e-03,2.571e-01,7.938e-01,4.856e-02
NTF3,8023,positive regulation of peptidyl-serine phosphorylation,GO:0033138,biological process,38.0,6.0,1.400e-01,5.921e-02,3.310e-01,3.808e-02,2.866e-02,5.060e-02,7.907e-01,7.522e-03
NTF3,8023,transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007169,biological process,38.0,26.0,1.400e-01,5.921e-02,3.310e-01,3.792e-02,1.286e-02,1.118e-01,7.894e-01,2.913e-02
NTF3,8023,negative regulation of neuron apoptotic process,GO:0043524,biological process,38.0,13.0,1.400e-01,5.921e-02,3.310e-01,5.649e-02,1.903e-02,1.677e-01,7.423e-01,3.283e-02
NTF3,8023,activation of MAPK activity,GO:0000187,biological process,38.0,8.0,1.400e-01,5.921e-02,3.310e-01,6.216e-02,2.229e-02,1.734e-01,7.309e-01,3.137e-02
NTF3,8023,positive regulation of cell migration,GO:0030335,biological process,38.0,31.0,1.402e-01,5.945e-02,3.306e-01,6.559e-02,2.780e-02,1.547e-01,7.251e-01,2.645e-02
NTF3,8023,positive regulation of cell population proliferation,GO:0008284,biological process,38.0,38.0,1.469e-01,5.289e-02,4.078e-01,5.281e-02,9.906e-03,2.815e-01,7.457e-01,5.164e-02
NTF3,8023,induction of positive chemotaxis,GO:0050930,biological process,38.0,3.0,1.752e-01,7.584e-02,4.045e-01,1.111e-01,3.982e-02,3.098e-01,6.514e-01,3.583e-02
NTF3,8023,regulation of neuron differentiation,GO:0045664,biological process,38.0,16.0,1.920e-01,5.838e-02,6.318e-01,1.208e-01,2.906e-02,5.022e-01,6.327e-01,5.696e-02
NTF3,8023,positive regulation of receptor internalization,GO:0002092,biological process,38.0,7.0,2.014e-01,9.526e-02,4.258e-01,1.121e-01,3.880e-02,3.240e-01,6.491e-01,4.009e-02
NTF3,8023,memory,GO:0007613,biological process,38.0,6.0,2.480e-01,9.179e-02,6.698e-01,1.788e-01,4.352e-02,7.345e-01,5.649e-01,6.659e-02
NTF3,8023,neuron projection morphogenesis,GO:0048812,biological process,38.0,7.0,2.796e-01,1.152e-01,6.787e-01,2.338e-01,7.880e-02,6.936e-01,5.190e-01,5.329e-02
NTF3,8023,nerve development,GO:0021675,biological process,38.0,3.0,3.231e-01,1.406e-01,7.426e-01,2.922e-01,1.020e-01,8.372e-01,4.720e-01,5.293e-02
NTF3,8023,modulation of chemical synaptic transmission,GO:0050804,biological process,38.0,30.0,3.584e-01,1.876e-01,6.849e-01,2.954e-01,1.224e-01,7.133e-01,4.725e-01,4.511e-02
NTF3,8023,positive regulation of actin cytoskeleton reorganization,GO:2000251,biological process,38.0,4.0,3.902e-01,3.029e-01,5.028e-01,3.660e-01,2.680e-01,5.000e-01,4.283e-01,1.821e-02
NTF3,8023,peripheral nervous system development,GO:0007422,biological process,38.0,2.0,4.126e-01,3.355e-01,5.075e-01,3.979e-01,2.864e-01,5.527e-01,4.066e-01,2.027e-02
NTF3,8023,synaptic vesicle,GO:0008021,cellular component,38.0,6.0,1.471e-01,5.310e-02,4.073e-01,7.891e-02,2.442e-02,2.550e-01,6.980e-01,3.965e-02
NTF3,8023,extracellular space,GO:0005615,cellular component,38.0,24.0,1.908e-01,1.050e-01,3.468e-01,1.214e-01,7.298e-02,2.019e-01,6.416e-01,1.862e-02
NTF3,8023,axon,GO:0030424,cellular component,38.0,12.0,2.864e-01,1.270e-01,6.455e-01,2.198e-01,7.927e-02,6.096e-01,5.333e-01,4.679e-02
NTF3,8023,cytoplasmic vesicle,GO:0031410,cellular component,38.0,29.0,2.913e-01,1.426e-01,5.954e-01,2.341e-01,9.343e-02,5.865e-01,5.212e-01,4.529e-02
NTF3,8023,dendrite,GO:0030425,cellular component,38.0,13.0,3.691e-01,3.220e-01,4.230e-01,3.128e-01,2.917e-01,3.355e-01,4.669e-01,3.832e-03
NTF3,8023,chemoattractant activity,GO:0042056,molecular function,38.0,6.0,1.400e-01,5.921e-02,3.310e-01,5.637e-02,1.913e-02,1.661e-01,7.427e-01,3.188e-02
NTF3,8023,growth factor activity,GO:0008083,molecular function,38.0,3.0,1.402e-01,5.945e-02,3.306e-01,4.648e-02,1.581e-02,1.366e-01,7.661e-01,2.947e-02
NTF3,8023,protein binding,GO:0005515,molecular function,38.0,318.0,2.596e-01,2.167e-01,3.111e-01,1.964e-01,1.478e-01,2.608e-01,5.612e-01,1.272e-02
NXPE2,26331,,,,nan,nan,,,,,,,,
NXPE4,23117,,,,nan,nan,,,,,,,,
OLFM2,17189,positive regulation of smooth muscle cell differentiation,GO:0051152,biological process,8.0,6.0,3.613e-01,1.286e-01,1.015e+00,2.019e-01,1.422e-02,2.865e+00,5.054e-01,1.209e-01
OLFM2,17189,protein secretion,GO:0009306,biological process,8.0,26.0,5.300e-01,3.622e-01,7.756e-01,5.264e-01,3.663e-01,7.566e-01,3.227e-01,2.840e-02
OLFM2,17189,extracellular region,GO:0005576,cellular component,8.0,16.0,2.901e-01,1.851e-01,4.546e-01,8.377e-02,6.717e-02,1.045e-01,6.959e-01,6.991e-03
OLFM2,17189,cytoplasm,GO:0005737,cellular component,8.0,72.0,2.901e-01,1.851e-01,4.546e-01,1.698e-01,1.282e-01,2.248e-01,5.873e-01,1.174e-02
OLFM2,17189,nucleus,GO:0005634,cellular component,8.0,86.0,2.901e-01,1.851e-01,4.546e-01,1.715e-01,1.295e-01,2.271e-01,5.854e-01,1.200e-02
OLFM2,17189,nucleoplasm,GO:0005654,cellular component,8.0,47.0,2.901e-01,1.851e-01,4.546e-01,2.020e-01,1.682e-01,2.427e-01,5.560e-01,8.231e-03
OLFM2,17189,protein binding,GO:0005515,molecular function,8.0,318.0,2.901e-01,1.851e-01,4.546e-01,2.290e-01,1.634e-01,3.209e-01,5.315e-01,1.580e-02
OPLAH,8149,,,,nan,nan,,,,,,,,
PALM3,33274,,,,nan,nan,,,,,,,,
PARP10,25895,protein ADP-ribosylation,GO:0006471,biological process,21.0,11.0,5.513e-02,3.457e-02,8.791e-02,6.634e-03,1.127e-03,3.903e-02,9.273e-01,1.588e-02
PARP10,25895,protein poly-ADP-ribosylation,GO:0070212,biological process,21.0,2.0,6.097e-02,4.177e-02,8.901e-02,1.236e-02,1.024e-02,1.491e-02,9.006e-01,3.270e-03
PARP10,25895,protein auto-ADP-ribosylation,GO:0070213,biological process,21.0,2.0,6.097e-02,4.177e-02,8.901e-02,1.248e-02,1.070e-02,1.455e-02,9.001e-01,2.586e-03
PARP10,25895,protein mono-ADP-ribosylation,GO:0140289,biological process,21.0,3.0,6.097e-02,4.177e-02,8.901e-02,1.308e-02,1.099e-02,1.556e-02,8.967e-01,3.268e-03
PARP10,25895,translesion synthesis,GO:0019985,biological process,21.0,5.0,7.222e-02,3.672e-02,1.420e-01,1.895e-02,4.458e-03,8.056e-02,8.558e-01,2.947e-02
PARP10,25895,negative regulation of gene expression,GO:0010629,biological process,21.0,26.0,9.761e-02,5.950e-02,1.601e-01,3.159e-02,1.988e-02,5.020e-02,8.108e-01,1.210e-02
PARP10,25895,negative regulation of fibroblast proliferation,GO:0048147,biological process,21.0,5.0,1.045e-01,5.812e-02,1.879e-01,5.031e-02,2.250e-02,1.125e-01,7.576e-01,2.311e-02
PARP10,25895,negative regulation of viral genome replication,GO:0045071,biological process,21.0,8.0,1.128e-01,7.336e-02,1.734e-01,5.300e-02,3.015e-02,9.317e-02,7.523e-01,1.613e-02
PARP10,25895,regulation of chromatin assembly,GO:0010847,biological process,21.0,5.0,1.183e-01,7.093e-02,1.975e-01,8.702e-02,5.647e-02,1.341e-01,6.903e-01,1.380e-02
PARP10,25895,negative regulation of protein K63-linked ubiquitination,GO:1900045,biological process,21.0,4.0,1.191e-01,6.995e-02,2.026e-01,7.875e-02,4.208e-02,1.474e-01,7.028e-01,2.027e-02
PARP10,25895,negative regulation of NF-kappaB transcription factor activity,GO:0032088,biological process,21.0,5.0,1.230e-01,6.480e-02,2.334e-01,9.540e-02,4.712e-02,1.931e-01,6.758e-01,2.462e-02
PARP10,25895,nucleolus,GO:0005730,cellular component,21.0,5.0,1.034e-01,5.592e-02,1.911e-01,5.187e-02,1.570e-02,1.713e-01,7.528e-01,3.279e-02
PARP10,25895,Golgi apparatus,GO:0005794,cellular component,21.0,16.0,1.230e-01,6.480e-02,2.334e-01,8.693e-02,3.713e-02,2.035e-01,6.878e-01,2.900e-02
PARP10,25895,cytosol,GO:0005829,cellular component,21.0,50.0,1.249e-01,6.249e-02,2.496e-01,1.039e-01,4.188e-02,2.579e-01,6.620e-01,3.307e-02
PARP10,25895,cytoplasm,GO:0005737,cellular component,21.0,72.0,1.249e-01,6.249e-02,2.496e-01,1.122e-01,5.070e-02,2.485e-01,6.516e-01,2.970e-02
PARP10,25895,nucleus,GO:0005634,cellular component,21.0,86.0,1.257e-01,6.378e-02,2.479e-01,1.075e-01,5.404e-02,2.139e-01,6.587e-01,2.526e-02
PARP10,25895,K63-linked polyubiquitin modification-dependent protein binding,GO:0070530,molecular function,21.0,2.0,9.867e-02,6.181e-02,1.575e-01,3.315e-02,1.750e-02,6.279e-02,8.053e-01,1.670e-02
PARP10,25895,NAD+ ADP-ribosyltransferase activity,GO:0003950,molecular function,21.0,3.0,1.147e-01,7.621e-02,1.728e-01,7.061e-02,5.345e-02,9.327e-02,7.180e-01,8.540e-03
PARP10,25895,protein ADP-ribosylase activity,GO:1990404,molecular function,21.0,4.0,1.237e-01,7.763e-02,1.971e-01,1.045e-01,8.247e-02,1.323e-01,6.653e-01,8.288e-03
PARP10,25895,protein binding,GO:0005515,molecular function,21.0,318.0,1.315e-01,6.741e-02,2.565e-01,1.293e-01,6.516e-02,2.565e-01,6.307e-01,2.698e-02
PARP14,29232,protein ADP-ribosylation,GO:0006471,biological process,16.0,11.0,1.132e-01,5.638e-02,2.274e-01,1.153e-02,2.820e-03,4.712e-02,8.966e-01,2.097e-02
PARP14,29232,protein mono-ADP-ribosylation,GO:0140289,biological process,16.0,3.0,1.219e-01,7.565e-02,1.964e-01,1.758e-02,1.020e-02,3.027e-02,8.701e-01,1.175e-02
PARP14,29232,positive regulation of tyrosine phosphorylation of STAT protein,GO:0042531,biological process,16.0,7.0,1.399e-01,1.056e-01,1.852e-01,3.483e-02,2.807e-02,4.322e-02,8.005e-01,5.696e-03
PARP14,29232,negative regulation of tyrosine phosphorylation of STAT protein,GO:0042532,biological process,16.0,4.0,1.487e-01,9.465e-02,2.337e-01,5.117e-02,1.608e-02,1.629e-01,7.543e-01,3.275e-02
PARP14,29232,negative regulation of gene expression,GO:0010629,biological process,16.0,26.0,1.705e-01,1.135e-01,2.562e-01,5.136e-02,2.883e-02,9.147e-02,7.560e-01,1.655e-02
PARP14,29232,negative regulation of interferon-gamma-mediated signaling pathway,GO:0060336,biological process,16.0,4.0,3.527e-01,1.413e-01,8.801e-01,3.368e-01,1.289e-01,8.799e-01,4.396e-01,5.216e-02
PARP14,29232,positive regulation of interleukin-4-mediated signaling pathway,GO:1902216,biological process,16.0,3.0,3.705e-01,1.782e-01,7.703e-01,3.621e-01,1.777e-01,7.379e-01,4.256e-01,4.164e-02
PARP14,29232,membrane,GO:0016020,cellular component,16.0,41.0,1.867e-01,1.167e-01,2.988e-01,1.151e-01,4.326e-02,3.060e-01,6.460e-01,3.764e-02
PARP14,29232,cytosol,GO:0005829,cellular component,16.0,50.0,1.867e-01,1.167e-01,2.988e-01,1.246e-01,6.057e-02,2.563e-01,6.362e-01,2.811e-02
PARP14,29232,cytoplasm,GO:0005737,cellular component,16.0,72.0,1.867e-01,1.167e-01,2.988e-01,1.271e-01,7.156e-02,2.257e-01,6.343e-01,2.237e-02
PARP14,29232,plasma membrane,GO:0005886,cellular component,16.0,67.0,1.867e-01,1.167e-01,2.988e-01,1.439e-01,7.757e-02,2.668e-01,6.138e-01,2.486e-02
PARP14,29232,NAD+ ADP-ribosyltransferase activity,GO:0003950,molecular function,16.0,3.0,1.867e-01,1.167e-01,2.988e-01,9.603e-02,5.750e-02,1.604e-01,6.764e-01,1.684e-02
PARP14,29232,protein ADP-ribosylase activity,GO:1990404,molecular function,16.0,4.0,1.867e-01,1.167e-01,2.988e-01,1.279e-01,1.228e-01,1.333e-01,6.349e-01,1.552e-03
PARP14,29232,protein binding,GO:0005515,molecular function,16.0,318.0,1.886e-01,1.176e-01,3.026e-01,1.569e-01,1.011e-01,2.435e-01,6.002e-01,1.807e-02
PARP14,29232,enzyme binding,GO:0019899,molecular function,16.0,35.0,2.311e-01,9.605e-02,5.559e-01,1.628e-01,5.244e-02,5.053e-01,5.874e-01,4.953e-02
PCDH1,8655,cell adhesion,GO:0007155,biological process,13.0,14.0,6.130e-02,3.594e-02,1.046e-01,3.610e-02,2.649e-02,4.920e-02,7.965e-01,8.193e-03
PCDH1,8655,integral component of plasma membrane,GO:0005887,cellular component,13.0,39.0,6.130e-02,3.594e-02,1.046e-01,2.918e-02,1.100e-02,7.739e-02,8.179e-01,2.442e-02
PCDH1,8655,intracellular membrane-bounded organelle,GO:0043231,cellular component,13.0,40.0,6.130e-02,3.594e-02,1.046e-01,3.418e-02,2.082e-02,5.610e-02,8.022e-01,1.312e-02
PCDH1,8655,cell junction,GO:0030054,cellular component,13.0,7.0,6.142e-02,3.587e-02,1.052e-01,3.588e-02,8.561e-03,1.504e-01,7.939e-01,3.640e-02
PCDH1,8655,nucleolus,GO:0005730,cellular component,13.0,5.0,6.142e-02,3.587e-02,1.052e-01,5.568e-02,3.127e-02,9.914e-02,7.465e-01,1.647e-02
PCDH1,8655,nucleoplasm,GO:0005654,cellular component,13.0,47.0,6.892e-02,3.172e-02,1.497e-01,6.892e-02,3.172e-02,1.497e-01,7.194e-01,2.317e-02
PCDH17,14267,cell adhesion,GO:0007155,biological process,4.0,14.0,8.632e-02,6.914e-02,1.078e-01,5.680e-02,4.353e-02,7.411e-02,7.447e-01,7.631e-03
PCDH17,14267,integral component of plasma membrane,GO:0005887,cellular component,4.0,39.0,8.313e-02,6.849e-02,1.009e-01,3.638e-02,1.990e-02,6.652e-02,7.951e-01,1.606e-02
PCDH17,14267,protein binding,GO:0005515,molecular function,4.0,318.0,1.081e-01,8.972e-02,1.302e-01,1.081e-01,8.972e-02,1.302e-01,6.605e-01,6.469e-03
PCDHGC4,8717,,,,nan,nan,,,,,,,,
PCSK4,8746,peptide hormone processing,GO:0016486,biological process,8.0,11.0,8.033e-02,6.028e-02,1.071e-01,1.525e-02,8.016e-03,2.903e-02,8.821e-01,1.290e-02
PCSK4,8746,protein processing,GO:0016485,biological process,8.0,21.0,9.338e-02,5.714e-02,1.526e-01,3.317e-02,1.345e-02,8.177e-02,8.048e-01,2.371e-02
PCSK4,8746,integral component of Golgi membrane,GO:0030173,cellular component,8.0,7.0,1.130e-01,8.338e-02,1.531e-01,7.066e-02,4.498e-02,1.110e-01,7.175e-01,1.345e-02
PCSK4,8746,membrane,GO:0016020,cellular component,8.0,41.0,1.282e-01,9.222e-02,1.783e-01,1.051e-01,5.371e-02,2.055e-01,6.622e-01,2.447e-02
PCSK4,8746,trans-Golgi network,GO:0005802,cellular component,8.0,4.0,1.532e-01,8.706e-02,2.696e-01,1.457e-01,7.189e-02,2.952e-01,6.111e-01,2.776e-02
PCSK4,8746,serine-type endopeptidase activity,GO:0004252,molecular function,8.0,5.0,1.130e-01,8.338e-02,1.531e-01,7.299e-02,3.723e-02,1.431e-01,7.127e-01,2.030e-02
PCSK4,8746,protein binding,GO:0005515,molecular function,8.0,318.0,1.201e-01,1.073e-01,1.344e-01,1.020e-01,8.197e-02,1.269e-01,6.688e-01,7.471e-03
PDE9A,8795,cGMP catabolic process,GO:0046069,biological process,13.0,4.0,1.915e-02,6.760e-03,5.425e-02,7.193e-03,2.815e-03,1.838e-02,9.284e-01,9.752e-03
PDE9A,8795,cGMP metabolic process,GO:0046068,biological process,13.0,5.0,1.915e-02,6.760e-03,5.425e-02,1.419e-02,6.666e-03,3.019e-02,8.873e-01,1.428e-02
PDE9A,8795,cGMP-mediated signaling,GO:0019934,biological process,13.0,5.0,2.424e-02,3.938e-03,1.493e-01,2.303e-02,3.324e-03,1.596e-01,8.358e-01,4.798e-02
PDE9A,8795,cytosol,GO:0005829,cellular component,13.0,50.0,1.915e-02,6.760e-03,5.425e-02,1.360e-02,3.565e-03,5.188e-02,8.844e-01,2.305e-02
PDE9A,8795,sarcolemma,GO:0042383,cellular component,13.0,3.0,1.916e-02,6.769e-03,5.422e-02,9.843e-03,2.066e-03,4.690e-02,9.055e-01,2.095e-02
PDE9A,8795,protein binding,GO:0005515,molecular function,13.0,318.0,1.915e-02,6.760e-03,5.425e-02,1.459e-02,7.600e-03,2.800e-02,8.856e-01,1.233e-02
PDE9A,8795,"3',5'-cyclic-GMP phosphodiesterase activity",GO:0047555,molecular function,13.0,3.0,2.018e-02,6.009e-03,6.780e-02,1.447e-02,3.250e-03,6.441e-02,8.792e-01,3.173e-02
PDGFB,8800,positive regulation of MAP kinase activity,GO:0043406,biological process,87.0,9.0,7.761e-02,5.909e-02,1.019e-01,5.337e-03,1.513e-03,1.883e-02,9.399e-01,1.082e-02
PDGFB,8800,positive regulation of peptidyl-tyrosine phosphorylation,GO:0050731,biological process,87.0,11.0,7.761e-02,5.909e-02,1.019e-01,6.690e-03,2.144e-03,2.088e-02,9.307e-01,1.147e-02
PDGFB,8800,platelet-derived growth factor receptor signaling pathway,GO:0048008,biological process,87.0,5.0,7.761e-02,5.909e-02,1.019e-01,6.167e-03,1.048e-03,3.628e-02,9.273e-01,2.193e-02
PDGFB,8800,interleukin-18-mediated signaling pathway,GO:0035655,biological process,87.0,2.0,7.761e-02,5.909e-02,1.019e-01,9.019e-03,7.483e-03,1.087e-02,9.203e-01,2.395e-03
PDGFB,8800,positive regulation of smooth muscle cell migration,GO:0014911,biological process,87.0,7.0,7.761e-02,5.909e-02,1.019e-01,9.389e-03,7.376e-03,1.195e-02,9.179e-01,3.085e-03
PDGFB,8800,activation of protein kinase B activity,GO:0032148,biological process,87.0,3.0,7.761e-02,5.909e-02,1.019e-01,1.246e-02,1.047e-02,1.484e-02,9.002e-01,2.988e-03
PDGFB,8800,positive regulation of ERK1 and ERK2 cascade,GO:0070374,biological process,87.0,7.0,7.761e-02,5.909e-02,1.019e-01,1.324e-02,8.286e-03,2.117e-02,8.945e-01,9.051e-03
PDGFB,8800,positive regulation of protein autophosphorylation,GO:0031954,biological process,87.0,4.0,7.761e-02,5.909e-02,1.019e-01,1.561e-02,8.630e-03,2.823e-02,8.804e-01,1.232e-02
PDGFB,8800,positive regulation of blood vessel endothelial cell migration,GO:0043536,biological process,87.0,7.0,7.761e-02,5.909e-02,1.019e-01,1.580e-02,8.942e-03,2.792e-02,8.795e-01,1.180e-02
PDGFB,8800,activation of protein kinase activity,GO:0032147,biological process,87.0,12.0,7.761e-02,5.909e-02,1.019e-01,1.721e-02,9.723e-03,3.047e-02,8.720e-01,1.205e-02
PDGFB,8800,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,GO:0035793,biological process,87.0,3.0,7.761e-02,5.909e-02,1.019e-01,2.031e-02,7.431e-03,5.550e-02,8.542e-01,2.301e-02
PDGFB,8800,positive regulation of smooth muscle cell proliferation,GO:0048661,biological process,87.0,6.0,7.770e-02,5.934e-02,1.017e-01,1.249e-02,1.818e-03,8.579e-02,8.838e-01,3.069e-02
PDGFB,8800,negative regulation of pri-miRNA transcription by RNA polymerase II,GO:1902894,biological process,87.0,3.0,7.770e-02,5.934e-02,1.017e-01,2.527e-02,1.605e-02,3.980e-02,8.345e-01,1.137e-02
PDGFB,8800,positive regulation of vascular smooth muscle cell dedifferentiation,GO:1905176,biological process,87.0,4.0,7.780e-02,5.880e-02,1.029e-01,2.264e-02,1.025e-02,4.997e-02,8.449e-01,1.945e-02
PDGFB,8800,positive regulation of metanephric mesenchymal cell migration,GO:2000591,biological process,87.0,5.0,7.931e-02,5.644e-02,1.114e-01,2.059e-02,3.939e-03,1.077e-01,8.491e-01,4.031e-02
PDGFB,8800,protein phosphorylation,GO:0006468,biological process,87.0,25.0,8.010e-02,6.018e-02,1.066e-01,2.529e-02,1.678e-02,3.811e-02,8.346e-01,1.016e-02
PDGFB,8800,protein kinase C signaling,GO:0070528,biological process,87.0,2.0,8.027e-02,6.017e-02,1.071e-01,1.877e-02,4.529e-03,7.781e-02,8.580e-01,3.128e-02
PDGFB,8800,positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045737,biological process,87.0,6.0,8.027e-02,6.017e-02,1.071e-01,2.862e-02,1.838e-02,4.457e-02,8.215e-01,1.144e-02
PDGFB,8800,positive regulation of vascular associated smooth muscle cell migration,GO:1904754,biological process,87.0,3.0,8.027e-02,6.017e-02,1.071e-01,3.052e-02,2.018e-02,4.616e-02,8.147e-01,1.063e-02
PDGFB,8800,positive regulation of pri-miRNA transcription by RNA polymerase II,GO:1902895,biological process,87.0,4.0,8.036e-02,6.047e-02,1.068e-01,3.238e-02,2.395e-02,4.378e-02,8.085e-01,7.918e-03
PDGFB,8800,positive regulation of phosphatidylinositol 3-kinase signaling,GO:0014068,biological process,87.0,5.0,8.036e-02,6.047e-02,1.068e-01,3.320e-02,2.974e-02,3.706e-02,8.058e-01,2.926e-03
PDGFB,8800,positive regulation of vascular smooth muscle cell proliferation,GO:1904707,biological process,87.0,3.0,8.077e-02,5.906e-02,1.105e-01,2.571e-02,1.225e-02,5.399e-02,8.322e-01,1.877e-02
PDGFB,8800,positive regulation of endothelial cell proliferation,GO:0001938,biological process,87.0,8.0,8.185e-02,5.829e-02,1.149e-01,3.462e-02,1.271e-02,9.433e-02,7.997e-01,2.682e-02
PDGFB,8800,positive regulation of fibroblast proliferation,GO:0048146,biological process,87.0,6.0,8.190e-02,6.408e-02,1.047e-01,3.339e-02,1.228e-02,9.078e-02,8.038e-01,2.571e-02
PDGFB,8800,positive regulation of reactive oxygen species metabolic process,GO:2000379,biological process,87.0,8.0,8.429e-02,5.865e-02,1.211e-01,4.453e-02,2.310e-02,8.585e-02,7.724e-01,1.776e-02
PDGFB,8800,positive regulation of MAPK cascade,GO:0043410,biological process,87.0,13.0,8.471e-02,6.379e-02,1.125e-01,4.210e-02,3.463e-02,5.120e-02,7.793e-01,5.313e-03
PDGFB,8800,positive regulation of calcium ion import,GO:0090280,biological process,87.0,6.0,8.621e-02,8.062e-02,9.218e-02,3.363e-02,1.332e-02,8.488e-02,8.032e-01,2.476e-02
PDGFB,8800,positive regulation of cell population proliferation,GO:0008284,biological process,87.0,38.0,8.647e-02,5.840e-02,1.281e-01,4.513e-02,1.667e-02,1.222e-01,7.696e-01,2.822e-02
PDGFB,8800,negative regulation of phosphatidylinositol biosynthetic process,GO:0010512,biological process,87.0,5.0,8.806e-02,5.616e-02,1.381e-01,4.451e-02,1.674e-02,1.184e-01,7.716e-01,2.619e-02
PDGFB,8800,positive regulation of protein tyrosine kinase activity,GO:0061098,biological process,87.0,7.0,8.930e-02,7.540e-02,1.058e-01,5.137e-02,4.678e-02,5.640e-02,7.567e-01,2.706e-03
PDGFB,8800,positive regulation of cell migration,GO:0030335,biological process,87.0,31.0,8.947e-02,6.144e-02,1.303e-01,5.324e-02,2.600e-02,1.090e-01,7.514e-01,2.076e-02
PDGFB,8800,positive regulation of DNA biosynthetic process,GO:2000573,biological process,87.0,11.0,9.012e-02,8.718e-02,9.317e-02,4.532e-02,2.117e-02,9.702e-02,7.703e-01,2.081e-02
PDGFB,8800,positive regulation of chemotaxis,GO:0050921,biological process,87.0,16.0,9.052e-02,8.190e-02,1.000e-01,5.395e-02,3.630e-02,8.018e-02,7.506e-01,1.114e-02
PDGFB,8800,negative regulation of platelet activation,GO:0010544,biological process,87.0,6.0,9.052e-02,6.324e-02,1.296e-01,5.332e-02,3.378e-02,8.414e-02,7.518e-01,1.278e-02
PDGFB,8800,monocyte chemotaxis,GO:0002548,biological process,87.0,5.0,9.240e-02,6.374e-02,1.339e-01,4.984e-02,2.635e-02,9.425e-02,7.593e-01,1.812e-02
PDGFB,8800,positive regulation of hyaluronan biosynthetic process,GO:1900127,biological process,87.0,7.0,9.693e-02,6.558e-02,1.433e-01,5.686e-02,2.795e-02,1.157e-01,7.434e-01,2.090e-02
PDGFB,8800,cellular response to growth factor stimulus,GO:0071363,biological process,87.0,12.0,9.880e-02,5.355e-02,1.823e-01,3.792e-02,5.002e-03,2.874e-01,7.828e-01,5.892e-02
PDGFB,8800,positive regulation of gene expression,GO:0010628,biological process,87.0,27.0,1.011e-01,7.477e-02,1.366e-01,7.295e-02,5.227e-02,1.018e-01,7.138e-01,1.039e-02
PDGFB,8800,positive regulation of phosphatidylinositol 3-kinase activity,GO:0043552,biological process,87.0,5.0,1.012e-01,6.688e-02,1.531e-01,7.237e-02,3.886e-02,1.348e-01,7.138e-01,1.902e-02
PDGFB,8800,negative regulation of vascular smooth muscle cell differentiation,GO:1905064,biological process,87.0,7.0,1.032e-01,5.091e-02,2.092e-01,6.810e-02,1.360e-02,3.409e-01,7.160e-01,4.673e-02
PDGFB,8800,cell chemotaxis,GO:0060326,biological process,87.0,22.0,1.149e-01,8.397e-02,1.573e-01,8.922e-02,5.291e-02,1.504e-01,6.866e-01,1.687e-02
PDGFB,8800,positive regulation of glomerular mesangial cell proliferation,GO:0072126,biological process,87.0,7.0,1.204e-01,4.646e-02,3.122e-01,8.824e-02,1.753e-02,4.441e-01,6.793e-01,5.197e-02
PDGFB,8800,negative regulation of protein binding,GO:0032091,biological process,87.0,14.0,1.228e-01,7.580e-02,1.989e-01,9.872e-02,5.061e-02,1.926e-01,6.712e-01,2.372e-02
PDGFB,8800,negative regulation of gene expression,GO:0010629,biological process,87.0,26.0,1.271e-01,1.013e-01,1.594e-01,1.020e-01,6.045e-02,1.720e-01,6.675e-01,1.824e-02
PDGFB,8800,peptidyl-serine phosphorylation,GO:0018105,biological process,87.0,13.0,1.299e-01,7.110e-02,2.373e-01,1.071e-01,4.199e-02,2.734e-01,6.576e-01,3.315e-02
PDGFB,8800,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,87.0,41.0,1.324e-01,9.530e-02,1.839e-01,1.117e-01,7.478e-02,1.669e-01,6.547e-01,1.473e-02
PDGFB,8800,positive regulation of mitotic nuclear division,GO:0045840,biological process,87.0,8.0,1.510e-01,1.041e-01,2.191e-01,1.353e-01,8.180e-02,2.237e-01,6.244e-01,1.900e-02
PDGFB,8800,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,87.0,39.0,1.553e-01,1.366e-01,1.766e-01,1.416e-01,1.212e-01,1.654e-01,6.182e-01,6.214e-03
PDGFB,8800,peptidyl-tyrosine phosphorylation,GO:0018108,biological process,87.0,8.0,1.955e-01,7.462e-02,5.124e-01,1.794e-01,5.420e-02,5.938e-01,5.693e-01,5.203e-02
PDGFB,8800,reactive oxygen species metabolic process,GO:0072593,biological process,87.0,7.0,2.304e-01,1.068e-01,4.971e-01,2.221e-01,9.815e-02,5.025e-01,5.340e-01,3.677e-02
PDGFB,8800,response to wounding,GO:0009611,biological process,87.0,10.0,3.038e-01,1.983e-01,4.654e-01,3.023e-01,1.981e-01,4.612e-01,4.728e-01,2.232e-02
PDGFB,8800,collagen-containing extracellular matrix,GO:0062023,cellular component,87.0,20.0,9.842e-02,6.525e-02,1.484e-01,6.380e-02,3.349e-02,1.215e-01,7.297e-01,1.957e-02
PDGFB,8800,extracellular space,GO:0005615,cellular component,87.0,24.0,1.089e-01,8.902e-02,1.333e-01,8.248e-02,7.027e-02,9.682e-02,6.980e-01,5.071e-03
PDGFB,8800,cell surface,GO:0009986,cellular component,87.0,20.0,1.102e-01,7.560e-02,1.606e-01,8.574e-02,5.035e-02,1.460e-01,6.920e-01,1.684e-02
PDGFB,8800,platelet-derived growth factor receptor binding,GO:0005161,molecular function,87.0,2.0,7.761e-02,5.909e-02,1.019e-01,8.280e-03,5.214e-03,1.315e-02,9.237e-01,5.359e-03
PDGFB,8800,growth factor activity,GO:0008083,molecular function,87.0,3.0,8.027e-02,6.017e-02,1.071e-01,2.664e-02,1.368e-02,5.185e-02,8.287e-01,1.659e-02
PDGFB,8800,chemoattractant activity,GO:0042056,molecular function,87.0,6.0,8.130e-02,5.932e-02,1.114e-01,3.443e-02,2.264e-02,5.235e-02,8.017e-01,1.121e-02
PDGFB,8800,platelet-derived growth factor binding,GO:0048407,molecular function,87.0,2.0,9.061e-02,8.023e-02,1.023e-01,5.778e-02,4.624e-02,7.220e-02,7.427e-01,6.363e-03
PDGFB,8800,collagen binding,GO:0005518,molecular function,87.0,5.0,9.137e-02,5.217e-02,1.601e-01,4.375e-02,1.176e-02,1.628e-01,7.720e-01,3.661e-02
PDGFB,8800,growth factor receptor binding,GO:0070851,molecular function,87.0,23.0,9.573e-02,5.323e-02,1.722e-01,4.976e-02,9.041e-03,2.738e-01,7.549e-01,4.685e-02
PDGFB,8800,identical protein binding,GO:0042802,molecular function,87.0,24.0,9.899e-02,8.073e-02,1.214e-01,6.430e-02,4.919e-02,8.406e-02,7.297e-01,7.824e-03
PDGFB,8800,protein heterodimerization activity,GO:0046982,molecular function,87.0,8.0,1.123e-01,9.336e-02,1.352e-01,8.729e-02,7.293e-02,1.045e-01,6.905e-01,5.782e-03
PDGFB,8800,protein homodimerization activity,GO:0042803,molecular function,87.0,23.0,1.419e-01,1.082e-01,1.861e-01,1.273e-01,9.031e-02,1.793e-01,6.350e-01,1.320e-02
PDGFB,8800,superoxide-generating NADPH oxidase activator activity,GO:0016176,molecular function,87.0,2.0,1.550e-01,9.990e-02,2.403e-01,1.385e-01,7.728e-02,2.483e-01,6.202e-01,2.240e-02
PDGFB,8800,protein binding,GO:0005515,molecular function,87.0,318.0,1.799e-01,1.376e-01,2.353e-01,1.707e-01,1.263e-01,2.307e-01,5.862e-01,1.289e-02
PER3,8847,,,,nan,nan,,,,,,,,
PHF1,8919,cellular response to DNA damage stimulus,GO:0006974,biological process,18.0,13.0,8.975e-02,5.068e-02,1.589e-01,3.571e-02,8.815e-03,1.446e-01,7.947e-01,3.819e-02
PHF1,8919,"regulation of transcription, DNA-templated",GO:0006355,biological process,18.0,35.0,1.096e-01,7.121e-02,1.688e-01,5.790e-02,1.713e-02,1.957e-01,7.388e-01,3.567e-02
PHF1,8919,chromatin organization,GO:0006325,biological process,18.0,14.0,1.212e-01,1.022e-01,1.437e-01,9.285e-02,5.702e-02,1.512e-01,6.812e-01,1.595e-02
PHF1,8919,negative regulation of histone H3-K27 methylation,GO:0061086,biological process,18.0,4.0,1.754e-01,1.064e-01,2.892e-01,1.586e-01,9.022e-02,2.788e-01,5.976e-01,2.373e-02
PHF1,8919,positive regulation of histone H3-K27 methylation,GO:0061087,biological process,18.0,4.0,2.108e-01,1.316e-01,3.377e-01,2.057e-01,1.204e-01,3.515e-01,5.511e-01,2.452e-02
PHF1,8919,site of double-strand break,GO:0035861,cellular component,18.0,3.0,5.446e-02,1.802e-02,1.646e-01,5.993e-03,9.664e-04,3.717e-02,9.318e-01,1.506e-02
PHF1,8919,ESC/E(Z) complex,GO:0035098,cellular component,18.0,3.0,7.868e-02,6.188e-02,1.000e-01,1.772e-02,1.484e-02,2.117e-02,8.701e-01,3.979e-03
PHF1,8919,centrosome,GO:0005813,cellular component,18.0,11.0,1.163e-01,1.067e-01,1.268e-01,6.257e-02,4.183e-02,9.360e-02,7.329e-01,1.174e-02
PHF1,8919,nucleus,GO:0005634,cellular component,18.0,86.0,1.163e-01,1.067e-01,1.268e-01,6.714e-02,6.157e-02,7.321e-02,7.246e-01,2.637e-03
PHF1,8919,nucleoplasm,GO:0005654,cellular component,18.0,47.0,1.163e-01,1.067e-01,1.268e-01,7.032e-02,5.696e-02,8.680e-02,7.186e-01,6.376e-03
PHF1,8919,DNA binding,GO:0003677,molecular function,18.0,29.0,7.868e-02,6.188e-02,1.000e-01,1.803e-02,1.176e-02,2.764e-02,8.684e-01,9.734e-03
PHF1,8919,methylated histone binding,GO:0035064,molecular function,18.0,7.0,1.098e-01,9.173e-02,1.315e-01,6.618e-02,2.237e-02,1.958e-01,7.232e-01,3.169e-02
PHF1,8919,chromatin binding,GO:0003682,molecular function,18.0,11.0,1.258e-01,7.044e-02,2.247e-01,7.588e-02,1.514e-02,3.804e-01,6.996e-01,5.248e-02
PHF1,8919,protein binding,GO:0005515,molecular function,18.0,318.0,1.317e-01,1.087e-01,1.596e-01,1.064e-01,8.370e-02,1.354e-01,6.626e-01,8.243e-03
PHYHD1,23396,,,,nan,nan,,,,,,,,
PIK3R6,27101,positive regulation of MAP kinase activity,GO:0043406,biological process,16.0,9.0,1.028e-01,5.458e-02,1.936e-01,2.963e-02,9.095e-03,9.653e-02,8.155e-01,2.913e-02
PIK3R6,27101,G protein-coupled receptor signaling pathway,GO:0007186,biological process,16.0,48.0,1.417e-01,7.822e-02,2.567e-01,7.345e-02,1.979e-02,2.726e-01,7.073e-01,4.121e-02
PIK3R6,27101,positive regulation of angiogenesis,GO:0045766,biological process,16.0,12.0,1.643e-01,1.498e-01,1.802e-01,1.129e-01,7.497e-02,1.701e-01,6.532e-01,1.442e-02
PIK3R6,27101,regulation of natural killer cell mediated cytotoxicity,GO:0042269,biological process,16.0,7.0,1.797e-01,1.454e-01,2.221e-01,1.256e-01,5.548e-02,2.845e-01,6.341e-01,2.969e-02
PIK3R6,27101,phosphatidylinositol 3-kinase complex,GO:0005942,cellular component,16.0,6.0,2.547e-01,1.217e-01,5.332e-01,2.547e-01,1.217e-01,5.332e-01,5.068e-01,3.607e-02
PIK3R6,27101,1-phosphatidylinositol-3-kinase regulator activity,GO:0046935,molecular function,16.0,2.0,1.028e-01,5.458e-02,1.936e-01,2.308e-02,1.331e-02,4.003e-02,8.437e-01,1.365e-02
PIK3R6,27101,protein binding,GO:0005515,molecular function,16.0,318.0,1.797e-01,1.454e-01,2.221e-01,1.527e-01,1.319e-01,1.768e-01,6.057e-01,5.895e-03
PIM3,19310,,,,nan,nan,,,,,,,,
PKN3,17999,peptidyl-serine phosphorylation,GO:0018105,biological process,6.0,13.0,3.413e-01,2.647e-01,4.401e-01,1.880e-01,7.706e-02,4.587e-01,5.644e-01,4.102e-02
PKN3,17999,intracellular signal transduction,GO:0035556,biological process,6.0,34.0,3.413e-01,2.647e-01,4.401e-01,2.197e-01,1.542e-01,3.132e-01,5.395e-01,1.637e-02
PKN3,17999,epithelial cell migration,GO:0010631,biological process,6.0,13.0,5.167e-01,3.681e-01,7.254e-01,5.167e-01,3.681e-01,7.254e-01,3.292e-01,2.677e-02
PKN3,17999,protein serine/threonine kinase activity,GO:0004674,molecular function,6.0,28.0,3.413e-01,2.647e-01,4.401e-01,1.487e-01,7.633e-02,2.895e-01,6.079e-01,2.743e-02
PKN3,17999,protein binding,GO:0005515,molecular function,6.0,318.0,3.413e-01,2.647e-01,4.401e-01,2.655e-01,2.250e-01,3.133e-01,5.022e-01,8.402e-03
PLA2G2D,9033,phospholipid metabolic process,GO:0006644,biological process,8.0,26.0,1.404e-01,1.212e-02,1.627e+00,9.152e-02,4.776e-03,1.754e+00,6.520e-01,9.787e-02
PLA2G2D,9033,negative regulation of T cell proliferation,GO:0042130,biological process,8.0,9.0,2.617e-01,2.253e-01,3.039e-01,2.462e-01,2.253e-01,2.691e-01,5.179e-01,4.308e-03
PLA2G2D,9033,calcium-dependent phospholipase A2 activity,GO:0047498,molecular function,8.0,2.0,5.803e-02,1.395e-02,2.413e-01,1.696e-02,6.460e-03,4.455e-02,8.709e-01,2.110e-02
PLA2G2D,9033,phospholipase A2 activity,GO:0004623,molecular function,8.0,5.0,5.803e-02,1.395e-02,2.413e-01,3.062e-02,1.550e-02,6.051e-02,8.140e-01,1.771e-02
PLA2G2D,9033,phospholipid binding,GO:0005543,molecular function,8.0,16.0,7.258e-02,8.244e-03,6.390e-01,4.881e-02,3.832e-03,6.218e-01,7.433e-01,8.251e-02
PLA2G2D,9033,calcium ion binding,GO:0005509,molecular function,8.0,7.0,8.961e-02,1.362e-02,5.896e-01,4.075e-02,1.550e-03,1.072e+00,7.526e-01,8.313e-02
PLK2,19699,,,,nan,nan,,,,,,,,
PLPPR3,23497,phospholipid dephosphorylation,GO:0046839,biological process,8.0,4.0,1.479e-01,2.747e-02,7.964e-01,8.425e-02,9.038e-03,7.854e-01,6.784e-01,6.994e-02
PLPPR3,23497,phospholipid metabolic process,GO:0006644,biological process,8.0,26.0,1.916e-01,4.182e-02,8.774e-01,1.434e-01,1.988e-02,1.035e+00,5.968e-01,7.225e-02
PLPPR3,23497,signal transduction,GO:0007165,biological process,8.0,48.0,3.982e-01,1.785e-01,8.882e-01,3.559e-01,1.092e-01,1.160e+00,4.201e-01,6.559e-02
PLPPR3,23497,integral component of plasma membrane,GO:0005887,cellular component,8.0,39.0,1.579e-01,5.159e-02,4.833e-01,8.878e-02,3.442e-02,2.290e-01,6.840e-01,3.275e-02
PLPPR3,23497,phosphatidate phosphatase activity,GO:0008195,molecular function,8.0,2.0,7.067e-02,3.290e-02,1.518e-01,1.838e-02,7.778e-03,4.343e-02,8.650e-01,2.036e-02
PLPPR3,23497,lipid phosphatase activity,GO:0042577,molecular function,8.0,4.0,7.067e-02,3.290e-02,1.518e-01,2.311e-02,1.220e-02,4.380e-02,8.432e-01,1.545e-02
PLPPR3,23497,phosphatase activity,GO:0016791,molecular function,8.0,72.0,3.122e-01,7.241e-02,1.346e+00,2.451e-01,4.068e-02,1.476e+00,4.810e-01,1.094e-01
PODN,23174,,,,nan,nan,,,,,,,,
POLA2,30073,DNA replication initiation,GO:0006270,biological process,8.0,3.0,4.255e-02,2.778e-02,6.517e-02,2.611e-02,1.543e-02,4.419e-02,8.312e-01,1.315e-02
POLA2,30073,nucleoplasm,GO:0005654,cellular component,8.0,47.0,4.255e-02,2.778e-02,6.517e-02,3.400e-02,2.031e-02,5.691e-02,8.027e-01,1.364e-02
POLA2,30073,alpha DNA polymerase:primase complex,GO:0005658,cellular component,8.0,3.0,4.255e-02,2.778e-02,6.517e-02,3.679e-02,1.942e-02,6.968e-02,7.941e-01,1.732e-02
POLA2,30073,cytosol,GO:0005829,cellular component,8.0,50.0,4.255e-02,2.778e-02,6.517e-02,4.255e-02,2.778e-02,6.517e-02,7.780e-01,1.170e-02
POLA2,30073,protein heterodimerization activity,GO:0046982,molecular function,8.0,8.0,4.255e-02,2.778e-02,6.517e-02,2.308e-02,1.042e-02,5.112e-02,8.429e-01,1.959e-02
POLD1,9175,DNA replication proofreading,GO:0045004,biological process,25.0,3.0,1.339e-01,5.572e-02,3.218e-01,4.499e-02,1.431e-02,1.415e-01,7.697e-01,3.119e-02
POLD1,9175,DNA replication,GO:0006260,biological process,25.0,5.0,1.339e-01,5.572e-02,3.218e-01,4.798e-02,2.040e-02,1.128e-01,7.630e-01,2.449e-02
POLD1,9175,DNA-dependent DNA replication,GO:0006261,biological process,25.0,7.0,1.339e-01,5.572e-02,3.218e-01,5.161e-02,3.235e-02,8.234e-02,7.558e-01,1.303e-02
POLD1,9175,DNA synthesis involved in DNA repair,GO:0000731,biological process,25.0,8.0,1.343e-01,5.547e-02,3.253e-01,5.541e-02,1.764e-02,1.740e-01,7.443e-01,3.414e-02
POLD1,9175,"nucleotide-excision repair, DNA gap filling",GO:0006297,biological process,25.0,2.0,1.413e-01,5.117e-02,3.902e-01,9.343e-02,3.687e-02,2.368e-01,6.771e-01,3.180e-02
POLD1,9175,"base-excision repair, gap-filling",GO:0006287,biological process,25.0,2.0,1.413e-01,5.117e-02,3.902e-01,9.644e-02,3.347e-02,2.779e-01,6.718e-01,3.638e-02
POLD1,9175,cellular response to UV,GO:0034644,biological process,25.0,10.0,1.417e-01,5.126e-02,3.919e-01,6.488e-02,5.786e-03,7.275e-01,7.133e-01,6.963e-02
POLD1,9175,fatty acid homeostasis,GO:0055089,biological process,25.0,4.0,1.619e-01,4.146e-02,6.320e-01,9.114e-02,1.224e-02,6.788e-01,6.659e-01,7.507e-02
POLD1,9175,aggresome,GO:0016235,cellular component,25.0,3.0,1.339e-01,5.572e-02,3.218e-01,1.912e-02,8.547e-03,4.279e-02,8.606e-01,1.762e-02
POLD1,9175,membrane,GO:0016020,cellular component,25.0,41.0,1.339e-01,5.572e-02,3.218e-01,5.219e-02,4.354e-02,6.256e-02,7.546e-01,5.198e-03
POLD1,9175,cytosol,GO:0005829,cellular component,25.0,50.0,1.339e-01,5.572e-02,3.218e-01,6.784e-02,4.397e-02,1.047e-01,7.228e-01,1.323e-02
POLD1,9175,nucleus,GO:0005634,cellular component,25.0,86.0,1.339e-01,5.572e-02,3.218e-01,7.335e-02,4.438e-02,1.212e-01,7.124e-01,1.558e-02
POLD1,9175,nucleoplasm,GO:0005654,cellular component,25.0,47.0,1.386e-01,6.452e-02,2.978e-01,7.968e-02,6.437e-02,9.864e-02,7.025e-01,6.764e-03
POLD1,9175,"nuclear chromosome, telomeric region",GO:0000784,cellular component,25.0,4.0,1.881e-01,1.304e-01,2.714e-01,1.574e-01,1.447e-01,1.712e-01,6.007e-01,3.319e-03
POLD1,9175,delta DNA polymerase complex,GO:0043625,cellular component,25.0,2.0,1.957e-01,5.037e-02,7.606e-01,1.778e-01,4.299e-02,7.353e-01,5.675e-01,5.947e-02
POLD1,9175,nucleotide-excision repair complex,GO:0000109,cellular component,25.0,11.0,3.961e-01,1.967e-01,7.973e-01,3.961e-01,1.967e-01,7.973e-01,4.016e-01,4.467e-02
POLD1,9175,damaged DNA binding,GO:0003684,molecular function,25.0,5.0,1.339e-01,5.572e-02,3.218e-01,2.415e-02,8.132e-03,7.174e-02,8.374e-01,2.724e-02
POLD1,9175,DNA binding,GO:0003677,molecular function,25.0,29.0,1.343e-01,5.547e-02,3.253e-01,6.017e-02,2.199e-02,1.646e-01,7.354e-01,2.908e-02
POLD1,9175,protein binding,GO:0005515,molecular function,25.0,318.0,1.347e-01,5.550e-02,3.271e-01,8.619e-02,4.033e-02,1.842e-01,6.902e-01,2.385e-02
POLD1,9175,DNA-directed DNA polymerase activity,GO:0003887,molecular function,25.0,2.0,1.543e-01,5.061e-02,4.707e-01,1.212e-01,3.563e-02,4.120e-01,6.358e-01,4.286e-02
POLD1,9175,chromatin binding,GO:0003682,molecular function,25.0,11.0,1.785e-01,3.990e-02,7.986e-01,1.385e-01,1.722e-02,1.114e+00,5.993e-01,8.021e-02
POLD1,9175,3'-5'-exodeoxyribonuclease activity,GO:0008296,molecular function,25.0,5.0,1.902e-01,6.726e-02,5.381e-01,1.587e-01,6.000e-02,4.198e-01,5.940e-01,4.178e-02
POLR3GL,28466,,,,nan,nan,,,,,,,,
PPARGC1A,9237,positive regulation of gene expression,GO:0010628,biological process,28.0,27.0,2.548e-02,1.906e-02,3.407e-02,6.374e-03,2.069e-03,1.964e-02,9.333e-01,1.041e-02
PPARGC1A,9237,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,28.0,41.0,2.548e-02,1.906e-02,3.407e-02,8.719e-03,2.984e-03,2.547e-02,9.178e-01,1.294e-02
PPARGC1A,9237,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,28.0,69.0,3.135e-02,2.075e-02,4.739e-02,1.910e-02,1.148e-02,3.176e-02,8.626e-01,1.158e-02
PPARGC1A,9237,"regulation of transcription, DNA-templated",GO:0006355,biological process,28.0,35.0,3.162e-02,1.988e-02,5.030e-02,1.748e-02,9.034e-03,3.382e-02,8.700e-01,1.508e-02
PPARGC1A,9237,negative regulation of neuron death,GO:1901215,biological process,28.0,5.0,4.566e-02,2.037e-02,1.023e-01,4.222e-02,1.690e-02,1.054e-01,7.777e-01,2.478e-02
PPARGC1A,9237,positive regulation of DNA-binding transcription factor activity,GO:0051091,biological process,28.0,12.0,5.228e-02,2.214e-02,1.234e-01,4.899e-02,2.088e-02,1.149e-01,7.609e-01,2.354e-02
PPARGC1A,9237,positive regulation of mitochondrion organization,GO:0010822,biological process,28.0,11.0,6.656e-02,2.686e-02,1.650e-01,6.531e-02,2.595e-02,1.643e-01,7.253e-01,2.847e-02
PPARGC1A,9237,nucleus,GO:0005634,cellular component,28.0,86.0,2.548e-02,1.906e-02,3.407e-02,8.177e-03,2.965e-03,2.255e-02,9.218e-01,1.076e-02
PPARGC1A,9237,nucleoplasm,GO:0005654,cellular component,28.0,47.0,2.760e-02,2.529e-02,3.012e-02,1.223e-02,6.635e-03,2.253e-02,8.992e-01,1.096e-02
PPARGC1A,9237,intracellular membrane-bounded organelle,GO:0043231,cellular component,28.0,40.0,3.247e-02,1.955e-02,5.395e-02,2.390e-02,1.482e-02,3.855e-02,8.403e-01,1.177e-02
PPARGC1A,9237,ubiquitin protein ligase binding,GO:0031625,molecular function,28.0,6.0,2.548e-02,1.906e-02,3.407e-02,3.050e-03,1.652e-03,5.631e-03,9.591e-01,4.018e-03
PPARGC1A,9237,transcription coactivator activity,GO:0003713,molecular function,28.0,3.0,2.659e-02,2.269e-02,3.116e-02,8.366e-03,5.811e-03,1.204e-02,9.234e-01,4.100e-03
PPARGC1A,9237,protein binding,GO:0005515,molecular function,28.0,318.0,2.974e-02,2.287e-02,3.869e-02,1.544e-02,9.459e-03,2.520e-02,8.822e-01,1.056e-02
PPARGC1A,9237,nuclear receptor transcription coactivator activity,GO:0030374,molecular function,28.0,5.0,3.122e-02,2.047e-02,4.763e-02,1.514e-02,8.213e-03,2.790e-02,8.828e-01,1.220e-02
PPARGC1A,9237,transcription factor binding,GO:0008134,molecular function,28.0,16.0,3.122e-02,2.047e-02,4.763e-02,1.687e-02,7.642e-03,3.724e-02,8.723e-01,1.603e-02
PPARGC1A,9237,sequence-specific DNA binding,GO:0043565,molecular function,28.0,14.0,3.231e-02,1.933e-02,5.400e-02,2.256e-02,1.188e-02,4.287e-02,8.457e-01,1.551e-02
PPARGC1A,9237,transcription coregulator activity,GO:0003712,molecular function,28.0,5.0,3.258e-02,1.854e-02,5.726e-02,2.189e-02,8.953e-03,5.351e-02,8.480e-01,2.183e-02
PPARGC1A,9237,nuclear receptor binding,GO:0016922,molecular function,28.0,8.0,3.288e-02,1.899e-02,5.693e-02,2.711e-02,1.544e-02,4.758e-02,8.271e-01,1.448e-02
PPEF2,9244,,,,nan,nan,,,,,,,,
PPM1J,20785,positive regulation of pyruvate dehydrogenase activity,GO:1904184,biological process,8.0,3.0,1.094e-01,6.070e-02,1.972e-01,1.034e-01,5.158e-02,2.072e-01,6.644e-01,2.514e-02
PPM1J,20785,mitochondrion,GO:0005739,cellular component,8.0,12.0,1.045e-01,6.776e-02,1.611e-01,7.036e-02,2.899e-02,1.707e-01,7.162e-01,2.688e-02
PPM1J,20785,magnesium-dependent protein serine/threonine phosphatase activity,GO:0004724,molecular function,8.0,2.0,8.014e-02,6.739e-02,9.530e-02,1.606e-02,1.352e-02,1.908e-02,8.794e-01,3.686e-03
PPM1J,20785,protein serine/threonine phosphatase activity,GO:0004722,molecular function,8.0,7.0,8.745e-02,7.321e-02,1.045e-01,5.866e-02,2.517e-02,1.367e-01,7.394e-01,2.401e-02
PPM1J,20785,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,GO:0004741,molecular function,8.0,2.0,8.745e-02,7.321e-02,1.045e-01,6.928e-02,3.500e-02,1.372e-01,7.193e-01,2.049e-02
PPP4R4,23788,,,,nan,nan,,,,,,,,
PRF1,9360,protein homooligomerization,GO:0051260,biological process,17.0,6.0,7.150e-02,3.423e-02,1.494e-01,1.024e-02,2.639e-03,3.972e-02,9.050e-01,1.759e-02
PRF1,9360,immunological synapse formation,GO:0001771,biological process,17.0,2.0,9.695e-02,8.538e-02,1.101e-01,5.583e-02,3.514e-02,8.870e-02,7.463e-01,1.334e-02
PRF1,9360,positive regulation of killing of cells of other organism,GO:0051712,biological process,17.0,8.0,1.086e-01,6.631e-02,1.778e-01,6.622e-02,1.588e-02,2.761e-01,7.193e-01,4.509e-02
PRF1,9360,cytolytic granule,GO:0044194,cellular component,17.0,2.0,8.606e-02,7.649e-02,9.682e-02,1.793e-02,1.486e-02,2.163e-02,8.692e-01,4.046e-03
PRF1,9360,integral component of membrane,GO:0016021,cellular component,17.0,19.0,9.191e-02,8.153e-02,1.036e-01,4.102e-02,2.318e-02,7.258e-02,7.820e-01,1.548e-02
PRF1,9360,membrane,GO:0016020,cellular component,17.0,41.0,1.268e-01,8.913e-02,1.803e-01,9.644e-02,5.441e-02,1.710e-01,6.753e-01,1.918e-02
PRF1,9360,cytosol,GO:0005829,cellular component,17.0,50.0,1.308e-01,1.024e-01,1.671e-01,1.137e-01,8.606e-02,1.502e-01,6.527e-01,1.007e-02
PRF1,9360,identical protein binding,GO:0042802,molecular function,17.0,24.0,9.146e-02,8.103e-02,1.032e-01,4.428e-02,2.678e-02,7.322e-02,7.732e-01,1.384e-02
PRF1,9360,wide pore channel activity,GO:0022829,molecular function,17.0,5.0,1.235e-01,7.650e-02,1.992e-01,9.279e-02,2.838e-02,3.034e-01,6.765e-01,3.804e-02
PRF1,9360,protein binding,GO:0005515,molecular function,17.0,318.0,1.310e-01,1.023e-01,1.678e-01,1.221e-01,8.862e-02,1.683e-01,6.415e-01,1.182e-02
PRKCG,9402,phosphorylation,GO:0016310,biological process,28.0,12.0,4.000e-02,1.468e-02,1.090e-01,1.352e-02,5.242e-03,3.489e-02,8.896e-01,1.948e-02
PRKCG,9402,positive regulation of mismatch repair,GO:0032425,biological process,28.0,3.0,4.575e-02,1.074e-02,1.948e-01,2.060e-02,2.401e-03,1.767e-01,8.435e-01,5.178e-02
PRKCG,9402,negative regulation of protein catabolic process,GO:0042177,biological process,28.0,9.0,6.942e-02,3.274e-02,1.472e-01,4.312e-02,2.548e-02,7.298e-02,7.764e-01,1.440e-02
PRKCG,9402,peptidyl-serine phosphorylation,GO:0018105,biological process,28.0,13.0,6.986e-02,3.243e-02,1.505e-01,4.539e-02,1.892e-02,1.089e-01,7.695e-01,2.366e-02
PRKCG,9402,negative regulation of protein ubiquitination,GO:0031397,biological process,28.0,11.0,7.220e-02,3.030e-02,1.720e-01,5.100e-02,1.861e-02,1.398e-01,7.551e-01,2.952e-02
PRKCG,9402,intracellular signal transduction,GO:0035556,biological process,28.0,34.0,1.006e-01,4.519e-02,2.241e-01,1.006e-01,4.519e-02,2.241e-01,6.675e-01,2.891e-02
PRKCG,9402,protein kinase activity,GO:0004672,molecular function,28.0,29.0,3.799e-02,1.649e-02,8.753e-02,6.375e-03,5.578e-03,7.287e-03,9.359e-01,1.457e-03
PRKCG,9402,protein serine/threonine/tyrosine kinase activity,GO:0004712,molecular function,28.0,4.0,3.879e-02,1.574e-02,9.556e-02,1.368e-02,1.054e-02,1.776e-02,8.928e-01,4.842e-03
PRKCG,9402,protein serine/threonine kinase activity,GO:0004674,molecular function,28.0,28.0,8.405e-02,4.498e-02,1.571e-01,7.320e-02,3.734e-02,1.435e-01,7.121e-01,2.118e-02
PRKD2,17293,positive regulation of endothelial cell chemotaxis,GO:2001028,biological process,37.0,6.0,5.991e-02,3.510e-02,1.022e-01,4.053e-03,9.556e-04,1.719e-02,9.488e-01,9.756e-03
PRKD2,17293,vascular endothelial growth factor receptor signaling pathway,GO:0048010,biological process,37.0,7.0,5.991e-02,3.510e-02,1.022e-01,8.646e-03,4.969e-03,1.504e-02,9.212e-01,7.300e-03
PRKD2,17293,positive regulation of blood vessel endothelial cell migration,GO:0043536,biological process,37.0,7.0,5.991e-02,3.510e-02,1.022e-01,9.412e-03,2.405e-03,3.684e-02,9.107e-01,1.621e-02
PRKD2,17293,protein kinase D signaling,GO:0089700,biological process,37.0,2.0,5.991e-02,3.510e-02,1.022e-01,1.022e-02,4.185e-03,2.495e-02,9.094e-01,1.258e-02
PRKD2,17293,positive regulation of cell adhesion,GO:0045785,biological process,37.0,10.0,5.991e-02,3.510e-02,1.022e-01,1.125e-02,3.869e-03,3.271e-02,9.016e-01,1.533e-02
PRKD2,17293,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,GO:0038033,biological process,37.0,4.0,5.991e-02,3.510e-02,1.022e-01,1.382e-02,8.577e-03,2.228e-02,8.910e-01,9.471e-03
PRKD2,17293,positive regulation of intracellular signal transduction,GO:1902533,biological process,37.0,26.0,5.991e-02,3.510e-02,1.022e-01,1.162e-02,1.522e-03,8.865e-02,8.878e-01,3.257e-02
PRKD2,17293,protein phosphorylation,GO:0006468,biological process,37.0,25.0,5.991e-02,3.510e-02,1.022e-01,1.737e-02,4.631e-03,6.519e-02,8.655e-01,2.821e-02
PRKD2,17293,positive regulation of endothelial cell migration,GO:0010595,biological process,37.0,8.0,5.991e-02,3.510e-02,1.022e-01,1.830e-02,7.478e-03,4.477e-02,8.640e-01,1.903e-02
PRKD2,17293,positive regulation of vascular endothelial growth factor receptor signaling pathway,GO:0030949,biological process,37.0,3.0,6.383e-02,4.599e-02,8.859e-02,2.096e-02,1.245e-02,3.531e-02,8.532e-01,1.224e-02
PRKD2,17293,cellular response to vascular endothelial growth factor stimulus,GO:0035924,biological process,37.0,3.0,6.383e-02,4.599e-02,8.859e-02,3.078e-02,1.796e-02,5.275e-02,8.137e-01,1.407e-02
PRKD2,17293,positive regulation of peptidyl-serine phosphorylation,GO:0033138,biological process,37.0,6.0,6.423e-02,4.609e-02,8.950e-02,2.210e-02,1.390e-02,3.516e-02,8.486e-01,1.136e-02
PRKD2,17293,positive regulation of CREB transcription factor activity,GO:0032793,biological process,37.0,3.0,6.423e-02,4.609e-02,8.950e-02,2.771e-02,2.686e-02,2.859e-02,8.251e-01,7.096e-04
PRKD2,17293,positive regulation of DNA-binding transcription factor activity,GO:0051091,biological process,37.0,12.0,6.853e-02,4.429e-02,1.060e-01,2.476e-02,7.530e-03,8.139e-02,8.345e-01,2.983e-02
PRKD2,17293,T cell receptor signaling pathway,GO:0050852,biological process,37.0,4.0,6.853e-02,4.429e-02,1.060e-01,3.519e-02,1.920e-02,6.448e-02,7.989e-01,1.592e-02
PRKD2,17293,positive regulation of NF-kappaB transcription factor activity,GO:0051092,biological process,37.0,6.0,7.024e-02,4.394e-02,1.123e-01,4.035e-02,2.006e-02,8.115e-02,7.835e-01,1.851e-02
PRKD2,17293,positive regulation of endothelial cell proliferation,GO:0001938,biological process,37.0,8.0,7.040e-02,3.778e-02,1.312e-01,3.471e-02,1.016e-02,1.185e-01,7.985e-01,3.341e-02
PRKD2,17293,positive regulation of fibroblast growth factor receptor signaling pathway,GO:0045743,biological process,37.0,5.0,7.703e-02,5.800e-02,1.023e-01,4.463e-02,2.944e-02,6.765e-02,7.727e-01,1.144e-02
PRKD2,17293,positive regulation of angiogenesis,GO:0045766,biological process,37.0,12.0,8.790e-02,6.470e-02,1.194e-01,6.009e-02,3.785e-02,9.541e-02,7.376e-01,1.369e-02
PRKD2,17293,positive regulation of interleukin-8 production,GO:0032757,biological process,37.0,6.0,9.061e-02,5.118e-02,1.604e-01,5.542e-02,2.363e-02,1.300e-01,7.461e-01,2.468e-02
PRKD2,17293,positive regulation of histone deacetylase activity,GO:1901727,biological process,37.0,4.0,9.183e-02,4.958e-02,1.701e-01,5.749e-02,2.364e-02,1.398e-01,7.413e-01,2.622e-02
PRKD2,17293,protein autophosphorylation,GO:0046777,biological process,37.0,11.0,1.107e-01,5.843e-02,2.099e-01,8.223e-02,4.151e-02,1.629e-01,6.968e-01,2.160e-02
PRKD2,17293,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,37.0,69.0,1.116e-01,4.005e-02,3.112e-01,8.119e-02,2.482e-02,2.656e-01,6.941e-01,4.056e-02
PRKD2,17293,intracellular signal transduction,GO:0035556,biological process,37.0,34.0,1.144e-01,6.244e-02,2.096e-01,8.423e-02,4.457e-02,1.592e-01,6.937e-01,2.058e-02
PRKD2,17293,peptidyl-serine phosphorylation,GO:0018105,biological process,37.0,13.0,1.160e-01,4.452e-02,3.022e-01,8.674e-02,2.974e-02,2.530e-01,6.863e-01,3.678e-02
PRKD2,17293,peptidyl-threonine phosphorylation,GO:0018107,biological process,37.0,9.0,1.422e-01,5.919e-02,3.418e-01,1.274e-01,4.561e-02,3.561e-01,6.298e-01,3.815e-02
PRKD2,17293,cell death,GO:0008219,biological process,37.0,6.0,2.412e-01,1.658e-01,3.509e-01,2.412e-01,1.658e-01,3.509e-01,5.211e-01,1.766e-02
PRKD2,17293,nucleus,GO:0005634,cellular component,37.0,86.0,1.551e-01,8.314e-02,2.893e-01,1.347e-01,6.665e-02,2.724e-01,6.239e-01,2.794e-02
PRKD2,17293,nucleoplasm,GO:0005654,cellular component,37.0,47.0,1.612e-01,9.533e-02,2.725e-01,1.449e-01,8.519e-02,2.466e-01,6.131e-01,2.153e-02
PRKD2,17293,cytosol,GO:0005829,cellular component,37.0,50.0,1.631e-01,1.034e-01,2.572e-01,1.481e-01,1.042e-01,2.105e-01,6.105e-01,1.411e-02
PRKD2,17293,cytoplasm,GO:0005737,cellular component,37.0,72.0,1.632e-01,1.037e-01,2.566e-01,1.469e-01,1.020e-01,2.116e-01,6.117e-01,1.486e-02
PRKD2,17293,protein kinase activity,GO:0004672,molecular function,37.0,29.0,6.383e-02,4.599e-02,8.859e-02,2.756e-02,1.831e-02,4.149e-02,8.256e-01,1.032e-02
PRKD2,17293,protein kinase C binding,GO:0005080,molecular function,37.0,3.0,6.853e-02,4.429e-02,1.060e-01,3.161e-02,1.693e-02,5.900e-02,8.104e-01,1.642e-02
PRKD2,17293,protein serine/threonine kinase activity,GO:0004674,molecular function,37.0,28.0,7.880e-02,7.106e-02,8.739e-02,5.113e-02,3.490e-02,7.491e-02,7.569e-01,1.073e-02
PRKD2,17293,protein binding,GO:0005515,molecular function,37.0,318.0,1.784e-01,1.157e-01,2.751e-01,1.716e-01,1.085e-01,2.713e-01,5.846e-01,1.970e-02
PRND,15748,,,,nan,nan,,,,,,,,
PROKR2,15836,G protein-coupled receptor signaling pathway,GO:0007186,biological process,8.0,48.0,1.997e-01,6.507e-02,6.127e-01,1.586e-01,6.169e-02,4.077e-01,5.945e-01,4.101e-02
PROKR2,15836,cellular response to hormone stimulus,GO:0032870,biological process,8.0,30.0,2.463e-01,2.787e-02,2.177e+00,1.434e-01,5.290e-03,3.886e+00,5.178e-01,1.831e-01
PROKR2,15836,circadian rhythm,GO:0007623,biological process,8.0,10.0,5.798e-01,4.262e-01,7.887e-01,5.507e-01,4.381e-01,6.923e-01,3.094e-01,1.875e-02
PROKR2,15836,integral component of plasma membrane,GO:0005887,cellular component,8.0,39.0,1.667e-01,7.035e-02,3.952e-01,4.508e-02,1.756e-02,1.157e-01,7.700e-01,2.673e-02
PROKR2,15836,plasma membrane,GO:0005886,cellular component,8.0,67.0,1.813e-01,6.976e-02,4.711e-01,1.161e-01,8.123e-02,1.658e-01,6.492e-01,1.291e-02
PROKR2,15836,peptide binding,GO:0042277,molecular function,8.0,12.0,1.727e-01,7.832e-02,3.809e-01,5.765e-02,4.748e-02,6.999e-02,7.429e-01,5.517e-03
PROKR2,15836,G protein-coupled receptor activity,GO:0004930,molecular function,8.0,47.0,1.877e-01,6.421e-02,5.487e-01,1.245e-01,5.405e-02,2.866e-01,6.354e-01,3.262e-02
PRPF40B,25031,,,,nan,nan,,,,,,,,
PRPS1,9462,purine nucleotide biosynthetic process,GO:0006164,biological process,16.0,8.0,1.232e-01,4.857e-02,3.125e-01,3.220e-02,1.495e-02,6.935e-02,8.083e-01,1.994e-02
PRPS1,9462,purine nucleobase metabolic process,GO:0006144,biological process,16.0,9.0,1.232e-01,4.857e-02,3.125e-01,4.531e-02,1.515e-02,1.355e-01,7.689e-01,3.025e-02
PRPS1,9462,nucleotide biosynthetic process,GO:0009165,biological process,16.0,17.0,1.232e-01,4.857e-02,3.125e-01,5.657e-02,3.482e-02,9.193e-02,7.448e-01,1.396e-02
PRPS1,9462,urate biosynthetic process,GO:0034418,biological process,16.0,4.0,1.232e-01,4.857e-02,3.125e-01,6.202e-02,2.573e-02,1.495e-01,7.323e-01,2.541e-02
PRPS1,9462,hypoxanthine biosynthetic process,GO:0046101,biological process,16.0,4.0,1.276e-01,5.602e-02,2.908e-01,8.328e-02,3.104e-02,2.234e-01,6.924e-01,3.367e-02
PRPS1,9462,5-phosphoribose 1-diphosphate biosynthetic process,GO:0006015,biological process,16.0,3.0,1.348e-01,4.931e-02,3.686e-01,1.019e-01,2.851e-02,3.644e-01,6.619e-01,4.189e-02
PRPS1,9462,nervous system development,GO:0007399,biological process,16.0,2.0,1.748e-01,8.396e-02,3.640e-01,1.664e-01,7.412e-02,3.736e-01,5.876e-01,3.441e-02
PRPS1,9462,cytoplasm,GO:0005737,cellular component,16.0,72.0,1.390e-01,5.634e-02,3.429e-01,1.060e-01,3.851e-02,2.917e-01,6.583e-01,3.398e-02
PRPS1,9462,ribose phosphate diphosphokinase complex,GO:0002189,cellular component,16.0,2.0,1.546e-01,8.138e-02,2.936e-01,1.129e-01,3.465e-02,3.677e-01,6.472e-01,4.163e-02
PRPS1,9462,ATP binding,GO:0005524,molecular function,16.0,6.0,1.232e-01,4.857e-02,3.125e-01,4.847e-02,1.285e-02,1.829e-01,7.599e-01,3.740e-02
PRPS1,9462,identical protein binding,GO:0042802,molecular function,16.0,24.0,1.232e-01,4.857e-02,3.125e-01,6.103e-02,3.109e-02,1.198e-01,7.351e-01,1.931e-02
PRPS1,9462,protein homodimerization activity,GO:0042803,molecular function,16.0,23.0,1.318e-01,4.954e-02,3.505e-01,8.360e-02,2.801e-02,2.495e-01,6.920e-01,3.409e-02
PRPS1,9462,protein binding,GO:0005515,molecular function,16.0,318.0,1.348e-01,4.931e-02,3.686e-01,8.324e-02,2.580e-02,2.685e-01,6.922e-01,3.636e-02
PRPS1,9462,ribose phosphate diphosphokinase activity,GO:0004749,molecular function,16.0,2.0,1.736e-01,7.205e-02,4.183e-01,1.641e-01,5.834e-02,4.616e-01,5.878e-01,4.151e-02
PRR5L,25878,positive regulation of intracellular protein transport,GO:0090316,biological process,10.0,17.0,3.903e-01,2.802e-01,5.439e-01,1.345e-01,6.393e-02,2.829e-01,6.240e-01,2.989e-02
PRR5L,25878,positive regulation of mRNA catabolic process,GO:0061014,biological process,10.0,12.0,3.903e-01,2.802e-01,5.439e-01,1.616e-01,7.641e-02,3.418e-01,5.932e-01,2.982e-02
PRR5L,25878,negative regulation of protein phosphorylation,GO:0001933,biological process,10.0,17.0,4.455e-01,3.149e-01,6.303e-01,3.040e-01,2.345e-01,3.940e-01,4.727e-01,1.382e-02
PRR5L,25878,regulation of fibroblast migration,GO:0010762,biological process,10.0,5.0,4.502e-01,3.144e-01,6.447e-01,3.596e-01,2.259e-01,5.722e-01,4.312e-01,2.663e-02
PRR5L,25878,TORC2 signaling,GO:0038203,biological process,10.0,2.0,4.502e-01,3.144e-01,6.447e-01,3.893e-01,2.857e-01,5.306e-01,4.125e-01,1.883e-02
PRR5L,25878,cellular response to oxidative stress,GO:0034599,biological process,10.0,7.0,6.785e-01,3.162e-01,1.456e+00,6.785e-01,3.162e-01,1.456e+00,2.018e-01,7.499e-02
PRR5L,25878,TORC2 complex,GO:0031932,cellular component,10.0,2.0,4.502e-01,3.144e-01,6.447e-01,3.954e-01,2.651e-01,5.897e-01,4.076e-01,2.444e-02
PRR5L,25878,ubiquitin protein ligase binding,GO:0031625,molecular function,10.0,6.0,3.582e-01,3.114e-01,4.121e-01,4.914e-02,2.539e-02,9.510e-02,7.609e-01,1.875e-02
PRR5L,25878,protein binding,GO:0005515,molecular function,10.0,318.0,4.396e-01,3.199e-01,6.041e-01,2.194e-01,2.047e-01,2.353e-01,5.405e-01,3.198e-03
PRR7,28130,negative regulation of protein ubiquitination,GO:0031397,biological process,11.0,11.0,2.997e-01,1.917e-01,4.684e-01,1.580e-01,3.823e-02,6.534e-01,5.892e-01,5.472e-02
PRR7,28130,positive regulation of cell death,GO:0010942,biological process,11.0,7.0,3.128e-01,2.635e-01,3.713e-01,1.651e-01,1.097e-01,2.485e-01,5.915e-01,1.744e-02
PRR7,28130,positive regulation of apoptotic process,GO:0043065,biological process,11.0,28.0,3.978e-01,2.892e-01,5.471e-01,3.680e-01,2.422e-01,5.593e-01,4.256e-01,2.483e-02
PRR7,28130,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,GO:2001269,biological process,11.0,5.0,3.978e-01,2.892e-01,5.471e-01,3.819e-01,2.550e-01,5.718e-01,4.165e-01,2.543e-02
PRR7,28130,plasma membrane,GO:0005886,cellular component,11.0,67.0,3.126e-01,2.631e-01,3.714e-01,1.360e-01,7.190e-02,2.573e-01,6.230e-01,2.560e-02
PRR7,28130,perinuclear region of cytoplasm,GO:0048471,cellular component,11.0,8.0,3.128e-01,2.635e-01,3.713e-01,1.773e-01,9.371e-02,3.354e-01,5.779e-01,2.723e-02
PRR7,28130,protein tyrosine kinase binding,GO:1990782,molecular function,11.0,4.0,2.622e-01,1.319e-01,5.214e-01,3.459e-02,1.969e-02,6.077e-02,8.008e-01,1.480e-02
PRR7,28130,ubiquitin-like protein ligase binding,GO:0044389,molecular function,11.0,3.0,2.622e-01,1.319e-01,5.214e-01,5.760e-02,2.516e-02,1.319e-01,7.416e-01,2.334e-02
PRR7,28130,protein binding,GO:0005515,molecular function,11.0,318.0,3.272e-01,2.819e-01,3.799e-01,2.439e-01,1.605e-01,3.706e-01,5.185e-01,2.044e-02
PRR7,28130,long-chain fatty acid binding,GO:0036041,molecular function,11.0,10.0,3.835e-01,2.734e-01,5.378e-01,3.305e-01,2.449e-01,4.459e-01,4.530e-01,1.668e-02
PRRT1,13943,,,,nan,nan,,,,,,,,
PRTN3,9495,,,,nan,nan,,,,,,,,
PSMB10,9538,proteasomal ubiquitin-independent protein catabolic process,GO:0010499,biological process,16.0,4.0,1.374e-02,6.351e-03,2.972e-02,1.717e-03,7.939e-04,3.715e-03,9.714e-01,3.220e-03
PSMB10,9538,proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043161,biological process,16.0,16.0,1.817e-02,9.389e-03,3.516e-02,7.057e-03,1.725e-03,2.888e-02,9.269e-01,1.405e-02
PSMB10,9538,proteasomal protein catabolic process,GO:0010498,biological process,16.0,8.0,2.306e-02,1.474e-02,3.609e-02,7.660e-03,4.427e-03,1.325e-02,9.271e-01,6.372e-03
PSMB10,9538,proteasome core complex,GO:0005839,cellular component,16.0,6.0,2.663e-02,1.364e-02,5.202e-02,1.345e-02,3.936e-03,4.595e-02,8.865e-01,2.092e-02
PSMB10,9538,cytoplasm,GO:0005737,cellular component,16.0,72.0,3.044e-02,2.424e-02,3.822e-02,2.746e-02,1.963e-02,3.841e-02,8.259e-01,8.554e-03
PSMB10,9538,nucleus,GO:0005634,cellular component,16.0,86.0,3.044e-02,2.424e-02,3.822e-02,2.855e-02,2.191e-02,3.721e-02,8.220e-01,6.644e-03
PSMB10,9538,endopeptidase activity,GO:0004175,molecular function,16.0,12.0,2.752e-02,1.561e-02,4.849e-02,1.757e-02,8.185e-03,3.770e-02,8.689e-01,1.599e-02
PSMB10,9538,protein binding,GO:0005515,molecular function,16.0,318.0,3.044e-02,2.424e-02,3.822e-02,2.851e-02,2.452e-02,3.317e-02,8.220e-01,3.869e-03
PSMB8,9545,proteasomal ubiquitin-independent protein catabolic process,GO:0010499,biological process,19.0,4.0,1.511e-02,6.006e-03,3.801e-02,1.407e-03,4.812e-04,4.112e-03,9.745e-01,3.793e-03
PSMB8,9545,proteasomal protein catabolic process,GO:0010498,biological process,19.0,8.0,2.299e-02,9.918e-03,5.331e-02,4.387e-03,1.276e-03,1.509e-02,9.466e-01,1.017e-02
PSMB8,9545,proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043161,biological process,19.0,16.0,2.433e-02,8.146e-03,7.269e-02,5.900e-03,1.155e-03,3.013e-02,9.337e-01,1.392e-02
PSMB8,9545,fat cell differentiation,GO:0045444,biological process,19.0,6.0,4.114e-02,3.749e-02,4.514e-02,1.675e-02,8.660e-03,3.242e-02,8.743e-01,1.519e-02
PSMB8,9545,regulation of endopeptidase activity,GO:0052548,biological process,19.0,8.0,4.160e-02,3.787e-02,4.570e-02,2.653e-02,1.675e-02,4.203e-02,8.294e-01,1.180e-02
PSMB8,9545,proteasome core complex,GO:0005839,cellular component,19.0,6.0,3.468e-02,1.966e-02,6.116e-02,1.588e-02,5.167e-03,4.879e-02,8.744e-01,2.122e-02
PSMB8,9545,extracellular exosome,GO:0070062,cellular component,19.0,39.0,4.377e-02,3.374e-02,5.679e-02,2.810e-02,1.087e-02,7.268e-02,8.225e-01,2.457e-02
PSMB8,9545,proteasome complex,GO:0000502,cellular component,19.0,5.0,4.455e-02,4.121e-02,4.816e-02,3.545e-02,2.352e-02,5.342e-02,7.984e-01,1.100e-02
PSMB8,9545,cytoplasm,GO:0005737,cellular component,19.0,72.0,4.508e-02,3.705e-02,5.483e-02,3.886e-02,2.415e-02,6.253e-02,7.881e-01,1.288e-02
PSMB8,9545,nucleus,GO:0005634,cellular component,19.0,86.0,4.597e-02,3.873e-02,5.457e-02,4.200e-02,3.713e-02,4.751e-02,7.796e-01,3.366e-03
PSMB8,9545,endopeptidase activity,GO:0004175,molecular function,19.0,12.0,4.264e-02,4.218e-02,4.311e-02,2.436e-02,1.400e-02,4.239e-02,8.381e-01,1.373e-02
PSMB8,9545,protein binding,GO:0005515,molecular function,19.0,318.0,4.735e-02,4.213e-02,5.322e-02,4.188e-02,3.447e-02,5.086e-02,7.800e-01,5.283e-03
PSMB9,9546,proteasomal ubiquitin-independent protein catabolic process,GO:0010499,biological process,19.0,4.0,1.882e-02,1.604e-02,2.207e-02,1.989e-03,1.055e-03,3.750e-03,9.694e-01,3.247e-03
PSMB9,9546,regulation of cysteine-type endopeptidase activity,GO:2000116,biological process,19.0,5.0,1.983e-02,1.854e-02,2.122e-02,5.020e-03,2.782e-03,9.060e-03,9.442e-01,4.869e-03
PSMB9,9546,proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043161,biological process,19.0,16.0,2.179e-02,1.729e-02,2.746e-02,7.048e-03,2.499e-03,1.988e-02,9.290e-01,1.022e-02
PSMB9,9546,proteasomal protein catabolic process,GO:0010498,biological process,19.0,8.0,2.456e-02,1.542e-02,3.912e-02,7.156e-03,2.854e-03,1.794e-02,9.283e-01,1.032e-02
PSMB9,9546,proteasome core complex,GO:0005839,cellular component,19.0,6.0,2.877e-02,1.576e-02,5.253e-02,1.510e-02,4.206e-03,5.418e-02,8.771e-01,2.375e-02
PSMB9,9546,extracellular exosome,GO:0070062,cellular component,19.0,39.0,3.328e-02,2.840e-02,3.900e-02,2.278e-02,1.115e-02,4.653e-02,8.446e-01,1.777e-02
PSMB9,9546,cytoplasm,GO:0005737,cellular component,19.0,72.0,3.503e-02,3.158e-02,3.885e-02,3.035e-02,2.266e-02,4.066e-02,8.155e-01,7.625e-03
PSMB9,9546,cytosol,GO:0005829,cellular component,19.0,50.0,3.503e-02,3.158e-02,3.885e-02,3.325e-02,2.821e-02,3.919e-02,8.056e-01,4.275e-03
PSMB9,9546,nucleus,GO:0005634,cellular component,19.0,86.0,3.516e-02,3.156e-02,3.916e-02,3.363e-02,2.757e-02,4.103e-02,8.044e-01,5.268e-03
PSMB9,9546,endopeptidase activity,GO:0004175,molecular function,19.0,12.0,3.168e-02,2.034e-02,4.934e-02,2.168e-02,9.397e-03,5.002e-02,8.487e-01,1.926e-02
PSMB9,9546,protein binding,GO:0005515,molecular function,19.0,318.0,3.503e-02,3.158e-02,3.885e-02,3.168e-02,2.875e-02,3.491e-02,8.110e-01,2.599e-03
PSORS1C2,17199,,,,nan,nan,,,,,,,,
PTGER2,9594,adenylate cyclase-activating G protein-coupled receptor signaling pathway,GO:0007189,biological process,10.0,15.0,1.243e-01,4.524e-02,3.416e-01,4.043e-02,1.470e-02,1.112e-01,7.824e-01,2.687e-02
PTGER2,9594,positive regulation of cytosolic calcium ion concentration,GO:0007204,biological process,10.0,12.0,1.243e-01,4.524e-02,3.416e-01,5.557e-02,1.414e-02,2.184e-01,7.435e-01,3.818e-02
PTGER2,9594,cellular response to prostaglandin E stimulus,GO:0071380,biological process,10.0,6.0,1.342e-01,3.912e-02,4.607e-01,1.085e-01,2.123e-02,5.547e-01,6.467e-01,6.119e-02
PTGER2,9594,inflammatory response,GO:0006954,biological process,10.0,15.0,1.418e-01,5.240e-02,3.835e-01,1.238e-01,6.597e-02,2.325e-01,6.377e-01,2.290e-02
PTGER2,9594,plasma membrane,GO:0005886,cellular component,10.0,67.0,1.246e-01,4.567e-02,3.400e-01,8.075e-02,3.500e-02,1.863e-01,6.987e-01,2.570e-02
PTGER2,9594,prostaglandin E receptor activity,GO:0004957,molecular function,10.0,3.0,1.347e-01,4.547e-02,3.992e-01,1.033e-01,3.219e-02,3.312e-01,6.602e-01,4.345e-02
PTGER4,9596,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,GO:0007188,biological process,15.0,5.0,2.493e-01,2.110e-01,2.945e-01,5.249e-02,2.869e-02,9.606e-02,7.534e-01,1.685e-02
PTGER4,9596,negative regulation of inflammatory response,GO:0050728,biological process,15.0,13.0,2.493e-01,2.110e-01,2.945e-01,9.263e-02,2.093e-02,4.099e-01,6.738e-01,4.733e-02
PTGER4,9596,immune response,GO:0006955,biological process,15.0,17.0,2.515e-01,2.116e-01,2.990e-01,7.404e-02,5.296e-02,1.035e-01,7.119e-01,1.045e-02
PTGER4,9596,adenylate cyclase-activating G protein-coupled receptor signaling pathway,GO:0007189,biological process,15.0,15.0,2.515e-01,2.116e-01,2.990e-01,8.884e-02,6.019e-02,1.311e-01,6.875e-01,1.297e-02
PTGER4,9596,positive regulation of cytosolic calcium ion concentration,GO:0007204,biological process,15.0,12.0,2.610e-01,2.051e-01,3.321e-01,1.132e-01,7.378e-02,1.735e-01,6.527e-01,1.516e-02
PTGER4,9596,negative regulation of eosinophil extravasation,GO:2000420,biological process,15.0,4.0,2.799e-01,1.796e-01,4.362e-01,1.397e-01,2.370e-02,8.230e-01,6.052e-01,6.419e-02
PTGER4,9596,inflammatory response,GO:0006954,biological process,15.0,15.0,2.906e-01,2.353e-01,3.589e-01,2.260e-01,1.866e-01,2.737e-01,5.347e-01,8.898e-03
PTGER4,9596,cellular response to prostaglandin E stimulus,GO:0071380,biological process,15.0,6.0,3.066e-01,1.463e-01,6.424e-01,1.958e-01,5.615e-02,6.830e-01,5.507e-01,6.102e-02
PTGER4,9596,response to mechanical stimulus,GO:0009612,biological process,15.0,9.0,3.415e-01,1.836e-01,6.351e-01,3.188e-01,1.515e-01,6.709e-01,4.556e-01,4.405e-02
PTGER4,9596,negative regulation of integrin activation,GO:0033624,biological process,15.0,3.0,4.039e-01,2.787e-01,5.855e-01,3.933e-01,2.866e-01,5.398e-01,4.098e-01,1.931e-02
PTGER4,9596,plasma membrane,GO:0005886,cellular component,15.0,67.0,2.610e-01,2.051e-01,3.321e-01,1.517e-01,1.149e-01,2.003e-01,6.067e-01,1.110e-02
PTGER4,9596,protein binding,GO:0005515,molecular function,15.0,318.0,2.712e-01,2.402e-01,3.063e-01,1.907e-01,1.318e-01,2.757e-01,5.661e-01,1.607e-02
PTGER4,9596,prostaglandin E receptor activity,GO:0004957,molecular function,15.0,3.0,2.901e-01,1.659e-01,5.073e-01,2.084e-01,7.873e-02,5.515e-01,5.448e-01,4.277e-02
PTMA,9623,negative regulation of apoptotic process,GO:0043066,biological process,12.0,25.0,9.726e-02,4.844e-02,1.953e-01,9.726e-02,4.844e-02,1.953e-01,6.733e-01,2.367e-02
PTMA,9623,cytosol,GO:0005829,cellular component,12.0,50.0,4.990e-02,2.577e-02,9.663e-02,2.625e-02,1.197e-02,5.757e-02,8.303e-01,2.027e-02
PTMA,9623,nucleoplasm,GO:0005654,cellular component,12.0,47.0,4.990e-02,2.577e-02,9.663e-02,3.387e-02,1.483e-02,7.732e-02,8.026e-01,2.188e-02
PTMA,9623,nucleus,GO:0005634,cellular component,12.0,86.0,4.990e-02,2.577e-02,9.663e-02,3.860e-02,1.624e-02,9.176e-02,7.879e-01,2.319e-02
PTMA,9623,protein binding,GO:0005515,molecular function,12.0,318.0,4.990e-02,2.577e-02,9.663e-02,3.056e-02,1.687e-02,5.537e-02,8.144e-01,1.542e-02
PTMA,9623,activating transcription factor binding,GO:0033613,molecular function,12.0,5.0,5.079e-02,2.739e-02,9.417e-02,2.967e-02,2.011e-02,4.377e-02,8.177e-01,9.941e-03
PYGO1,30256,kidney development,GO:0001822,biological process,5.0,5.0,4.692e-02,2.589e-02,8.505e-02,1.478e-02,8.504e-03,2.569e-02,8.851e-01,1.070e-02
PYGO1,30256,spermatid nucleus differentiation,GO:0007289,biological process,5.0,3.0,6.635e-02,3.024e-02,1.456e-01,4.675e-02,1.881e-02,1.161e-01,7.659e-01,2.585e-02
PYGO1,30256,methylated histone binding,GO:0035064,molecular function,5.0,7.0,5.299e-02,2.528e-02,1.110e-01,2.407e-02,4.621e-03,1.254e-01,8.317e-01,3.597e-02
PYGO1,30256,protein binding,GO:0005515,molecular function,5.0,318.0,1.154e-01,8.200e-02,1.624e-01,1.154e-01,8.200e-02,1.624e-01,6.501e-01,1.231e-02
RAMP2,9844,adenylate cyclase-activating G protein-coupled receptor signaling pathway,GO:0007189,biological process,32.0,15.0,4.220e-01,2.815e-01,6.327e-01,6.982e-02,3.658e-02,1.333e-01,7.182e-01,2.010e-02
RAMP2,9844,adherens junction assembly,GO:0034333,biological process,32.0,5.0,4.220e-01,2.815e-01,6.327e-01,8.311e-02,1.803e-02,3.832e-01,6.879e-01,5.069e-02
RAMP2,9844,protein transport,GO:0015031,biological process,32.0,24.0,4.220e-01,2.815e-01,6.327e-01,1.106e-01,6.006e-02,2.037e-01,6.550e-01,2.267e-02
RAMP2,9844,G protein-coupled receptor signaling pathway,GO:0007186,biological process,32.0,48.0,4.220e-01,2.815e-01,6.327e-01,1.530e-01,5.752e-02,4.068e-01,6.004e-01,3.930e-02
RAMP2,9844,calcium ion transport,GO:0006816,biological process,32.0,11.0,4.220e-01,2.815e-01,6.327e-01,1.560e-01,6.835e-02,3.563e-01,5.986e-01,3.534e-02
RAMP2,9844,bicellular tight junction assembly,GO:0070830,biological process,32.0,3.0,4.220e-01,2.815e-01,6.327e-01,2.273e-01,1.666e-01,3.102e-01,5.332e-01,1.431e-02
RAMP2,9844,negative regulation of vascular permeability,GO:0043116,biological process,32.0,3.0,4.220e-01,2.815e-01,6.327e-01,2.245e-01,9.565e-02,5.267e-01,5.307e-01,4.272e-02
RAMP2,9844,positive regulation of gene expression,GO:0010628,biological process,32.0,27.0,4.220e-01,2.815e-01,6.327e-01,2.472e-01,1.572e-01,3.887e-01,5.155e-01,2.252e-02
RAMP2,9844,negative regulation of endothelial cell apoptotic process,GO:2000352,biological process,32.0,4.0,4.220e-01,2.815e-01,6.327e-01,2.624e-01,1.345e-01,5.121e-01,5.005e-01,3.534e-02
RAMP2,9844,protein localization to plasma membrane,GO:0072659,biological process,32.0,6.0,4.220e-01,2.815e-01,6.327e-01,2.809e-01,2.058e-01,3.834e-01,4.898e-01,1.577e-02
RAMP2,9844,angiogenesis,GO:0001525,biological process,32.0,13.0,4.281e-01,2.723e-01,6.732e-01,2.827e-01,9.910e-02,8.068e-01,4.769e-01,6.001e-02
RAMP2,9844,adrenomedullin receptor signaling pathway,GO:1990410,biological process,32.0,2.0,4.656e-01,3.015e-01,7.189e-01,3.728e-01,2.174e-01,6.393e-01,4.210e-01,3.197e-02
RAMP2,9844,vasculogenesis,GO:0001570,biological process,32.0,5.0,4.656e-01,3.015e-01,7.189e-01,3.959e-01,2.432e-01,6.444e-01,4.061e-01,2.948e-02
RAMP2,9844,cellular response to hormone stimulus,GO:0032870,biological process,32.0,30.0,5.345e-01,2.464e-01,1.159e+00,3.918e-01,9.553e-02,1.607e+00,3.756e-01,9.908e-02
RAMP2,9844,amylin receptor signaling pathway,GO:0097647,biological process,32.0,5.0,5.429e-01,3.792e-01,7.773e-01,5.233e-01,3.686e-01,7.427e-01,3.249e-01,2.656e-02
RAMP2,9844,receptor internalization,GO:0031623,biological process,32.0,11.0,5.657e-01,4.317e-01,7.411e-01,5.381e-01,4.073e-01,7.110e-01,3.166e-01,2.356e-02
RAMP2,9844,plasma membrane,GO:0005886,cellular component,32.0,67.0,4.220e-01,2.815e-01,6.327e-01,1.316e-01,1.127e-01,1.538e-01,6.302e-01,6.036e-03
RAMP2,9844,cell surface,GO:0009986,cellular component,32.0,20.0,4.220e-01,2.815e-01,6.327e-01,1.577e-01,1.254e-01,1.983e-01,6.001e-01,9.356e-03
RAMP2,9844,cytoplasm,GO:0005737,cellular component,32.0,72.0,4.220e-01,2.815e-01,6.327e-01,2.514e-01,2.209e-01,2.861e-01,5.136e-01,6.260e-03
RAMP2,9844,amylin receptor complex 2,GO:0150057,cellular component,32.0,2.0,4.426e-01,3.012e-01,6.504e-01,2.123e-01,8.626e-02,5.225e-01,5.420e-01,4.001e-02
RAMP2,9844,receptor complex,GO:0043235,cellular component,32.0,30.0,4.581e-01,3.036e-01,6.912e-01,3.430e-01,2.520e-01,4.668e-01,4.443e-01,1.828e-02
RAMP2,9844,cell,GO:0005623,cellular component,32.0,2.0,4.673e-01,2.917e-01,7.486e-01,3.623e-01,1.524e-01,8.615e-01,4.209e-01,5.455e-02
RAMP2,9844,adrenomedullin receptor complex,GO:1903143,cellular component,32.0,3.0,4.795e-01,3.699e-01,6.215e-01,3.934e-01,3.656e-01,4.234e-01,4.110e-01,4.615e-03
RAMP2,9844,coreceptor activity,GO:0015026,molecular function,32.0,4.0,4.220e-01,2.815e-01,6.327e-01,1.352e-01,7.897e-02,2.313e-01,6.244e-01,2.029e-02
RAMP2,9844,protein binding,GO:0005515,molecular function,32.0,318.0,4.220e-01,2.815e-01,6.327e-01,2.225e-01,1.759e-01,2.814e-01,5.376e-01,1.085e-02
RAMP2,9844,amylin receptor activity,GO:0097643,molecular function,32.0,2.0,4.220e-01,2.815e-01,6.327e-01,2.632e-01,1.175e-01,5.895e-01,4.986e-01,4.188e-02
RAMP2,9844,adrenomedullin receptor activity,GO:0001605,molecular function,32.0,2.0,4.220e-01,2.815e-01,6.327e-01,2.643e-01,1.120e-01,6.236e-01,4.968e-01,4.492e-02
RAMP2,9844,adrenomedullin binding,GO:1990409,molecular function,32.0,2.0,4.581e-01,3.036e-01,6.912e-01,3.761e-01,2.451e-01,5.772e-01,4.201e-01,2.577e-02
RASA4,23181,cellular response to calcium ion,GO:0071277,biological process,9.0,4.0,1.237e-01,8.174e-02,1.871e-01,8.329e-02,5.547e-02,1.251e-01,6.962e-01,1.315e-02
RASA4,23181,negative regulation of GTPase activity,GO:0034260,biological process,9.0,5.0,1.237e-01,8.174e-02,1.871e-01,8.685e-02,4.531e-02,1.665e-01,6.894e-01,2.168e-02
RASA4,23181,plasma membrane,GO:0005886,cellular component,9.0,67.0,1.237e-01,8.174e-02,1.871e-01,7.756e-02,7.028e-02,8.559e-02,7.061e-01,3.115e-03
RASA4,23181,cytosol,GO:0005829,cellular component,9.0,50.0,1.267e-01,8.869e-02,1.810e-01,1.155e-01,1.076e-01,1.240e-01,6.509e-01,2.529e-03
RASA4,23181,GTPase activator activity,GO:0005096,molecular function,9.0,4.0,1.446e-01,5.688e-02,3.676e-01,1.250e-01,3.844e-02,4.066e-01,6.309e-01,4.730e-02
RASGRP3,14545,protein binding,GO:0005515,molecular function,4.0,318.0,1.932e-01,1.313e-01,2.842e-01,1.632e-01,1.412e-01,1.886e-01,5.945e-01,5.787e-03
RASGRP3,14545,GTPase activator activity,GO:0005096,molecular function,4.0,4.0,1.932e-01,1.313e-01,2.842e-01,1.727e-01,8.894e-02,3.355e-01,5.824e-01,2.828e-02
RASIP1,24716,negative regulation of Rho-dependent protein serine/threonine kinase activity,GO:2000299,biological process,12.0,3.0,3.068e-01,6.935e-02,1.357e+00,4.904e-02,2.809e-03,8.561e-01,7.379e-01,8.987e-02
RASIP1,24716,positive regulation of integrin activation,GO:0033625,biological process,12.0,4.0,4.084e-01,9.957e-02,1.675e+00,2.750e-01,7.835e-02,9.654e-01,4.823e-01,6.065e-02
RASIP1,24716,negative regulation of Rho protein signal transduction,GO:0035024,biological process,12.0,3.0,4.231e-01,9.594e-02,1.866e+00,3.560e-01,6.632e-02,1.912e+00,4.019e-01,9.472e-02
RASIP1,24716,negative regulation of membrane permeability,GO:1905709,biological process,12.0,4.0,5.018e-01,8.593e-02,2.931e+00,3.197e-01,1.185e-02,8.628e+00,3.329e-01,1.783e-01
RASIP1,24716,negative regulation of autophagy,GO:0010507,biological process,12.0,8.0,5.239e-01,2.411e-01,1.138e+00,4.400e-01,2.504e-01,7.731e-01,3.742e-01,4.023e-02
RASIP1,24716,cell-cell junction,GO:0005911,cellular component,12.0,18.0,4.036e-01,1.007e-01,1.618e+00,2.280e-01,8.769e-02,5.928e-01,5.271e-01,4.362e-02
RASIP1,24716,protein-containing complex,GO:0032991,cellular component,12.0,474.0,4.149e-01,9.703e-02,1.774e+00,2.381e-01,1.871e-02,3.031e+00,4.776e-01,1.123e-01
RASIP1,24716,protein binding,GO:0005515,molecular function,12.0,318.0,4.020e-01,1.010e-01,1.600e+00,1.626e-01,9.118e-02,2.898e-01,5.936e-01,2.371e-02
RASIP1,24716,protein homodimerization activity,GO:0042803,molecular function,12.0,23.0,4.020e-01,1.010e-01,1.600e+00,1.879e-01,1.101e-01,3.205e-01,5.680e-01,2.337e-02
RASIP1,24716,GTPase binding,GO:0051020,molecular function,12.0,4.0,4.935e-01,2.430e-01,1.002e+00,2.678e-01,1.697e-01,4.225e-01,4.990e-01,2.240e-02
RASL12,30289,Ras protein signal transduction,GO:0007265,biological process,8.0,11.0,1.662e-01,7.354e-02,3.756e-01,8.382e-02,3.817e-02,1.841e-01,6.938e-01,2.453e-02
RASL12,30289,plasma membrane,GO:0005886,cellular component,8.0,67.0,1.599e-01,7.326e-02,3.491e-01,6.741e-02,2.799e-02,1.623e-01,7.215e-01,2.739e-02
RASL12,30289,calmodulin binding,GO:0005516,molecular function,8.0,4.0,1.263e-01,8.360e-02,1.909e-01,2.347e-02,1.845e-02,2.986e-02,8.426e-01,6.108e-03
RASL12,30289,GTP binding,GO:0005525,molecular function,8.0,6.0,1.944e-01,6.584e-02,5.738e-01,1.432e-01,3.988e-02,5.140e-01,6.081e-01,4.834e-02
RASL12,30289,GTPase activity,GO:0003924,molecular function,8.0,6.0,2.157e-01,1.033e-01,4.503e-01,1.950e-01,1.132e-01,3.359e-01,5.611e-01,2.341e-02
RASL12,30289,GDP binding,GO:0019003,molecular function,8.0,4.0,2.159e-01,1.032e-01,4.517e-01,2.115e-01,9.448e-02,4.735e-01,5.435e-01,3.582e-02
RASSF6,20796,,,,nan,nan,,,,,,,,
RASSF9,15739,intracellular transport,GO:0046907,biological process,8.0,33.0,5.623e-02,2.113e-02,1.497e-01,3.181e-02,1.625e-02,6.225e-02,8.098e-01,1.712e-02
RASSF9,15739,recycling endosome,GO:0055037,cellular component,8.0,6.0,5.023e-02,1.770e-02,1.425e-01,1.804e-02,1.444e-02,2.254e-02,8.687e-01,4.953e-03
RASSF9,15739,endosome,GO:0005768,cellular component,8.0,11.0,5.023e-02,1.770e-02,1.425e-01,2.380e-02,5.645e-03,1.003e-01,8.368e-01,3.555e-02
RASSF9,15739,trans-Golgi network transport vesicle membrane,GO:0012510,cellular component,8.0,4.0,5.023e-02,1.770e-02,1.425e-01,2.807e-02,9.905e-03,7.958e-02,8.223e-01,2.726e-02
RASSF9,15739,extracellular exosome,GO:0070062,cellular component,8.0,39.0,6.071e-02,1.131e-02,3.259e-01,4.025e-02,6.668e-03,2.430e-01,7.777e-01,5.208e-02
RASSF9,15739,cytosol,GO:0005829,cellular component,8.0,50.0,9.176e-02,2.468e-02,3.411e-01,8.280e-02,1.896e-02,3.616e-01,6.887e-01,5.025e-02
RASSF9,15739,protein binding,GO:0005515,molecular function,8.0,318.0,1.037e-01,3.016e-02,3.563e-01,1.036e-01,3.018e-02,3.558e-01,6.596e-01,4.267e-02
RENBP,9959,,,,nan,nan,,,,,,,,
RERE,9965,nucleus,GO:0005634,cellular component,7.0,86.0,4.521e-02,2.566e-02,7.965e-02,3.617e-02,2.053e-02,6.372e-02,7.959e-01,1.483e-02
RERE,9965,RNA polymerase II transcription factor binding,GO:0001085,molecular function,7.0,4.0,2.723e-02,2.270e-02,3.267e-02,5.447e-03,4.540e-03,6.535e-03,9.422e-01,1.563e-03
RERE,9965,DNA binding,GO:0003677,molecular function,7.0,29.0,3.332e-02,2.612e-02,4.249e-02,1.521e-02,1.053e-02,2.197e-02,8.840e-01,7.793e-03
RERE,9965,transcription corepressor activity,GO:0003714,molecular function,7.0,5.0,3.544e-02,2.425e-02,5.180e-02,2.127e-02,1.455e-02,3.108e-02,8.522e-01,9.173e-03
RERE,9965,protein binding,GO:0005515,molecular function,7.0,318.0,5.717e-02,3.636e-02,8.989e-02,5.717e-02,3.636e-02,8.989e-02,7.436e-01,1.281e-02
RFLNA,27051,,,,nan,nan,,,,,,,,
RGS4,10000,nucleus,GO:0005634,cellular component,3.0,86.0,6.205e-02,4.317e-02,8.919e-02,5.860e-02,4.228e-02,8.123e-02,7.408e-01,9.474e-03
RGS4,10000,cytoplasm,GO:0005737,cellular component,3.0,72.0,6.205e-02,4.317e-02,8.919e-02,6.156e-02,4.172e-02,9.082e-02,7.350e-01,1.133e-02
RGS5,10001,,,,nan,nan,,,,,,,,
RHOH,686,Rho protein signal transduction,GO:0007266,biological process,13.0,3.0,1.665e-01,7.590e-02,3.654e-01,4.424e-02,4.701e-03,4.163e-01,7.626e-01,6.147e-02
RHOH,686,negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043124,biological process,13.0,6.0,1.763e-01,9.744e-02,3.189e-01,7.349e-02,2.891e-02,1.868e-01,7.106e-01,2.782e-02
RHOH,686,positive regulation of T cell differentiation,GO:0045582,biological process,13.0,12.0,2.396e-01,7.819e-02,7.344e-01,1.909e-01,2.885e-02,1.263e+00,5.459e-01,7.659e-02
RHOH,686,cytoplasm,GO:0005737,cellular component,13.0,72.0,1.900e-01,8.985e-02,4.016e-01,1.220e-01,9.114e-02,1.633e-01,6.417e-01,1.068e-02
RHOH,686,protein binding,GO:0005515,molecular function,13.0,318.0,1.900e-01,8.985e-02,4.016e-01,1.116e-01,1.043e-01,1.194e-01,6.560e-01,2.407e-03
RHOH,686,GTP binding,GO:0005525,molecular function,13.0,6.0,1.900e-01,8.985e-02,4.016e-01,1.318e-01,4.941e-02,3.515e-01,6.250e-01,3.896e-02
RHOH,686,GTPase activity,GO:0003924,molecular function,13.0,6.0,2.132e-01,1.134e-01,4.007e-01,1.809e-01,1.250e-01,2.617e-01,5.755e-01,1.570e-02
RHOH,686,kinase inhibitor activity,GO:0019210,molecular function,13.0,4.0,2.254e-01,7.868e-02,6.456e-01,1.626e-01,3.730e-02,7.093e-01,5.827e-01,6.068e-02
RIPPLY3,3047,,,,nan,nan,,,,,,,,
RNF122,21147,proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043161,biological process,10.0,16.0,9.167e-02,3.661e-02,2.295e-01,2.132e-02,9.635e-03,4.717e-02,8.506e-01,1.832e-02
RNF122,21147,protein autoubiquitination,GO:0051865,biological process,10.0,2.0,9.167e-02,3.661e-02,2.295e-01,2.048e-02,5.617e-03,7.470e-02,8.503e-01,2.750e-02
RNF122,21147,negative regulation of mitochondrial membrane potential,GO:0010917,biological process,10.0,3.0,2.838e-01,1.352e-01,5.956e-01,2.596e-01,1.113e-01,6.055e-01,5.013e-01,4.155e-02
RNF122,21147,positive regulation of apoptotic process,GO:0043065,biological process,10.0,28.0,2.931e-01,2.061e-01,4.169e-01,2.803e-01,1.991e-01,3.948e-01,4.899e-01,1.796e-02
RNF122,21147,cytoplasm,GO:0005737,cellular component,10.0,72.0,1.381e-01,5.478e-02,3.480e-01,6.440e-02,2.922e-02,1.419e-01,7.280e-01,2.289e-02
RNF122,21147,endomembrane system,GO:0012505,cellular component,10.0,3.0,1.690e-01,9.157e-02,3.119e-01,1.193e-01,6.832e-02,2.082e-01,6.441e-01,2.042e-02
RNF122,21147,protein binding,GO:0005515,molecular function,10.0,318.0,1.408e-01,5.751e-02,3.445e-01,8.501e-02,3.723e-02,1.941e-01,6.916e-01,2.567e-02
RNF122,21147,ubiquitin protein ligase activity,GO:0061630,molecular function,10.0,8.0,1.419e-01,5.285e-02,3.810e-01,7.897e-02,1.879e-02,3.318e-01,6.963e-01,4.619e-02
RNF152,26811,protein K63-linked ubiquitination,GO:0070534,biological process,12.0,4.0,4.960e-02,9.165e-03,2.684e-01,1.140e-02,2.334e-03,5.567e-02,8.949e-01,2.558e-02
RNF152,26811,protein K48-linked ubiquitination,GO:0070936,biological process,12.0,2.0,4.960e-02,9.165e-03,2.684e-01,1.634e-02,3.657e-03,7.297e-02,8.694e-01,3.210e-02
RNF152,26811,negative regulation of TORC1 signaling,GO:1904262,biological process,12.0,3.0,1.023e-01,2.313e-02,4.526e-01,5.272e-02,6.341e-03,4.383e-01,7.435e-01,5.923e-02
RNF152,26811,cellular response to amino acid starvation,GO:0034198,biological process,12.0,6.0,1.437e-01,5.860e-02,3.523e-01,1.252e-01,5.181e-02,3.024e-01,6.341e-01,3.248e-02
RNF152,26811,positive regulation of autophagy,GO:0010508,biological process,12.0,9.0,1.511e-01,3.731e-02,6.118e-01,1.186e-01,1.993e-02,7.056e-01,6.310e-01,6.628e-02
RNF152,26811,lysosome,GO:0005764,cellular component,12.0,9.0,1.265e-01,4.600e-02,3.480e-01,8.696e-02,3.158e-02,2.394e-01,6.868e-01,3.307e-02
RNF152,26811,integral component of organelle membrane,GO:0031301,cellular component,12.0,18.0,1.547e-01,4.687e-02,5.109e-01,1.285e-01,3.561e-02,4.637e-01,6.256e-01,4.868e-02
RNF152,26811,lysosomal membrane,GO:0005765,cellular component,12.0,7.0,1.749e-01,7.960e-02,3.843e-01,1.585e-01,8.754e-02,2.868e-01,5.979e-01,2.410e-02
RNF152,26811,small GTPase binding,GO:0031267,molecular function,12.0,4.0,2.569e-02,1.321e-03,4.997e-01,4.609e-03,9.259e-05,2.294e-01,9.146e-01,3.958e-02
RNF152,26811,ubiquitin-protein transferase activity,GO:0004842,molecular function,12.0,9.0,5.095e-02,9.503e-03,2.732e-01,1.907e-02,2.001e-03,1.818e-01,8.458e-01,4.599e-02
RNF152,26811,ubiquitin protein ligase activity,GO:0061630,molecular function,12.0,8.0,9.876e-02,5.418e-02,1.801e-01,4.616e-02,3.840e-02,5.549e-02,7.690e-01,5.101e-03
RNF31,16031,protein linear polyubiquitination,GO:0097039,biological process,19.0,2.0,1.404e-02,7.402e-03,2.664e-02,2.019e-03,5.708e-04,7.144e-03,9.675e-01,6.839e-03
RNF31,16031,positive regulation of NF-kappaB transcription factor activity,GO:0051092,biological process,19.0,6.0,1.506e-02,6.562e-03,3.455e-02,2.553e-03,5.555e-04,1.174e-02,9.613e-01,1.000e-02
RNF31,16031,positive regulation of protein targeting to mitochondrion,GO:1903955,biological process,19.0,6.0,2.052e-02,1.091e-02,3.858e-02,1.037e-02,3.126e-03,3.440e-02,9.060e-01,1.815e-02
RNF31,16031,protein polyubiquitination,GO:0000209,biological process,19.0,11.0,2.202e-02,1.864e-02,2.600e-02,1.210e-02,3.329e-03,4.395e-02,8.941e-01,1.931e-02
RNF31,16031,positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043123,biological process,19.0,12.0,2.317e-02,9.922e-03,5.410e-02,1.206e-02,1.925e-03,7.554e-02,8.878e-01,3.521e-02
RNF31,16031,T cell receptor signaling pathway,GO:0050852,biological process,19.0,4.0,2.327e-02,1.595e-02,3.394e-02,1.760e-02,1.301e-02,2.381e-02,8.708e-01,6.735e-03
RNF31,16031,LUBAC complex,GO:0071797,cellular component,19.0,2.0,4.069e-02,2.846e-02,5.818e-02,3.806e-02,2.125e-02,6.818e-02,7.902e-01,1.536e-02
RNF31,16031,ubiquitin-protein transferase activity,GO:0004842,molecular function,19.0,9.0,1.933e-02,9.737e-03,3.839e-02,7.862e-03,2.268e-03,2.725e-02,9.206e-01,1.741e-02
RNF31,16031,ubiquitin protein ligase binding,GO:0031625,molecular function,19.0,6.0,2.313e-02,1.562e-02,3.423e-02,1.331e-02,7.468e-03,2.372e-02,8.934e-01,1.074e-02
RNF31,16031,ubiquitin binding,GO:0043130,molecular function,19.0,3.0,2.327e-02,1.595e-02,3.394e-02,1.595e-02,1.220e-02,2.085e-02,8.801e-01,5.780e-03
RNF31,16031,protein binding,GO:0005515,molecular function,19.0,318.0,2.799e-02,1.263e-02,6.204e-02,2.627e-02,1.065e-02,6.479e-02,8.298e-01,2.335e-02
ROBO4,17985,homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007156,biological process,9.0,4.0,2.352e-01,1.764e-01,3.136e-01,1.065e-01,5.858e-02,1.937e-01,6.609e-01,2.032e-02
ROBO4,17985,angiogenesis,GO:0001525,biological process,9.0,13.0,2.937e-01,1.695e-01,5.090e-01,1.961e-01,4.563e-02,8.428e-01,5.477e-01,6.529e-02
ROBO4,17985,axon guidance,GO:0007411,biological process,9.0,22.0,3.170e-01,2.057e-01,4.884e-01,2.317e-01,8.836e-02,6.076e-01,5.224e-01,4.959e-02
ROBO4,17985,dendrite self-avoidance,GO:0070593,biological process,9.0,2.0,3.590e-01,2.587e-01,4.981e-01,3.186e-01,1.851e-01,5.485e-01,4.594e-01,3.005e-02
ROBO4,17985,plasma membrane,GO:0005886,cellular component,9.0,67.0,2.352e-01,1.764e-01,3.136e-01,8.159e-02,6.684e-02,9.959e-02,6.994e-01,6.421e-03
ROBO4,17985,extracellular exosome,GO:0070062,cellular component,9.0,39.0,2.557e-01,2.076e-01,3.149e-01,1.441e-01,1.215e-01,1.708e-01,6.154e-01,6.811e-03
ROBO4,17985,axon,GO:0030424,cellular component,9.0,12.0,3.235e-01,2.089e-01,5.012e-01,2.803e-01,1.392e-01,5.644e-01,4.862e-01,3.756e-02
ROBO4,17985,cell-cell adhesion mediator activity,GO:0098632,molecular function,9.0,5.0,2.352e-01,1.764e-01,3.136e-01,6.964e-02,3.773e-02,1.285e-01,7.187e-01,1.868e-02
RORC,10260,cellular response to sterol,GO:0036315,biological process,13.0,9.0,4.468e-02,2.459e-02,8.120e-02,2.300e-02,1.083e-02,4.886e-02,8.433e-01,1.792e-02
RORC,10260,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,13.0,55.0,5.971e-02,3.833e-02,9.299e-02,4.755e-02,2.659e-02,8.503e-02,7.650e-01,1.625e-02
RORC,10260,nucleus,GO:0005634,cellular component,13.0,86.0,5.995e-02,2.219e-02,1.620e-01,4.409e-02,1.392e-02,1.397e-01,7.722e-01,3.087e-02
RORC,10260,nuclear body,GO:0016604,cellular component,13.0,18.0,6.134e-02,2.091e-02,1.800e-01,4.777e-02,9.649e-03,2.365e-01,7.597e-01,4.564e-02
RORC,10260,ligand-activated transcription factor activity,GO:0098531,molecular function,13.0,5.0,3.322e-02,1.695e-02,6.513e-02,4.062e-03,1.583e-03,1.042e-02,9.506e-01,6.368e-03
RORC,10260,transcription coactivator binding,GO:0001223,molecular function,13.0,4.0,4.060e-02,2.942e-02,5.603e-02,1.075e-02,7.884e-03,1.465e-02,9.099e-01,4.678e-03
RORC,10260,"DNA-binding transcription repressor activity, RNA polymerase II-specific",GO:0001227,molecular function,13.0,10.0,4.468e-02,2.459e-02,8.120e-02,2.111e-02,1.716e-02,2.597e-02,8.535e-01,5.146e-03
RORC,10260,RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,molecular function,13.0,30.0,4.927e-02,2.587e-02,9.384e-02,3.130e-02,2.274e-02,4.307e-02,8.119e-01,8.215e-03
RORC,10260,oxysterol binding,GO:0008142,molecular function,13.0,2.0,5.721e-02,2.199e-02,1.489e-01,4.240e-02,1.499e-02,1.199e-01,7.768e-01,2.829e-02
RORC,10260,protein binding,GO:0005515,molecular function,13.0,318.0,6.688e-02,1.964e-02,2.278e-01,5.522e-02,8.663e-03,3.520e-01,7.410e-01,5.206e-02
RPRML,32422,,,,nan,nan,,,,,,,,
RSAD2,30908,,,,nan,nan,,,,,,,,
RSRP1,25234,,,,nan,nan,,,,,,,,
RTL5,29430,,,,nan,nan,,,,,,,,
RTP3,15572,,,,nan,nan,,,,,,,,
RWDD3,21393,,,,nan,nan,,,,,,,,
SALL2,10526,"regulation of transcription, DNA-templated",GO:0006355,biological process,11.0,35.0,7.969e-02,3.792e-02,1.674e-01,4.641e-02,2.047e-02,1.052e-01,7.670e-01,2.319e-02
SALL2,10526,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,11.0,55.0,8.045e-02,3.809e-02,1.699e-01,4.584e-02,2.295e-02,9.153e-02,7.691e-01,1.896e-02
SALL2,10526,eye development,GO:0001654,biological process,11.0,6.0,8.463e-02,3.804e-02,1.883e-01,5.990e-02,2.264e-02,1.585e-01,7.363e-01,2.783e-02
SALL2,10526,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,11.0,69.0,9.380e-02,5.142e-02,1.711e-01,8.562e-02,4.371e-02,1.677e-01,6.914e-01,2.157e-02
SALL2,10526,nucleus,GO:0005634,cellular component,11.0,86.0,9.113e-02,5.361e-02,1.549e-01,6.595e-02,4.430e-02,9.819e-02,7.262e-01,1.181e-02
SALL2,10526,RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000977,molecular function,11.0,16.0,6.571e-02,3.910e-02,1.104e-01,9.879e-03,6.255e-03,1.560e-02,9.140e-01,6.731e-03
SALL2,10526,"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,molecular function,11.0,11.0,6.571e-02,3.910e-02,1.104e-01,1.700e-02,1.210e-02,2.388e-02,8.740e-01,7.522e-03
SALL2,10526,DNA-binding transcription factor activity,GO:0003700,molecular function,11.0,17.0,6.617e-02,3.942e-02,1.111e-01,1.992e-02,8.673e-03,4.578e-02,8.570e-01,1.879e-02
SALL2,10526,protein binding,GO:0005515,molecular function,11.0,318.0,1.152e-01,8.524e-02,1.556e-01,1.152e-01,8.524e-02,1.556e-01,6.506e-01,1.071e-02
SCARF1,16820,,,,nan,nan,,,,,,,,
SEMA6A,10738,negative regulation of cell adhesion involved in sprouting angiogenesis,GO:0106089,biological process,21.0,4.0,8.676e-02,4.497e-02,1.674e-01,7.135e-03,4.776e-03,1.066e-02,9.310e-01,4.175e-03
SEMA6A,10738,negative regulation of sprouting angiogenesis,GO:1903671,biological process,21.0,6.0,8.676e-02,4.497e-02,1.674e-01,1.192e-02,2.936e-03,4.839e-02,8.942e-01,2.216e-02
SEMA6A,10738,negative regulation of ERK1 and ERK2 cascade,GO:0070373,biological process,21.0,4.0,9.158e-02,5.398e-02,1.554e-01,2.107e-02,7.641e-03,5.810e-02,8.514e-01,2.486e-02
SEMA6A,10738,positive regulation of neuron migration,GO:2001224,biological process,21.0,5.0,9.158e-02,5.398e-02,1.554e-01,2.931e-02,1.582e-02,5.429e-02,8.189e-01,1.582e-02
SEMA6A,10738,cellular response to vascular endothelial growth factor stimulus,GO:0035924,biological process,21.0,3.0,9.158e-02,5.398e-02,1.554e-01,4.372e-02,2.339e-02,8.171e-02,7.746e-01,1.737e-02
SEMA6A,10738,negative regulation of vascular endothelial growth factor signaling pathway,GO:1900747,biological process,21.0,4.0,9.571e-02,6.086e-02,1.505e-01,4.371e-02,1.732e-02,1.103e-01,7.738e-01,2.487e-02
SEMA6A,10738,positive regulation of cell migration,GO:0030335,biological process,21.0,31.0,1.055e-01,5.517e-02,2.017e-01,5.854e-02,2.657e-02,1.290e-01,7.397e-01,2.320e-02
SEMA6A,10738,negative regulation of angiogenesis,GO:0016525,biological process,21.0,7.0,1.058e-01,5.989e-02,1.870e-01,5.402e-02,2.599e-02,1.123e-01,7.495e-01,2.103e-02
SEMA6A,10738,neural crest cell migration,GO:0001755,biological process,21.0,6.0,1.437e-01,9.409e-02,2.195e-01,1.050e-01,6.112e-02,1.805e-01,6.631e-01,1.966e-02
SEMA6A,10738,negative chemotaxis,GO:0050919,biological process,21.0,11.0,1.656e-01,1.027e-01,2.671e-01,1.512e-01,8.189e-02,2.791e-01,6.055e-01,2.562e-02
SEMA6A,10738,semaphorin-plexin signaling pathway,GO:0071526,biological process,21.0,6.0,1.673e-01,1.026e-01,2.728e-01,1.395e-01,6.293e-02,3.093e-01,6.176e-01,2.996e-02
SEMA6A,10738,negative regulation of axon extension involved in axon guidance,GO:0048843,biological process,21.0,4.0,1.998e-01,1.095e-01,3.647e-01,1.940e-01,9.636e-02,3.905e-01,5.610e-01,3.016e-02
SEMA6A,10738,integral component of plasma membrane,GO:0005887,cellular component,21.0,39.0,1.393e-01,1.178e-01,1.647e-01,1.033e-01,7.968e-02,1.338e-01,6.669e-01,9.086e-03
SEMA6A,10738,extracellular space,GO:0005615,cellular component,21.0,24.0,1.475e-01,1.019e-01,2.134e-01,1.065e-01,6.734e-02,1.683e-01,6.618e-01,1.576e-02
SEMA6A,10738,semaphorin receptor binding,GO:0030215,molecular function,21.0,2.0,9.158e-02,5.398e-02,1.554e-01,3.278e-02,2.586e-02,4.154e-02,8.072e-01,6.283e-03
SEMA6A,10738,chemorepellent activity,GO:0045499,molecular function,21.0,2.0,9.158e-02,5.398e-02,1.554e-01,3.873e-02,1.377e-02,1.089e-01,7.872e-01,2.784e-02
SEMA6A,10738,protein binding,GO:0005515,molecular function,21.0,318.0,1.922e-01,1.789e-01,2.064e-01,1.728e-01,1.335e-01,2.236e-01,5.842e-01,1.089e-02
SEMA6B,10739,,,,nan,nan,,,,,,,,
SH2D3C,16884,positive regulation of peptidyl-serine phosphorylation,GO:0033138,biological process,3.0,6.0,3.970e-02,2.785e-02,5.660e-02,1.985e-02,1.393e-02,2.830e-02,8.591e-01,8.104e-03
SH2D3C,16884,protein binding,GO:0005515,molecular function,3.0,318.0,1.235e-01,1.000e-01,1.525e-01,1.235e-01,1.000e-01,1.525e-01,6.401e-01,7.989e-03
SH3D21,26236,,,,nan,nan,,,,,,,,
SHANK3,14294,,,,nan,nan,,,,,,,,
SHCBP1L,16788,,,,nan,nan,,,,,,,,
SHE,27004,,,,nan,nan,,,,,,,,
SHF,25116,,,,nan,nan,,,,,,,,
SLAMF7,21394,identical protein binding,GO:0042802,molecular function,2.0,24.0,2.085e-02,1.509e-02,2.882e-02,2.085e-02,1.509e-02,2.882e-02,8.546e-01,8.049e-03
SLC22A18,10964,,,,nan,nan,,,,,,,,
SLC22A23,21106,,,,nan,nan,,,,,,,,
SLC26A10,14470,integral component of plasma membrane,GO:0005887,cellular component,9.0,39.0,2.082e-01,1.167e-01,3.713e-01,5.110e-02,3.459e-02,7.551e-02,7.570e-01,1.099e-02
SLC26A10,14470,basolateral plasma membrane,GO:0016323,cellular component,9.0,4.0,2.310e-01,1.446e-01,3.690e-01,2.287e-01,1.466e-01,3.569e-01,5.314e-01,2.064e-02
SLC26A10,14470,bicarbonate transmembrane transporter activity,GO:0015106,molecular function,9.0,5.0,2.082e-01,1.167e-01,3.713e-01,6.870e-02,3.765e-02,1.253e-01,7.207e-01,1.802e-02
SLC26A10,14470,sulfate transmembrane transporter activity,GO:0015116,molecular function,9.0,6.0,2.082e-01,1.167e-01,3.713e-01,1.282e-01,6.446e-02,2.551e-01,6.319e-01,2.624e-02
SLC26A10,14470,anion:anion antiporter activity,GO:0015301,molecular function,9.0,21.0,2.082e-01,1.167e-01,3.713e-01,1.386e-01,1.279e-01,1.502e-01,6.217e-01,3.147e-03
SLC26A10,14470,chloride transmembrane transporter activity,GO:0015108,molecular function,9.0,7.0,2.082e-01,1.167e-01,3.713e-01,1.777e-01,9.704e-02,3.253e-01,5.777e-01,2.605e-02
SLC26A10,14470,oxalate transmembrane transporter activity,GO:0019531,molecular function,9.0,2.0,2.082e-01,1.167e-01,3.713e-01,1.782e-01,8.116e-02,3.912e-01,5.754e-01,3.514e-02
SLC28A2,11002,nucleoside transmembrane transport,GO:1901642,biological process,6.0,4.0,1.511e-02,8.789e-03,2.597e-02,8.376e-03,6.368e-03,1.102e-02,9.240e-01,3.403e-03
SLC28A2,11002,integral component of plasma membrane,GO:0005887,cellular component,6.0,39.0,1.834e-02,1.112e-02,3.025e-02,1.834e-02,1.112e-02,3.025e-02,8.665e-01,1.111e-02
SLC28A2,11002,nucleoside transmembrane transporter activity,GO:0005337,molecular function,6.0,11.0,1.511e-02,8.789e-03,2.597e-02,7.770e-03,6.446e-03,9.364e-03,9.275e-01,1.879e-03
SLC28A2,11002,nucleoside:sodium symporter activity,GO:0005415,molecular function,6.0,4.0,1.530e-02,8.535e-03,2.742e-02,8.065e-03,3.640e-03,1.787e-02,9.232e-01,1.039e-02
SLC28A2,11002,purine nucleoside transmembrane transporter activity,GO:0015211,molecular function,6.0,4.0,1.543e-02,8.469e-03,2.812e-02,1.236e-02,4.677e-03,3.268e-02,8.960e-01,1.789e-02
SLC46A3,27501,,,,nan,nan,,,,,,,,
SLC4A11,16438,,,,nan,nan,,,,,,,,
SLC5A6,11041,biotin transport,GO:0015878,biological process,4.0,8.0,3.850e-02,6.286e-03,2.358e-01,2.733e-02,4.299e-03,1.738e-01,8.188e-01,4.506e-02
SLC5A6,11041,pantothenate transmembrane transport,GO:0015887,biological process,4.0,7.0,3.850e-02,6.286e-03,2.358e-01,2.857e-02,5.008e-03,1.629e-01,8.159e-01,4.438e-02
SLC5A6,11041,sodium-dependent multivitamin transmembrane transporter activity,GO:0008523,molecular function,4.0,3.0,5.670e-02,1.306e-02,2.462e-01,4.999e-02,8.009e-03,3.120e-01,7.522e-01,5.283e-02
SLC6A6,11052,transport,GO:0006810,biological process,7.0,38.0,3.907e-02,1.967e-02,7.760e-02,1.281e-02,1.002e-02,1.636e-02,8.980e-01,4.203e-03
SLC6A6,11052,taurine transport,GO:0015734,biological process,7.0,3.0,3.973e-02,1.972e-02,8.004e-02,2.203e-02,8.257e-03,5.879e-02,8.465e-01,2.309e-02
SLC6A6,11052,neuron projection,GO:0043005,cellular component,7.0,20.0,3.907e-02,1.967e-02,7.760e-02,1.547e-02,4.421e-03,5.411e-02,8.765e-01,2.721e-02
SLC6A6,11052,plasma membrane,GO:0005886,cellular component,7.0,67.0,8.953e-02,6.566e-02,1.221e-01,8.953e-02,6.566e-02,1.221e-01,6.867e-01,1.003e-02
SLC6A6,11052,gamma-aminobutyric acid:sodium symporter activity,GO:0005332,molecular function,7.0,5.0,5.142e-02,3.998e-02,6.613e-02,2.998e-02,1.851e-02,4.855e-02,8.166e-01,1.245e-02
SLC6A6,11052,neurotransmitter binding,GO:0042165,molecular function,7.0,11.0,7.332e-02,6.531e-02,8.231e-02,6.279e-02,5.289e-02,7.454e-02,7.327e-01,5.047e-03
SLCO2B1,10962,sodium-independent organic anion transport,GO:0043252,biological process,11.0,2.0,8.505e-02,2.901e-02,2.494e-01,5.151e-02,1.304e-02,2.036e-01,7.524e-01,3.864e-02
SLCO2B1,10962,bile acid and bile salt transport,GO:0015721,biological process,11.0,5.0,9.167e-02,2.829e-02,2.970e-01,7.536e-02,1.562e-02,3.635e-01,7.014e-01,4.993e-02
SLCO2B1,10962,integral component of plasma membrane,GO:0005887,cellular component,11.0,39.0,3.434e-02,4.377e-03,2.695e-01,6.649e-03,5.237e-04,8.443e-02,9.126e-01,3.623e-02
SLCO2B1,10962,sodium-independent organic anion transmembrane transporter activity,GO:0015347,molecular function,11.0,4.0,7.491e-02,3.404e-02,1.648e-01,2.933e-02,1.733e-02,4.963e-02,8.187e-01,1.356e-02
SLCO2B1,10962,organic anion transmembrane transporter activity,GO:0008514,molecular function,11.0,46.0,7.776e-02,3.977e-02,1.520e-01,4.801e-02,3.634e-02,6.344e-02,7.643e-01,7.726e-03
SLCO2B1,10962,bile acid transmembrane transporter activity,GO:0015125,molecular function,11.0,7.0,1.027e-01,3.342e-02,3.158e-01,9.930e-02,3.487e-02,2.828e-01,6.679e-01,3.446e-02
SMCO4,24810,,,,nan,nan,,,,,,,,
SMIM19,25166,,,,nan,nan,,,,,,,,
SMIM5,40030,,,,nan,nan,,,,,,,,
SMOC1,20318,regulation of osteoblast differentiation,GO:0045667,biological process,5.0,6.0,7.469e-02,6.475e-02,8.615e-02,2.693e-02,6.755e-03,1.073e-01,8.252e-01,3.616e-02
SMOC1,20318,eye development,GO:0001654,biological process,5.0,6.0,1.113e-01,5.238e-02,2.366e-01,6.471e-02,3.128e-02,1.339e-01,7.276e-01,2.117e-02
SMOC1,20318,limb development,GO:0060173,biological process,5.0,2.0,1.136e-01,5.007e-02,2.576e-01,7.333e-02,1.731e-02,3.107e-01,7.059e-01,4.640e-02
SMOC1,20318,protein binding,GO:0005515,molecular function,5.0,318.0,1.429e-01,8.186e-02,2.496e-01,1.429e-01,8.186e-02,2.496e-01,6.153e-01,2.164e-02
SOX11,11191,"regulation of transcription, DNA-templated",GO:0006355,biological process,25.0,35.0,1.057e-01,7.936e-02,1.409e-01,3.717e-02,1.448e-02,9.538e-02,7.921e-01,2.470e-02
SOX11,11191,signal transduction involved in cell cycle checkpoint,GO:0072395,biological process,25.0,6.0,1.057e-01,7.565e-02,1.478e-01,3.748e-02,7.059e-03,1.989e-01,7.875e-01,4.375e-02
SOX11,11191,positive regulation of neuron differentiation,GO:0045666,biological process,25.0,13.0,1.095e-01,8.349e-02,1.437e-01,4.263e-02,2.702e-02,6.727e-02,7.777e-01,1.245e-02
SOX11,11191,cell differentiation,GO:0030154,biological process,25.0,91.0,1.095e-01,8.349e-02,1.437e-01,5.407e-02,4.246e-02,6.885e-02,7.505e-01,6.933e-03
SOX11,11191,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,25.0,55.0,1.095e-01,8.349e-02,1.437e-01,5.622e-02,4.345e-02,7.274e-02,7.459e-01,7.351e-03
SOX11,11191,negative regulation of glial cell proliferation,GO:0060253,biological process,25.0,5.0,1.106e-01,8.668e-02,1.410e-01,4.431e-02,1.877e-02,1.046e-01,7.724e-01,2.357e-02
SOX11,11191,positive regulation of ossification,GO:0045778,biological process,25.0,5.0,1.107e-01,8.391e-02,1.459e-01,3.108e-02,7.872e-03,1.227e-01,8.100e-01,3.688e-02
SOX11,11191,neuron differentiation,GO:0030182,biological process,25.0,19.0,1.107e-01,8.391e-02,1.459e-01,5.049e-02,3.181e-02,8.013e-02,7.583e-01,1.291e-02
SOX11,11191,positive regulation of osteoblast differentiation,GO:0045669,biological process,25.0,5.0,1.118e-01,8.254e-02,1.514e-01,5.672e-02,2.200e-02,1.463e-01,7.430e-01,2.686e-02
SOX11,11191,negative regulation of gene expression,GO:0010629,biological process,25.0,26.0,1.118e-01,8.254e-02,1.514e-01,6.271e-02,4.220e-02,9.320e-02,7.325e-01,1.153e-02
SOX11,11191,positive regulation of stem cell proliferation,GO:2000648,biological process,25.0,7.0,1.147e-01,8.286e-02,1.588e-01,6.028e-02,2.961e-02,1.228e-01,7.364e-01,2.108e-02
SOX11,11191,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,25.0,69.0,1.196e-01,9.322e-02,1.535e-01,8.638e-02,6.727e-02,1.109e-01,6.917e-01,8.155e-03
SOX11,11191,positive regulation of gene expression,GO:0010628,biological process,25.0,27.0,1.422e-01,6.915e-02,2.923e-01,1.152e-01,4.514e-02,2.940e-01,6.465e-01,3.462e-02
SOX11,11191,regulation of transforming growth factor beta receptor signaling pathway,GO:0017015,biological process,25.0,8.0,1.441e-01,6.952e-02,2.987e-01,1.066e-01,3.509e-02,3.241e-01,6.569e-01,3.776e-02
SOX11,11191,anatomical structure morphogenesis,GO:0009653,biological process,25.0,91.0,1.706e-01,1.034e-01,2.814e-01,1.443e-01,6.994e-02,2.978e-01,6.126e-01,2.762e-02
SOX11,11191,negative regulation of lymphocyte proliferation,GO:0050672,biological process,25.0,8.0,3.505e-01,1.956e-01,6.279e-01,3.505e-01,1.956e-01,6.279e-01,4.361e-01,3.265e-02
SOX11,11191,nuclear transcription factor complex,GO:0044798,cellular component,25.0,9.0,1.047e-01,7.752e-02,1.413e-01,2.290e-02,9.115e-03,5.751e-02,8.435e-01,2.302e-02
SOX11,11191,nucleus,GO:0005634,cellular component,25.0,86.0,1.479e-01,1.105e-01,1.978e-01,1.177e-01,8.117e-02,1.707e-01,6.470e-01,1.387e-02
SOX11,11191,nucleoplasm,GO:0005654,cellular component,25.0,47.0,1.896e-01,1.443e-01,2.490e-01,1.647e-01,1.210e-01,2.243e-01,5.925e-01,1.282e-02
SOX11,11191,cytoplasm,GO:0005737,cellular component,25.0,72.0,2.104e-01,1.668e-01,2.654e-01,2.012e-01,1.595e-01,2.538e-01,5.568e-01,1.050e-02
SOX11,11191,cis-regulatory region sequence-specific DNA binding,GO:0000987,molecular function,25.0,6.0,1.023e-01,7.265e-02,1.439e-01,1.129e-02,1.765e-03,7.228e-02,8.920e-01,2.709e-02
SOX11,11191,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,25.0,17.0,1.047e-01,7.752e-02,1.413e-01,2.184e-02,1.387e-02,3.439e-02,8.492e-01,1.075e-02
SOX11,11191,RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,molecular function,25.0,30.0,1.095e-01,8.349e-02,1.437e-01,5.542e-02,3.493e-02,8.794e-02,7.474e-01,1.301e-02
SOX17,18122,cell differentiation,GO:0030154,biological process,25.0,91.0,9.246e-02,6.091e-02,1.403e-01,1.717e-02,1.378e-02,2.139e-02,8.734e-01,4.728e-03
SOX17,18122,endoderm formation,GO:0001706,biological process,25.0,2.0,1.020e-01,5.569e-02,1.869e-01,4.157e-02,2.001e-02,8.639e-02,7.802e-01,1.948e-02
SOX17,18122,"regulation of transcription, DNA-templated",GO:0006355,biological process,25.0,35.0,1.148e-01,4.463e-02,2.955e-01,4.871e-02,1.452e-02,1.635e-01,7.599e-01,3.379e-02
SOX17,18122,anatomical structure morphogenesis,GO:0009653,biological process,25.0,91.0,1.195e-01,4.823e-02,2.961e-01,5.862e-02,1.762e-02,1.950e-01,7.372e-01,3.590e-02
SOX17,18122,cardiac cell fate determination,GO:0060913,biological process,25.0,5.0,1.205e-01,1.023e-01,1.420e-01,5.120e-02,3.580e-02,7.321e-02,7.569e-01,1.009e-02
SOX17,18122,ureter development,GO:0072189,biological process,25.0,3.0,1.581e-01,8.065e-02,3.099e-01,7.491e-02,1.339e-02,4.192e-01,7.013e-01,5.350e-02
SOX17,18122,mRNA transcription by RNA polymerase II,GO:0042789,biological process,25.0,3.0,1.628e-01,1.070e-01,2.476e-01,8.571e-02,3.140e-02,2.340e-01,6.894e-01,3.140e-02
SOX17,18122,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,25.0,69.0,1.631e-01,1.033e-01,2.575e-01,9.124e-02,4.066e-02,2.048e-01,6.818e-01,2.616e-02
SOX17,18122,vasculogenesis,GO:0001570,biological process,25.0,5.0,1.968e-01,1.736e-01,2.232e-01,1.333e-01,9.802e-02,1.812e-01,6.279e-01,1.200e-02
SOX17,18122,metanephros development,GO:0001656,biological process,25.0,3.0,2.099e-01,1.364e-01,3.232e-01,1.409e-01,6.060e-02,3.277e-01,6.154e-01,3.395e-02
SOX17,18122,protein destabilization,GO:0031648,biological process,25.0,2.0,2.240e-01,1.479e-01,3.394e-01,1.662e-01,7.951e-02,3.475e-01,5.885e-01,3.123e-02
SOX17,18122,angiogenesis,GO:0001525,biological process,25.0,13.0,2.539e-01,1.902e-01,3.390e-01,2.020e-01,1.497e-01,2.726e-01,5.557e-01,1.336e-02
SOX17,18122,protein stabilization,GO:0050821,biological process,25.0,3.0,2.714e-01,1.749e-01,4.211e-01,2.362e-01,1.140e-01,4.895e-01,5.226e-01,3.352e-02
SOX17,18122,negative regulation of cell growth,GO:0030308,biological process,25.0,18.0,2.793e-01,2.729e-01,2.858e-01,2.486e-01,2.147e-01,2.878e-01,5.159e-01,7.100e-03
SOX17,18122,heart development,GO:0007507,biological process,25.0,5.0,3.025e-01,2.360e-01,3.877e-01,2.845e-01,2.139e-01,3.784e-01,4.870e-01,1.515e-02
SOX17,18122,negative regulation of canonical Wnt signaling pathway,GO:0090090,biological process,25.0,13.0,3.224e-01,2.229e-01,4.664e-01,3.179e-01,2.129e-01,4.747e-01,4.613e-01,2.274e-02
SOX17,18122,nuclear transcription factor complex,GO:0044798,cellular component,25.0,9.0,9.224e-02,6.091e-02,1.397e-01,4.311e-03,3.433e-03,5.413e-03,9.496e-01,1.678e-03
SOX17,18122,transcription factor complex,GO:0005667,cellular component,25.0,8.0,9.246e-02,6.091e-02,1.403e-01,2.613e-02,1.519e-02,4.498e-02,8.312e-01,1.361e-02
SOX17,18122,nucleus,GO:0005634,cellular component,25.0,86.0,1.962e-01,1.712e-01,2.248e-01,1.278e-01,9.874e-02,1.653e-01,6.347e-01,1.002e-02
SOX17,18122,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,25.0,17.0,9.246e-02,6.091e-02,1.403e-01,2.069e-02,1.232e-02,3.477e-02,8.547e-01,1.234e-02
SOX17,18122,beta-catenin binding,GO:0008013,molecular function,25.0,5.0,9.246e-02,6.091e-02,1.403e-01,2.345e-02,1.252e-02,4.391e-02,8.422e-01,1.584e-02
SOX17,18122,"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,molecular function,25.0,11.0,9.246e-02,6.091e-02,1.403e-01,2.771e-02,1.370e-02,5.603e-02,8.247e-01,1.796e-02
SOX17,18122,transcription factor binding,GO:0008134,molecular function,25.0,16.0,9.246e-02,6.091e-02,1.403e-01,2.880e-02,1.242e-02,6.678e-02,8.201e-01,2.180e-02
SOX17,18122,protein binding,GO:0005515,molecular function,25.0,318.0,2.919e-01,2.570e-01,3.316e-01,2.573e-01,2.043e-01,3.239e-01,5.086e-01,1.142e-02
SOX18,11194,,,,nan,nan,,,,,,,,
SOX7,18196,,,,nan,nan,,,,,,,,
SP100,11206,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",GO:0006978,biological process,32.0,4.0,1.096e-01,5.341e-02,2.248e-01,1.341e-02,2.154e-03,8.347e-02,8.806e-01,3.582e-02
SP100,11206,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,32.0,41.0,1.096e-01,5.341e-02,2.248e-01,3.023e-02,1.808e-02,5.054e-02,8.157e-01,1.335e-02
SP100,11206,negative regulation of DNA-binding transcription factor activity,GO:0043433,biological process,32.0,10.0,1.096e-01,5.341e-02,2.248e-01,3.523e-02,2.048e-02,6.062e-02,7.988e-01,1.430e-02
SP100,11206,response to type I interferon,GO:0034340,biological process,32.0,4.0,1.145e-01,4.960e-02,2.644e-01,3.014e-02,4.565e-03,1.990e-01,8.081e-01,4.526e-02
SP100,11206,negative regulation of DNA binding,GO:0043392,biological process,32.0,12.0,1.145e-01,4.960e-02,2.644e-01,5.189e-02,2.347e-02,1.147e-01,7.541e-01,2.243e-02
SP100,11206,response to interferon-gamma,GO:0034341,biological process,32.0,6.0,1.292e-01,3.905e-02,4.278e-01,7.159e-02,1.138e-02,4.505e-01,7.041e-01,6.110e-02
SP100,11206,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,32.0,55.0,1.570e-01,1.309e-01,1.883e-01,9.409e-02,6.579e-02,1.346e-01,6.798e-01,1.200e-02
SP100,11206,negative regulation of endothelial cell migration,GO:0010596,biological process,32.0,6.0,1.681e-01,8.052e-02,3.511e-01,9.343e-02,2.098e-02,4.160e-01,6.711e-01,5.283e-02
SP100,11206,regulation of angiogenesis,GO:0045765,biological process,32.0,9.0,1.728e-01,1.180e-01,2.531e-01,1.076e-01,4.681e-02,2.474e-01,6.576e-01,3.054e-02
SP100,11206,negative regulation of cellular component movement,GO:0051271,biological process,32.0,18.0,1.809e-01,9.428e-02,3.471e-01,1.228e-01,5.244e-02,2.876e-01,6.374e-01,3.102e-02
SP100,11206,regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902041,biological process,32.0,5.0,2.458e-01,1.783e-01,3.389e-01,2.014e-01,1.232e-01,3.295e-01,5.553e-01,2.201e-02
SP100,11206,negative regulation of protein export from nucleus,GO:0046826,biological process,32.0,7.0,2.538e-01,1.250e-01,5.151e-01,2.142e-01,9.348e-02,4.909e-01,5.411e-01,3.656e-02
SP100,11206,telomere maintenance,GO:0000723,biological process,32.0,12.0,2.832e-01,1.788e-01,4.483e-01,2.493e-01,1.446e-01,4.296e-01,5.130e-01,2.737e-02
SP100,11206,regulation of Fas signaling pathway,GO:1902044,biological process,32.0,4.0,4.061e-01,3.347e-01,4.929e-01,3.964e-01,3.192e-01,4.923e-01,4.084e-01,1.341e-02
SP100,11206,maintenance of protein location,GO:0045185,biological process,32.0,9.0,4.244e-01,3.052e-01,5.903e-01,4.092e-01,2.741e-01,6.107e-01,3.980e-01,2.631e-02
SP100,11206,nuclear body,GO:0016604,cellular component,32.0,18.0,1.096e-01,5.341e-02,2.248e-01,3.199e-02,1.133e-02,9.029e-02,8.081e-01,2.625e-02
SP100,11206,PML body,GO:0016605,cellular component,32.0,3.0,1.131e-01,6.102e-02,2.096e-01,3.980e-02,2.459e-02,6.441e-02,7.855e-01,1.286e-02
SP100,11206,nucleoplasm,GO:0005654,cellular component,32.0,47.0,1.170e-01,4.769e-02,2.871e-01,5.311e-02,1.361e-02,2.073e-01,7.486e-01,3.873e-02
SP100,11206,nucleus,GO:0005634,cellular component,32.0,86.0,1.174e-01,4.781e-02,2.881e-01,6.374e-02,1.973e-02,2.059e-01,7.272e-01,3.478e-02
SP100,11206,cytoplasm,GO:0005737,cellular component,32.0,72.0,1.256e-01,4.147e-02,3.802e-01,6.982e-02,1.462e-02,3.334e-01,7.113e-01,5.014e-02
SP100,11206,"nuclear chromosome, telomeric region",GO:0000784,cellular component,32.0,4.0,1.625e-01,8.914e-02,2.960e-01,1.128e-01,5.732e-02,2.220e-01,6.517e-01,2.465e-02
SP100,11206,Mre11 complex,GO:0030870,cellular component,32.0,2.0,3.737e-01,3.029e-01,4.612e-01,3.555e-01,2.642e-01,4.784e-01,4.355e-01,1.720e-02
SP100,11206,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,32.0,17.0,1.096e-01,5.341e-02,2.248e-01,2.488e-02,1.178e-02,5.251e-02,8.352e-01,1.820e-02
SP100,11206,chromo shadow domain binding,GO:0070087,molecular function,32.0,2.0,1.096e-01,5.341e-02,2.248e-01,2.597e-02,1.651e-02,4.083e-02,8.316e-01,1.145e-02
SP100,11206,kinase binding,GO:0019900,molecular function,32.0,7.0,1.096e-01,5.341e-02,2.248e-01,2.568e-02,9.430e-03,6.992e-02,8.312e-01,2.419e-02
SP100,11206,identical protein binding,GO:0042802,molecular function,32.0,24.0,1.170e-01,4.769e-02,2.871e-01,4.892e-02,1.477e-02,1.621e-01,7.591e-01,3.505e-02
SP100,11206,protein binding,GO:0005515,molecular function,32.0,318.0,1.459e-01,5.663e-02,3.759e-01,9.667e-02,2.876e-02,3.249e-01,6.699e-01,4.172e-02
SP100,11206,protein domain specific binding,GO:0019904,molecular function,32.0,78.0,1.511e-01,9.869e-02,2.315e-01,8.685e-02,3.675e-02,2.053e-01,6.885e-01,2.698e-02
SP110,5401,,,,nan,nan,,,,,,,,
SPACA6,27113,,,,nan,nan,,,,,,,,
SPATA22,30705,,,,nan,nan,,,,,,,,
ST3GAL4,10864,protein sialylation,GO:1990743,biological process,18.0,3.0,4.300e-02,1.464e-02,1.263e-01,1.163e-02,2.553e-03,5.302e-02,8.944e-01,2.525e-02
ST3GAL4,10864,sialylation,GO:0097503,biological process,18.0,4.0,4.300e-02,1.464e-02,1.263e-01,1.392e-02,7.135e-03,2.716e-02,8.898e-01,1.355e-02
ST3GAL4,10864,glycoprotein biosynthetic process,GO:0009101,biological process,18.0,14.0,4.491e-02,1.344e-02,1.501e-01,1.442e-02,1.594e-03,1.305e-01,8.686e-01,3.623e-02
ST3GAL4,10864,glycolipid biosynthetic process,GO:0009247,biological process,18.0,15.0,5.291e-02,1.156e-02,2.422e-01,2.439e-02,2.183e-03,2.725e-01,8.207e-01,5.105e-02
ST3GAL4,10864,protein glycosylation,GO:0006486,biological process,18.0,17.0,6.085e-02,1.599e-02,2.316e-01,4.727e-02,1.379e-02,1.621e-01,7.634e-01,3.452e-02
ST3GAL4,10864,oligosaccharide biosynthetic process,GO:0009312,biological process,18.0,8.0,6.247e-02,1.517e-02,2.572e-01,4.540e-02,1.022e-02,2.017e-01,7.671e-01,4.019e-02
ST3GAL4,10864,lipid glycosylation,GO:0030259,biological process,18.0,3.0,6.560e-02,5.920e-03,7.269e-01,3.957e-02,2.163e-03,7.238e-01,7.638e-01,9.073e-02
ST3GAL4,10864,cognition,GO:0050890,biological process,18.0,4.0,1.386e-01,8.969e-03,2.143e+00,1.308e-01,7.758e-03,2.206e+00,5.831e-01,1.232e-01
ST3GAL4,10864,membrane,GO:0016020,cellular component,18.0,41.0,1.697e-01,3.045e-02,9.457e-01,1.648e-01,3.108e-02,8.744e-01,5.779e-01,6.410e-02
ST3GAL4,10864,monosialoganglioside sialyltransferase activity,GO:0047288,molecular function,18.0,2.0,4.300e-02,1.464e-02,1.263e-01,1.775e-02,7.209e-03,4.372e-02,8.666e-01,1.878e-02
ST3GAL4,10864,"beta-galactoside (CMP) alpha-2,3-sialyltransferase activity",GO:0003836,molecular function,18.0,2.0,4.300e-02,1.464e-02,1.263e-01,1.878e-02,9.119e-03,3.867e-02,8.629e-01,1.593e-02
ST3GAL4,10864,sialyltransferase activity,GO:0008373,molecular function,18.0,16.0,5.156e-02,1.445e-02,1.840e-01,3.107e-02,1.273e-02,7.584e-02,8.118e-01,2.352e-02
ST3GAL6,18080,protein glycosylation,GO:0006486,biological process,12.0,17.0,1.730e-02,2.612e-03,1.146e-01,3.493e-03,1.776e-04,6.867e-02,9.409e-01,2.198e-02
ST3GAL6,18080,glycolipid biosynthetic process,GO:0009247,biological process,12.0,15.0,2.286e-02,8.533e-03,6.123e-02,5.544e-03,2.087e-03,1.472e-02,9.395e-01,8.543e-03
ST3GAL6,18080,glycolipid metabolic process,GO:0006664,biological process,12.0,15.0,3.006e-02,6.702e-03,1.348e-01,1.513e-02,1.764e-03,1.298e-01,8.649e-01,3.465e-02
ST3GAL6,18080,cellular response to interleukin-6,GO:0071354,biological process,12.0,3.0,4.308e-02,1.942e-02,9.557e-02,3.479e-02,1.170e-02,1.034e-01,7.989e-01,2.856e-02
ST3GAL6,18080,oligosaccharide metabolic process,GO:0009311,biological process,12.0,19.0,4.427e-02,3.334e-02,5.877e-02,3.159e-02,2.712e-02,3.681e-02,8.112e-01,4.046e-03
ST3GAL6,18080,cellular protein modification process,GO:0006464,biological process,12.0,66.0,6.678e-02,5.343e-02,8.347e-02,6.065e-02,4.161e-02,8.841e-02,7.366e-01,1.114e-02
ST3GAL6,18080,extracellular exosome,GO:0070062,cellular component,12.0,39.0,1.687e-01,1.274e-02,2.233e+00,1.554e-01,9.105e-03,2.651e+00,5.526e-01,1.230e-01
ST3GAL6,18080,"beta-galactoside alpha-2,3-sialyltransferase activity",GO:0052798,molecular function,12.0,2.0,2.586e-02,7.445e-03,8.983e-02,8.288e-03,4.016e-03,1.711e-02,9.227e-01,8.541e-03
ST3GAL6,18080,sialyltransferase activity,GO:0008373,molecular function,12.0,16.0,2.674e-02,6.579e-03,1.087e-01,9.771e-03,1.027e-03,9.294e-02,8.972e-01,2.763e-02
ST6GALNAC3,19343,sialylation,GO:0097503,biological process,13.0,4.0,4.602e-02,3.504e-02,6.043e-02,8.505e-03,4.087e-03,1.770e-02,9.209e-01,9.835e-03
ST6GALNAC3,19343,glycosylceramide metabolic process,GO:0006677,biological process,13.0,7.0,4.628e-02,3.592e-02,5.965e-02,1.933e-02,8.570e-03,4.361e-02,8.603e-01,1.953e-02
ST6GALNAC3,19343,glycoprotein metabolic process,GO:0009100,biological process,13.0,11.0,5.231e-02,2.971e-02,9.209e-02,2.277e-02,7.743e-03,6.699e-02,8.431e-01,2.591e-02
ST6GALNAC3,19343,glycosphingolipid metabolic process,GO:0006687,biological process,13.0,11.0,7.390e-02,2.118e-02,2.578e-01,4.827e-02,9.656e-03,2.413e-01,7.582e-01,4.603e-02
ST6GALNAC3,19343,ganglioside biosynthetic process,GO:0001574,biological process,13.0,5.0,8.676e-02,3.032e-02,2.483e-01,6.968e-02,2.890e-02,1.680e-01,7.175e-01,2.667e-02
ST6GALNAC3,19343,oligosaccharide metabolic process,GO:0009311,biological process,13.0,19.0,1.033e-01,2.069e-02,5.161e-01,9.219e-02,1.253e-02,6.781e-01,6.687e-01,6.293e-02
ST6GALNAC3,19343,nucleoplasm,GO:0005654,cellular component,13.0,47.0,1.224e-01,5.407e-02,2.771e-01,1.132e-01,5.685e-02,2.252e-01,6.512e-01,2.432e-02
ST6GALNAC3,19343,"alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity",GO:0001665,molecular function,13.0,2.0,4.602e-02,3.504e-02,6.043e-02,1.636e-02,6.421e-03,4.170e-02,8.736e-01,1.825e-02
ST6GALNAC3,19343,sialyltransferase activity,GO:0008373,molecular function,13.0,16.0,5.129e-02,2.924e-02,8.998e-02,2.931e-02,1.610e-02,5.337e-02,8.188e-01,1.538e-02
STARD9,19162,spindle assembly,GO:0051225,biological process,7.0,7.0,2.021e-01,1.750e-01,2.334e-01,1.529e-01,8.691e-02,2.691e-01,6.039e-01,2.350e-02
STARD9,19162,centriole,GO:0005814,cellular component,7.0,3.0,1.919e-01,1.633e-01,2.256e-01,5.401e-02,3.135e-02,9.307e-02,7.503e-01,1.526e-02
STARD9,19162,nucleus,GO:0005634,cellular component,7.0,86.0,2.067e-01,1.703e-01,2.508e-01,2.000e-01,1.514e-01,2.641e-01,5.578e-01,1.241e-02
STARD9,19162,cytoplasm,GO:0005737,cellular component,7.0,72.0,2.067e-01,1.703e-01,2.508e-01,2.012e-01,1.754e-01,2.308e-01,5.569e-01,6.103e-03
STARD9,19162,microtubule motor activity,GO:0003777,molecular function,7.0,3.0,1.919e-01,1.633e-01,2.256e-01,6.774e-02,4.754e-02,9.652e-02,7.229e-01,1.078e-02
STARD9,19162,microtubule binding,GO:0008017,molecular function,7.0,8.0,2.021e-01,1.750e-01,2.334e-01,1.431e-01,1.002e-01,2.042e-01,6.162e-01,1.430e-02
STX1B,18539,exocytosis,GO:0006887,biological process,13.0,8.0,4.179e-02,2.988e-02,5.845e-02,1.473e-02,1.067e-02,2.032e-02,8.863e-01,6.470e-03
STX1B,18539,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,GO:0098967,biological process,13.0,3.0,4.179e-02,2.988e-02,5.845e-02,1.981e-02,1.479e-02,2.654e-02,8.595e-01,6.670e-03
STX1B,18539,vesicle docking,GO:0048278,biological process,13.0,5.0,4.509e-02,2.532e-02,8.028e-02,2.483e-02,8.696e-03,7.090e-02,8.346e-01,2.563e-02
STX1B,18539,intracellular protein transport,GO:0006886,biological process,13.0,20.0,4.509e-02,2.532e-02,8.028e-02,2.525e-02,5.106e-03,1.249e-01,8.281e-01,3.627e-02
STX1B,18539,vesicle fusion,GO:0006906,biological process,13.0,19.0,5.651e-02,2.860e-02,1.117e-01,5.285e-02,2.213e-02,1.262e-01,7.517e-01,2.480e-02
STX1B,18539,integral component of membrane,GO:0016021,cellular component,13.0,19.0,4.179e-02,2.988e-02,5.845e-02,1.815e-02,1.191e-02,2.767e-02,8.677e-01,9.599e-03
STX1B,18539,SNARE complex,GO:0031201,cellular component,13.0,21.0,4.509e-02,2.532e-02,8.028e-02,2.951e-02,1.255e-02,6.938e-02,8.177e-01,2.215e-02
STX1B,18539,plasma membrane,GO:0005886,cellular component,13.0,67.0,4.883e-02,3.180e-02,7.497e-02,3.612e-02,2.439e-02,5.350e-02,7.963e-01,1.051e-02
STX1B,18539,endomembrane system,GO:0012505,cellular component,13.0,3.0,4.883e-02,3.180e-02,7.497e-02,4.214e-02,2.205e-02,8.055e-02,7.788e-01,1.760e-02
STX1B,18539,SNARE binding,GO:0000149,molecular function,13.0,4.0,4.179e-02,2.988e-02,5.845e-02,8.352e-03,2.746e-03,2.540e-02,9.191e-01,1.502e-02
STX1B,18539,SNAP receptor activity,GO:0005484,molecular function,13.0,2.0,4.864e-02,3.106e-02,7.616e-02,3.990e-02,2.237e-02,7.116e-02,7.851e-01,1.562e-02
SWAP70,17070,plasma membrane,GO:0005886,cellular component,7.0,67.0,1.162e-01,9.656e-02,1.397e-01,5.697e-02,4.698e-02,6.908e-02,7.444e-01,5.512e-03
SWAP70,17070,nucleus,GO:0005634,cellular component,7.0,86.0,1.162e-01,9.656e-02,1.397e-01,7.621e-02,5.311e-02,1.094e-01,7.081e-01,1.136e-02
SWAP70,17070,cytoplasm,GO:0005737,cellular component,7.0,72.0,1.162e-01,9.656e-02,1.397e-01,8.315e-02,7.290e-02,9.484e-02,6.970e-01,4.157e-03
SWAP70,17070,actin cytoskeleton,GO:0015629,cellular component,7.0,6.0,1.162e-01,9.656e-02,1.397e-01,1.115e-01,8.863e-02,1.404e-01,6.557e-01,8.332e-03
SWAP70,17070,cadherin binding,GO:0045296,molecular function,7.0,9.0,1.162e-01,9.656e-02,1.397e-01,6.093e-02,4.057e-02,9.152e-02,7.361e-01,1.195e-02
SWAP70,17070,protein binding,GO:0005515,molecular function,7.0,318.0,1.162e-01,9.656e-02,1.397e-01,1.046e-01,7.814e-02,1.399e-01,6.651e-01,9.939e-03
SYNGR3,11501,,,,nan,nan,,,,,,,,
TAL1,11556,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,48.0,41.0,6.035e-02,3.891e-02,9.362e-02,9.286e-03,5.216e-03,1.653e-02,9.170e-01,8.089e-03
TAL1,11556,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,48.0,69.0,7.922e-02,5.341e-02,1.175e-01,2.717e-02,1.585e-02,4.657e-02,8.270e-01,1.380e-02
TAL1,11556,positive regulation of cell division,GO:0051781,biological process,48.0,9.0,9.957e-02,5.095e-02,1.946e-01,5.241e-02,2.344e-02,1.172e-01,7.532e-01,2.232e-02
TAL1,11556,positive regulation of mitotic cell cycle,GO:0045931,biological process,48.0,16.0,1.083e-01,6.872e-02,1.708e-01,6.924e-02,3.659e-02,1.310e-01,7.194e-01,1.911e-02
TAL1,11556,positive regulation of chromatin assembly or disassembly,GO:0045799,biological process,48.0,5.0,1.100e-01,7.478e-02,1.619e-01,6.265e-02,2.890e-02,1.358e-01,7.316e-01,2.247e-02
TAL1,11556,basophil differentiation,GO:0030221,biological process,48.0,2.0,1.550e-01,1.016e-01,2.363e-01,1.231e-01,7.895e-02,1.921e-01,6.398e-01,1.711e-02
TAL1,11556,regulation of transcription by RNA polymerase II,GO:0006357,biological process,48.0,51.0,1.553e-01,7.983e-02,3.022e-01,1.207e-01,4.822e-02,3.019e-01,6.396e-01,3.347e-02
TAL1,11556,positive regulation of erythrocyte differentiation,GO:0045648,biological process,48.0,5.0,1.663e-01,5.774e-02,4.787e-01,1.273e-01,2.916e-02,5.553e-01,6.246e-01,5.428e-02
TAL1,11556,megakaryocyte differentiation,GO:0030219,biological process,48.0,2.0,2.019e-01,1.689e-01,2.415e-01,1.760e-01,1.401e-01,2.211e-01,5.810e-01,9.585e-03
TAL1,11556,positive regulation of protein-containing complex assembly,GO:0031334,biological process,48.0,36.0,2.471e-01,1.077e-01,5.670e-01,2.307e-01,8.486e-02,6.271e-01,5.238e-01,4.682e-02
TAL1,11556,erythrocyte differentiation,GO:0030218,biological process,48.0,6.0,2.681e-01,2.390e-01,3.008e-01,2.509e-01,2.259e-01,2.787e-01,5.141e-01,5.127e-03
TAL1,11556,nucleoplasm,GO:0005654,cellular component,48.0,47.0,5.712e-02,3.749e-02,8.702e-02,4.185e-03,8.567e-04,2.044e-02,9.471e-01,1.148e-02
TAL1,11556,nucleus,GO:0005634,cellular component,48.0,86.0,5.827e-02,4.089e-02,8.302e-02,5.910e-03,2.064e-03,1.692e-02,9.365e-01,1.041e-02
TAL1,11556,nuclear chromatin,GO:0000790,cellular component,48.0,11.0,1.164e-01,8.241e-02,1.643e-01,7.721e-02,4.029e-02,1.479e-01,7.054e-01,2.015e-02
TAL1,11556,transcription factor complex,GO:0005667,cellular component,48.0,8.0,1.189e-01,9.850e-02,1.435e-01,8.226e-02,7.348e-02,9.210e-02,6.984e-01,3.583e-03
TAL1,11556,Lsd1/2 complex,GO:0033193,cellular component,48.0,2.0,1.417e-01,7.170e-02,2.800e-01,1.001e-01,3.331e-02,3.011e-01,6.656e-01,3.924e-02
TAL1,11556,histone deacetylase complex,GO:0000118,cellular component,48.0,12.0,3.408e-01,2.862e-01,4.058e-01,3.364e-01,2.787e-01,4.059e-01,4.497e-01,1.102e-02
TAL1,11556,protein binding,GO:0005515,molecular function,48.0,318.0,6.192e-02,3.719e-02,1.031e-01,1.093e-02,5.056e-03,2.361e-02,9.061e-01,1.112e-02
TAL1,11556,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,48.0,17.0,7.218e-02,5.068e-02,1.028e-01,1.964e-02,1.260e-02,3.062e-02,8.599e-01,1.045e-02
TAL1,11556,E-box binding,GO:0070888,molecular function,48.0,5.0,7.484e-02,5.346e-02,1.048e-01,1.993e-02,1.685e-02,2.357e-02,8.592e-01,3.997e-03
TAL1,11556,histone deacetylase binding,GO:0042826,molecular function,48.0,3.0,7.922e-02,5.341e-02,1.175e-01,2.944e-02,1.622e-02,5.343e-02,8.182e-01,1.548e-02
TAL1,11556,RNA polymerase II transcription factor binding,GO:0001085,molecular function,48.0,4.0,7.949e-02,5.329e-02,1.186e-01,2.800e-02,2.168e-02,3.618e-02,8.241e-01,6.496e-03
TAL1,11556,chromatin binding,GO:0003682,molecular function,48.0,11.0,8.911e-02,4.324e-02,1.836e-01,3.697e-02,5.025e-03,2.720e-01,7.858e-01,5.150e-02
TAL1,11556,RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000977,molecular function,48.0,16.0,8.947e-02,4.669e-02,1.714e-01,3.821e-02,1.993e-02,7.328e-02,7.896e-01,1.739e-02
TAL1,11556,DNA-binding transcription factor activity,GO:0003700,molecular function,48.0,17.0,9.310e-02,4.840e-02,1.791e-01,4.840e-02,2.226e-02,1.052e-01,7.623e-01,2.194e-02
TAL1,11556,enzyme binding,GO:0019899,molecular function,48.0,35.0,1.036e-01,4.283e-02,2.507e-01,4.581e-02,8.322e-03,2.521e-01,7.639e-01,4.830e-02
TAP1,43,cytosol to endoplasmic reticulum transport,GO:0046967,biological process,27.0,8.0,5.669e-02,3.572e-02,8.998e-02,9.065e-03,7.073e-03,1.162e-02,9.200e-01,3.210e-03
TAP1,43,transmembrane transport,GO:0055085,biological process,27.0,28.0,5.913e-02,3.469e-02,1.008e-01,1.792e-02,1.446e-02,2.222e-02,8.694e-01,4.766e-03
TAP1,43,peptide transport,GO:0015833,biological process,27.0,16.0,6.262e-02,3.559e-02,1.102e-01,2.465e-02,1.103e-02,5.509e-02,8.361e-01,1.989e-02
TAP1,43,antigen processing and presentation of endogenous peptide antigen via MHC class I,GO:0019885,biological process,27.0,6.0,7.007e-02,3.139e-02,1.564e-01,4.125e-02,1.343e-02,1.266e-01,7.799e-01,2.968e-02
TAP1,43,integral component of membrane,GO:0016021,cellular component,27.0,19.0,7.463e-02,4.219e-02,1.320e-01,4.525e-02,2.340e-02,8.749e-02,7.705e-01,1.820e-02
TAP1,43,integral component of endoplasmic reticulum membrane,GO:0030176,cellular component,27.0,6.0,7.497e-02,4.287e-02,1.311e-01,5.231e-02,1.945e-02,1.407e-01,7.522e-01,2.907e-02
TAP1,43,endoplasmic reticulum,GO:0005783,cellular component,27.0,16.0,7.824e-02,4.529e-02,1.352e-01,6.311e-02,3.422e-02,1.164e-01,7.311e-01,1.782e-02
TAP1,43,MHC class I peptide loading complex,GO:0042824,cellular component,27.0,3.0,8.194e-02,5.577e-02,1.204e-01,6.802e-02,3.703e-02,1.249e-01,7.216e-01,1.877e-02
TAP1,43,TAP complex,GO:0042825,cellular component,27.0,3.0,8.194e-02,5.577e-02,1.204e-01,6.883e-02,3.840e-02,1.234e-01,7.203e-01,1.804e-02
TAP1,43,centriolar satellite,GO:0034451,cellular component,27.0,5.0,9.495e-02,8.067e-02,1.118e-01,8.747e-02,7.796e-02,9.814e-02,6.903e-01,3.729e-03
TAP1,43,membrane,GO:0016020,cellular component,27.0,41.0,1.014e-01,8.172e-02,1.257e-01,9.853e-02,8.340e-02,1.164e-01,6.738e-01,5.631e-03
TAP1,43,ATPase-coupled peptide transmembrane transporter activity,GO:0015440,molecular function,27.0,8.0,5.387e-02,3.259e-02,8.904e-02,6.298e-03,2.535e-03,1.565e-02,9.347e-01,8.082e-03
TAP1,43,ATPase-coupled peptide antigen transmembrane transporter activity,GO:0015433,molecular function,27.0,3.0,5.387e-02,3.259e-02,8.904e-02,6.500e-03,2.858e-03,1.478e-02,9.335e-01,8.550e-03
TAP1,43,MHC class Ib protein binding,GO:0023029,molecular function,27.0,5.0,6.300e-02,3.039e-02,1.306e-01,1.725e-02,3.835e-03,7.761e-02,8.654e-01,3.371e-02
TAP1,43,peptide transmembrane transporter activity,GO:1904680,molecular function,27.0,11.0,6.300e-02,3.039e-02,1.306e-01,2.147e-02,6.577e-03,7.011e-02,8.480e-01,2.779e-02
TAP1,43,MHC class I protein binding,GO:0042288,molecular function,27.0,5.0,6.463e-02,2.874e-02,1.454e-01,2.356e-02,6.482e-03,8.564e-02,8.392e-01,3.250e-02
TAP1,43,ADP binding,GO:0043531,molecular function,27.0,3.0,6.681e-02,4.701e-02,9.494e-02,2.537e-02,1.520e-02,4.235e-02,8.344e-01,1.273e-02
TAP1,43,ATP binding,GO:0005524,molecular function,27.0,6.0,6.837e-02,5.180e-02,9.024e-02,3.564e-02,2.073e-02,6.129e-02,7.976e-01,1.413e-02
TAP1,43,TAP2 binding,GO:0046979,molecular function,27.0,2.0,7.143e-02,3.162e-02,1.614e-01,4.342e-02,1.309e-02,1.440e-01,7.736e-01,3.190e-02
TAP1,43,ATPase-coupled transmembrane transporter activity,GO:0042626,molecular function,27.0,29.0,7.497e-02,4.287e-02,1.311e-01,4.861e-02,1.588e-02,1.488e-01,7.605e-01,3.209e-02
TAP1,43,protein binding,GO:0005515,molecular function,27.0,318.0,1.057e-01,6.109e-02,1.828e-01,1.022e-01,5.369e-02,1.946e-01,6.665e-01,2.238e-02
TAP2,44,peptide antigen transport,GO:0046968,biological process,27.0,2.0,3.402e-02,2.095e-02,5.523e-02,3.436e-03,1.275e-03,9.257e-03,9.552e-01,6.271e-03
TAP2,44,cytosol to endoplasmic reticulum transport,GO:0046967,biological process,27.0,8.0,3.402e-02,2.095e-02,5.523e-02,7.823e-03,4.741e-03,1.291e-02,9.266e-01,5.612e-03
TAP2,44,transmembrane transport,GO:0055085,biological process,27.0,28.0,4.578e-02,2.400e-02,8.735e-02,1.467e-02,1.268e-02,1.697e-02,8.874e-01,3.012e-03
TAP2,44,peptide transport,GO:0015833,biological process,27.0,16.0,4.913e-02,2.197e-02,1.099e-01,2.107e-02,1.188e-02,3.738e-02,8.526e-01,1.352e-02
TAP2,44,"antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent",GO:0002489,biological process,27.0,2.0,4.916e-02,2.048e-02,1.180e-01,2.385e-02,7.913e-03,7.188e-02,8.385e-01,2.689e-02
TAP2,44,antigen processing and presentation of endogenous peptide antigen via MHC class I,GO:0019885,biological process,27.0,6.0,5.125e-02,2.188e-02,1.200e-01,2.931e-02,1.234e-02,6.963e-02,8.181e-01,2.208e-02
TAP2,44,integral component of endoplasmic reticulum membrane,GO:0030176,cellular component,27.0,6.0,5.948e-02,2.801e-02,1.263e-01,3.968e-02,1.060e-02,1.485e-01,7.830e-01,3.646e-02
TAP2,44,integral component of membrane,GO:0016021,cellular component,27.0,19.0,6.277e-02,3.330e-02,1.183e-01,4.117e-02,1.946e-02,8.707e-02,7.812e-01,2.062e-02
TAP2,44,MHC class I peptide loading complex,GO:0042824,cellular component,27.0,3.0,6.652e-02,3.855e-02,1.148e-01,5.753e-02,2.822e-02,1.173e-01,7.420e-01,2.104e-02
TAP2,44,TAP complex,GO:0042825,cellular component,27.0,3.0,6.652e-02,3.855e-02,1.148e-01,5.800e-02,2.900e-02,1.160e-01,7.410e-01,2.044e-02
TAP2,44,endoplasmic reticulum,GO:0005783,cellular component,27.0,16.0,6.663e-02,3.892e-02,1.141e-01,5.234e-02,3.513e-02,7.796e-02,7.543e-01,1.137e-02
TAP2,44,nuclear speck,GO:0016607,cellular component,27.0,7.0,7.700e-02,5.711e-02,1.038e-01,6.973e-02,5.492e-02,8.854e-02,7.196e-01,7.175e-03
TAP2,44,membrane,GO:0016020,cellular component,27.0,41.0,8.345e-02,6.768e-02,1.029e-01,7.999e-02,6.481e-02,9.871e-02,7.019e-01,6.586e-03
TAP2,44,ATPase-coupled peptide antigen transmembrane transporter activity,GO:0015433,molecular function,27.0,3.0,3.402e-02,2.095e-02,5.523e-02,4.430e-03,1.980e-03,9.912e-03,9.478e-01,6.600e-03
TAP2,44,ATPase-coupled peptide transmembrane transporter activity,GO:0015440,molecular function,27.0,8.0,3.402e-02,2.095e-02,5.523e-02,5.668e-03,3.722e-03,8.630e-03,9.400e-01,3.589e-03
TAP2,44,MHC class Ib protein binding,GO:0023029,molecular function,27.0,5.0,4.105e-02,1.387e-02,1.215e-01,1.171e-02,2.133e-03,6.428e-02,8.912e-01,3.242e-02
TAP2,44,peptide transmembrane transporter activity,GO:1904680,molecular function,27.0,11.0,4.424e-02,1.745e-02,1.122e-01,1.802e-02,6.522e-03,4.979e-02,8.652e-01,2.212e-02
TAP2,44,MHC class I protein binding,GO:0042288,molecular function,27.0,5.0,4.475e-02,1.684e-02,1.190e-01,1.646e-02,4.073e-03,6.656e-02,8.701e-01,3.073e-02
TAP2,44,TAP1 binding,GO:0046978,molecular function,27.0,2.0,5.341e-02,2.218e-02,1.286e-01,3.226e-02,1.098e-02,9.480e-02,8.072e-01,2.736e-02
TAP2,44,ATP binding,GO:0005524,molecular function,27.0,6.0,5.612e-02,3.185e-02,9.889e-02,2.659e-02,1.343e-02,5.267e-02,8.288e-01,1.748e-02
TAP2,44,ATPase-coupled transmembrane transporter activity,GO:0042626,molecular function,27.0,29.0,5.948e-02,2.801e-02,1.263e-01,3.908e-02,1.324e-02,1.154e-01,7.860e-01,2.935e-02
TAP2,44,protein binding,GO:0005515,molecular function,27.0,318.0,9.981e-02,5.991e-02,1.663e-01,9.827e-02,5.620e-02,1.719e-01,6.728e-01,1.883e-02
TBX21,11599,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,15.0,41.0,1.620e-01,1.185e-01,2.214e-01,6.999e-02,4.058e-02,1.207e-01,7.181e-01,1.689e-02
TBX21,11599,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,15.0,55.0,1.711e-01,1.308e-01,2.239e-01,1.118e-01,9.848e-02,1.268e-01,6.556e-01,4.441e-03
TBX21,11599,heart looping,GO:0001947,biological process,15.0,2.0,1.786e-01,1.080e-01,2.953e-01,1.012e-01,3.397e-02,3.016e-01,6.647e-01,3.644e-02
TBX21,11599,response to virus,GO:0009615,biological process,15.0,10.0,1.818e-01,1.084e-01,3.050e-01,1.401e-01,6.138e-02,3.199e-01,6.166e-01,3.115e-02
TBX21,11599,lymphocyte migration,GO:0072676,biological process,15.0,5.0,1.868e-01,1.042e-01,3.347e-01,1.516e-01,5.434e-02,4.228e-01,6.015e-01,3.962e-02
TBX21,11599,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,15.0,69.0,1.932e-01,1.457e-01,2.562e-01,1.564e-01,1.207e-01,2.027e-01,6.015e-01,1.048e-02
TBX21,11599,cell fate specification,GO:0001708,biological process,15.0,23.0,4.121e-01,2.947e-01,5.762e-01,4.121e-01,2.947e-01,5.762e-01,3.968e-01,2.245e-02
TBX21,11599,nucleus,GO:0005634,cellular component,15.0,86.0,1.711e-01,1.308e-01,2.239e-01,1.000e-01,8.784e-02,1.139e-01,6.717e-01,4.454e-03
TBX21,11599,RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000977,molecular function,15.0,16.0,1.501e-01,1.166e-01,1.933e-01,4.179e-02,1.991e-02,8.774e-02,7.794e-01,2.045e-02
TBX21,11599,sequence-specific DNA binding,GO:0043565,molecular function,15.0,14.0,1.501e-01,1.166e-01,1.933e-01,4.550e-02,2.707e-02,7.647e-02,7.704e-01,1.416e-02
TBX21,11599,transcription regulatory region DNA binding,GO:0044212,molecular function,15.0,22.0,1.501e-01,1.166e-01,1.933e-01,5.084e-02,2.997e-02,8.624e-02,7.573e-01,1.504e-02
TBX21,11599,"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,molecular function,15.0,11.0,1.501e-01,1.166e-01,1.933e-01,5.870e-02,3.676e-02,9.373e-02,7.402e-01,1.354e-02
TBX21,11599,RNA polymerase II activating transcription factor binding,GO:0001102,molecular function,15.0,5.0,1.501e-01,1.166e-01,1.933e-01,6.688e-02,4.082e-02,1.096e-01,7.242e-01,1.472e-02
TBX21,11599,protein binding,GO:0005515,molecular function,15.0,318.0,1.954e-01,1.472e-01,2.595e-01,1.637e-01,1.473e-01,1.820e-01,5.940e-01,4.256e-03
TCEA2,11614,protein binding,GO:0005515,molecular function,4.0,318.0,1.174e-02,4.134e-03,3.334e-02,1.174e-02,4.134e-03,3.334e-02,8.988e-01,1.794e-02
TCF7L2,11641,regulation of transcription by RNA polymerase II,GO:0006357,biological process,48.0,51.0,7.529e-02,4.005e-02,1.416e-01,7.538e-03,3.272e-03,1.737e-02,9.270e-01,8.326e-03
TCF7L2,11641,glucose homeostasis,GO:0042593,biological process,48.0,3.0,7.529e-02,4.005e-02,1.416e-01,1.855e-02,1.162e-02,2.962e-02,8.656e-01,1.062e-02
TCF7L2,11641,canonical Wnt signaling pathway,GO:0060070,biological process,48.0,20.0,7.529e-02,4.005e-02,1.416e-01,1.933e-02,1.372e-02,2.724e-02,8.617e-01,7.828e-03
TCF7L2,11641,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,GO:0044334,biological process,48.0,2.0,7.529e-02,4.005e-02,1.416e-01,1.950e-02,1.580e-02,2.408e-02,8.612e-01,4.925e-03
TCF7L2,11641,cell cycle arrest,GO:0007050,biological process,48.0,7.0,7.770e-02,4.316e-02,1.399e-01,2.634e-02,1.969e-02,3.522e-02,8.304e-01,7.349e-03
TCF7L2,11641,fat cell differentiation,GO:0045444,biological process,48.0,6.0,7.891e-02,4.529e-02,1.375e-01,2.488e-02,1.389e-02,4.457e-02,8.360e-01,1.467e-02
TCF7L2,11641,"regulation of transcription, DNA-templated",GO:0006355,biological process,48.0,35.0,7.938e-02,4.449e-02,1.417e-01,2.090e-02,4.653e-03,9.390e-02,8.464e-01,3.197e-02
TCF7L2,11641,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,48.0,55.0,7.938e-02,4.449e-02,1.417e-01,3.012e-02,1.213e-02,7.480e-02,8.150e-01,2.304e-02
TCF7L2,11641,myoblast fate commitment,GO:0048625,biological process,48.0,5.0,7.942e-02,4.594e-02,1.373e-01,2.915e-02,6.940e-03,1.225e-01,8.155e-01,3.495e-02
TCF7L2,11641,positive regulation of heparan sulfate proteoglycan biosynthetic process,GO:0010909,biological process,48.0,4.0,8.145e-02,3.321e-02,1.998e-01,2.433e-02,1.313e-03,4.508e-01,8.138e-01,6.637e-02
TCF7L2,11641,regulation of smooth muscle cell proliferation,GO:0048660,biological process,48.0,5.0,8.544e-02,5.077e-02,1.438e-01,2.746e-02,8.785e-03,8.585e-02,8.239e-01,2.873e-02
TCF7L2,11641,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,48.0,69.0,9.177e-02,4.547e-02,1.852e-01,4.657e-02,1.510e-02,1.437e-01,7.659e-01,3.045e-02
TCF7L2,11641,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,48.0,39.0,9.749e-02,5.699e-02,1.668e-01,5.407e-02,2.492e-02,1.173e-01,7.493e-01,2.243e-02
TCF7L2,11641,positive regulation of epithelial cell proliferation,GO:0050679,biological process,48.0,18.0,1.025e-01,8.613e-02,1.220e-01,5.801e-02,3.969e-02,8.477e-02,7.421e-01,1.113e-02
TCF7L2,11641,negative regulation of DNA-binding transcription factor activity,GO:0043433,biological process,48.0,10.0,1.169e-01,9.375e-02,1.456e-01,7.853e-02,5.448e-02,1.132e-01,7.040e-01,1.165e-02
TCF7L2,11641,maintenance of DNA repeat elements,GO:0043570,biological process,48.0,6.0,1.209e-01,1.155e-01,1.265e-01,8.612e-02,6.703e-02,1.107e-01,6.922e-01,8.028e-03
TCF7L2,11641,positive regulation of insulin secretion,GO:0032024,biological process,48.0,5.0,1.281e-01,1.052e-01,1.559e-01,9.834e-02,7.303e-02,1.324e-01,6.738e-01,1.023e-02
TCF7L2,11641,positive regulation of protein binding,GO:0032092,biological process,48.0,13.0,1.342e-01,6.354e-02,2.835e-01,1.004e-01,3.135e-02,3.216e-01,6.652e-01,3.874e-02
TCF7L2,11641,Wnt signaling pathway,GO:0016055,biological process,48.0,19.0,1.402e-01,9.855e-02,1.995e-01,1.105e-01,5.363e-02,2.277e-01,6.546e-01,2.588e-02
TCF7L2,11641,positive regulation of protein export from nucleus,GO:0046827,biological process,48.0,8.0,1.722e-01,1.006e-01,2.949e-01,1.499e-01,7.857e-02,2.861e-01,6.068e-01,2.554e-02
TCF7L2,11641,regulation of hormone metabolic process,GO:0032350,biological process,48.0,18.0,1.816e-01,7.038e-02,4.686e-01,1.596e-01,4.800e-02,5.304e-01,5.900e-01,5.149e-02
TCF7L2,11641,positive regulation of protein kinase B signaling,GO:0051897,biological process,48.0,5.0,1.992e-01,1.443e-01,2.749e-01,1.866e-01,1.318e-01,2.644e-01,5.701e-01,1.535e-02
TCF7L2,11641,negative regulation of canonical Wnt signaling pathway,GO:0090090,biological process,48.0,13.0,2.326e-01,1.362e-01,3.974e-01,2.199e-01,1.212e-01,3.988e-01,5.380e-01,2.703e-02
TCF7L2,11641,blood vessel development,GO:0001568,biological process,48.0,8.0,3.026e-01,2.107e-01,4.346e-01,3.003e-01,2.084e-01,4.326e-01,4.746e-01,1.991e-02
TCF7L2,11641,transcription factor complex,GO:0005667,cellular component,48.0,8.0,7.529e-02,4.005e-02,1.416e-01,2.288e-02,1.088e-02,4.812e-02,8.443e-01,1.861e-02
TCF7L2,11641,nuclear chromatin,GO:0000790,cellular component,48.0,11.0,7.891e-02,4.529e-02,1.375e-01,3.394e-02,1.971e-02,5.844e-02,8.028e-01,1.424e-02
TCF7L2,11641,nucleus,GO:0005634,cellular component,48.0,86.0,1.087e-01,9.235e-02,1.279e-01,6.902e-02,5.400e-02,8.821e-02,7.209e-01,7.514e-03
TCF7L2,11641,protein-DNA complex,GO:0032993,cellular component,48.0,21.0,1.279e-01,9.533e-02,1.715e-01,9.363e-02,5.073e-02,1.728e-01,6.791e-01,2.130e-02
TCF7L2,11641,nucleoplasm,GO:0005654,cellular component,48.0,47.0,1.373e-01,9.959e-02,1.892e-01,1.079e-01,7.093e-02,1.642e-01,6.598e-01,1.502e-02
TCF7L2,11641,beta-catenin-TCF7L2 complex,GO:0070369,cellular component,48.0,3.0,1.845e-01,9.717e-02,3.504e-01,1.672e-01,8.041e-02,3.477e-01,5.874e-01,2.966e-02
TCF7L2,11641,RNA polymerase II repressing transcription factor binding,GO:0001103,molecular function,48.0,3.0,7.529e-02,4.005e-02,1.416e-01,1.973e-02,9.253e-03,4.207e-02,8.585e-01,1.819e-02
TCF7L2,11641,sequence-specific DNA binding,GO:0043565,molecular function,48.0,14.0,7.529e-02,4.005e-02,1.416e-01,2.136e-02,5.592e-03,8.157e-02,8.484e-01,3.315e-02
TCF7L2,11641,DNA-binding transcription factor activity,GO:0003700,molecular function,48.0,17.0,7.529e-02,4.005e-02,1.416e-01,2.270e-02,1.473e-02,3.497e-02,8.456e-01,1.056e-02
TCF7L2,11641,transcription factor binding,GO:0008134,molecular function,48.0,16.0,7.529e-02,4.005e-02,1.416e-01,2.415e-02,1.142e-02,5.105e-02,8.390e-01,1.904e-02
TCF7L2,11641,beta-catenin binding,GO:0008013,molecular function,48.0,5.0,7.529e-02,4.005e-02,1.416e-01,3.020e-02,1.319e-02,6.915e-02,8.152e-01,2.168e-02
TCF7L2,11641,nuclear hormone receptor binding,GO:0035257,molecular function,48.0,8.0,7.529e-02,4.005e-02,1.416e-01,3.033e-02,1.627e-02,5.654e-02,8.150e-01,1.631e-02
TCF7L2,11641,transcription regulatory region DNA binding,GO:0044212,molecular function,48.0,22.0,7.529e-02,4.005e-02,1.416e-01,3.024e-02,9.998e-03,9.146e-02,8.141e-01,2.921e-02
TCF7L2,11641,gamma-catenin binding,GO:0045295,molecular function,48.0,3.0,7.529e-02,4.005e-02,1.416e-01,3.120e-02,9.043e-03,1.077e-01,8.103e-01,3.313e-02
TCF7L2,11641,RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,molecular function,48.0,30.0,8.083e-02,4.746e-02,1.377e-01,3.651e-02,2.272e-02,5.866e-02,7.951e-01,1.264e-02
TCF7L2,11641,armadillo repeat domain binding,GO:0070016,molecular function,48.0,2.0,1.092e-01,9.444e-02,1.262e-01,6.783e-02,4.568e-02,1.007e-01,7.228e-01,1.202e-02
TCF7L2,11641,protein kinase binding,GO:0019901,molecular function,48.0,19.0,1.110e-01,7.977e-02,1.544e-01,7.457e-02,4.285e-02,1.298e-01,7.103e-01,1.710e-02
TCF7L2,11641,chromatin binding,GO:0003682,molecular function,48.0,11.0,1.259e-01,1.057e-01,1.500e-01,9.361e-02,7.085e-02,1.237e-01,6.806e-01,9.386e-03
TCF7L2,11641,protein binding,GO:0005515,molecular function,48.0,318.0,1.791e-01,1.220e-01,2.630e-01,1.610e-01,1.029e-01,2.518e-01,5.957e-01,1.889e-02
TCIRG1,11647,vacuolar acidification,GO:0007035,biological process,10.0,3.0,7.996e-02,4.136e-03,1.546e+00,6.722e-02,2.442e-03,1.850e+00,6.905e-01,9.731e-02
TCIRG1,11647,apical plasma membrane,GO:0016324,cellular component,10.0,4.0,5.287e-02,5.700e-03,4.905e-01,3.741e-02,4.118e-03,3.398e-01,7.820e-01,5.450e-02
TCIRG1,11647,vacuolar proton-transporting V-type ATPase complex,GO:0016471,cellular component,10.0,3.0,5.287e-02,5.700e-03,4.905e-01,3.375e-02,1.897e-03,6.006e-01,7.817e-01,6.580e-02
TCIRG1,11647,plasma membrane,GO:0005886,cellular component,10.0,67.0,5.806e-02,8.545e-03,3.945e-01,4.484e-02,8.818e-03,2.280e-01,7.672e-01,4.541e-02
TCIRG1,11647,lysosomal membrane,GO:0005765,cellular component,10.0,7.0,7.069e-02,7.730e-03,6.465e-01,6.356e-02,6.370e-03,6.343e-01,7.175e-01,6.591e-02
TCIRG1,11647,"proton-transporting ATPase activity, rotational mechanism",GO:0046961,molecular function,10.0,4.0,3.501e-02,7.269e-03,1.686e-01,1.002e-02,2.960e-03,3.393e-02,9.070e-01,2.004e-02
TCIRG1,11647,ATPase binding,GO:0051117,molecular function,10.0,3.0,3.812e-02,6.921e-03,2.100e-01,8.517e-03,7.294e-04,9.945e-02,9.039e-01,2.689e-02
TEF,11722,nucleus,GO:0005634,cellular component,12.0,86.0,6.467e-03,3.744e-03,1.117e-02,2.156e-03,1.248e-03,3.723e-03,9.678e-01,2.734e-03
TEF,11722,protein binding,GO:0005515,molecular function,12.0,318.0,9.368e-03,8.392e-03,1.046e-02,6.245e-03,5.595e-03,6.972e-03,9.368e-01,1.173e-03
TEF,11722,RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000977,molecular function,12.0,16.0,1.574e-02,1.375e-02,1.802e-02,1.574e-02,1.375e-02,1.802e-02,8.810e-01,3.029e-03
TFAP4,11745,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,54.0,41.0,6.663e-02,6.017e-02,7.380e-02,1.792e-02,7.221e-03,4.445e-02,8.660e-01,1.880e-02
TFAP4,11745,negative regulation of cell cycle arrest,GO:0071157,biological process,54.0,4.0,7.769e-02,4.727e-02,1.277e-01,3.857e-02,1.893e-02,7.859e-02,7.885e-01,1.946e-02
TFAP4,11745,negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045736,biological process,54.0,7.0,7.910e-02,4.532e-02,1.381e-01,4.010e-02,1.027e-02,1.566e-01,7.820e-01,3.649e-02
TFAP4,11745,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,54.0,39.0,7.999e-02,4.574e-02,1.399e-01,4.478e-02,1.221e-02,1.642e-01,7.693e-01,3.653e-02
TFAP4,11745,regulation of mitotic cell cycle phase transition,GO:1901990,biological process,54.0,10.0,8.299e-02,5.084e-02,1.355e-01,5.992e-02,3.280e-02,1.095e-01,7.375e-01,1.746e-02
TFAP4,11745,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",GO:0006978,biological process,54.0,4.0,9.150e-02,4.186e-02,2.000e-01,7.351e-02,2.626e-02,2.057e-01,7.094e-01,3.319e-02
TFAP4,11745,negative regulation by host of viral transcription,GO:0043922,biological process,54.0,6.0,9.496e-02,5.753e-02,1.567e-01,6.705e-02,3.211e-02,1.400e-01,7.231e-01,2.180e-02
TFAP4,11745,regulation of transcription by RNA polymerase II,GO:0006357,biological process,54.0,51.0,9.513e-02,5.746e-02,1.575e-01,7.016e-02,3.247e-02,1.516e-01,7.172e-01,2.280e-02
TFAP4,11745,negative regulation of cell population proliferation,GO:0008285,biological process,54.0,34.0,1.108e-01,5.792e-02,2.120e-01,9.763e-02,4.211e-02,2.263e-01,6.720e-01,2.779e-02
TFAP4,11745,negative regulation of DNA binding,GO:0043392,biological process,54.0,12.0,1.169e-01,8.779e-02,1.557e-01,1.028e-01,8.434e-02,1.253e-01,6.677e-01,6.837e-03
TFAP4,11745,positive regulation by host of viral transcription,GO:0043923,biological process,54.0,3.0,1.188e-01,8.026e-02,1.758e-01,1.057e-01,6.111e-02,1.827e-01,6.621e-01,1.980e-02
TFAP4,11745,positive regulation of apoptotic process,GO:0043065,biological process,54.0,28.0,1.315e-01,1.114e-01,1.551e-01,1.262e-01,1.070e-01,1.489e-01,6.369e-01,6.425e-03
TFAP4,11745,protein-containing complex assembly,GO:0065003,biological process,54.0,46.0,1.952e-01,3.741e-02,1.019e+00,1.750e-01,2.330e-02,1.314e+00,5.592e-01,8.046e-02
TFAP4,11745,nucleus,GO:0005634,cellular component,54.0,86.0,6.663e-02,6.017e-02,7.380e-02,1.352e-02,9.443e-03,1.937e-02,8.932e-01,7.035e-03
TFAP4,11745,mitochondrion,GO:0005739,cellular component,54.0,12.0,6.663e-02,6.017e-02,7.380e-02,1.541e-02,4.518e-03,5.256e-02,8.769e-01,2.621e-02
TFAP4,11745,nucleoplasm,GO:0005654,cellular component,54.0,47.0,6.663e-02,6.017e-02,7.380e-02,1.850e-02,1.713e-02,1.997e-02,8.667e-01,1.734e-03
TFAP4,11745,E-box binding,GO:0070888,molecular function,54.0,5.0,6.663e-02,6.017e-02,7.380e-02,1.673e-02,1.296e-02,2.160e-02,8.756e-01,5.528e-03
TFAP4,11745,protein homodimerization activity,GO:0042803,molecular function,54.0,23.0,6.663e-02,6.017e-02,7.380e-02,1.998e-02,1.265e-02,3.157e-02,8.581e-01,1.085e-02
TFAP4,11745,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,54.0,17.0,6.663e-02,6.017e-02,7.380e-02,2.008e-02,1.284e-02,3.139e-02,8.578e-01,1.039e-02
TFAP4,11745,histone deacetylase binding,GO:0042826,molecular function,54.0,3.0,6.663e-02,6.017e-02,7.380e-02,2.445e-02,1.490e-02,4.011e-02,8.380e-01,1.214e-02
TFAP4,11745,protein binding,GO:0005515,molecular function,54.0,318.0,6.787e-02,6.281e-02,7.333e-02,2.949e-02,1.926e-02,4.516e-02,8.182e-01,1.102e-02
TFAP4,11745,sequence-specific DNA binding,GO:0043565,molecular function,54.0,14.0,7.482e-02,5.156e-02,1.086e-01,3.628e-02,2.063e-02,6.381e-02,7.956e-01,1.477e-02
TFAP4,11745,DNA-binding transcription factor activity,GO:0003700,molecular function,54.0,17.0,7.769e-02,4.727e-02,1.277e-01,3.320e-02,1.146e-02,9.616e-02,8.043e-01,2.779e-02
TFAP4,11745,DNA binding,GO:0003677,molecular function,54.0,29.0,7.925e-02,5.028e-02,1.249e-01,4.750e-02,3.580e-02,6.303e-02,7.656e-01,7.810e-03
TFAP4,11745,transcription regulatory region DNA binding,GO:0044212,molecular function,54.0,22.0,8.102e-02,4.859e-02,1.351e-01,5.084e-02,2.612e-02,9.893e-02,7.569e-01,1.871e-02
THAP3,20855,protein binding,GO:0005515,molecular function,2.0,318.0,7.712e-02,6.736e-02,8.830e-02,7.712e-02,6.736e-02,8.830e-02,7.068e-01,4.202e-03
TIE1,11809,transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007169,biological process,10.0,26.0,2.430e-01,1.960e-01,3.012e-01,9.286e-02,2.730e-02,3.158e-01,6.758e-01,4.131e-02
TIE1,11809,positive regulation of angiogenesis,GO:0045766,biological process,10.0,12.0,2.430e-01,1.960e-01,3.012e-01,1.270e-01,8.429e-02,1.914e-01,6.349e-01,1.533e-02
TIE1,11809,angiogenesis,GO:0001525,biological process,10.0,13.0,2.736e-01,1.953e-01,3.833e-01,1.717e-01,4.942e-02,5.967e-01,5.766e-01,5.341e-02
TIE1,11809,multicellular organism development,GO:0007275,biological process,10.0,18.0,2.775e-01,2.484e-01,3.101e-01,2.454e-01,1.951e-01,3.087e-01,5.182e-01,1.088e-02
TIE1,11809,positive regulation of kinase activity,GO:0033674,biological process,10.0,13.0,2.860e-01,1.722e-01,4.751e-01,2.054e-01,7.213e-02,5.849e-01,5.449e-01,5.118e-02
TIE1,11809,integral component of plasma membrane,GO:0005887,cellular component,10.0,39.0,2.430e-01,1.960e-01,3.012e-01,4.798e-02,2.926e-02,7.866e-02,7.642e-01,1.388e-02
TIE1,11809,receptor complex,GO:0043235,cellular component,10.0,30.0,3.090e-01,2.135e-01,4.473e-01,2.699e-01,1.802e-01,4.044e-01,4.975e-01,2.107e-02
TIE1,11809,transmembrane receptor protein tyrosine kinase activity,GO:0004714,molecular function,10.0,20.0,2.430e-01,1.960e-01,3.012e-01,1.132e-01,7.749e-02,1.653e-01,6.530e-01,1.338e-02
TIE1,11809,protein binding,GO:0005515,molecular function,10.0,318.0,2.603e-01,2.107e-01,3.214e-01,1.919e-01,1.601e-01,2.301e-01,5.656e-01,8.158e-03
TIMELESS,11813,positive regulation of double-strand break repair via homologous recombination,GO:1905168,biological process,22.0,4.0,8.026e-02,3.855e-02,1.671e-01,1.539e-02,1.343e-02,1.763e-02,8.832e-01,3.058e-03
TIMELESS,11813,positive regulation of double-strand break repair,GO:2000781,biological process,22.0,5.0,8.194e-02,3.912e-02,1.716e-01,2.195e-02,1.191e-02,4.046e-02,8.486e-01,1.464e-02
TIMELESS,11813,cellular response to DNA damage stimulus,GO:0006974,biological process,22.0,13.0,8.194e-02,3.912e-02,1.716e-01,2.348e-02,9.092e-03,6.062e-02,8.408e-01,2.367e-02
TIMELESS,11813,DNA replication checkpoint,GO:0000076,biological process,22.0,5.0,8.456e-02,3.477e-02,2.057e-01,2.440e-02,6.532e-03,9.115e-02,8.355e-01,3.346e-02
TIMELESS,11813,cell cycle phase transition,GO:0044770,biological process,22.0,7.0,8.656e-02,3.566e-02,2.101e-01,4.615e-02,1.317e-02,1.617e-01,7.661e-01,3.464e-02
TIMELESS,11813,DNA repair,GO:0006281,biological process,22.0,18.0,9.753e-02,5.546e-02,1.715e-01,4.285e-02,2.234e-02,8.221e-02,7.771e-01,1.757e-02
TIMELESS,11813,replication fork protection,GO:0048478,biological process,22.0,3.0,9.753e-02,5.546e-02,1.715e-01,4.689e-02,2.268e-02,9.693e-02,7.662e-01,2.043e-02
TIMELESS,11813,replication fork arrest,GO:0043111,biological process,22.0,7.0,1.007e-01,5.960e-02,1.700e-01,6.966e-02,3.077e-02,1.577e-01,7.178e-01,2.476e-02
TIMELESS,11813,cellular response to bleomycin,GO:1904976,biological process,22.0,4.0,1.040e-01,6.133e-02,1.764e-01,6.592e-02,3.436e-02,1.265e-01,7.256e-01,1.908e-02
TIMELESS,11813,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,22.0,39.0,1.071e-01,6.878e-02,1.668e-01,7.919e-02,7.708e-02,8.136e-02,7.035e-01,8.392e-04
TIMELESS,11813,cellular response to hydroxyurea,GO:0072711,biological process,22.0,5.0,1.074e-01,4.360e-02,2.648e-01,6.427e-02,1.518e-02,2.721e-01,7.239e-01,4.371e-02
TIMELESS,11813,regulation of circadian rhythm,GO:0042752,biological process,22.0,10.0,1.239e-01,3.625e-02,4.235e-01,8.786e-02,1.471e-02,5.248e-01,6.754e-01,6.462e-02
TIMELESS,11813,cellular response to cisplatin,GO:0072719,biological process,22.0,4.0,1.558e-01,5.276e-02,4.604e-01,1.434e-01,4.182e-02,4.914e-01,6.085e-01,4.670e-02
TIMELESS,11813,site of double-strand break,GO:0035861,cellular component,22.0,3.0,8.026e-02,3.855e-02,1.671e-01,7.783e-03,4.534e-03,1.336e-02,9.268e-01,6.152e-03
TIMELESS,11813,nuclear chromatin,GO:0000790,cellular component,22.0,11.0,8.456e-02,3.477e-02,2.057e-01,2.626e-02,1.060e-02,6.502e-02,8.298e-01,2.344e-02
TIMELESS,11813,nuclear chromosome,GO:0000228,cellular component,22.0,4.0,9.209e-02,3.688e-02,2.300e-01,5.700e-02,1.261e-02,2.577e-01,7.397e-01,4.208e-02
TIMELESS,11813,nucleus,GO:0005634,cellular component,22.0,86.0,1.074e-01,6.778e-02,1.701e-01,8.113e-02,5.886e-02,1.118e-01,6.999e-01,1.029e-02
TIMELESS,11813,nucleoplasm,GO:0005654,cellular component,22.0,47.0,1.170e-01,5.614e-02,2.440e-01,9.660e-02,4.700e-02,1.986e-01,6.741e-01,2.507e-02
TIMELESS,11813,replication fork protection complex,GO:0031298,cellular component,22.0,2.0,1.918e-01,5.833e-02,6.309e-01,1.785e-01,4.376e-02,7.280e-01,5.667e-01,6.061e-02
TIMELESS,11813,DNA binding,GO:0003677,molecular function,22.0,29.0,8.123e-02,3.767e-02,1.752e-01,1.818e-02,8.411e-03,3.931e-02,8.665e-01,1.813e-02
TIMELESS,11813,protein binding,GO:0005515,molecular function,22.0,318.0,1.576e-01,7.432e-02,3.344e-01,1.450e-01,7.603e-02,2.764e-01,6.124e-01,2.580e-02
TMCO6,28814,,,,nan,nan,,,,,,,,
TMEM265,51241,,,,nan,nan,,,,,,,,
TMEM269,52381,,,,nan,nan,,,,,,,,
TMEM35B,40021,,,,nan,nan,,,,,,,,
TMEM44,25120,,,,nan,nan,,,,,,,,
TMEM86A,26890,,,,nan,nan,,,,,,,,
TMEM88,32371,protein stabilization,GO:0050821,biological process,8.0,3.0,3.393e-01,2.611e-01,4.409e-01,2.204e-01,8.788e-02,5.527e-01,5.345e-01,4.118e-02
TMEM88,32371,protein localization to plasma membrane,GO:0072659,biological process,8.0,6.0,3.393e-01,2.611e-01,4.409e-01,2.830e-01,2.043e-01,3.920e-01,4.879e-01,1.718e-02
TMEM88,32371,negative regulation of canonical Wnt signaling pathway,GO:0090090,biological process,8.0,13.0,4.009e-01,2.117e-01,7.593e-01,3.694e-01,1.570e-01,8.693e-01,4.161e-01,5.417e-02
TMEM88,32371,plasma membrane,GO:0005886,cellular component,8.0,67.0,3.393e-01,2.611e-01,4.409e-01,1.173e-01,6.407e-02,2.147e-01,6.463e-01,2.179e-02
TMEM88,32371,cytosol,GO:0005829,cellular component,8.0,50.0,3.393e-01,2.611e-01,4.409e-01,2.119e-01,1.344e-01,3.340e-01,5.460e-01,2.132e-02
TMEM88,32371,protein binding,GO:0005515,molecular function,8.0,318.0,3.393e-01,2.611e-01,4.409e-01,2.024e-01,1.199e-01,3.415e-01,5.544e-01,2.431e-02
TMEM88,32371,PDZ domain binding,GO:0030165,molecular function,8.0,3.0,3.492e-01,2.813e-01,4.334e-01,2.920e-01,2.295e-01,3.715e-01,4.815e-01,1.294e-02
TMEM88B,37099,,,,nan,nan,,,,,,,,
TNC,5318,osteoblast differentiation,GO:0001649,biological process,10.0,2.0,2.581e-01,1.057e-01,6.300e-01,1.684e-01,6.623e-02,4.282e-01,5.843e-01,3.978e-02
TNC,5318,response to wounding,GO:0009611,biological process,10.0,10.0,4.071e-01,2.609e-01,6.353e-01,4.071e-01,2.609e-01,6.353e-01,3.988e-01,2.904e-02
TNC,5318,collagen-containing extracellular matrix,GO:0062023,cellular component,10.0,20.0,2.475e-01,1.094e-01,5.599e-01,5.599e-02,1.495e-02,2.097e-01,7.427e-01,3.744e-02
TNC,5318,extracellular region,GO:0005576,cellular component,10.0,16.0,2.475e-01,1.094e-01,5.599e-01,1.026e-01,4.684e-02,2.246e-01,6.653e-01,2.640e-02
TNC,5318,extracellular space,GO:0005615,cellular component,10.0,24.0,2.475e-01,1.094e-01,5.599e-01,1.325e-01,7.012e-02,2.504e-01,6.271e-01,2.360e-02
TNC,5318,focal adhesion,GO:0005925,cellular component,10.0,7.0,2.475e-01,1.094e-01,5.599e-01,1.540e-01,5.847e-02,4.058e-01,5.994e-01,3.811e-02
TNC,5318,membrane,GO:0016020,cellular component,10.0,41.0,2.475e-01,1.094e-01,5.599e-01,1.838e-01,1.091e-01,3.094e-01,5.720e-01,2.199e-02
TNC,5318,protein binding,GO:0005515,molecular function,10.0,318.0,2.475e-01,1.094e-01,5.599e-01,1.954e-01,1.011e-01,3.779e-01,5.598e-01,2.883e-02
TNC,5318,syndecan binding,GO:0045545,molecular function,10.0,2.0,2.636e-01,1.033e-01,6.728e-01,2.231e-01,7.409e-02,6.716e-01,5.297e-01,4.933e-02
TNFRSF4,11918,negative regulation of cytokine secretion,GO:0050710,biological process,7.0,23.0,1.422e-01,2.565e-02,7.882e-01,9.275e-02,7.847e-03,1.096e+00,6.558e-01,9.015e-02
TNFRSF4,11918,inflammatory response,GO:0006954,biological process,7.0,15.0,1.687e-01,8.834e-02,3.221e-01,1.566e-01,8.466e-02,2.897e-01,5.995e-01,2.554e-02
TNFRSF4,11918,external side of plasma membrane,GO:0009897,cellular component,7.0,16.0,8.870e-02,4.295e-02,1.832e-01,2.554e-02,9.509e-03,6.860e-02,8.323e-01,2.543e-02
TNFRSF4,11918,tumor necrosis factor-activated receptor activity,GO:0005031,molecular function,7.0,3.0,1.019e-01,3.892e-02,2.671e-01,4.668e-02,2.755e-02,7.909e-02,7.673e-01,1.453e-02
TNFRSF4,11918,protein binding,GO:0005515,molecular function,7.0,318.0,1.560e-01,9.355e-02,2.601e-01,1.238e-01,8.023e-02,1.911e-01,6.387e-01,1.593e-02
TNFSF10,11925,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043280,biological process,15.0,7.0,8.716e-02,2.630e-02,2.889e-01,1.040e-02,2.609e-03,4.147e-02,9.035e-01,2.037e-02
TNFSF10,11925,positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043123,biological process,15.0,12.0,1.376e-01,6.874e-02,2.756e-01,8.087e-02,3.185e-02,2.053e-01,6.976e-01,2.954e-02
TNFSF10,11925,positive regulation of apoptotic process,GO:0043065,biological process,15.0,28.0,1.676e-01,1.325e-01,2.119e-01,1.181e-01,6.782e-02,2.056e-01,6.456e-01,2.070e-02
TNFSF10,11925,positive regulation of release of cytochrome c from mitochondria,GO:0090200,biological process,15.0,4.0,1.693e-01,1.301e-01,2.202e-01,1.554e-01,1.271e-01,1.900e-01,6.027e-01,8.097e-03
TNFSF10,11925,positive regulation of extrinsic apoptotic signaling pathway,GO:2001238,biological process,15.0,5.0,1.744e-01,1.223e-01,2.487e-01,1.701e-01,1.112e-01,2.601e-01,5.863e-01,1.794e-02
TNFSF10,11925,extracellular exosome,GO:0070062,cellular component,15.0,39.0,1.376e-01,6.874e-02,2.756e-01,7.666e-02,1.527e-02,3.848e-01,6.993e-01,4.948e-02
TNFSF10,11925,identical protein binding,GO:0042802,molecular function,15.0,24.0,1.305e-01,7.333e-02,2.324e-01,3.936e-02,2.774e-02,5.586e-02,7.869e-01,9.418e-03
TNFSF10,11925,zinc ion binding,GO:0008270,molecular function,15.0,4.0,1.380e-01,6.737e-02,2.827e-01,7.037e-02,1.570e-02,3.154e-01,7.101e-01,4.965e-02
TNFSF10,11925,protein binding,GO:0005515,molecular function,15.0,318.0,1.429e-01,8.026e-02,2.544e-01,9.459e-02,4.567e-02,1.959e-01,6.769e-01,2.532e-02
TNK2,19297,peptidyl-tyrosine autophosphorylation,GO:0038083,biological process,30.0,3.0,7.506e-02,6.814e-02,8.269e-02,1.122e-02,7.312e-03,1.722e-02,9.067e-01,6.864e-03
TNK2,19297,regulation of clathrin-dependent endocytosis,GO:2000369,biological process,30.0,4.0,7.508e-02,6.811e-02,8.277e-02,3.449e-02,2.573e-02,4.623e-02,8.016e-01,7.805e-03
TNK2,19297,positive regulation of peptidyl-tyrosine phosphorylation,GO:0050731,biological process,30.0,11.0,7.508e-02,6.811e-02,8.277e-02,3.725e-02,1.337e-02,1.038e-01,7.916e-01,2.716e-02
TNK2,19297,phosphorylation,GO:0016310,biological process,30.0,12.0,7.885e-02,6.189e-02,1.004e-01,5.506e-02,5.256e-02,5.769e-02,7.486e-01,1.297e-03
TNK2,19297,regulation of cell population proliferation,GO:0042127,biological process,30.0,37.0,7.900e-02,6.272e-02,9.950e-02,5.773e-02,4.335e-02,7.688e-02,7.427e-01,8.273e-03
TNK2,19297,transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007169,biological process,30.0,26.0,1.011e-01,3.556e-02,2.872e-01,4.163e-02,3.040e-03,5.700e-01,7.630e-01,7.775e-02
TNK2,19297,cell differentiation,GO:0030154,biological process,30.0,91.0,3.053e-01,1.358e-01,6.862e-01,3.053e-01,1.358e-01,6.862e-01,4.652e-01,4.484e-02
TNK2,19297,clathrin-coated pit,GO:0005905,cellular component,30.0,2.0,7.864e-02,6.226e-02,9.931e-02,4.952e-02,2.735e-02,8.967e-02,7.603e-01,1.652e-02
TNK2,19297,cytoophidium,GO:0097268,cellular component,30.0,2.0,7.864e-02,6.226e-02,9.931e-02,5.161e-02,3.144e-02,8.471e-02,7.556e-01,1.389e-02
TNK2,19297,extrinsic component of cytoplasmic side of plasma membrane,GO:0031234,cellular component,30.0,2.0,7.864e-02,6.226e-02,9.931e-02,5.496e-02,3.756e-02,8.043e-02,7.483e-01,1.093e-02
TNK2,19297,Grb2-EGFR complex,GO:0070436,cellular component,30.0,2.0,7.929e-02,6.111e-02,1.029e-01,4.425e-02,1.535e-02,1.276e-01,7.720e-01,2.840e-02
TNK2,19297,nucleus,GO:0005634,cellular component,30.0,86.0,8.186e-02,5.680e-02,1.180e-01,5.800e-02,3.498e-02,9.617e-02,7.417e-01,1.491e-02
TNK2,19297,cytoplasm,GO:0005737,cellular component,30.0,72.0,8.213e-02,5.635e-02,1.197e-01,6.068e-02,2.841e-02,1.296e-01,7.353e-01,2.243e-02
TNK2,19297,membrane,GO:0016020,cellular component,30.0,41.0,8.213e-02,5.635e-02,1.197e-01,6.158e-02,3.098e-02,1.224e-01,7.339e-01,2.012e-02
TNK2,19297,plasma membrane,GO:0005886,cellular component,30.0,67.0,8.213e-02,5.635e-02,1.197e-01,7.033e-02,4.276e-02,1.157e-01,7.179e-01,1.535e-02
TNK2,19297,clathrin-coated vesicle,GO:0030136,cellular component,30.0,6.0,8.338e-02,5.599e-02,1.242e-01,3.218e-02,3.856e-03,2.686e-01,7.993e-01,5.473e-02
TNK2,19297,non-membrane spanning protein tyrosine kinase activity,GO:0004715,molecular function,30.0,3.0,7.506e-02,6.814e-02,8.269e-02,2.252e-02,3.320e-03,1.528e-01,8.373e-01,4.543e-02
TNK2,19297,protein tyrosine kinase activity,GO:0004713,molecular function,30.0,4.0,7.508e-02,6.811e-02,8.277e-02,2.898e-02,1.895e-02,4.433e-02,8.201e-01,1.096e-02
TNK2,19297,signaling receptor binding,GO:0005102,molecular function,30.0,63.0,7.508e-02,6.811e-02,8.277e-02,3.526e-02,3.061e-02,4.061e-02,7.992e-01,3.773e-03
TNK2,19297,protein serine/threonine/tyrosine kinase activity,GO:0004712,molecular function,30.0,4.0,7.508e-02,6.811e-02,8.277e-02,3.650e-02,1.423e-02,9.365e-02,7.941e-01,2.557e-02
TNK2,19297,epidermal growth factor receptor binding,GO:0005154,molecular function,30.0,3.0,7.508e-02,6.811e-02,8.277e-02,3.779e-02,1.869e-02,7.641e-02,7.908e-01,1.887e-02
TNK2,19297,ubiquitin protein ligase binding,GO:0031625,molecular function,30.0,6.0,7.929e-02,6.111e-02,1.029e-01,3.623e-02,1.313e-02,9.993e-02,7.948e-01,2.750e-02
TNK2,19297,identical protein binding,GO:0042802,molecular function,30.0,24.0,8.186e-02,5.680e-02,1.180e-01,4.629e-02,1.511e-02,1.418e-01,7.663e-01,3.093e-02
TNK2,19297,protein binding,GO:0005515,molecular function,30.0,318.0,8.996e-02,4.546e-02,1.780e-01,7.157e-02,2.621e-02,1.954e-01,7.128e-01,3.238e-02
TNS2,19737,negative regulation of cell population proliferation,GO:0008285,biological process,9.0,34.0,8.065e-02,4.986e-02,1.305e-01,8.065e-02,4.986e-02,1.305e-01,7.003e-01,1.545e-02
TNS2,19737,focal adhesion,GO:0005925,cellular component,9.0,7.0,5.188e-02,1.453e-02,1.852e-01,3.473e-02,6.698e-03,1.801e-01,7.959e-01,4.367e-02
TNS2,19737,kinase binding,GO:0019900,molecular function,9.0,7.0,3.448e-02,4.393e-03,2.707e-01,1.785e-02,7.813e-04,4.077e-01,8.373e-01,5.980e-02
TNS2,19737,protein binding,GO:0005515,molecular function,9.0,318.0,4.954e-02,1.333e-02,1.841e-01,2.999e-02,7.877e-03,1.142e-01,8.143e-01,3.567e-02
TPST1,12020,peptidyl-tyrosine sulfation,GO:0006478,biological process,8.0,3.0,1.898e-01,4.382e-02,8.217e-01,1.416e-01,1.621e-02,1.236e+00,5.946e-01,8.144e-02
TPST1,12020,Golgi apparatus,GO:0005794,cellular component,8.0,16.0,1.803e-01,4.684e-02,6.940e-01,9.986e-02,1.752e-02,5.691e-01,6.594e-01,5.754e-02
TPST1,12020,integral component of Golgi membrane,GO:0030173,cellular component,8.0,7.0,2.165e-01,1.029e-01,4.554e-01,1.090e-01,4.348e-02,2.735e-01,6.552e-01,3.212e-02
TPST1,12020,protein-tyrosine sulfotransferase activity,GO:0008476,molecular function,8.0,3.0,1.803e-01,4.684e-02,6.940e-01,6.524e-02,5.458e-03,7.797e-01,7.106e-01,7.407e-02
TPST1,12020,protein homodimerization activity,GO:0042803,molecular function,8.0,23.0,1.870e-01,5.487e-02,6.372e-01,9.970e-02,3.985e-02,2.495e-01,6.681e-01,3.145e-02
TPST1,12020,sulfotransferase activity,GO:0008146,molecular function,8.0,48.0,3.755e-01,9.317e-02,1.514e+00,3.755e-01,9.317e-02,1.514e+00,3.872e-01,9.927e-02
TRBC1,12156,B cell receptor signaling pathway,GO:0050853,biological process,19.0,4.0,1.240e-02,3.849e-04,3.998e-01,1.626e-03,1.728e-05,1.531e-01,9.455e-01,3.131e-02
TRBC1,12156,"complement activation, classical pathway",GO:0006958,biological process,19.0,2.0,4.595e-02,2.140e-02,9.870e-02,1.444e-02,4.962e-03,4.204e-02,8.830e-01,2.119e-02
TRBC1,12156,"phagocytosis, recognition",GO:0006910,biological process,19.0,3.0,4.677e-02,2.579e-02,8.480e-02,1.154e-02,3.517e-03,3.786e-02,8.988e-01,1.834e-02
TRBC1,12156,innate immune response,GO:0045087,biological process,19.0,24.0,1.108e-01,5.099e-02,2.407e-01,8.588e-02,5.135e-02,1.436e-01,6.918e-01,1.654e-02
TRBC1,12156,"phagocytosis, engulfment",GO:0006911,biological process,19.0,3.0,1.138e-01,4.113e-02,3.147e-01,8.545e-02,2.132e-02,3.426e-01,6.851e-01,4.756e-02
TRBC1,12156,defense response to bacterium,GO:0042742,biological process,19.0,14.0,1.161e-01,4.586e-02,2.938e-01,9.625e-02,4.411e-02,2.100e-01,6.743e-01,2.667e-02
TRBC1,12156,positive regulation of B cell activation,GO:0050871,biological process,19.0,8.0,1.354e-01,6.691e-02,2.741e-01,1.260e-01,6.761e-02,2.349e-01,6.352e-01,2.361e-02
TRBC1,12156,external side of plasma membrane,GO:0009897,cellular component,19.0,16.0,4.507e-02,2.230e-02,9.107e-02,1.349e-02,6.528e-03,2.789e-02,8.909e-01,1.251e-02
TRBC1,12156,"immunoglobulin complex, circulating",GO:0042571,cellular component,19.0,7.0,7.638e-02,4.812e-02,1.212e-01,4.463e-02,1.593e-02,1.250e-01,7.710e-01,2.910e-02
TRBC1,12156,immunoglobulin receptor binding,GO:0034987,molecular function,19.0,3.0,6.800e-02,2.951e-02,1.567e-01,4.336e-02,7.839e-03,2.398e-01,7.705e-01,4.708e-02
TRBC1,12156,antigen binding,GO:0003823,molecular function,19.0,6.0,1.242e-01,5.032e-02,3.064e-01,1.153e-01,4.132e-02,3.218e-01,6.452e-01,3.966e-02
TRBC2,12157,,,,nan,nan,,,,,,,,
TREML4,30807,,,,nan,nan,,,,,,,,
TRIB2,30809,negative regulation of interleukin-10 biosynthetic process,GO:0045081,biological process,7.0,4.0,7.777e-02,3.636e-02,1.663e-01,1.979e-02,6.553e-03,5.978e-02,8.554e-01,2.388e-02
TRIB2,30809,regulation of MAP kinase activity,GO:0043405,biological process,7.0,9.0,1.370e-01,7.516e-02,2.496e-01,9.311e-02,4.140e-02,2.094e-01,6.790e-01,2.605e-02
TRIB2,30809,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032436,biological process,7.0,9.0,2.300e-01,7.784e-02,6.799e-01,2.300e-01,7.784e-02,6.799e-01,5.240e-01,4.862e-02
TRIB2,30809,nucleus,GO:0005634,cellular component,7.0,86.0,1.478e-01,1.045e-01,2.091e-01,1.163e-01,8.319e-02,1.626e-01,6.490e-01,1.224e-02
TRIB2,30809,mitogen-activated protein kinase kinase binding,GO:0031434,molecular function,7.0,2.0,7.845e-02,3.765e-02,1.635e-01,3.138e-02,1.506e-02,6.538e-02,8.111e-01,1.904e-02
TRIM25,12932,positive regulation of NF-kappaB transcription factor activity,GO:0051092,biological process,52.0,6.0,2.083e-02,9.011e-03,4.816e-02,5.392e-03,1.756e-03,1.656e-02,9.404e-01,9.048e-03
TRIM25,12932,positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043123,biological process,52.0,12.0,2.761e-02,1.400e-02,5.445e-02,1.275e-02,3.304e-03,4.921e-02,8.896e-01,2.589e-02
TRIM25,12932,innate immune response,GO:0045087,biological process,52.0,24.0,3.908e-02,2.525e-02,6.049e-02,2.650e-02,1.985e-02,3.537e-02,8.298e-01,7.296e-03
TRIM25,12932,response to estrogen,GO:0043627,biological process,52.0,4.0,3.982e-02,1.762e-02,9.002e-02,2.003e-02,2.224e-03,1.803e-01,8.414e-01,4.342e-02
TRIM25,12932,ubiquitin-dependent protein catabolic process,GO:0006511,biological process,52.0,6.0,4.124e-02,2.249e-02,7.561e-02,2.646e-02,1.159e-02,6.043e-02,8.286e-01,2.015e-02
TRIM25,12932,positive regulation of DNA-binding transcription factor activity,GO:0051091,biological process,52.0,12.0,4.791e-02,2.341e-02,9.803e-02,3.854e-02,1.813e-02,8.192e-02,7.883e-01,1.987e-02
TRIM25,12932,ubiquitin-dependent ERAD pathway,GO:0030433,biological process,52.0,4.0,5.022e-02,1.792e-02,1.407e-01,3.875e-02,1.017e-02,1.477e-01,7.860e-01,3.599e-02
TRIM25,12932,protein monoubiquitination,GO:0006513,biological process,52.0,3.0,5.335e-02,2.346e-02,1.213e-01,4.536e-02,1.797e-02,1.145e-01,7.694e-01,2.618e-02
TRIM25,12932,regulation of viral entry into host cell,GO:0046596,biological process,52.0,5.0,6.735e-02,2.844e-02,1.595e-01,6.004e-02,2.074e-02,1.738e-01,7.357e-01,3.040e-02
TRIM25,12932,regulation of viral release from host cell,GO:1902186,biological process,52.0,7.0,1.090e-01,5.379e-02,2.207e-01,1.090e-01,5.379e-02,2.207e-01,6.567e-01,2.592e-02
TRIM25,12932,cytosol,GO:0005829,cellular component,52.0,50.0,1.916e-02,8.367e-03,4.390e-02,3.581e-03,9.425e-04,1.361e-02,9.529e-01,9.741e-03
TRIM25,12932,nucleoplasm,GO:0005654,cellular component,52.0,47.0,1.916e-02,8.367e-03,4.390e-02,3.781e-03,3.988e-04,3.585e-02,9.449e-01,1.917e-02
TRIM25,12932,nuclear body,GO:0016604,cellular component,52.0,18.0,2.283e-02,8.823e-03,5.909e-02,8.604e-03,1.603e-03,4.618e-02,9.125e-01,2.149e-02
TRIM25,12932,cytoplasmic stress granule,GO:0010494,cellular component,52.0,2.0,3.202e-02,1.567e-02,6.545e-02,1.449e-02,4.820e-03,4.354e-02,8.829e-01,2.327e-02
TRIM25,12932,ubiquitin protein ligase activity,GO:0061630,molecular function,52.0,8.0,2.083e-02,9.011e-03,4.816e-02,5.222e-03,2.363e-03,1.154e-02,9.426e-01,6.666e-03
TRIM25,12932,cadherin binding,GO:0045296,molecular function,52.0,9.0,2.584e-02,1.969e-02,3.392e-02,9.501e-03,7.040e-03,1.282e-02,9.174e-01,3.907e-03
TRIM25,12932,protein binding,GO:0005515,molecular function,52.0,318.0,2.634e-02,1.622e-02,4.276e-02,9.539e-03,3.576e-03,2.545e-02,9.122e-01,1.507e-02
TRIM25,12932,RNA binding,GO:0003723,molecular function,52.0,44.0,3.306e-02,1.735e-02,6.302e-02,1.562e-02,6.953e-03,3.508e-02,8.790e-01,1.544e-02
TRIM25,12932,RIG-I binding,GO:0039552,molecular function,52.0,2.0,4.751e-02,2.245e-02,1.005e-01,3.678e-02,1.469e-02,9.211e-02,7.933e-01,2.409e-02
TRIM5,16276,positive regulation of DNA-binding transcription factor activity,GO:0051091,biological process,24.0,12.0,1.349e-01,1.200e-01,1.516e-01,2.313e-02,1.245e-02,4.296e-02,8.434e-01,1.530e-02
TRIM5,16276,positive regulation of NF-kappaB transcription factor activity,GO:0051092,biological process,24.0,6.0,1.349e-01,1.200e-01,1.516e-01,2.483e-02,1.642e-02,3.754e-02,8.364e-01,1.033e-02
TRIM5,16276,protein K63-linked ubiquitination,GO:0070534,biological process,24.0,4.0,1.349e-01,1.200e-01,1.516e-01,5.228e-02,4.484e-02,6.096e-02,7.546e-01,4.351e-03
TRIM5,16276,positive regulation of MAPK cascade,GO:0043410,biological process,24.0,13.0,1.349e-01,1.200e-01,1.516e-01,6.314e-02,2.865e-02,1.392e-01,7.305e-01,2.331e-02
TRIM5,16276,activation of innate immune response,GO:0002218,biological process,24.0,8.0,1.418e-01,1.065e-01,1.889e-01,6.967e-02,4.071e-02,1.192e-01,7.189e-01,1.591e-02
TRIM5,16276,negative regulation of viral release from host cell,GO:1902187,biological process,24.0,6.0,1.553e-01,9.747e-02,2.476e-01,8.696e-02,3.258e-02,2.321e-01,6.874e-01,3.123e-02
TRIM5,16276,positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043123,biological process,24.0,12.0,1.558e-01,8.962e-02,2.709e-01,8.985e-02,3.458e-02,2.335e-01,6.824e-01,3.338e-02
TRIM5,16276,innate immune response,GO:0045087,biological process,24.0,24.0,1.618e-01,1.242e-01,2.108e-01,1.101e-01,4.146e-02,2.923e-01,6.532e-01,3.361e-02
TRIM5,16276,negative regulation of viral entry into host cell,GO:0046597,biological process,24.0,4.0,1.656e-01,9.937e-02,2.760e-01,1.283e-01,5.090e-02,3.235e-01,6.296e-01,3.472e-02
TRIM5,16276,autophagy,GO:0006914,biological process,24.0,10.0,1.966e-01,5.364e-02,7.204e-01,1.467e-01,2.423e-02,8.880e-01,5.919e-01,8.168e-02
TRIM5,16276,regulation of protein localization,GO:0032880,biological process,24.0,8.0,2.285e-01,1.463e-01,3.569e-01,2.188e-01,1.342e-01,3.568e-01,5.394e-01,2.341e-02
TRIM5,16276,regulation of lipopolysaccharide-mediated signaling pathway,GO:0031664,biological process,24.0,7.0,2.620e-01,1.068e-01,6.428e-01,2.461e-01,9.538e-02,6.349e-01,5.110e-01,4.605e-02
TRIM5,16276,P-body,GO:0000932,cellular component,24.0,3.0,1.349e-01,1.200e-01,1.516e-01,6.666e-02,4.875e-02,9.116e-02,7.250e-01,9.409e-03
TRIM5,16276,omegasome,GO:1990462,cellular component,24.0,2.0,1.456e-01,1.000e-01,2.120e-01,3.824e-02,6.476e-03,2.258e-01,7.840e-01,4.874e-02
TRIM5,16276,cytoplasm,GO:0005737,cellular component,24.0,72.0,1.816e-01,1.390e-01,2.372e-01,1.395e-01,1.127e-01,1.727e-01,6.205e-01,8.436e-03
TRIM5,16276,"protein binding, bridging",GO:0030674,molecular function,24.0,13.0,1.349e-01,1.200e-01,1.516e-01,2.168e-02,1.694e-02,2.775e-02,8.507e-01,6.217e-03
TRIM5,16276,protein kinase binding,GO:0019901,molecular function,24.0,19.0,1.349e-01,1.200e-01,1.516e-01,3.192e-02,1.630e-02,6.250e-02,8.096e-01,1.762e-02
TRIM5,16276,pattern recognition receptor activity,GO:0038187,molecular function,24.0,7.0,1.349e-01,1.200e-01,1.516e-01,4.968e-02,4.135e-02,5.970e-02,7.604e-01,5.089e-03
TRIM5,16276,identical protein binding,GO:0042802,molecular function,24.0,24.0,1.362e-01,1.236e-01,1.502e-01,6.044e-02,4.747e-02,7.695e-02,7.373e-01,7.064e-03
TRIM5,16276,protein homodimerization activity,GO:0042803,molecular function,24.0,23.0,1.539e-01,1.038e-01,2.281e-01,1.022e-01,7.911e-02,1.320e-01,6.685e-01,8.722e-03
TRIM5,16276,ubiquitin-protein transferase activity,GO:0004842,molecular function,24.0,9.0,1.590e-01,9.132e-02,2.767e-01,1.160e-01,5.921e-02,2.271e-01,6.477e-01,2.542e-02
TRIM5,16276,protein binding,GO:0005515,molecular function,24.0,318.0,1.959e-01,1.603e-01,2.394e-01,1.764e-01,1.620e-01,1.921e-01,5.810e-01,3.744e-03
TRIM69,17857,nuclear speck,GO:0016607,cellular component,6.0,7.0,5.991e-02,3.468e-02,1.035e-01,2.356e-02,1.082e-02,5.130e-02,8.409e-01,1.858e-02
TRIM69,17857,cytoplasm,GO:0005737,cellular component,6.0,72.0,6.254e-02,3.956e-02,9.888e-02,4.562e-02,3.367e-02,6.180e-02,7.702e-01,8.306e-03
TRIM69,17857,nucleus,GO:0005634,cellular component,6.0,86.0,6.519e-02,4.629e-02,9.181e-02,6.034e-02,5.303e-02,6.866e-02,7.376e-01,3.775e-03
TRIM69,17857,ubiquitin-protein transferase activity,GO:0004842,molecular function,6.0,9.0,5.991e-02,3.468e-02,1.035e-01,2.279e-02,1.472e-02,3.529e-02,8.452e-01,1.069e-02
TRIM69,17857,protein binding,GO:0005515,molecular function,6.0,318.0,6.254e-02,3.956e-02,9.888e-02,5.806e-02,2.914e-02,1.157e-01,7.412e-01,1.978e-02
TRPC6,12338,calcium ion transmembrane transport,GO:0070588,biological process,33.0,11.0,8.746e-02,6.914e-02,1.106e-01,1.992e-02,1.151e-02,3.446e-02,8.583e-01,1.295e-02
TRPC6,12338,regulation of cytosolic calcium ion concentration,GO:0051480,biological process,33.0,8.0,8.746e-02,6.914e-02,1.106e-01,3.459e-02,1.486e-02,8.048e-02,8.005e-01,2.193e-02
TRPC6,12338,positive regulation of calcium ion transport,GO:0051928,biological process,33.0,8.0,8.769e-02,6.967e-02,1.104e-01,3.382e-02,1.720e-02,6.652e-02,8.031e-01,1.783e-02
TRPC6,12338,positive regulation of ion transmembrane transporter activity,GO:0032414,biological process,33.0,14.0,8.769e-02,6.967e-02,1.104e-01,4.623e-02,3.282e-02,6.513e-02,7.687e-01,9.499e-03
TRPC6,12338,manganese ion transport,GO:0006828,biological process,33.0,3.0,8.834e-02,7.097e-02,1.100e-01,4.334e-02,3.027e-02,6.207e-02,7.759e-01,9.846e-03
TRPC6,12338,single fertilization,GO:0007338,biological process,33.0,2.0,1.097e-01,6.686e-02,1.800e-01,9.115e-02,4.188e-02,1.984e-01,6.819e-01,2.639e-02
TRPC6,12338,integral component of plasma membrane,GO:0005887,cellular component,33.0,39.0,8.746e-02,6.914e-02,1.106e-01,2.518e-02,2.475e-02,2.562e-02,8.350e-01,4.345e-04
TRPC6,12338,plasma membrane,GO:0005886,cellular component,33.0,67.0,8.781e-02,6.990e-02,1.103e-01,4.968e-02,4.213e-02,5.857e-02,7.606e-01,4.618e-03
TRPC6,12338,cation channel complex,GO:0034703,cellular component,33.0,9.0,9.043e-02,6.515e-02,1.255e-01,5.321e-02,3.338e-02,8.481e-02,7.521e-01,1.325e-02
TRPC6,12338,membrane,GO:0016020,cellular component,33.0,41.0,1.305e-01,1.148e-01,1.482e-01,1.151e-01,9.956e-02,1.331e-01,6.512e-01,5.263e-03
TRPC6,12338,cytoplasm,GO:0005737,cellular component,33.0,72.0,1.348e-01,1.203e-01,1.512e-01,1.345e-01,1.204e-01,1.502e-01,6.267e-01,4.335e-03
TRPC6,12338,store-operated calcium channel activity,GO:0015279,molecular function,33.0,2.0,8.746e-02,6.914e-02,1.106e-01,1.241e-02,8.918e-03,1.728e-02,9.001e-01,5.662e-03
TRPC6,12338,cation channel activity,GO:0005261,molecular function,33.0,15.0,8.746e-02,6.914e-02,1.106e-01,3.478e-02,1.654e-02,7.316e-02,7.999e-01,1.934e-02
TRPC6,12338,"inositol 1,4,5 trisphosphate binding",GO:0070679,molecular function,33.0,3.0,1.040e-01,6.267e-02,1.726e-01,7.806e-02,3.635e-02,1.676e-01,7.030e-01,2.486e-02
TRPC6,12338,protein homodimerization activity,GO:0042803,molecular function,33.0,23.0,1.133e-01,8.297e-02,1.548e-01,8.708e-02,7.285e-02,1.041e-01,6.907e-01,5.747e-03
TRPC6,12338,protein binding,GO:0005515,molecular function,33.0,318.0,1.316e-01,1.189e-01,1.456e-01,1.182e-01,1.109e-01,1.260e-01,6.473e-01,2.378e-03
TRPV1,12716,calcium ion import across plasma membrane,GO:0098703,biological process,25.0,4.0,3.116e-02,2.849e-02,3.407e-02,8.775e-03,3.762e-03,2.047e-02,9.192e-01,1.011e-02
TRPV1,12716,thermoception,GO:0050955,biological process,25.0,4.0,3.841e-02,2.522e-02,5.850e-02,2.744e-02,1.398e-02,5.387e-02,8.257e-01,1.702e-02
TRPV1,12716,response to capsazepine,GO:1901594,biological process,25.0,5.0,4.288e-02,3.821e-02,4.812e-02,3.306e-02,2.355e-02,4.641e-02,8.060e-01,8.815e-03
TRPV1,12716,cellular response to acidic pH,GO:0071468,biological process,25.0,5.0,6.327e-02,2.423e-02,1.652e-01,5.448e-02,1.691e-02,1.755e-01,7.469e-01,3.253e-02
TRPV1,12716,cellular response to heat,GO:0034605,biological process,25.0,7.0,8.527e-02,3.444e-02,2.112e-01,8.527e-02,3.444e-02,2.112e-01,6.904e-01,2.910e-02
TRPV1,12716,integral component of plasma membrane,GO:0005887,cellular component,25.0,39.0,3.163e-02,2.892e-02,3.459e-02,1.221e-02,6.303e-03,2.367e-02,8.990e-01,1.079e-02
TRPV1,12716,integral component of membrane,GO:0016021,cellular component,25.0,19.0,3.288e-02,2.821e-02,3.832e-02,1.947e-02,1.367e-02,2.773e-02,8.610e-01,8.132e-03
TRPV1,12716,extracellular ligand-gated ion channel activity,GO:0005230,molecular function,25.0,7.0,3.116e-02,2.849e-02,3.407e-02,8.370e-03,5.441e-03,1.288e-02,9.234e-01,4.763e-03
TRPV1,12716,phosphoprotein binding,GO:0051219,molecular function,25.0,3.0,3.116e-02,2.849e-02,3.407e-02,1.046e-02,3.905e-03,2.800e-02,9.078e-01,1.307e-02
TRPV1,12716,calcium channel activity,GO:0005262,molecular function,25.0,8.0,3.116e-02,2.849e-02,3.407e-02,1.151e-02,9.605e-03,1.380e-02,9.057e-01,3.064e-03
TRPV1,12716,ion channel activity,GO:0005216,molecular function,25.0,12.0,3.134e-02,2.811e-02,3.493e-02,1.445e-02,8.138e-03,2.565e-02,8.868e-01,1.077e-02
TRPV1,12716,protein binding,GO:0005515,molecular function,25.0,318.0,4.586e-02,2.980e-02,7.056e-02,3.790e-02,2.398e-02,5.988e-02,7.911e-01,1.224e-02
TRPV3,18084,negative regulation of hair cycle,GO:0042636,biological process,6.0,4.0,1.799e-01,7.623e-02,4.245e-01,1.576e-01,5.743e-02,4.327e-01,5.948e-01,4.149e-02
TRPV3,18084,integral component of plasma membrane,GO:0005887,cellular component,6.0,39.0,1.063e-01,5.846e-02,1.933e-01,6.378e-02,3.508e-02,1.160e-01,7.297e-01,1.804e-02
TRPV3,18084,receptor complex,GO:0043235,cellular component,6.0,30.0,1.873e-01,6.340e-02,5.533e-01,1.739e-01,5.592e-02,5.406e-01,5.755e-01,5.145e-02
TRPV3,18084,calcium channel activity,GO:0005262,molecular function,6.0,8.0,4.638e-02,1.200e-02,1.793e-01,1.358e-02,4.057e-03,4.544e-02,8.867e-01,2.501e-02
TRPV3,18084,ion channel activity,GO:0005216,molecular function,6.0,12.0,4.903e-02,1.225e-02,1.961e-01,1.793e-02,3.336e-03,9.636e-02,8.575e-01,3.219e-02
TSPAN4,11859,protein-containing complex assembly,GO:0065003,biological process,9.0,46.0,9.628e-02,3.237e-02,2.864e-01,7.518e-02,1.702e-02,3.321e-01,7.014e-01,5.068e-02
TSPAN4,11859,vesicle,GO:0031982,cellular component,9.0,5.0,6.783e-02,5.189e-02,8.867e-02,2.166e-02,1.026e-02,4.572e-02,8.492e-01,1.745e-02
TSPAN4,11859,integral component of plasma membrane,GO:0005887,cellular component,9.0,39.0,6.783e-02,5.189e-02,8.867e-02,2.214e-02,8.446e-03,5.803e-02,8.460e-01,2.230e-02
TSPAN4,11859,plasma membrane,GO:0005886,cellular component,9.0,67.0,6.783e-02,5.189e-02,8.867e-02,2.848e-02,2.325e-02,3.488e-02,8.221e-01,5.149e-03
TSPAN4,11859,focal adhesion,GO:0005925,cellular component,9.0,7.0,7.504e-02,5.293e-02,1.064e-01,5.575e-02,3.965e-02,7.840e-02,7.469e-01,9.839e-03
TSPAN4,11859,integrin binding,GO:0005178,molecular function,9.0,11.0,6.783e-02,5.189e-02,8.867e-02,3.248e-02,2.156e-02,4.893e-02,8.079e-01,1.060e-02
TSPAN4,11859,antigen binding,GO:0003823,molecular function,9.0,6.0,8.682e-02,4.643e-02,1.624e-01,6.451e-02,2.603e-02,1.598e-01,7.273e-01,2.622e-02
TSPAN4,11859,protein binding,GO:0005515,molecular function,9.0,318.0,1.184e-01,8.192e-02,1.710e-01,1.132e-01,8.421e-02,1.522e-01,6.533e-01,1.049e-02
TST,12388,,,,nan,nan,,,,,,,,
TTC36,33708,,,,nan,nan,,,,,,,,
UACA,15947,extracellular exosome,GO:0070062,cellular component,6.0,39.0,3.903e-02,2.919e-02,5.219e-02,1.944e-02,9.238e-03,4.093e-02,8.596e-01,1.678e-02
UACA,15947,cytosol,GO:0005829,cellular component,6.0,50.0,3.903e-02,2.919e-02,5.219e-02,2.965e-02,2.171e-02,4.049e-02,8.178e-01,7.928e-03
UACA,15947,nucleoplasm,GO:0005654,cellular component,6.0,47.0,3.903e-02,2.919e-02,5.219e-02,3.146e-02,2.436e-02,4.064e-02,8.118e-01,6.723e-03
UACA,15947,protein binding,GO:0005515,molecular function,6.0,318.0,4.182e-02,2.723e-02,6.423e-02,4.182e-02,2.723e-02,6.423e-02,7.799e-01,1.161e-02
UBA7,12471,ISG15-protein conjugation,GO:0032020,biological process,15.0,3.0,3.698e-03,2.041e-04,6.702e-02,5.283e-04,2.915e-05,9.574e-03,9.826e-01,3.876e-03
UBA7,12471,protein modification by small protein conjugation,GO:0032446,biological process,15.0,9.0,3.300e-02,1.836e-02,5.934e-02,1.518e-02,8.444e-03,2.729e-02,8.831e-01,1.235e-02
UBA7,12471,cellular protein modification process,GO:0006464,biological process,15.0,66.0,2.227e-01,3.564e-02,1.391e+00,2.227e-01,3.564e-02,1.391e+00,5.120e-01,8.742e-02
UBA7,12471,cytoplasm,GO:0005737,cellular component,15.0,72.0,4.531e-02,1.807e-02,1.136e-01,2.804e-02,1.092e-02,7.199e-02,8.222e-01,2.332e-02
UBA7,12471,ISG15 activating enzyme activity,GO:0019782,molecular function,15.0,2.0,3.456e-02,2.054e-02,5.813e-02,1.790e-02,1.434e-02,2.233e-02,8.693e-01,4.948e-03
UBA7,12471,ubiquitin-protein transferase activity,GO:0004842,molecular function,15.0,9.0,3.819e-02,1.295e-02,1.126e-01,1.759e-02,2.491e-03,1.242e-01,8.590e-01,4.502e-02
UBA7,12471,protein binding,GO:0005515,molecular function,15.0,318.0,4.954e-02,1.861e-02,1.318e-01,4.246e-02,1.595e-02,1.130e-01,7.770e-01,2.621e-02
UBD,18795,aggresome assembly,GO:0070842,biological process,20.0,2.0,7.390e-02,6.417e-02,8.512e-02,1.573e-02,4.893e-03,5.054e-02,8.749e-01,2.169e-02
UBD,18795,ubiquitin-dependent protein catabolic process,GO:0006511,biological process,20.0,6.0,7.390e-02,6.417e-02,8.512e-02,2.409e-02,8.591e-03,6.756e-02,8.378e-01,2.566e-02
UBD,18795,protein ubiquitination,GO:0016567,biological process,20.0,8.0,7.390e-02,6.417e-02,8.512e-02,2.729e-02,1.890e-02,3.939e-02,8.268e-01,9.243e-03
UBD,18795,response to tumor necrosis factor,GO:0034612,biological process,20.0,4.0,8.426e-02,5.463e-02,1.300e-01,3.625e-02,1.049e-02,1.252e-01,7.939e-01,3.364e-02
UBD,18795,myeloid dendritic cell differentiation,GO:0043011,biological process,20.0,6.0,8.501e-02,4.608e-02,1.568e-01,3.798e-02,6.355e-03,2.270e-01,7.849e-01,5.051e-02
UBD,18795,response to interferon-gamma,GO:0034341,biological process,20.0,6.0,9.607e-02,6.454e-02,1.430e-01,6.888e-02,2.702e-02,1.756e-01,7.187e-01,2.847e-02
UBD,18795,regulation of mitotic cell cycle phase transition,GO:1901990,biological process,20.0,10.0,1.003e-01,7.445e-02,1.352e-01,7.845e-02,4.128e-02,1.491e-01,7.031e-01,2.043e-02
UBD,18795,positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043123,biological process,20.0,12.0,1.395e-01,8.533e-02,2.280e-01,1.249e-01,6.769e-02,2.306e-01,6.367e-01,2.355e-02
UBD,18795,positive regulation of apoptotic process,GO:0043065,biological process,20.0,28.0,2.730e-01,1.261e-01,5.912e-01,2.730e-01,1.261e-01,5.912e-01,4.910e-01,4.042e-02
UBD,18795,aggresome,GO:0016235,cellular component,20.0,3.0,8.589e-02,5.944e-02,1.241e-01,4.252e-02,2.225e-02,8.124e-02,7.777e-01,1.779e-02
UBD,18795,nucleus,GO:0005634,cellular component,20.0,86.0,8.685e-02,6.153e-02,1.226e-01,4.007e-02,2.497e-02,6.430e-02,7.849e-01,1.264e-02
UBD,18795,nucleoplasm,GO:0005654,cellular component,20.0,47.0,8.714e-02,6.103e-02,1.244e-01,5.232e-02,3.285e-02,8.334e-02,7.541e-01,1.320e-02
UBD,18795,fibrillar center,GO:0001650,cellular component,20.0,2.0,1.109e-01,1.040e-01,1.183e-01,8.263e-02,5.354e-02,1.275e-01,6.972e-01,1.364e-02
UBD,18795,proteasome binding,GO:0070628,molecular function,20.0,2.0,6.455e-02,3.652e-02,1.141e-01,9.044e-03,1.114e-03,7.343e-02,9.035e-01,3.111e-02
UBD,18795,protein binding,GO:0005515,molecular function,20.0,318.0,9.918e-02,6.403e-02,1.536e-01,7.018e-02,4.022e-02,1.225e-01,7.180e-01,1.655e-02
UNC45B,14304,,,,nan,nan,,,,,,,,
USHBP1,24058,protein binding,GO:0005515,molecular function,5.0,318.0,1.199e-01,8.657e-02,1.661e-01,7.726e-02,3.948e-02,1.512e-01,7.051e-01,2.138e-02
USHBP1,24058,PDZ domain binding,GO:0030165,molecular function,5.0,3.0,1.215e-01,8.392e-02,1.760e-01,1.132e-01,6.775e-02,1.891e-01,6.522e-01,1.898e-02
USP18,12616,regulation of inflammatory response,GO:0050727,biological process,10.0,15.0,2.301e-01,7.457e-02,7.101e-01,9.131e-02,1.563e-02,5.333e-01,6.701e-01,6.420e-02
USP18,12616,protein deubiquitination,GO:0016579,biological process,10.0,13.0,3.182e-01,1.027e-01,9.855e-01,2.871e-01,9.524e-02,8.655e-01,4.730e-01,6.141e-02
USP18,12616,cytosol,GO:0005829,cellular component,10.0,50.0,2.292e-01,7.525e-02,6.981e-01,1.185e-01,5.585e-02,2.516e-01,6.436e-01,2.880e-02
USP18,12616,nucleus,GO:0005634,cellular component,10.0,86.0,2.292e-01,7.525e-02,6.981e-01,1.216e-01,5.216e-02,2.837e-01,6.390e-01,3.025e-02
USP18,12616,protein binding,GO:0005515,molecular function,10.0,318.0,2.292e-01,7.525e-02,6.981e-01,1.260e-01,6.764e-02,2.346e-01,6.352e-01,2.419e-02
USP18,12616,cysteine-type endopeptidase activity,GO:0004197,molecular function,10.0,7.0,2.539e-01,5.964e-02,1.081e+00,1.599e-01,2.889e-02,8.851e-01,5.793e-01,7.695e-02
USP18,12616,thiol-dependent ubiquitin-specific protease activity,GO:0004843,molecular function,10.0,2.0,3.463e-01,9.594e-02,1.250e+00,3.290e-01,8.453e-02,1.280e+00,4.248e-01,9.370e-02
VAMP5,12646,Golgi to plasma membrane protein transport,GO:0043001,biological process,8.0,5.0,5.386e-02,3.874e-02,7.488e-02,2.189e-02,1.101e-02,4.351e-02,8.486e-01,1.639e-02
VAMP5,12646,plasma membrane,GO:0005886,cellular component,8.0,67.0,5.386e-02,3.874e-02,7.488e-02,2.362e-02,1.780e-02,3.133e-02,8.419e-01,7.185e-03
VAMP5,12646,cell surface,GO:0009986,cellular component,8.0,20.0,5.386e-02,3.874e-02,7.488e-02,3.781e-02,2.093e-02,6.828e-02,7.910e-01,1.602e-02
VAMP5,12646,extracellular exosome,GO:0070062,cellular component,8.0,39.0,5.810e-02,4.435e-02,7.613e-02,4.414e-02,3.669e-02,5.309e-02,7.741e-01,4.992e-03
VAMP5,12646,protein binding,GO:0005515,molecular function,8.0,318.0,6.661e-02,4.993e-02,8.887e-02,6.661e-02,4.993e-02,8.887e-02,7.252e-01,8.626e-03
VCAM1,12663,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007157,biological process,37.0,3.0,3.455e-02,1.736e-02,6.875e-02,8.587e-03,4.255e-03,1.733e-02,9.214e-01,7.931e-03
VCAM1,12663,heterotypic cell-cell adhesion,GO:0034113,biological process,37.0,8.0,3.455e-02,1.736e-02,6.875e-02,7.618e-03,1.239e-03,4.682e-02,9.169e-01,2.420e-02
VCAM1,12663,cell-cell adhesion in response to extracellular stimulus,GO:0140039,biological process,37.0,2.0,3.780e-02,2.574e-02,5.551e-02,1.139e-02,7.849e-03,1.654e-02,9.058e-01,5.644e-03
VCAM1,12663,leukocyte cell-cell adhesion,GO:0007159,biological process,37.0,7.0,3.808e-02,2.658e-02,5.455e-02,1.496e-02,9.377e-03,2.386e-02,8.850e-01,9.907e-03
VCAM1,12663,cell-matrix adhesion,GO:0007160,biological process,37.0,11.0,3.808e-02,2.658e-02,5.455e-02,1.711e-02,1.086e-02,2.696e-02,8.730e-01,9.697e-03
VCAM1,12663,calcium-mediated signaling using intracellular calcium source,GO:0035584,biological process,37.0,2.0,3.989e-02,2.562e-02,6.209e-02,1.809e-02,7.318e-03,4.471e-02,8.661e-01,2.128e-02
VCAM1,12663,leukocyte tethering or rolling,GO:0050901,biological process,37.0,2.0,4.215e-02,3.986e-02,4.457e-02,2.111e-02,1.755e-02,2.540e-02,8.535e-01,4.580e-03
VCAM1,12663,amine metabolic process,GO:0009308,biological process,37.0,10.0,4.914e-02,3.689e-02,6.546e-02,2.988e-02,1.107e-02,8.065e-02,8.157e-01,2.521e-02
VCAM1,12663,membrane to membrane docking,GO:0022614,biological process,37.0,2.0,4.927e-02,2.938e-02,8.264e-02,3.128e-02,9.644e-03,1.014e-01,8.101e-01,3.076e-02
VCAM1,12663,cell adhesion,GO:0007155,biological process,37.0,14.0,5.279e-02,4.650e-02,5.993e-02,4.169e-02,3.014e-02,5.766e-02,7.805e-01,8.818e-03
VCAM1,12663,positive regulation of T cell proliferation,GO:0042102,biological process,37.0,11.0,7.162e-02,4.275e-02,1.200e-01,6.752e-02,3.632e-02,1.255e-01,7.226e-01,1.892e-02
VCAM1,12663,cellular response to amyloid-beta,GO:1904646,biological process,37.0,3.0,9.356e-02,4.833e-02,1.811e-01,9.243e-02,4.631e-02,1.845e-01,6.804e-01,2.366e-02
VCAM1,12663,early endosome,GO:0005769,cellular component,37.0,4.0,3.455e-02,1.736e-02,6.875e-02,4.704e-03,2.358e-03,9.381e-03,9.467e-01,5.267e-03
VCAM1,12663,filopodium,GO:0030175,cellular component,37.0,4.0,3.455e-02,1.736e-02,6.875e-02,8.982e-03,3.045e-03,2.649e-02,9.152e-01,1.526e-02
VCAM1,12663,microvillus,GO:0005902,cellular component,37.0,5.0,3.455e-02,1.736e-02,6.875e-02,1.301e-02,3.211e-03,5.274e-02,8.873e-01,2.222e-02
VCAM1,12663,cell surface,GO:0009986,cellular component,37.0,20.0,3.780e-02,2.574e-02,5.551e-02,1.645e-02,6.711e-03,4.031e-02,8.736e-01,1.755e-02
VCAM1,12663,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,GO:0071065,cellular component,37.0,2.0,4.570e-02,4.153e-02,5.030e-02,2.312e-02,1.091e-02,4.900e-02,8.428e-01,1.797e-02
VCAM1,12663,external side of plasma membrane,GO:0009897,cellular component,37.0,16.0,4.629e-02,3.724e-02,5.753e-02,2.696e-02,1.262e-02,5.759e-02,8.272e-01,1.927e-02
VCAM1,12663,extracellular exosome,GO:0070062,cellular component,37.0,39.0,4.653e-02,3.746e-02,5.779e-02,2.866e-02,1.838e-02,4.468e-02,8.214e-01,1.124e-02
VCAM1,12663,apical part of cell,GO:0045177,cellular component,37.0,4.0,4.807e-02,4.219e-02,5.479e-02,3.121e-02,2.462e-02,3.957e-02,8.124e-01,6.108e-03
VCAM1,12663,integral component of plasma membrane,GO:0005887,cellular component,37.0,39.0,4.852e-02,3.538e-02,6.654e-02,2.918e-02,7.875e-03,1.081e-01,8.165e-01,3.249e-02
VCAM1,12663,podosome,GO:0002102,cellular component,37.0,2.0,5.383e-02,4.004e-02,7.237e-02,4.163e-02,1.949e-02,8.893e-02,7.798e-01,2.025e-02
VCAM1,12663,extracellular space,GO:0005615,cellular component,37.0,24.0,5.833e-02,5.477e-02,6.212e-02,4.927e-02,4.438e-02,5.469e-02,7.616e-01,2.959e-03
VCAM1,12663,endoplasmic reticulum,GO:0005783,cellular component,37.0,16.0,6.282e-02,5.255e-02,7.511e-02,5.904e-02,4.767e-02,7.313e-02,7.401e-01,6.091e-03
VCAM1,12663,Golgi apparatus,GO:0005794,cellular component,37.0,16.0,6.579e-02,4.544e-02,9.526e-02,5.749e-02,3.315e-02,9.971e-02,7.425e-01,1.612e-02
VCAM1,12663,cell adhesion molecule binding,GO:0050839,molecular function,37.0,6.0,2.776e-02,6.649e-03,1.159e-01,1.433e-03,1.715e-04,1.198e-02,9.709e-01,7.164e-03
VCAM1,12663,primary amine oxidase activity,GO:0008131,molecular function,37.0,2.0,4.272e-02,1.498e-02,1.218e-01,2.047e-02,1.528e-03,2.743e-01,8.326e-01,4.742e-02
VCAM1,12663,integrin binding,GO:0005178,molecular function,37.0,11.0,4.326e-02,3.942e-02,4.747e-02,2.179e-02,1.792e-02,2.650e-02,8.501e-01,4.812e-03
VTN,12724,smooth muscle cell-matrix adhesion,GO:0061302,biological process,24.0,2.0,4.118e-02,2.017e-02,8.409e-02,5.658e-03,1.335e-03,2.398e-02,9.350e-01,1.578e-02
VTN,12724,cell-matrix adhesion,GO:0007160,biological process,24.0,11.0,4.118e-02,2.017e-02,8.409e-02,6.778e-03,2.898e-03,1.585e-02,9.315e-01,9.597e-03
VTN,12724,positive regulation of peptidyl-tyrosine phosphorylation,GO:0050731,biological process,24.0,11.0,4.118e-02,2.017e-02,8.409e-02,8.405e-03,6.192e-03,1.141e-02,9.235e-01,3.543e-03
VTN,12724,positive regulation of smooth muscle cell migration,GO:0014911,biological process,24.0,7.0,4.320e-02,2.023e-02,9.228e-02,2.340e-02,6.915e-03,7.917e-02,8.392e-01,2.899e-02
VTN,12724,negative regulation of endopeptidase activity,GO:0010951,biological process,24.0,7.0,4.353e-02,2.069e-02,9.155e-02,2.591e-02,1.536e-02,4.371e-02,8.319e-01,1.314e-02
VTN,12724,endodermal cell differentiation,GO:0035987,biological process,24.0,3.0,4.424e-02,2.126e-02,9.205e-02,2.345e-02,1.170e-02,4.700e-02,8.415e-01,1.673e-02
VTN,12724,positive regulation of receptor-mediated endocytosis,GO:0048260,biological process,24.0,7.0,4.775e-02,1.596e-02,1.429e-01,2.093e-02,3.125e-03,1.401e-01,8.451e-01,4.611e-02
VTN,12724,cell adhesion mediated by integrin,GO:0033627,biological process,24.0,3.0,4.775e-02,1.596e-02,1.429e-01,2.296e-02,3.687e-03,1.429e-01,8.378e-01,4.627e-02
VTN,12724,positive regulation of protein binding,GO:0032092,biological process,24.0,13.0,4.971e-02,1.450e-02,1.704e-01,3.178e-02,5.227e-03,1.932e-01,8.048e-01,4.954e-02
VTN,12724,cell migration,GO:0016477,biological process,24.0,41.0,5.483e-02,1.194e-02,2.519e-01,4.311e-02,6.249e-03,2.974e-01,7.678e-01,5.761e-02
VTN,12724,collagen-containing extracellular matrix,GO:0062023,cellular component,24.0,20.0,4.118e-02,2.017e-02,8.409e-02,7.237e-03,1.562e-03,3.352e-02,9.225e-01,1.941e-02
VTN,12724,extracellular region,GO:0005576,cellular component,24.0,16.0,4.320e-02,2.023e-02,9.228e-02,2.244e-02,1.159e-02,4.345e-02,8.462e-01,1.593e-02
VTN,12724,extracellular space,GO:0005615,cellular component,24.0,24.0,4.353e-02,2.069e-02,9.155e-02,2.725e-02,1.342e-02,5.533e-02,8.262e-01,1.816e-02
VTN,12724,endoplasmic reticulum,GO:0005783,cellular component,24.0,16.0,4.566e-02,2.278e-02,9.151e-02,3.200e-02,1.851e-02,5.532e-02,8.093e-01,1.408e-02
VTN,12724,extracellular exosome,GO:0070062,cellular component,24.0,39.0,4.667e-02,2.510e-02,8.679e-02,3.451e-02,2.470e-02,4.822e-02,8.014e-01,8.826e-03
VTN,12724,blood microparticle,GO:0072562,cellular component,24.0,4.0,5.669e-02,1.384e-02,2.322e-01,4.666e-02,8.465e-03,2.572e-01,7.610e-01,5.013e-02
VTN,12724,intracellular membrane-bounded organelle,GO:0043231,cellular component,24.0,40.0,5.729e-02,1.922e-02,1.708e-01,5.029e-02,1.680e-02,1.506e-01,7.567e-01,3.101e-02
VTN,12724,integrin binding,GO:0005178,molecular function,24.0,11.0,4.313e-02,2.283e-02,8.147e-02,2.238e-02,1.155e-02,4.337e-02,8.465e-01,1.596e-02
VTN,12724,protein binding,GO:0005515,molecular function,24.0,318.0,1.061e-01,7.184e-02,1.566e-01,9.802e-02,5.880e-02,1.634e-01,6.733e-01,1.784e-02
WDR86,28020,,,,nan,nan,,,,,,,,
XAF1,30932,response to interferon-beta,GO:0035456,biological process,5.0,3.0,1.670e-02,7.850e-03,3.555e-02,7.028e-03,1.801e-03,2.743e-02,9.261e-01,1.578e-02
XAF1,30932,mitochondrion,GO:0005739,cellular component,5.0,12.0,1.738e-02,9.086e-03,3.323e-02,1.136e-02,6.142e-03,2.100e-02,9.049e-01,9.128e-03
XAF1,30932,nucleoplasm,GO:0005654,cellular component,5.0,47.0,2.144e-02,1.035e-02,4.444e-02,2.144e-02,1.035e-02,4.444e-02,8.505e-01,1.747e-02
XCR1,1625,chemotaxis,GO:0006935,biological process,12.0,16.0,1.496e-02,3.793e-03,5.900e-02,3.044e-03,2.715e-04,3.414e-02,9.515e-01,1.385e-02
XCR1,1625,immune response,GO:0006955,biological process,12.0,17.0,2.540e-02,1.291e-02,4.999e-02,1.406e-02,4.582e-03,4.313e-02,8.852e-01,2.358e-02
XCR1,1625,positive regulation of cytosolic calcium ion concentration,GO:0007204,biological process,12.0,12.0,2.885e-02,1.201e-02,6.932e-02,1.828e-02,4.893e-03,6.828e-02,8.599e-01,2.604e-02
XCR1,1625,cell chemotaxis,GO:0060326,biological process,12.0,22.0,3.456e-02,2.152e-02,5.550e-02,2.313e-02,5.745e-03,9.314e-02,8.383e-01,3.086e-02
XCR1,1625,calcium-mediated signaling,GO:0019722,biological process,12.0,15.0,4.001e-02,1.727e-02,9.270e-02,3.847e-02,1.512e-02,9.786e-02,7.882e-01,2.534e-02
XCR1,1625,external side of plasma membrane,GO:0009897,cellular component,12.0,16.0,2.333e-02,1.413e-02,3.854e-02,1.063e-02,7.601e-03,1.487e-02,9.103e-01,4.697e-03
XCR1,1625,chemokine binding,GO:0019956,molecular function,12.0,7.0,2.333e-02,1.413e-02,3.854e-02,1.025e-02,6.340e-03,1.657e-02,9.121e-01,6.593e-03
XCR1,1625,C-C chemokine binding,GO:0019957,molecular function,12.0,10.0,2.387e-02,1.378e-02,4.135e-02,1.132e-02,3.838e-03,3.338e-02,9.009e-01,1.551e-02
XCR1,1625,C-C chemokine receptor activity,GO:0016493,molecular function,12.0,8.0,3.709e-02,1.805e-02,7.618e-02,3.251e-02,1.406e-02,7.515e-02,8.073e-01,2.186e-02
